activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	1516928	CHEMBL830740	Selectivity for EPH receptor B4 by scintillation proximity assay	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccn4)c3)o2)c1		CHEMBL194176	=	Selectivity	uM	0.66	CHEMBL5147	Homo sapiens	Selectivity	uM	0.66
	1516928	CHEMBL830740	Selectivity for EPH receptor B4 by scintillation proximity assay	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccn4)c3)o2)c1		CHEMBL194176	=	Selectivity	uM	0.66	CHEMBL5147	Homo sapiens	Selectivity	uM	0.66
Not Determined	1517062	CHEMBL830756	Selectivity for EPH receptor B4 by scintillation proximity assay; No data	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474		Selectivity			CHEMBL5147	Homo sapiens	Selectivity	uM	
Not Determined	1517177	CHEMBL830756	Selectivity for EPH receptor B4 by scintillation proximity assay; No data	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4Cl)c3)o2)c1		CHEMBL191993		Selectivity			CHEMBL5147	Homo sapiens	Selectivity	uM	
Not Active	1650504	CHEMBL860636	Average Binding Constant for EPHB4; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL5147	Homo sapiens	Kd		
	1650505	CHEMBL860636	Average Binding Constant for EPHB4; NA=Not Active at 10 uM	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	=	Kd	nM	1300.0	CHEMBL5147	Homo sapiens	Kd	uM	1.3
Not Active	1650506	CHEMBL860636	Average Binding Constant for EPHB4; NA=Not Active at 10 uM	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253		Kd			CHEMBL5147	Homo sapiens	Kd		
	1650507	CHEMBL860636	Average Binding Constant for EPHB4; NA=Not Active at 10 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	2200.0	CHEMBL5147	Homo sapiens	Kd	uM	2.2
Not Active	1650508	CHEMBL860636	Average Binding Constant for EPHB4; NA=Not Active at 10 uM	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660		Kd			CHEMBL5147	Homo sapiens	Kd		
Not Active	1650509	CHEMBL860636	Average Binding Constant for EPHB4; NA=Not Active at 10 uM	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829		Kd			CHEMBL5147	Homo sapiens	Kd		
	1650510	CHEMBL860636	Average Binding Constant for EPHB4; NA=Not Active at 10 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	3900.0	CHEMBL5147	Homo sapiens	Kd	uM	3.9
Not Active	1650511	CHEMBL860636	Average Binding Constant for EPHB4; NA=Not Active at 10 uM	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762		Kd			CHEMBL5147	Homo sapiens	Kd		
Not Active	1650512	CHEMBL860636	Average Binding Constant for EPHB4; NA=Not Active at 10 uM	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690		Kd			CHEMBL5147	Homo sapiens	Kd		
Not Active	1651093	CHEMBL860636	Average Binding Constant for EPHB4; NA=Not Active at 10 uM	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978		Kd			CHEMBL5147	Homo sapiens	Kd		
Not Active	1651094	CHEMBL860636	Average Binding Constant for EPHB4; NA=Not Active at 10 uM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041		Kd			CHEMBL5147	Homo sapiens	Kd		
Not Active	1651095	CHEMBL860636	Average Binding Constant for EPHB4; NA=Not Active at 10 uM	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10		Kd			CHEMBL5147	Homo sapiens	Kd		
	1651096	CHEMBL860636	Average Binding Constant for EPHB4; NA=Not Active at 10 uM	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	=	Kd	nM	1000.0	CHEMBL5147	Homo sapiens	Kd	uM	1.0
Not Active	1651097	CHEMBL860636	Average Binding Constant for EPHB4; NA=Not Active at 10 uM	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667		Kd			CHEMBL5147	Homo sapiens	Kd		
Not Active	1651098	CHEMBL860636	Average Binding Constant for EPHB4; NA=Not Active at 10 uM	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279		Kd			CHEMBL5147	Homo sapiens	Kd		
Not Active	1651099	CHEMBL860636	Average Binding Constant for EPHB4; NA=Not Active at 10 uM	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941		Kd			CHEMBL5147	Homo sapiens	Kd		
Not Active	1651100	CHEMBL860636	Average Binding Constant for EPHB4; NA=Not Active at 10 uM	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939		Kd			CHEMBL5147	Homo sapiens	Kd		
Not Active	1651101	CHEMBL860636	Average Binding Constant for EPHB4; NA=Not Active at 10 uM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553		Kd			CHEMBL5147	Homo sapiens	Kd		
	1651102	CHEMBL860636	Average Binding Constant for EPHB4; NA=Not Active at 10 uM	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	2600.0	CHEMBL5147	Homo sapiens	Kd	uM	2.6
	1651103	CHEMBL860636	Average Binding Constant for EPHB4; NA=Not Active at 10 uM	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	5000.0	CHEMBL5147	Homo sapiens	Kd	uM	5.0
	1697680	CHEMBL866551	Protective index against EphB4 at 10 uM by HTRF method	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2ccc(Cl)cc2)o1		CHEMBL203056	<	Activity	%	30.0	CHEMBL5147	Homo sapiens	Activity	%	30.0
	1697844	CHEMBL866551	Protective index against EphB4 at 10 uM by HTRF method	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2ccc(Cc3ccccc3)cc2)o1		CHEMBL383126	<	Activity	%	30.0	CHEMBL5147	Homo sapiens	Activity	%	30.0
	1697845	CHEMBL866551	Protective index against EphB4 at 10 uM by HTRF method	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2ccc(Oc3ccccc3)cc2)o1		CHEMBL206267	<	Activity	%	30.0	CHEMBL5147	Homo sapiens	Activity	%	30.0
	1697846	CHEMBL866551	Protective index against EphB4 at 10 uM by HTRF method	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2ccc(-c3ccccc3)cc2)o1		CHEMBL205464	<	Activity	%	30.0	CHEMBL5147	Homo sapiens	Activity	%	30.0
	1697847	CHEMBL866551	Protective index against EphB4 at 10 uM by HTRF method	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2ccc(Br)cc2)o1		CHEMBL205463	<	Activity	%	30.0	CHEMBL5147	Homo sapiens	Activity	%	30.0
	1697848	CHEMBL866551	Protective index against EphB4 at 10 uM by HTRF method	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(NCc2ccc3c(c2)OCO3)o1		CHEMBL202892	<	Activity	%	30.0	CHEMBL5147	Homo sapiens	Activity	%	30.0
	1697849	CHEMBL866551	Protective index against EphB4 at 10 uM by HTRF method	B	Cc1ccc(Nc2nnc(-c3c(NCc4ccncc4)ncn3C)o2)c(F)c1		CHEMBL379908	<	Activity	%	30.0	CHEMBL5147	Homo sapiens	Activity	%	30.0
	1697850	CHEMBL866551	Protective index against EphB4 at 10 uM by HTRF method	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2ccc(Cl)c(C(F)(F)F)c2)o1		CHEMBL205127	<	Activity	%	30.0	CHEMBL5147	Homo sapiens	Activity	%	30.0
	1697851	CHEMBL866551	Protective index against EphB4 at 10 uM by HTRF method	B	COc1ccc(Nc2nnc(-c3c(NCc4ccncc4)ncn3C)o2)cc1OC		CHEMBL378592	<	Activity	%	30.0	CHEMBL5147	Homo sapiens	Activity	%	30.0
	1697852	CHEMBL866551	Protective index against EphB4 at 10 uM by HTRF method	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2ccc(Cl)c(Cl)c2)o1		CHEMBL204874	<	Activity	%	30.0	CHEMBL5147	Homo sapiens	Activity	%	30.0
	1697853	CHEMBL866551	Protective index against EphB4 at 10 uM by HTRF method	B	Cc1ccccc1Nc1nnc(-c2c(NCc3ccncc3)ncn2C)o1		CHEMBL379239	<	Activity	%	30.0	CHEMBL5147	Homo sapiens	Activity	%	30.0
	1697854	CHEMBL866551	Protective index against EphB4 at 10 uM by HTRF method	B	COc1ccccc1Nc1nnc(-c2c(NCc3ccncc3)ncn2C)o1		CHEMBL204312	<	Activity	%	30.0	CHEMBL5147	Homo sapiens	Activity	%	30.0
	1697855	CHEMBL866551	Protective index against EphB4 at 10 uM by HTRF method	B	COc1cccc(Nc2nnc(-c3c(NCc4ccncc4)ncn3C)o2)c1		CHEMBL203796	<	Activity	%	30.0	CHEMBL5147	Homo sapiens	Activity	%	30.0
	1697856	CHEMBL866551	Protective index against EphB4 at 10 uM by HTRF method	B	Cc1cccc(Nc2nnc(-c3c(NCc4ccncc4)ncn3C)o2)c1		CHEMBL203789	<	Activity	%	30.0	CHEMBL5147	Homo sapiens	Activity	%	30.0
	1697857	CHEMBL866551	Protective index against EphB4 at 10 uM by HTRF method	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2cccc(OC(F)(F)F)c2)o1		CHEMBL206538	<	Activity	%	30.0	CHEMBL5147	Homo sapiens	Activity	%	30.0
	1697858	CHEMBL866551	Protective index against EphB4 at 10 uM by HTRF method	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2ccc(C(F)(F)F)cc2)o1		CHEMBL380131	<	Activity	%	30.0	CHEMBL5147	Homo sapiens	Activity	%	30.0
	1697859	CHEMBL866551	Protective index against EphB4 at 10 uM by HTRF method	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2ccc(OC(F)(F)F)cc2)o1		CHEMBL383255	<	Activity	%	30.0	CHEMBL5147	Homo sapiens	Activity	%	30.0
	1697860	CHEMBL866551	Protective index against EphB4 at 10 uM by HTRF method	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2ccc(OC(F)(F)Cl)cc2)o1		CHEMBL205884	<	Activity	%	30.0	CHEMBL5147	Homo sapiens	Activity	%	30.0
	1697861	CHEMBL866551	Protective index against EphB4 at 10 uM by HTRF method	B	CC(C)c1ccc(Nc2nnc(-c3c(NCc4ccncc4)ncn3C)o2)cc1		CHEMBL203119	<	Activity	%	30.0	CHEMBL5147	Homo sapiens	Activity	%	30.0
	1697862	CHEMBL866551	Protective index against EphB4 at 10 uM by HTRF method	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2ccc(C(C)(C)C)cc2)o1		CHEMBL203731	<	Activity	%	30.0	CHEMBL5147	Homo sapiens	Activity	%	30.0
	1697863	CHEMBL866551	Protective index against EphB4 at 10 uM by HTRF method	B	Cn1cnc(NCc2cccc3ncccc23)c1-c1nnc(Nc2ccc(Cl)cc2)o1		CHEMBL378165	<	Activity	%	30.0	CHEMBL5147	Homo sapiens	Activity	%	30.0
	1697864	CHEMBL866551	Protective index against EphB4 at 10 uM by HTRF method	B	Cn1cnc(NCc2ccc3ccccc3n2)c1-c1nnc(Nc2ccc(Cl)cc2)o1		CHEMBL204718	<	Activity	%	30.0	CHEMBL5147	Homo sapiens	Activity	%	30.0
	1697865	CHEMBL866551	Protective index against EphB4 at 10 uM by HTRF method	B	Cn1cnc(NCc2ccc3[nH]ncc3c2)c1-c1nnc(Nc2ccc(Cl)cc2)o1		CHEMBL206118	<	Activity	%	30.0	CHEMBL5147	Homo sapiens	Activity	%	30.0
	1697866	CHEMBL866551	Protective index against EphB4 at 10 uM by HTRF method	B	Cn1cnc(NCc2ccc(F)c(F)c2)c1-c1nnc(Nc2ccc(Cl)cc2)o1		CHEMBL203394	<	Activity	%	30.0	CHEMBL5147	Homo sapiens	Activity	%	30.0
	1697867	CHEMBL866551	Protective index against EphB4 at 10 uM by HTRF method	B	Cn1cnc(NCCc2ccc3c(c2)OCO3)c1-c1nnc(Nc2ccc(Cl)cc2)o1		CHEMBL382672	<	Activity	%	30.0	CHEMBL5147	Homo sapiens	Activity	%	30.0
	1697868	CHEMBL866551	Protective index against EphB4 at 10 uM by HTRF method	B	Cn1cnc(NCc2ccccn2)c1-c1nnc(Nc2ccc(Cl)cc2)o1		CHEMBL202904	<	Activity	%	30.0	CHEMBL5147	Homo sapiens	Activity	%	30.0
	1697869	CHEMBL866551	Protective index against EphB4 at 10 uM by HTRF method	B	Cn1cnc(NCc2cccnc2)c1-c1nnc(Nc2ccc(Cl)cc2)o1		CHEMBL206742	<	Activity	%	30.0	CHEMBL5147	Homo sapiens	Activity	%	30.0
	1707907	CHEMBL866855	Inhibition of EPHB4 at 10 uM in presence of 0.1 uM ATP	B	O=C1Nc2ccccc2C(=O)[C@@H]2[C@@H](c3cccc(Cl)c3)C[C@](O)(c3ccccc3)[C@@H]12		CHEMBL382654	>	Inhibition	%	50.0	CHEMBL5147	Homo sapiens	Inhibition	%	50.0
	1790447	CHEMBL912735	Inhibition of human EPHB4	B	COc1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL201511	=	IC50	nM	16000.0	CHEMBL5147	Homo sapiens	IC50	M	0.000016
	1807178	CHEMBL908995	Inhibition of EphB4	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(OCCN4CCCC4)cc3)nnc2c1		CHEMBL436137	=	IC50	nM	64.0	CHEMBL5147	Homo sapiens	IC50	uM	0.064
	1815196	CHEMBL908515	Inhibition of EPHB4	B	CNc1ncnc(-c2cccnc2Oc2ccc(F)c(C(=O)Nc3cc(C(F)(F)F)ccc3N(C)CCCN(C)C)c2)n1		CHEMBL373882	=	IC50	nM	8300.0	CHEMBL5147	Homo sapiens	IC50	nM	8300.0
	1815237	CHEMBL908515	Inhibition of EPHB4	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1Nc1ncccc1-c1ccncn1		CHEMBL385956	<	IC50	nM	25.0	CHEMBL5147	Homo sapiens	IC50	nM	25.0
	1815351	CHEMBL910184	Inhibition of EpHB4	B	CN(C)[C@H]1CCCN(c2ccc(C(F)(F)F)cc2NC(=O)c2cc(C#Cc3cnc(N)nc3)ccc2F)C1		CHEMBL386637	=	IC50	nM	290.0	CHEMBL5147	Homo sapiens	IC50	nM	290.0
	1891430	CHEMBL905854	Inhibition of EphB4	B	Cc1cc(-c2c(Cl)cccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL230686	=	Ki	nM	63.8	CHEMBL5147	Homo sapiens	Ki	nM	63.8
	1996180	CHEMBL898756	Inhibition of EphB4 at 10 uM	B	CSc1nc(Nc2cccc(Cl)c2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL400211	<	Inhibition	%	30.0	CHEMBL5147	Homo sapiens	Inhibition	%	30.0
	2000754	CHEMBL900483	Inhibition of EphB4 at 10 nM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCF)CC2)n1		CHEMBL240158	=	Inhibition	%	97.0	CHEMBL5147	Homo sapiens	Inhibition	%	97.0
	2000793	CHEMBL900483	Inhibition of EphB4 at 10 nM	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Inhibition	%	94.1	CHEMBL5147	Homo sapiens	Inhibition	%	94.1
	2011558	CHEMBL902105	Inhibition of human EphB4 by scintillation proximity method	B	COc1cc(-c2cnc(N)c3c(Br)csc23)cc(OC)c1OC		CHEMBL247696	>	IC50	nM	25000.0	CHEMBL5147	Homo sapiens	IC50	nM	25000.0
	2011559	CHEMBL902105	Inhibition of human EphB4 by scintillation proximity method	B	COc1ccc(-c2csc3c(-c4cc(OC)c(OC)c(OC)c4)cnc(N)c23)cc1		CHEMBL396912	=	IC50	nM	7100.0	CHEMBL5147	Homo sapiens	IC50	nM	7100.0
	2011560	CHEMBL902105	Inhibition of human EphB4 by scintillation proximity method	B	COc1cc(-c2cnc(N)c3c(-c4cccc(Cl)c4Cl)csc23)cc(OC)c1OC		CHEMBL245636	=	IC50	nM	230.0	CHEMBL5147	Homo sapiens	IC50	nM	230.0
	2011561	CHEMBL902105	Inhibition of human EphB4 by scintillation proximity method	B	COc1cc(-c2cnc(N)c3c(-c4ccc(S(C)(=O)=O)cc4)csc23)cc(OC)c1OC		CHEMBL394638	>	IC50	nM	23000.0	CHEMBL5147	Homo sapiens	IC50	nM	23000.0
	2011562	CHEMBL902105	Inhibition of human EphB4 by scintillation proximity method	B	COc1cc(-c2cnc(N)c3c(-c4cccnc4)csc23)cc(OC)c1OC		CHEMBL394384	=	IC50	nM	3900.0	CHEMBL5147	Homo sapiens	IC50	nM	3900.0
	2011563	CHEMBL902105	Inhibition of human EphB4 by scintillation proximity method	B	COc1cc(-c2cnc(N)c3c(-c4ccc(C(C)=O)cc4)csc23)cc(OC)c1OC		CHEMBL394383	>	IC50	nM	25000.0	CHEMBL5147	Homo sapiens	IC50	nM	25000.0
	2011564	CHEMBL902105	Inhibition of human EphB4 by scintillation proximity method	B	COc1cc(-c2cnc(N)c3c(-c4cccc(CC(N)=O)c4)csc23)cc(OC)c1OC		CHEMBL248306	>	IC50	nM	25000.0	CHEMBL5147	Homo sapiens	IC50	nM	25000.0
	2011565	CHEMBL902105	Inhibition of human EphB4 by scintillation proximity method	B	COc1cc(-c2cnc(N)c3c(-c4ccc(F)c(Cl)c4)csc23)cc(OC)c1OC		CHEMBL248304	=	IC50	nM	110.0	CHEMBL5147	Homo sapiens	IC50	nM	110.0
	2011566	CHEMBL902105	Inhibition of human EphB4 by scintillation proximity method	B	COc1cc(-c2cnc(N)c3c(-c4ccc(Cl)cc4)csc23)cc(OC)c1OC		CHEMBL248100	=	IC50	nM	190.0	CHEMBL5147	Homo sapiens	IC50	nM	190.0
	2011567	CHEMBL902105	Inhibition of human EphB4 by scintillation proximity method	B	COc1cc(-c2cnc(N)c3c(-c4ccc5ccccc5c4)csc23)cc(OC)c1OC		CHEMBL396913	=	IC50	nM	2200.0	CHEMBL5147	Homo sapiens	IC50	nM	2200.0
	2011568	CHEMBL902105	Inhibition of human EphB4 by scintillation proximity method	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	IC50	nM	21.0	CHEMBL5147	Homo sapiens	IC50	nM	21.0
	2011569	CHEMBL902105	Inhibition of human EphB4 by scintillation proximity method	B	CS(=O)(=O)c1cccc(-c2cnc(N)c3c(-c4ccc(F)c(Cl)c4)csc23)c1		CHEMBL391691	=	IC50	nM	59.0	CHEMBL5147	Homo sapiens	IC50	nM	59.0
	2011570	CHEMBL902105	Inhibition of human EphB4 by scintillation proximity method	B	Nc1ncc(-c2cccnc2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241516	=	IC50	nM	51.0	CHEMBL5147	Homo sapiens	IC50	nM	51.0
	2011571	CHEMBL902105	Inhibition of human EphB4 by scintillation proximity method	B	NC(=O)Cc1cccc(-c2cnc(N)c3c(-c4ccc(F)c(Cl)c4)csc23)c1		CHEMBL239182	=	IC50	nM	44.0	CHEMBL5147	Homo sapiens	IC50	nM	44.0
	2011572	CHEMBL902105	Inhibition of human EphB4 by scintillation proximity method	B	Nc1ncc(Br)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL239180	=	IC50	nM	575.0	CHEMBL5147	Homo sapiens	IC50	nM	575.0
	2011573	CHEMBL902105	Inhibition of human EphB4 by scintillation proximity method	B	Nc1nccc2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL396585	=	IC50	nM	1350.0	CHEMBL5147	Homo sapiens	IC50	nM	1350.0
	2011574	CHEMBL902105	Inhibition of human EphB4 by scintillation proximity method	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL241682	=	IC50	nM	0.4	CHEMBL5147	Homo sapiens	IC50	nM	0.4
	2011575	CHEMBL902105	Inhibition of human EphB4 by scintillation proximity method	B	Nc1ncc(-c2cccc(Cl)c2)c2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL391692	=	IC50	nM	389.0	CHEMBL5147	Homo sapiens	IC50	nM	389.0
	2011576	CHEMBL902105	Inhibition of human EphB4 by scintillation proximity method	B	Nc1ncc(-c2ccccc2)c2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL241681	=	IC50	nM	14.0	CHEMBL5147	Homo sapiens	IC50	nM	14.0
Not Determined	2011577	CHEMBL902106	Inhibition of autophosphorylation of chimeric cfms-EphB4 receptor expressed in NIH3T3 cells by ELISA	B	Nc1nccc2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL396585		IC50			CHEMBL5147	Homo sapiens	IC50		
Not Determined	2011578	CHEMBL902106	Inhibition of autophosphorylation of chimeric cfms-EphB4 receptor expressed in NIH3T3 cells by ELISA	B	Nc1ncc(Br)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL239180		IC50			CHEMBL5147	Homo sapiens	IC50		
	2011579	CHEMBL902106	Inhibition of autophosphorylation of chimeric cfms-EphB4 receptor expressed in NIH3T3 cells by ELISA	B	NC(=O)Cc1cccc(-c2cnc(N)c3c(-c4ccc(F)c(Cl)c4)csc23)c1		CHEMBL239182	=	IC50	nM	20.0	CHEMBL5147	Homo sapiens	IC50	nM	20.0
	2011580	CHEMBL902106	Inhibition of autophosphorylation of chimeric cfms-EphB4 receptor expressed in NIH3T3 cells by ELISA	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	IC50	nM	19.0	CHEMBL5147	Homo sapiens	IC50	nM	19.0
	2011581	CHEMBL902106	Inhibition of autophosphorylation of chimeric cfms-EphB4 receptor expressed in NIH3T3 cells by ELISA	B	CS(=O)(=O)c1cccc(-c2cnc(N)c3c(-c4ccc(F)c(Cl)c4)csc23)c1		CHEMBL391691	=	IC50	nM	18.0	CHEMBL5147	Homo sapiens	IC50	nM	18.0
	2011582	CHEMBL902106	Inhibition of autophosphorylation of chimeric cfms-EphB4 receptor expressed in NIH3T3 cells by ELISA	B	Nc1ncc(-c2cccnc2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241516	=	IC50	nM	29.0	CHEMBL5147	Homo sapiens	IC50	nM	29.0
	2025138	CHEMBL886965	Inhibition of human EphB4 at 1 uM relative to control	B	CN(C)c1cc2cc(n1)CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CCC2		CHEMBL247067	=	Inhibition	%	103.0	CHEMBL5147	Homo sapiens	Inhibition	%	103.0
	2025306	CHEMBL886965	Inhibition of human EphB4 at 1 uM relative to control	B	CN(C)c1nc2ccc1CCCn1cc(c3ccccc31)C1=C(C(=O)NC1=O)c1cn(c3ccccc13)CC2		CHEMBL1162963	=	Inhibition	%	89.0	CHEMBL5147	Homo sapiens	Inhibition	%	89.0
	2025307	CHEMBL886965	Inhibition of human EphB4 at 1 uM relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1ccc(c(N3CCCC3)n1)CCCn1cc2c2ccccc21		CHEMBL396327	=	Inhibition	%	100.0	CHEMBL5147	Homo sapiens	Inhibition	%	100.0
	2025308	CHEMBL886965	Inhibition of human EphB4 at 1 uM relative to control	B	O=C1NC(=O)C2=C1c1cn(c3ccccc13)CCCc1cc(nc(N3CCCC3)c1)CCCn1cc2c2ccccc21		CHEMBL397771	=	Inhibition	%	109.0	CHEMBL5147	Homo sapiens	Inhibition	%	109.0
	2029829	CHEMBL886296	Inhibition of EphB4 at 10 uM	B	O=C1Cc2cnn(-c3ccccc3)c2-c2ccccc2N1		CHEMBL250583	<=	Inhibition	%	40.0	CHEMBL5147	Homo sapiens	Inhibition	%	40.0
	2029852	CHEMBL886296	Inhibition of EphB4 at 10 uM	B	O=C1Cc2cnn(-c3ccc([N+](=O)[O-])cc3)c2-c2ccccc2N1		CHEMBL400310	<=	Inhibition	%	40.0	CHEMBL5147	Homo sapiens	Inhibition	%	40.0
	2029853	CHEMBL886296	Inhibition of EphB4 at 10 uM	B	O=C1Cc2cnn(-c3ccc(F)cc3F)c2-c2ccccc2N1		CHEMBL248954	<=	Inhibition	%	40.0	CHEMBL5147	Homo sapiens	Inhibition	%	40.0
	2029854	CHEMBL886296	Inhibition of EphB4 at 10 uM	B	O=C1Cc2cnn(-c3ccccc3Br)c2-c2ccccc2N1		CHEMBL400113	<=	Inhibition	%	40.0	CHEMBL5147	Homo sapiens	Inhibition	%	40.0
	2029855	CHEMBL886296	Inhibition of EphB4 at 10 uM	B	O=C1Cc2cnn(-c3ccccc3F)c2-c2ccccc2N1		CHEMBL399076	<=	Inhibition	%	40.0	CHEMBL5147	Homo sapiens	Inhibition	%	40.0
	2029856	CHEMBL886296	Inhibition of EphB4 at 10 uM	B	O=C1Cc2cnn(-c3cccc(Cl)c3)c2-c2ccccc2N1		CHEMBL248760	<=	Inhibition	%	40.0	CHEMBL5147	Homo sapiens	Inhibition	%	40.0
	2029857	CHEMBL886296	Inhibition of EphB4 at 10 uM	B	O=C1Cc2cnn(-c3ccccc3Cl)c2-c2ccccc2N1		CHEMBL248759	<=	Inhibition	%	40.0	CHEMBL5147	Homo sapiens	Inhibition	%	40.0
	2029858	CHEMBL886296	Inhibition of EphB4 at 10 uM	B	CC(C)(C)c1ccc(-n2ncc3c2-c2ccccc2NC(=O)C3)cc1		CHEMBL398877	<=	Inhibition	%	40.0	CHEMBL5147	Homo sapiens	Inhibition	%	40.0
	2029859	CHEMBL886296	Inhibition of EphB4 at 10 uM	B	O=C1Cc2cnn(-c3cc(Cl)cc(Cl)c3)c2-c2ccccc2N1		CHEMBL248758	<=	Inhibition	%	40.0	CHEMBL5147	Homo sapiens	Inhibition	%	40.0
	2029860	CHEMBL886296	Inhibition of EphB4 at 10 uM	B	O=C1Cc2cnn(-c3ccc(C(F)(F)F)cc3)c2-c2ccccc2N1		CHEMBL398876	<=	Inhibition	%	40.0	CHEMBL5147	Homo sapiens	Inhibition	%	40.0
	2029861	CHEMBL886296	Inhibition of EphB4 at 10 uM	B	Cc1ccc(-n2ncc3c2-c2ccccc2NC(=O)C3)cc1		CHEMBL400898	<=	Inhibition	%	40.0	CHEMBL5147	Homo sapiens	Inhibition	%	40.0
	2029862	CHEMBL886296	Inhibition of EphB4 at 10 uM	B	COc1ccc(-n2ncc3c2-c2ccccc2NC(=O)C3)cc1		CHEMBL248558	<=	Inhibition	%	40.0	CHEMBL5147	Homo sapiens	Inhibition	%	40.0
	2029863	CHEMBL886296	Inhibition of EphB4 at 10 uM	B	Cc1ccccc1-n1ncc2c1-c1ccccc1NC(=O)C2		CHEMBL400897	<=	Inhibition	%	40.0	CHEMBL5147	Homo sapiens	Inhibition	%	40.0
	2029864	CHEMBL886296	Inhibition of EphB4 at 10 uM	B	O=C1Cc2cnn(-c3ccc(Cl)cc3)c2-c2ccccc2N1		CHEMBL248557	<=	Inhibition	%	40.0	CHEMBL5147	Homo sapiens	Inhibition	%	40.0
	2029865	CHEMBL886296	Inhibition of EphB4 at 10 uM	B	O=C1Cc2cnn(-c3ccc(Br)cc3)c2-c2ccccc2N1		CHEMBL398288	<=	Inhibition	%	40.0	CHEMBL5147	Homo sapiens	Inhibition	%	40.0
	2050268	CHEMBL925566	Inhibition of EphB4 at 1 uM	B	CC1CCN(c2ccc(CO)cc2NC(=O)c2ccc(C#N)o2)CC1		CHEMBL400754	=	Inhibition	%	-2.0	CHEMBL5147	Homo sapiens	Inhibition	%	-2.0
	2080200	CHEMBL929555	Inhibition of EphB4	B	CCN(CC)CCOc1ccc(Nc2cc(NC(=O)Nc3c(Cl)cccc3Cl)ncn2)cc1		CHEMBL253292	=	IC50	nM	430.0	CHEMBL5147	Homo sapiens	IC50	uM	0.43
	2110632	CHEMBL952110	Inhibition of EphB4 by Panvera FRET-based assay	B	Cn1c(=O)[nH]c(=O)c2c1nc1n(CCCCO)c(-c3ccccc3)cn21		CHEMBL271179	=	IC50	nM	1600.0	CHEMBL5147	Homo sapiens	IC50	uM	1.6
	2110633	CHEMBL952110	Inhibition of EphB4 by Panvera FRET-based assay	B	CC1(C)Cc2c(sc(NC(=O)Nc3ccccc3)c2C(N)=O)CO1		CHEMBL407817	=	IC50	nM	76000.0	CHEMBL5147	Homo sapiens	IC50	uM	76.0
	2110634	CHEMBL952110	Inhibition of EphB4 by Panvera FRET-based assay	B	CCCCn1c(-c2ccccc2)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL271967	=	IC50	nM	1500.0	CHEMBL5147	Homo sapiens	IC50	uM	1.5
	2110635	CHEMBL952111	Inhibition of EphB4 by FRET assay	B	Cn1c(=O)[nH]c(=O)c2c1nc1n(CCCCO)c(-c3ccccc3)cn21		CHEMBL271179	=	IC50	nM	6800.0	CHEMBL5147	Homo sapiens	IC50	uM	6.8
Not Determined	2110636	CHEMBL952111	Inhibition of EphB4 by FRET assay	B	CC1(C)Cc2c(sc(NC(=O)Nc3ccccc3)c2C(N)=O)CO1		CHEMBL407817		IC50			CHEMBL5147	Homo sapiens	IC50		
	2110637	CHEMBL952111	Inhibition of EphB4 by FRET assay	B	CCCCn1c(-c2ccccc2)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL271967	=	IC50	nM	8300.0	CHEMBL5147	Homo sapiens	IC50	uM	8.3
	2147256	CHEMBL921846	Activity of human EphB4 kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	84.0	CHEMBL5147	Homo sapiens	Activity	%	84.0
	2147542	CHEMBL922442	Inhibition of EphB4 by luminescence based kinase assay	B	Cc1cc(-c2c(Cl)cccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL230686	=	Ki	nM	63.8	CHEMBL5147	Homo sapiens	Ki	nM	63.8
	2147547	CHEMBL922442	Inhibition of EphB4 by luminescence based kinase assay	B	Cc1cc(-c2c(Cl)cccc2Cl)cc2nnc(Nc3ccc(OCC[N+]4([O-])CCCC4)cc3)nc12		CHEMBL256101	=	Ki	nM	7.27	CHEMBL5147	Homo sapiens	Ki	nM	7.27
	2167587	CHEMBL932336	Inhibition of EphB4	B	Clc1ccc2c(c1Nc1ccnc(Nc3ccc(N4CCOCC4)cc3)n1)OCO2		CHEMBL255875	=	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	uM	1.0
	2167588	CHEMBL932336	Inhibition of EphB4	B	COc1cc2c(Nc3c(Cl)ccc4c3OCO4)ncnc2cc1OCCCN1CCCCC1		CHEMBL169186	=	IC50	nM	350.0	CHEMBL5147	Homo sapiens	IC50	uM	0.35
	2167589	CHEMBL932336	Inhibition of EphB4	B	COc1cc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)cc(OC)c1OC		CHEMBL256725	=	IC50	nM	240.0	CHEMBL5147	Homo sapiens	IC50	uM	0.24
	2167590	CHEMBL932336	Inhibition of EphB4	B	COc1cc(Nc2cc(Nc3c(Cl)ccc4c3OCO4)ncn2)cc(OC)c1OC		CHEMBL253741	=	IC50	nM	2540.0	CHEMBL5147	Homo sapiens	IC50	uM	2.54
	2167591	CHEMBL932336	Inhibition of EphB4	B	COc1cc(Nc2ncnc(Nc3c(Cl)ccc4c3OCO4)n2)cc(OC)c1OC		CHEMBL403672	=	IC50	nM	2960.0	CHEMBL5147	Homo sapiens	IC50	uM	2.96
	2167592	CHEMBL932336	Inhibition of EphB4	B	COc1ccc(Nc2ncnc(Nc3cc(OC)c(OC)c(OC)c3)n2)cc1Cl		CHEMBL403673	=	IC50	nM	16000.0	CHEMBL5147	Homo sapiens	IC50	uM	16.0
	2167593	CHEMBL932336	Inhibition of EphB4	B	Clc1ccc2c(c1Nc1ccnc(Nc3cccc(N4CCOCC4)c3)n1)OCO2		CHEMBL255874	=	IC50	nM	580.0	CHEMBL5147	Homo sapiens	IC50	uM	0.58
	2167594	CHEMBL932336	Inhibition of EphB4	B	Clc1ccc2c(c1Nc1ccnc(Nc3ccccc3N3CCOCC3)n1)OCO2		CHEMBL257771	=	IC50	nM	7850.0	CHEMBL5147	Homo sapiens	IC50	uM	7.85
	2167595	CHEMBL932336	Inhibition of EphB4	B	CS(=O)(=O)c1ccc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)cc1		CHEMBL258016	=	IC50	nM	630.0	CHEMBL5147	Homo sapiens	IC50	uM	0.63
	2167596	CHEMBL932336	Inhibition of EphB4	B	CS(=O)(=O)c1cccc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)c1		CHEMBL445162	=	IC50	nM	90.0	CHEMBL5147	Homo sapiens	IC50	uM	0.09
	2167597	CHEMBL932336	Inhibition of EphB4	B	CS(=O)(=O)c1ccccc1Nc1nccc(Nc2c(Cl)ccc3c2OCO3)n1		CHEMBL404178	=	IC50	nM	41000.0	CHEMBL5147	Homo sapiens	IC50	uM	41.0
	2167598	CHEMBL932336	Inhibition of EphB4	B	NS(=O)(=O)c1ccc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)cc1		CHEMBL256348	=	IC50	nM	300.0	CHEMBL5147	Homo sapiens	IC50	uM	0.3
	2167599	CHEMBL932336	Inhibition of EphB4	B	NS(=O)(=O)c1cccc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)c1		CHEMBL257553	=	IC50	nM	40.0	CHEMBL5147	Homo sapiens	IC50	uM	0.04
	2167600	CHEMBL932336	Inhibition of EphB4	B	NS(=O)(=O)c1ccccc1Nc1nccc(Nc2c(Cl)ccc3c2OCO3)n1		CHEMBL403614	=	IC50	nM	35500.0	CHEMBL5147	Homo sapiens	IC50	uM	35.5
	2167601	CHEMBL932336	Inhibition of EphB4	B	N#Cc1ccc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)cc1		CHEMBL258435	=	IC50	nM	1250.0	CHEMBL5147	Homo sapiens	IC50	uM	1.25
	2167602	CHEMBL932336	Inhibition of EphB4	B	N#Cc1cccc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)c1		CHEMBL254588	=	IC50	nM	550.0	CHEMBL5147	Homo sapiens	IC50	uM	0.55
	2167603	CHEMBL932336	Inhibition of EphB4	B	N#Cc1ccccc1Nc1nccc(Nc2c(Cl)ccc3c2OCO3)n1		CHEMBL428067	=	IC50	nM	20490.0	CHEMBL5147	Homo sapiens	IC50	uM	20.49
	2167604	CHEMBL932336	Inhibition of EphB4	B	COc1ccc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)cc1		CHEMBL257576	=	IC50	nM	1940.0	CHEMBL5147	Homo sapiens	IC50	uM	1.94
	2167605	CHEMBL932336	Inhibition of EphB4	B	COc1cccc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)c1		CHEMBL402903	=	IC50	nM	640.0	CHEMBL5147	Homo sapiens	IC50	uM	0.64
	2167606	CHEMBL932336	Inhibition of EphB4	B	COc1ccccc1Nc1nccc(Nc2c(Cl)ccc3c2OCO3)n1		CHEMBL253957	=	IC50	nM	3880.0	CHEMBL5147	Homo sapiens	IC50	uM	3.88
	2167607	CHEMBL932336	Inhibition of EphB4	B	Cc1ccc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)cc1		CHEMBL404445	=	IC50	nM	1600.0	CHEMBL5147	Homo sapiens	IC50	uM	1.6
	2167608	CHEMBL932336	Inhibition of EphB4	B	Cc1cccc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)c1		CHEMBL404444	=	IC50	nM	460.0	CHEMBL5147	Homo sapiens	IC50	uM	0.46
	2167609	CHEMBL932336	Inhibition of EphB4	B	Cc1ccccc1Nc1nccc(Nc2c(Cl)ccc3c2OCO3)n1		CHEMBL254157	=	IC50	nM	13960.0	CHEMBL5147	Homo sapiens	IC50	uM	13.96
	2167610	CHEMBL932336	Inhibition of EphB4	B	Clc1ccc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)cc1		CHEMBL255947	=	IC50	nM	6000.0	CHEMBL5147	Homo sapiens	IC50	uM	6.0
	2167611	CHEMBL932336	Inhibition of EphB4	B	Clc1cccc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)c1		CHEMBL401907	=	IC50	nM	1330.0	CHEMBL5147	Homo sapiens	IC50	uM	1.33
	2167612	CHEMBL932336	Inhibition of EphB4	B	Clc1ccccc1Nc1nccc(Nc2c(Cl)ccc3c2OCO3)n1		CHEMBL255949	=	IC50	nM	11320.0	CHEMBL5147	Homo sapiens	IC50	uM	11.32
	2167613	CHEMBL932336	Inhibition of EphB4	B	Fc1ccc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)cc1		CHEMBL402584	=	IC50	nM	2300.0	CHEMBL5147	Homo sapiens	IC50	uM	2.3
	2167614	CHEMBL932336	Inhibition of EphB4	B	Fc1cccc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)c1		CHEMBL256724	=	IC50	nM	1150.0	CHEMBL5147	Homo sapiens	IC50	uM	1.15
	2167615	CHEMBL932336	Inhibition of EphB4	B	Fc1ccccc1Nc1nccc(Nc2c(Cl)ccc3c2OCO3)n1		CHEMBL402933	=	IC50	nM	5000.0	CHEMBL5147	Homo sapiens	IC50	uM	5.0
	2167616	CHEMBL932336	Inhibition of EphB4	B	Clc1ccc2c(c1Nc1ccnc(Nc3ccccc3)n1)OCO2		CHEMBL402934	=	IC50	nM	1550.0	CHEMBL5147	Homo sapiens	IC50	uM	1.55
Not Active	2172623	CHEMBL921641	Inhibition of human recombinant EphB4 at 10 uM	B	Cc1ccc(N2CCN(CCCNC(=O)c3nc(-c4cccnc4)no3)CC2)cc1C		CHEMBL427726		Activity			CHEMBL5147	Homo sapiens	Activity		
Not Active	2172637	CHEMBL921641	Inhibition of human recombinant EphB4 at 10 uM	B	Cc1cccc(N2CCN(CCCNC(=O)c3nc(-c4cccnc4)no3)C(C)C2)c1		CHEMBL254582		Activity			CHEMBL5147	Homo sapiens	Activity		
Not Active	2172638	CHEMBL921641	Inhibition of human recombinant EphB4 at 10 uM	B	COc1ccccc1N1CCN(CCCNC(=O)c2nc(-c3cccnc3)no2)CC1		CHEMBL402228		Activity			CHEMBL5147	Homo sapiens	Activity		
	2197997	CHEMBL1005539	Inhibition of Tel-fused EphB4 kinase-mediated mouse BaF3 cell proliferation	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	IC50	nM	1300.0	CHEMBL5147	Homo sapiens	IC50	uM	1.3
	2206893	CHEMBL973090	Inhibition of EphB4 by cellular assay	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1N1Cc2cnc(N)nc2N(C)C1=O		CHEMBL459850	=	EC50	nM	4.0	CHEMBL5147	Homo sapiens	EC50	nM	4.0
	2206942	CHEMBL973090	Inhibition of EphB4 by cellular assay	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	>	EC50	nM	1000.0	CHEMBL5147	Homo sapiens	EC50	uM	1.0
	2206981	CHEMBL966754	Inhibition of EphB4	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	IC50	nM	10000.0	CHEMBL5147	Homo sapiens	IC50	uM	10.0
	2238314	CHEMBL976281	Inhibition of EphB4	B	Cc1cccc(C)c1/C=C/n1cnc2c(Nc3ccc(P(C)(C)=O)cc3)ncnc21		CHEMBL488840	=	IC50	nM	30.0	CHEMBL5147	Homo sapiens	IC50	nM	30.0
	2256025	CHEMBL1007022	Inhibition of EphB4	B	NS(=O)(=O)c1cccc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)c1		CHEMBL257553	=	IC50	nM	40.0	CHEMBL5147	Homo sapiens	IC50	uM	0.04
	2256026	CHEMBL1007022	Inhibition of EphB4	B	CS(=O)(=O)c1cccc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)c1		CHEMBL445162	=	IC50	nM	90.0	CHEMBL5147	Homo sapiens	IC50	uM	0.09
	2256027	CHEMBL1007022	Inhibition of EphB4	B	CS(=O)(=O)Nc1cccc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)c1		CHEMBL496574	=	IC50	nM	794.0	CHEMBL5147	Homo sapiens	IC50	uM	0.794
	2256028	CHEMBL1007022	Inhibition of EphB4	B	Clc1ccc2c(c1Nc1ccnc(Nc3cccc(N4CCOCC4)c3)n1)OCO2		CHEMBL255874	=	IC50	nM	580.0	CHEMBL5147	Homo sapiens	IC50	uM	0.58
	2256029	CHEMBL1007022	Inhibition of EphB4	B	NC(=O)c1cccc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)c1		CHEMBL500724	=	IC50	nM	220.0	CHEMBL5147	Homo sapiens	IC50	uM	0.22
	2256030	CHEMBL1007022	Inhibition of EphB4	B	CS(=O)(=O)c1cc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)cc(S(C)(=O)=O)c1		CHEMBL497194	=	IC50	nM	114.0	CHEMBL5147	Homo sapiens	IC50	uM	0.114
	2256031	CHEMBL1007022	Inhibition of EphB4	B	CS(=O)(=O)Nc1cc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)cc(S(C)(=O)=O)c1		CHEMBL523088	=	IC50	nM	12.0	CHEMBL5147	Homo sapiens	IC50	uM	0.012
	2256032	CHEMBL1007022	Inhibition of EphB4	B	CS(=O)(=O)c1cc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)cc(C(N)=O)c1		CHEMBL497195	=	IC50	nM	23.0	CHEMBL5147	Homo sapiens	IC50	uM	0.023
	2256033	CHEMBL1007022	Inhibition of EphB4	B	CS(=O)(=O)c1cc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)cc(N2CCOCC2)c1		CHEMBL497198	=	IC50	nM	2.0	CHEMBL5147	Homo sapiens	IC50	uM	0.002
	2256034	CHEMBL1007022	Inhibition of EphB4	B	CS(=O)(=O)Nc1cc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)cc(S(N)(=O)=O)c1		CHEMBL496760	=	IC50	nM	1.0	CHEMBL5147	Homo sapiens	IC50	uM	0.001
	2256035	CHEMBL1007022	Inhibition of EphB4	B	CS(=O)(=O)Nc1cc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)cc(N2CCOCC2)c1		CHEMBL523744	=	IC50	nM	2.0	CHEMBL5147	Homo sapiens	IC50	uM	0.002
	2256036	CHEMBL1007022	Inhibition of EphB4	B	CS(=O)(=O)Nc1cc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)cc(NS(C)(=O)=O)c1		CHEMBL496968	=	IC50	nM	15.0	CHEMBL5147	Homo sapiens	IC50	uM	0.015
	2256037	CHEMBL1007022	Inhibition of EphB4	B	CS(=O)(=O)Nc1cc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)cc(C(N)=O)c1		CHEMBL498404	=	IC50	nM	370.0	CHEMBL5147	Homo sapiens	IC50	uM	0.37
	2256038	CHEMBL1007022	Inhibition of EphB4	B	Clc1ccc2c(c1Nc1ccnc(Nc3cc(N4CCOCC4)cc(N4CCOCC4)c3)n1)OCO2		CHEMBL468970	=	IC50	nM	2.0	CHEMBL5147	Homo sapiens	IC50	uM	0.002
	2256039	CHEMBL1007022	Inhibition of EphB4	B	NC(=O)c1cc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)cc(N2CCOCC2)c1		CHEMBL517720	=	IC50	nM	13.0	CHEMBL5147	Homo sapiens	IC50	uM	0.013
	2256040	CHEMBL1007022	Inhibition of EphB4	B	NC(=O)c1cc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)cc(C(N)=O)c1		CHEMBL460600	=	IC50	nM	77.0	CHEMBL5147	Homo sapiens	IC50	uM	0.077
	2256041	CHEMBL1007023	Inhibition of Myc-His-tagged EphB4 expressed in CHOK1 cells assessed as phosphorylation by ELISA	B	NS(=O)(=O)c1cccc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)c1		CHEMBL257553	=	IC50	nM	172.0	CHEMBL5147	Homo sapiens	IC50	uM	0.172
	2256042	CHEMBL1007023	Inhibition of Myc-His-tagged EphB4 expressed in CHOK1 cells assessed as phosphorylation by ELISA	B	CS(=O)(=O)c1cccc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)c1		CHEMBL445162	=	IC50	nM	190.0	CHEMBL5147	Homo sapiens	IC50	uM	0.19
	2256043	CHEMBL1007023	Inhibition of Myc-His-tagged EphB4 expressed in CHOK1 cells assessed as phosphorylation by ELISA	B	CS(=O)(=O)Nc1cccc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)c1		CHEMBL496574	=	IC50	nM	741.0	CHEMBL5147	Homo sapiens	IC50	uM	0.741
Not Determined	2256044	CHEMBL1007023	Inhibition of Myc-His-tagged EphB4 expressed in CHOK1 cells assessed as phosphorylation by ELISA	B	Clc1ccc2c(c1Nc1ccnc(Nc3cccc(N4CCOCC4)c3)n1)OCO2		CHEMBL255874		IC50			CHEMBL5147	Homo sapiens	IC50		
	2256045	CHEMBL1007023	Inhibition of Myc-His-tagged EphB4 expressed in CHOK1 cells assessed as phosphorylation by ELISA	B	NC(=O)c1cccc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)c1		CHEMBL500724	=	IC50	nM	900.0	CHEMBL5147	Homo sapiens	IC50	uM	0.9
	2256046	CHEMBL1007023	Inhibition of Myc-His-tagged EphB4 expressed in CHOK1 cells assessed as phosphorylation by ELISA	B	CS(=O)(=O)c1cc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)cc(S(C)(=O)=O)c1		CHEMBL497194	=	IC50	nM	209.0	CHEMBL5147	Homo sapiens	IC50	uM	0.209
	2256047	CHEMBL1007023	Inhibition of Myc-His-tagged EphB4 expressed in CHOK1 cells assessed as phosphorylation by ELISA	B	CS(=O)(=O)Nc1cc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)cc(S(C)(=O)=O)c1		CHEMBL523088	=	IC50	nM	2054.0	CHEMBL5147	Homo sapiens	IC50	uM	2.054
	2256048	CHEMBL1007023	Inhibition of Myc-His-tagged EphB4 expressed in CHOK1 cells assessed as phosphorylation by ELISA	B	CS(=O)(=O)c1cc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)cc(C(N)=O)c1		CHEMBL497195	=	IC50	nM	22200.0	CHEMBL5147	Homo sapiens	IC50	uM	22.2
	2256049	CHEMBL1007023	Inhibition of Myc-His-tagged EphB4 expressed in CHOK1 cells assessed as phosphorylation by ELISA	B	CS(=O)(=O)c1cc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)cc(N2CCOCC2)c1		CHEMBL497198	=	IC50	nM	32.0	CHEMBL5147	Homo sapiens	IC50	uM	0.032
	2256050	CHEMBL1007023	Inhibition of Myc-His-tagged EphB4 expressed in CHOK1 cells assessed as phosphorylation by ELISA	B	CS(=O)(=O)Nc1cc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)cc(S(N)(=O)=O)c1		CHEMBL496760	=	IC50	nM	14117.0	CHEMBL5147	Homo sapiens	IC50	uM	14.117
	2256051	CHEMBL1007023	Inhibition of Myc-His-tagged EphB4 expressed in CHOK1 cells assessed as phosphorylation by ELISA	B	CS(=O)(=O)Nc1cc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)cc(N2CCOCC2)c1		CHEMBL523744	=	IC50	nM	170.0	CHEMBL5147	Homo sapiens	IC50	uM	0.17
	2256052	CHEMBL1007023	Inhibition of Myc-His-tagged EphB4 expressed in CHOK1 cells assessed as phosphorylation by ELISA	B	CS(=O)(=O)Nc1cc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)cc(NS(C)(=O)=O)c1		CHEMBL496968	=	IC50	nM	7175.0	CHEMBL5147	Homo sapiens	IC50	uM	7.175
	2256053	CHEMBL1007023	Inhibition of Myc-His-tagged EphB4 expressed in CHOK1 cells assessed as phosphorylation by ELISA	B	CS(=O)(=O)Nc1cc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)cc(C(N)=O)c1		CHEMBL498404	>	IC50	nM	30000.0	CHEMBL5147	Homo sapiens	IC50	uM	30.0
	2256054	CHEMBL1007023	Inhibition of Myc-His-tagged EphB4 expressed in CHOK1 cells assessed as phosphorylation by ELISA	B	Clc1ccc2c(c1Nc1ccnc(Nc3cc(N4CCOCC4)cc(N4CCOCC4)c3)n1)OCO2		CHEMBL468970	=	IC50	nM	17.0	CHEMBL5147	Homo sapiens	IC50	uM	0.017
	2256055	CHEMBL1007023	Inhibition of Myc-His-tagged EphB4 expressed in CHOK1 cells assessed as phosphorylation by ELISA	B	NC(=O)c1cc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)cc(N2CCOCC2)c1		CHEMBL517720	=	IC50	nM	887.0	CHEMBL5147	Homo sapiens	IC50	uM	0.887
	2256056	CHEMBL1007023	Inhibition of Myc-His-tagged EphB4 expressed in CHOK1 cells assessed as phosphorylation by ELISA	B	NC(=O)c1cc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)cc(C(N)=O)c1		CHEMBL460600	>	IC50	nM	30000.0	CHEMBL5147	Homo sapiens	IC50	uM	30.0
	2256057	CHEMBL1007024	Binding affinity to EphB4 Glu697 site	B	NS(=O)(=O)c1cccc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)c1		CHEMBL257553	=	Activity	%	50.0	CHEMBL5147	Homo sapiens	Activity	%	50.0
	2256058	CHEMBL1007024	Binding affinity to EphB4 Glu697 site	B	CS(=O)(=O)c1cccc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)c1		CHEMBL445162	=	Activity	%	70.0	CHEMBL5147	Homo sapiens	Activity	%	70.0
	2256059	CHEMBL1007024	Binding affinity to EphB4 Glu697 site	B	CS(=O)(=O)Nc1cccc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)c1		CHEMBL496574	=	Activity	%	30.0	CHEMBL5147	Homo sapiens	Activity	%	30.0
	2256060	CHEMBL1007024	Binding affinity to EphB4 Glu697 site	B	Clc1ccc2c(c1Nc1ccnc(Nc3cccc(N4CCOCC4)c3)n1)OCO2		CHEMBL255874	=	Activity	%	100.0	CHEMBL5147	Homo sapiens	Activity	%	100.0
	2256061	CHEMBL1007024	Binding affinity to EphB4 Glu697 site	B	NC(=O)c1cccc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)c1		CHEMBL500724	<	Activity	%	20.0	CHEMBL5147	Homo sapiens	Activity	%	20.0
	2256062	CHEMBL1007025	Binding affinity to EphB4 Ile621 site	B	NS(=O)(=O)c1cccc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)c1		CHEMBL257553	=	Activity	%	50.0	CHEMBL5147	Homo sapiens	Activity	%	50.0
	2256063	CHEMBL1007025	Binding affinity to EphB4 Ile621 site	B	CS(=O)(=O)c1cccc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)c1		CHEMBL445162	=	Activity	%	30.0	CHEMBL5147	Homo sapiens	Activity	%	30.0
	2256064	CHEMBL1007025	Binding affinity to EphB4 Ile621 site	B	CS(=O)(=O)Nc1cccc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)c1		CHEMBL496574	=	Activity	%	70.0	CHEMBL5147	Homo sapiens	Activity	%	70.0
	2256065	CHEMBL1007025	Binding affinity to EphB4 Ile621 site	B	Clc1ccc2c(c1Nc1ccnc(Nc3cccc(N4CCOCC4)c3)n1)OCO2		CHEMBL255874	=	Activity	%	0.0	CHEMBL5147	Homo sapiens	Activity	%	0.0
	2256066	CHEMBL1007025	Binding affinity to EphB4 Ile621 site	B	NC(=O)c1cccc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)c1		CHEMBL500724	>	Activity	%	80.0	CHEMBL5147	Homo sapiens	Activity	%	80.0
	2270372	CHEMBL964951	Inhibition of EphB4 by virtual HTS assay	B	c1cc(Nc2ncnc3[nH]ccc23)cc(-c2nc3ccccc3s2)c1		CHEMBL490555	>	IC50	nM	10000.0	CHEMBL5147	Homo sapiens	IC50	uM	10.0
	2270373	CHEMBL964951	Inhibition of EphB4 by virtual HTS assay	B	Cc1cc(Nc2ccnc(Nc3cccc(-c4nc5ccccc5s4)c3)n2)n[nH]1		CHEMBL491686	>	IC50	nM	10000.0	CHEMBL5147	Homo sapiens	IC50	uM	10.0
	2270374	CHEMBL964951	Inhibition of EphB4 by virtual HTS assay	B	CNc1nc(Nc2ccc(-c3nc4ccccc4s3)cc2)c2cc(OC)c(OC)cc2n1		CHEMBL514941	>	IC50	nM	10000.0	CHEMBL5147	Homo sapiens	IC50	uM	10.0
	2270375	CHEMBL964951	Inhibition of EphB4 by virtual HTS assay	B	COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)c(OC)c3)c2cc1OC		CHEMBL473553	>	IC50	nM	10000.0	CHEMBL5147	Homo sapiens	IC50	uM	10.0
	2270376	CHEMBL964951	Inhibition of EphB4 by virtual HTS assay	B	COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)c(O)c3)c2cc1OC		CHEMBL473351	>	IC50	nM	10000.0	CHEMBL5147	Homo sapiens	IC50	uM	10.0
	2270377	CHEMBL964951	Inhibition of EphB4 by virtual HTS assay	B	COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)cc3C)c2cc1OC		CHEMBL514942	>	IC50	nM	10000.0	CHEMBL5147	Homo sapiens	IC50	uM	10.0
	2270378	CHEMBL964951	Inhibition of EphB4 by virtual HTS assay	B	COc1cc2ncnc(Nc3ccc(-c4nc5ccccc5s4)cc3)c2cc1OC		CHEMBL473556	>	IC50	nM	10000.0	CHEMBL5147	Homo sapiens	IC50	uM	10.0
	2270379	CHEMBL964951	Inhibition of EphB4 by virtual HTS assay	B	Cc1cc2c(Nc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1Cl		CHEMBL473354	>	IC50	nM	10000.0	CHEMBL5147	Homo sapiens	IC50	uM	10.0
	2270380	CHEMBL964951	Inhibition of EphB4 by virtual HTS assay	B	COc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1-c1nc2ccccc2s1		CHEMBL474544	>	IC50	nM	10000.0	CHEMBL5147	Homo sapiens	IC50	uM	10.0
	2270479	CHEMBL964951	Inhibition of EphB4 by virtual HTS assay	B	COc1cc2nc(Nc3cc(C)[nH]n3)nc(Nc3ccc(-c4nc5ccccc5s4)cc3)c2cc1OC		CHEMBL473761	=	IC50	nM	3300.0	CHEMBL5147	Homo sapiens	IC50	uM	3.3
	2270517	CHEMBL964951	Inhibition of EphB4 by virtual HTS assay	B	Clc1ccc2c(Nc3ccc(-c4nc5ccccc5s4)cc3)ccnc2c1		CHEMBL474543	=	IC50	nM	1400.0	CHEMBL5147	Homo sapiens	IC50	uM	1.4
	2270528	CHEMBL964951	Inhibition of EphB4 by virtual HTS assay	B	Fc1cc(-c2nc3ccccc3s2)ccc1Nc1ncnc2cc(Cl)ccc12		CHEMBL473557	=	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	uM	1.0
	2270542	CHEMBL964951	Inhibition of EphB4 by virtual HTS assay	B	c1cc(Nc2ncnc3[nH]cnc23)cc(-c2nc3ccccc3s2)c1		CHEMBL443906	=	IC50	nM	840.0	CHEMBL5147	Homo sapiens	IC50	uM	0.84
	2270545	CHEMBL964951	Inhibition of EphB4 by virtual HTS assay	B	Clc1ccc2c(Nc3ccc(-c4nc5ccccc5s4)c(Cl)c3)ncnc2c1		CHEMBL514016	=	IC50	nM	800.0	CHEMBL5147	Homo sapiens	IC50	uM	0.8
	2270549	CHEMBL964951	Inhibition of EphB4 by virtual HTS assay	B	COc1cc2nc(Nc3cc(C)[nH]n3)nc(Nc3cccc(-c4nc5ccccc5s4)c3)c2cc1OC		CHEMBL522785	=	IC50	nM	780.0	CHEMBL5147	Homo sapiens	IC50	uM	0.78
	2270558	CHEMBL964951	Inhibition of EphB4 by virtual HTS assay	B	O=C(NC(=S)Nc1ccc(O)c(-c2nc3ccccc3s2)c1)c1ccc([N+](=O)[O-])cc1		CHEMBL460746	=	IC50	nM	610.0	CHEMBL5147	Homo sapiens	IC50	uM	0.61
	2270563	CHEMBL964951	Inhibition of EphB4 by virtual HTS assay	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OC		CHEMBL301018	=	IC50	nM	480.0	CHEMBL5147	Homo sapiens	IC50	uM	0.48
Not Active	2301946	CHEMBL949879	Inhibition of EPHB4 up to 100 uM	B	COc1ncnc2ncn(CC(=O)c3ccccc3)c12		CHEMBL483271		Inhibition	%		CHEMBL5147	Homo sapiens	INH		
Not Active	2301970	CHEMBL949879	Inhibition of EPHB4 up to 100 uM	B	COc1ncnc2c1ncn2CC(=O)c1ccccc1		CHEMBL519976		Inhibition	%		CHEMBL5147	Homo sapiens	INH		
Not Active	2301994	CHEMBL949879	Inhibition of EPHB4 up to 100 uM	B	Nc1ncnc2c1ncn2CC(=O)c1cccnc1		CHEMBL501256		Inhibition	%		CHEMBL5147	Homo sapiens	INH		
Not Active	2302018	CHEMBL949879	Inhibition of EPHB4 up to 100 uM	B	Nc1ncnc2c1ncn2CC(=O)c1ccccn1		CHEMBL504135		Inhibition	%		CHEMBL5147	Homo sapiens	INH		
Not Active	2302042	CHEMBL949879	Inhibition of EPHB4 up to 100 uM	B	Nc1ncnc2ncn(CC(=O)c3ccccc3)c12		CHEMBL485444		Inhibition	%		CHEMBL5147	Homo sapiens	INH		
Not Active	2302066	CHEMBL949879	Inhibition of EPHB4 up to 100 uM	B	Nc1ncnc2c1ncn2CC(=O)c1ccccc1		CHEMBL520515		Inhibition	%		CHEMBL5147	Homo sapiens	INH		
Not Active	2302090	CHEMBL949879	Inhibition of EPHB4 up to 100 uM	B	Nc1ncnc2ncn(CC(=O)c3c[nH]c4ccccc34)c12		CHEMBL485246		Inhibition	%		CHEMBL5147	Homo sapiens	INH		
Not Active	2302114	CHEMBL949879	Inhibition of EPHB4 up to 100 uM	B	Nc1ncnc2c1ncn2CC(=O)c1c[nH]c2ccccc12		CHEMBL521155		Inhibition	%		CHEMBL5147	Homo sapiens	INH		
Not Active	2302126	CHEMBL949879	Inhibition of EPHB4 up to 100 uM	B	CN(C)c1ncnc2c1ncn2CC(=O)c1c[nH]c2ccccc12		CHEMBL519977		Inhibition	%		CHEMBL5147	Homo sapiens	INH		
	2341411	CHEMBL953371	Inhibition of EphB4 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(N3CCN(C(=O)Cc4c[nH]c5ccccc45)CC3)ncn2)c1		CHEMBL524898	=	Inhibition	%	0.0	CHEMBL5147	Homo sapiens	INH	%	0.0
	2341451	CHEMBL953371	Inhibition of EphB4 at 10 uM by HTRF assay relative to control	B	CN(C)CC(C)(C)CNC(=O)c1cccc(Nc2nccc(Nc3ccc4ncsc4c3)n2)c1		CHEMBL501459	=	Inhibition	%	18.0	CHEMBL5147	Homo sapiens	INH	%	18.0
	2341492	CHEMBL953371	Inhibition of EphB4 at 10 uM by HTRF assay relative to control	B	Nc1nc(N2CCOCC2)cc(N2CCC(C(=O)NCCc3ccc(O)cc3)CC2)n1		CHEMBL501728	=	Inhibition	%	0.0	CHEMBL5147	Homo sapiens	INH	%	0.0
	2341533	CHEMBL953371	Inhibition of EphB4 at 10 uM by HTRF assay relative to control	B	O=C(NCCc1ccc(O)cc1)c1cccc(Nc2nccc(Nc3ccc4ncsc4c3)n2)c1		CHEMBL499617	=	Inhibition	%	0.0	CHEMBL5147	Homo sapiens	INH	%	0.0
	2341574	CHEMBL953371	Inhibition of EphB4 at 10 uM by HTRF assay relative to control	B	O=C(c1nc(SCc2ccc(Cl)cc2)n2ccccc12)N1CCN(c2cc(Nc3cccc(Br)c3)ncn2)CC1		CHEMBL501200	=	Inhibition	%	0.0	CHEMBL5147	Homo sapiens	INH	%	0.0
	2341615	CHEMBL953371	Inhibition of EphB4 at 10 uM by HTRF assay relative to control	B	Nc1nc(Nc2ccc3ncsc3c2)cc(N2CCC[C@H]2C(=O)N[C@@H](CO)c2ccccc2)n1		CHEMBL525070	=	Inhibition	%	0.0	CHEMBL5147	Homo sapiens	INH	%	0.0
	2341656	CHEMBL953371	Inhibition of EphB4 at 10 uM by HTRF assay relative to control	B	Nc1nc(Nc2ccc3ncsc3c2)cc(N2CCC[C@H]2C(=O)NCCc2cccc(I)c2)n1		CHEMBL501463	=	Inhibition	%	0.0	CHEMBL5147	Homo sapiens	INH	%	0.0
	2341697	CHEMBL953371	Inhibition of EphB4 at 10 uM by HTRF assay relative to control	B	O=C(NC1Cc2ccccc2C1)c1cccc(Nc2ccnc(N3CCN(c4ccccc4)CC3)n2)c1		CHEMBL499624	=	Inhibition	%	0.0	CHEMBL5147	Homo sapiens	INH	%	0.0
	2341738	CHEMBL953371	Inhibition of EphB4 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)NCc4ccc(N(C)C)cc4)c3)ncn2)c1		CHEMBL502826	=	Inhibition	%	4.0	CHEMBL5147	Homo sapiens	INH	%	4.0
	2341779	CHEMBL953371	Inhibition of EphB4 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3ccc(CC(=O)Nc4ccc5ncsc5c4)cc3)ncn2)c1		CHEMBL502827	=	Inhibition	%	0.0	CHEMBL5147	Homo sapiens	INH	%	0.0
	2341820	CHEMBL953371	Inhibition of EphB4 at 10 uM by HTRF assay relative to control	B	COc1ccc(NC(=O)Cc2ccc(Nc3cc(N(C)c4cccc(C)c4)ncn3)cc2)cn1		CHEMBL526914	=	Inhibition	%	0.0	CHEMBL5147	Homo sapiens	INH	%	0.0
	2341861	CHEMBL953371	Inhibition of EphB4 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2nccc(Nc3cccc(C(=O)NCc4ccc(N(C)C)cc4)c3)n2)c1		CHEMBL501471	=	Inhibition	%	0.0	CHEMBL5147	Homo sapiens	INH	%	0.0
	2341902	CHEMBL953371	Inhibition of EphB4 at 10 uM by HTRF assay relative to control	B	O=C(NCc1cccnc1)c1cccc(-c2ccc(Nc3ccc4ncsc4c3)nn2)c1		CHEMBL501182	=	Inhibition	%	0.0	CHEMBL5147	Homo sapiens	INH	%	0.0
	2341943	CHEMBL953371	Inhibition of EphB4 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)N4CCCC5CCCCC54)c3)ncn2)c1		CHEMBL499606	=	Inhibition	%	0.0	CHEMBL5147	Homo sapiens	INH	%	0.0
	2341984	CHEMBL953371	Inhibition of EphB4 at 10 uM by HTRF assay relative to control	B	COc1cccc(Nc2cc(Nc3cccc(C(=O)N(C)CCc4ccccn4)c3)nc(N)n2)c1		CHEMBL499865	=	Inhibition	%	0.0	CHEMBL5147	Homo sapiens	INH	%	0.0
	2342025	CHEMBL953371	Inhibition of EphB4 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2nccc(Nc3cccc(C(=O)N(C)CCc4ccccn4)c3)n2)c1		CHEMBL499866	=	Inhibition	%	5.0	CHEMBL5147	Homo sapiens	INH	%	5.0
	2342066	CHEMBL953371	Inhibition of EphB4 at 10 uM by HTRF assay relative to control	B	O=C(CN1CCN(c2ncnc3c2CN(Cc2ccccc2)CC3)CC1)Nc1cc(F)ccc1F		CHEMBL520451	=	Inhibition	%	0.0	CHEMBL5147	Homo sapiens	INH	%	0.0
	2342107	CHEMBL953371	Inhibition of EphB4 at 10 uM by HTRF assay relative to control	B	O=C(NCc1ccncc1)c1cccc(Nc2cc(Nc3cccc(Br)c3)ncn2)c1		CHEMBL482513	=	Inhibition	%	0.0	CHEMBL5147	Homo sapiens	INH	%	0.0
	2342148	CHEMBL953371	Inhibition of EphB4 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2cc(Nc3cccc(C(=O)N(CC(C)O)CC(C)O)c3)ncn2)c1		CHEMBL483318	=	Inhibition	%	0.0	CHEMBL5147	Homo sapiens	INH	%	0.0
	2342189	CHEMBL953371	Inhibition of EphB4 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)NCCCn4ccnc4)c3)ncn2)c1		CHEMBL520971	=	Inhibition	%	0.0	CHEMBL5147	Homo sapiens	INH	%	0.0
	2342232	CHEMBL953371	Inhibition of EphB4 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)N(C)CCc4ccccn4)c3)ncn2)c1		CHEMBL521469	=	Inhibition	%	0.0	CHEMBL5147	Homo sapiens	INH	%	0.0
	2342271	CHEMBL953371	Inhibition of EphB4 at 10 uM by HTRF assay relative to control	B	CC(=O)N1CCN(C(=O)c2cccc(Nc3cc(N(C)c4cccc(C)c4)ncn3)c2)CC1		CHEMBL521478	=	Inhibition	%	0.0	CHEMBL5147	Homo sapiens	INH	%	0.0
	2342312	CHEMBL953371	Inhibition of EphB4 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)NCc4ccncc4)c3)ncn2)c1		CHEMBL483506	=	Inhibition	%	0.0	CHEMBL5147	Homo sapiens	INH	%	0.0
	2342353	CHEMBL953371	Inhibition of EphB4 at 10 uM by HTRF assay relative to control	B	CN(CCc1ccccn1)C(=O)c1cccc(Nc2nccc(Nc3ccc4ncsc4c3)n2)c1		CHEMBL483507	=	Inhibition	%	17.0	CHEMBL5147	Homo sapiens	INH	%	17.0
	2342394	CHEMBL953371	Inhibition of EphB4 at 10 uM by HTRF assay relative to control	B	COc1cccc(Nc2cc(Nc3cccc(C(=O)NCCCn4ccnc4)c3)nc(N)n2)c1		CHEMBL520980	=	Inhibition	%	0.0	CHEMBL5147	Homo sapiens	INH	%	0.0
	2342435	CHEMBL953371	Inhibition of EphB4 at 10 uM by HTRF assay relative to control	B	COC[C@@H]1CCCN1C(=O)[C@@H]1CCCN1c1cc(Nc2cccc(OC)c2)nc(N)n1		CHEMBL519962	=	Inhibition	%	0.0	CHEMBL5147	Homo sapiens	INH	%	0.0
	2342476	CHEMBL953371	Inhibition of EphB4 at 10 uM by HTRF assay relative to control	B	COc1cccc(Nc2cc(N3CCC[C@H]3C(=O)NCCN3CCCCC3)nc(N)n2)c1		CHEMBL526526	=	Inhibition	%	0.0	CHEMBL5147	Homo sapiens	INH	%	0.0
	2342517	CHEMBL953371	Inhibition of EphB4 at 10 uM by HTRF assay relative to control	B	O=C(COc1ccccc1)N1CCN(c2nccc(Nc3ccc4ncsc4c3)n2)CC1		CHEMBL482488	=	Inhibition	%	0.0	CHEMBL5147	Homo sapiens	INH	%	0.0
	2342788	CHEMBL953371	Inhibition of EphB4 at 10 uM by HTRF assay relative to control	B	O=C(NC[C@@H]1CCCO1)c1cccc(Nc2nccc(Nc3ccc4ncsc4c3)n2)c1		CHEMBL500661	=	Inhibition	%	57.0	CHEMBL5147	Homo sapiens	INH	%	57.0
	2342823	CHEMBL953371	Inhibition of EphB4 at 10 uM by HTRF assay relative to control	B	Clc1ccc2sc(CN3CCN(c4ncnc5c4CN(Cc4ccccc4)CC5)CC3)cc2c1		CHEMBL483710	=	Inhibition	%	0.0	CHEMBL5147	Homo sapiens	INH	%	0.0
	2343098	CHEMBL953371	Inhibition of EphB4 at 10 uM by HTRF assay relative to control	B	Nc1nc(Nc2ccccc2)cc(N2CCC(C(=O)NCCc3ccccn3)CC2)n1		CHEMBL521002	=	Inhibition	%	0.0	CHEMBL5147	Homo sapiens	INH	%	0.0
	2343122	CHEMBL953371	Inhibition of EphB4 at 10 uM by HTRF assay relative to control	B	CC(=O)CCCCC(=O)N1CCN(c2nccc(Oc3cccc(C)c3)n2)CC1		CHEMBL484713	=	Inhibition	%	0.0	CHEMBL5147	Homo sapiens	INH	%	0.0
	2343144	CHEMBL953371	Inhibition of EphB4 at 10 uM by HTRF assay relative to control	B	COc1ccc(-c2noc(CN3CCN(c4cc(Nc5cccc(O)c5)ncn4)CC3)n2)cc1		CHEMBL483715	=	Inhibition	%	0.0	CHEMBL5147	Homo sapiens	INH	%	0.0
	2343168	CHEMBL953371	Inhibition of EphB4 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Oc2ccnc(N3CCN(CC(=O)Nc4cccc5c4CCCC5)CC3)n2)c1		CHEMBL520512	=	Inhibition	%	0.0	CHEMBL5147	Homo sapiens	INH	%	0.0
	2343192	CHEMBL953371	Inhibition of EphB4 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(N3CCN(CC(=O)Nc4nc(-c5ccccc5)cs4)CC3)ncn2)c1		CHEMBL519534	=	Inhibition	%	0.0	CHEMBL5147	Homo sapiens	INH	%	0.0
	2343216	CHEMBL953371	Inhibition of EphB4 at 10 uM by HTRF assay relative to control	B	Nc1nc(Nc2ccc(C(=O)NCCc3ccncc3)cc2)cc(N2CCOCC2)n1		CHEMBL485524	=	Inhibition	%	0.0	CHEMBL5147	Homo sapiens	INH	%	0.0
	2343240	CHEMBL953371	Inhibition of EphB4 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2nccc3c2CN(C(=O)c2cc(C)n(C)c2C)CC3)c1		CHEMBL519146	=	Inhibition	%	0.0	CHEMBL5147	Homo sapiens	INH	%	0.0
	2343264	CHEMBL953371	Inhibition of EphB4 at 10 uM by HTRF assay relative to control	B	Cc1cc(C(=O)N2CCN(c3ncnc4c3CN(Cc3ccccc3)CC4)CC2)c(C)n1C		CHEMBL482710	=	Inhibition	%	0.0	CHEMBL5147	Homo sapiens	INH	%	0.0
	2343625	CHEMBL953371	Inhibition of EphB4 at 10 uM by HTRF assay relative to control	B	Nc1nc(N2CCOCC2)cc(N2CCC(C(=O)NCc3cccs3)CC2)n1		CHEMBL482910	=	Inhibition	%	0.0	CHEMBL5147	Homo sapiens	INH	%	0.0
	2343686	CHEMBL953371	Inhibition of EphB4 at 10 uM by HTRF assay relative to control	B	COc1cccc(Nc2cc(N3CCC[C@H]3C(=O)NCCc3ccc(O)cc3)nc(N)n2)c1		CHEMBL483518	=	Inhibition	%	0.0	CHEMBL5147	Homo sapiens	INH	%	0.0
	2343707	CHEMBL953371	Inhibition of EphB4 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Oc2ccnc(N3CCC[C@H]3C(=O)NCc3cccnc3)n2)c1		CHEMBL482717	=	Inhibition	%	0.0	CHEMBL5147	Homo sapiens	INH	%	0.0
	2343729	CHEMBL953371	Inhibition of EphB4 at 10 uM by HTRF assay relative to control	B	COC(=O)C(CO)NC(=O)[C@@H]1CCCN1c1nccc(Oc2cccc(C)c2)n1		CHEMBL519310	=	Inhibition	%	0.0	CHEMBL5147	Homo sapiens	INH	%	0.0
	2343749	CHEMBL953371	Inhibition of EphB4 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Oc2ccnc(N3CCN(C(=O)c4c(C)noc4C)CC3)n2)c1		CHEMBL482721	=	Inhibition	%	0.0	CHEMBL5147	Homo sapiens	INH	%	0.0
	2343773	CHEMBL953371	Inhibition of EphB4 at 10 uM by HTRF assay relative to control	B	CN(C)CC(C)(C)CNC(=O)C1CCN(c2cc(N3CCOCC3)nc(N)n2)CC1		CHEMBL519311	=	Inhibition	%	0.0	CHEMBL5147	Homo sapiens	INH	%	0.0
	2343795	CHEMBL953371	Inhibition of EphB4 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Oc2ccnc(N3CCC[C@H]3C(=O)NCCCn3ccnc3)n2)c1		CHEMBL482722	=	Inhibition	%	0.0	CHEMBL5147	Homo sapiens	INH	%	0.0
	2343816	CHEMBL953371	Inhibition of EphB4 at 10 uM by HTRF assay relative to control	B	O=C(c1nc(SCc2ccc(Cl)cc2)n2ccccc12)N1CCN(c2ncnc3c2CN(Cc2ccccc2)CC3)CC1		CHEMBL446637	=	Inhibition	%	0.0	CHEMBL5147	Homo sapiens	INH	%	0.0
	2343838	CHEMBL953371	Inhibition of EphB4 at 10 uM by HTRF assay relative to control	B	CN(C)c1ccc(C(=O)N2CCN(c3ncnc4c3CN(Cc3ccccc3)CC4)CC2)c2ccccc12		CHEMBL520331	=	Inhibition	%	0.0	CHEMBL5147	Homo sapiens	INH	%	0.0
	2343860	CHEMBL953371	Inhibition of EphB4 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2ncnc3c2CN(C(=O)c2ccc(N(C)C)c4ccccc24)CC3)c1		CHEMBL484324	=	Inhibition	%	0.0	CHEMBL5147	Homo sapiens	INH	%	0.0
	2343882	CHEMBL953371	Inhibition of EphB4 at 10 uM by HTRF assay relative to control	B	COC[C@@H]1CCCN1C(=O)C1CCCN1c1cc(Nc2cccc(Br)c2)ncn1		CHEMBL484521	=	Inhibition	%	0.0	CHEMBL5147	Homo sapiens	INH	%	0.0
	2343904	CHEMBL953371	Inhibition of EphB4 at 10 uM by HTRF assay relative to control	B	COC[C@@H]1CCCN1C(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1		CHEMBL519349	=	Inhibition	%	0.0	CHEMBL5147	Homo sapiens	INH	%	0.0
	2343926	CHEMBL953371	Inhibition of EphB4 at 10 uM by HTRF assay relative to control	B	CN(C)CC(C)(C)CNC(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1		CHEMBL521000	=	Inhibition	%	0.0	CHEMBL5147	Homo sapiens	INH	%	0.0
	2343948	CHEMBL953371	Inhibition of EphB4 at 10 uM by HTRF assay relative to control	B	O=C(C1CCN(c2nccc(Nc3ccccc3)n2)CC1)N1CC[C@@H](O)C1		CHEMBL484706	=	Inhibition	%	0.0	CHEMBL5147	Homo sapiens	INH	%	0.0
	2343969	CHEMBL953371	Inhibition of EphB4 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)N(CC(C)C)CC(C)C)c3)ncn2)c1		CHEMBL484707	=	Inhibition	%	0.0	CHEMBL5147	Homo sapiens	INH	%	0.0
	2343991	CHEMBL953371	Inhibition of EphB4 at 10 uM by HTRF assay relative to control	B	CN(CCc1ccccn1)C(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1		CHEMBL521479	=	Inhibition	%	0.0	CHEMBL5147	Homo sapiens	INH	%	0.0
	2344014	CHEMBL953371	Inhibition of EphB4 at 10 uM by HTRF assay relative to control	B	CN(CCCn1ccnc1)C(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1		CHEMBL519658	=	Inhibition	%	0.0	CHEMBL5147	Homo sapiens	INH	%	0.0
	2344721	CHEMBL953371	Inhibition of EphB4 at 10 uM by HTRF assay relative to control	B	Cc1cccc(CN2CCN(c3cc(N(C)c4cccc(C)c4)ncn3)CC2)c1		CHEMBL446087	=	Inhibition	%	0.0	CHEMBL5147	Homo sapiens	INH	%	0.0
	2344744	CHEMBL953371	Inhibition of EphB4 at 10 uM by HTRF assay relative to control	B	Cc1ccc(CN2CCN(c3nccc(C(C#N)c4ccccn4)n3)CC2)cc1		CHEMBL521145	=	Inhibition	%	0.0	CHEMBL5147	Homo sapiens	INH	%	0.0
	2461683	CHEMBL962867	Inhibition of recombinant EPHB4	B	Cc1cc(O)cc2oc(=O)c3c(O)cc(O)cc3c12		CHEMBL519982	>	IC50	ug.mL-1	10.0	CHEMBL5147	Homo sapiens	IC50	10'-5g/ml	1.0
	2461753	CHEMBL962867	Inhibition of recombinant EPHB4	B	O=C1C[C@H](O)[C@@H]2c3c(ccc(O)c31)-c1ccc(O)c3c1[C@@]2(O)CCC3=O		CHEMBL521470	=	IC50	ug.mL-1	8.9	CHEMBL5147	Homo sapiens	IC50	10'-6g/ml	8.9
	2461754	CHEMBL962867	Inhibition of recombinant EPHB4	B	COc1cc(O)c(C(=O)O)c(C2=C(C)C[C@@H](O)C2=O)c1		CHEMBL519395	>	IC50	ug.mL-1	10.0	CHEMBL5147	Homo sapiens	IC50	10'-5g/ml	1.0
	2461755	CHEMBL962867	Inhibition of recombinant EPHB4	B	COc1cc(O)c2c(c1)C1(OC2=O)C(C)=CC(=O)C1O		CHEMBL408995	>	IC50	ug.mL-1	10.0	CHEMBL5147	Homo sapiens	IC50	10'-5g/ml	1.0
	2461756	CHEMBL962867	Inhibition of recombinant EPHB4	B	COc1cc(O)c2c(c1)-c1cc(O)c(O)cc1COC2=O		CHEMBL507058	>	IC50	ug.mL-1	10.0	CHEMBL5147	Homo sapiens	IC50	10'-5g/ml	1.0
	2461757	CHEMBL962867	Inhibition of recombinant EPHB4	B	Cc1cc(O)c(O)cc1-c1cc(O)cc(O)c1C(=O)O		CHEMBL483532	=	IC50	ug.mL-1	5.9	CHEMBL5147	Homo sapiens	IC50	10'-6g/ml	5.9
	2461758	CHEMBL962867	Inhibition of recombinant EPHB4	B	COc1cc(O)c(C(=O)O)c(-c2cc(O)c(O)cc2C)c1		CHEMBL483531	=	IC50	ug.mL-1	9.4	CHEMBL5147	Homo sapiens	IC50	10'-6g/ml	9.4
	2461759	CHEMBL962867	Inhibition of recombinant EPHB4	B	COc1cc(O)c2c(=O)oc3c(O)c(O)cc(C)c3c2c1		CHEMBL520144	=	IC50	ug.mL-1	2.1	CHEMBL5147	Homo sapiens	IC50	10'-6g/ml	2.1
	2461760	CHEMBL962867	Inhibition of recombinant EPHB4	B	COc1cc(O)c2c(=O)oc3cc(O)cc(C)c3c2c1		CHEMBL483526	=	IC50	ug.mL-1	1.4	CHEMBL5147	Homo sapiens	IC50	10'-6g/ml	1.4
	2461761	CHEMBL962867	Inhibition of recombinant EPHB4	B	Cc1cc(O)cc2oc(=O)c3c(O)cc(OS(=O)(=O)O)cc3c12		CHEMBL483525	=	IC50	ug.mL-1	3.1	CHEMBL5147	Homo sapiens	IC50	10'-6g/ml	3.1
	2464996	CHEMBL957973	Inhibition of human recombinant EPHB4	B	COc1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL201511	=	IC50	nM	5100.0	CHEMBL5147	Homo sapiens	IC50	uM	5.1
	2465043	CHEMBL957973	Inhibition of human recombinant EPHB4	B	COc1cc(C2=C(c3cn(COCc4ccccc4)c4ccccc34)CNC2=O)cc(OC)c1OC		CHEMBL453336	=	IC50	nM	37000.0	CHEMBL5147	Homo sapiens	IC50	uM	37.0
	2465044	CHEMBL957973	Inhibition of human recombinant EPHB4	B	COc1cc(C2=C(c3cn(COC(C)(C)C)c4ccccc34)CNC2=O)cc(OC)c1OC		CHEMBL488646	=	IC50	nM	20000.0	CHEMBL5147	Homo sapiens	IC50	uM	20.0
	2465045	CHEMBL957973	Inhibition of human recombinant EPHB4	B	COc1cc(C2=C(c3cn(COCC[Si](C)(C)C)c4ccccc34)CNC2=O)cc(OC)c1OC		CHEMBL486437	=	IC50	nM	44000.0	CHEMBL5147	Homo sapiens	IC50	uM	44.0
	2470179	CHEMBL1034128	Inhibition of EPHB4 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL5147	Homo sapiens	INH	%	10.0
	2476663	CHEMBL1024915	Binding affinity to human EPHB4 at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Activity	%	29.8	CHEMBL5147	Homo sapiens	Activity	%	29.8
Not Evaluated	2476866	CHEMBL1024915	Binding affinity to human EPHB4 at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL5147	Homo sapiens	Activity		
Not Evaluated	2478705	CHEMBL1024915	Binding affinity to human EPHB4 at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL5147	Homo sapiens	Activity		
Not Evaluated	2479763	CHEMBL1024915	Binding affinity to human EPHB4 at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312		Activity			CHEMBL5147	Homo sapiens	Activity		
Not Evaluated	2480560	CHEMBL1024915	Binding affinity to human EPHB4 at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755		Activity			CHEMBL5147	Homo sapiens	Activity		
	2480762	CHEMBL1024915	Binding affinity to human EPHB4 at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409	=	Activity	%	0.7	CHEMBL5147	Homo sapiens	Activity	%	0.7
	2489760	CHEMBL1035625	Inhibition of EphB4 at 1 uM	B	COc1cc2ncc(C(N)=O)c(Nc3ccc(F)cc3F)c2cc1OC		CHEMBL479847	=	Inhibition	%	51.0	CHEMBL5147	Homo sapiens	INH	%	51.0
	2506945	CHEMBL942612	Inhibition of EphB4 at 10 uM	B	COc1cc(O)ccc1-c1ccc2c(-c3nc4c(N5CCN(C)CC5)cccc4[nH]3)n[nH]c2c1		CHEMBL474619	<	Inhibition	%	50.0	CHEMBL5147	Homo sapiens	INH	%	50.0
	2506946	CHEMBL942612	Inhibition of EphB4 at 10 uM	B	CN1CCN(c2cccc3nc(-c4n[nH]c5cc(-c6ccc(N)cc6)ccc45)[nH]c23)CC1		CHEMBL480391	<	Inhibition	%	50.0	CHEMBL5147	Homo sapiens	INH	%	50.0
	2507061	CHEMBL947775	Inhibition of EphB4	B	Nc1ncc(NC(=O)c2cc(NC(=O)c3cccc(C(F)(F)F)c3)ccc2Cl)cc1Cl		CHEMBL475817	=	IC50	nM	672.0	CHEMBL5147	Homo sapiens	IC50	uM	0.672
	2511576	CHEMBL972535	Inhibition of EPHB4	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	233.0	CHEMBL5147	Homo sapiens	IC50	uM	0.233
	2567241	CHEMBL974573	Inhibition of human EphB4 kinase assessed as residual enzyme activity at 0.1 uM	B	CCN1C(=O)C(C)(C)c2cc3[nH]c4c(c3cc21)CCCc1c(C)n[nH]c1-4		CHEMBL223147	=	Activity	%	99.0	CHEMBL5147	Homo sapiens	Activity	%	99.0
Not Evaluated	2577384	CHEMBL1024915	Binding affinity to human EPHB4 at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901		Activity			CHEMBL5147	Homo sapiens	Activity		
	2582026	CHEMBL962244	Inhibition of human EPHB4	B	N=C(N)SCCCn1c(=O)c2c(c1=O)n1c3ccccc3cc1c1cccc3ccn2c31		CHEMBL489083	=	IC50	nM	2300.0	CHEMBL5147	Homo sapiens	IC50	uM	2.3
	2582040	CHEMBL962244	Inhibition of human EPHB4	B	CNC(=N)SCCCn1c(=O)c2c(c1=O)n1c3ccccc3cc1c1cccc3ccn2c31		CHEMBL488271	=	IC50	nM	3900.0	CHEMBL5147	Homo sapiens	IC50	uM	3.9
	2584873	CHEMBL955783	Inhibition of EphB4	B	O=c1[nH]cnc2[nH]c(-c3ccnc(/C=C/c4ccc(CN5CCOCC5)cc4)c3)cc12		CHEMBL461139	=	IC50	nM	1700.0	CHEMBL5147	Homo sapiens	IC50	uM	1.7
	2584901	CHEMBL955783	Inhibition of EphB4	B	CN(C)CCOc1ccc(/C=C/c2cc(-c3cc4c(=O)[nH]cnc4[nH]3)ccn2)cc1		CHEMBL461140	=	IC50	nM	1400.0	CHEMBL5147	Homo sapiens	IC50	uM	1.4
	2593589	CHEMBL1024915	Binding affinity to human EPHB4 at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Activity	%	10.7	CHEMBL5147	Homo sapiens	Activity	%	10.7
Active	2593792	CHEMBL1024915	Binding affinity to human EPHB4 at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097		Activity			CHEMBL5147	Homo sapiens	Activity		
Not Evaluated	2593855	CHEMBL1024915	Binding affinity to human EPHB4 at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337		Activity			CHEMBL5147	Homo sapiens	Activity		
Not Evaluated	2594058	CHEMBL1024915	Binding affinity to human EPHB4 at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519		Activity			CHEMBL5147	Homo sapiens	Activity		
Not Evaluated	2595001	CHEMBL1024915	Binding affinity to human EPHB4 at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL5147	Homo sapiens	Activity		
	2595270	CHEMBL1024915	Binding affinity to human EPHB4 at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466	=	Activity	%	7.9	CHEMBL5147	Homo sapiens	Activity	%	7.9
Not Evaluated	2596198	CHEMBL1024915	Binding affinity to human EPHB4 at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL5147	Homo sapiens	Activity		
Not Evaluated	2596401	CHEMBL1024915	Binding affinity to human EPHB4 at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342		Activity			CHEMBL5147	Homo sapiens	Activity		
Not Evaluated	2597670	CHEMBL1024915	Binding affinity to human EPHB4 at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019		Activity			CHEMBL5147	Homo sapiens	Activity		
Not Evaluated	2597873	CHEMBL1024915	Binding affinity to human EPHB4 at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL5147	Homo sapiens	Activity		
	2671893	CHEMBL1026227	Inhibition of recombinant EPHB4	B	COc1cc(O)c2c(c1)C(=O)C1=C(C2=O)[C@H](O)[C@@H](O)[C@@](C)(O)[C@@H]1O		CHEMBL512054	>	IC50	ug.mL-1	10.0	CHEMBL5147	Homo sapiens	IC50	ug ml-1	10.0
	2671895	CHEMBL1026227	Inhibition of recombinant EPHB4	B	COc1cc(O)c2c(c1)C(=O)c1cc(C)c(O)cc1C2=O		CHEMBL463054	>	IC50	ug.mL-1	10.0	CHEMBL5147	Homo sapiens	IC50	ug ml-1	10.0
	2671896	CHEMBL1026227	Inhibition of recombinant EPHB4	B	COc1cc(O)c2c(c1)C(=O)c1cc(C)c(O)c(O)c1C2=O		CHEMBL556684	>	IC50	ug.mL-1	10.0	CHEMBL5147	Homo sapiens	IC50	ug ml-1	10.0
	2672267	CHEMBL1026227	Inhibition of recombinant EPHB4	B	COc1cc2c(c(O)c1-c1c(OC)cc(O)c3c1C(=O)C1=C(C3=O)[C@H](O)[C@@H](O)[C@@](C)(O)[C@@H]1O)C(=O)c1cc(O)c(C)cc1C2=O		CHEMBL554993	=	IC50	ug.mL-1	4.2	CHEMBL5147	Homo sapiens	IC50	ug ml-1	4.2
	2721022	CHEMBL1057431	Inhibition of EphB4 at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL5147	Homo sapiens	INH	%	50.0
	2905990	CHEMBL1060192	Binding constant for EPHB4 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Kd	nM	1400.0	CHEMBL5147	Homo sapiens	Kd	nM	1400.0
	2905991	CHEMBL1060192	Binding constant for EPHB4 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	uM	10.0
	2905992	CHEMBL1060192	Binding constant for EPHB4 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	uM	10.0
	2905993	CHEMBL1060192	Binding constant for EPHB4 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	uM	10.0
	2905994	CHEMBL1060192	Binding constant for EPHB4 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	uM	10.0
	2905995	CHEMBL1060192	Binding constant for EPHB4 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	uM	10.0
	2905996	CHEMBL1060192	Binding constant for EPHB4 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	uM	10.0
	2905997	CHEMBL1060192	Binding constant for EPHB4 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	uM	10.0
	2905998	CHEMBL1060192	Binding constant for EPHB4 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	1800.0	CHEMBL5147	Homo sapiens	Kd	nM	1800.0
	2905999	CHEMBL1060192	Binding constant for EPHB4 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	uM	10.0
	2906000	CHEMBL1060192	Binding constant for EPHB4 kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	uM	10.0
	2906001	CHEMBL1060192	Binding constant for EPHB4 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	0.34	CHEMBL5147	Homo sapiens	Kd	nM	0.34
	2906002	CHEMBL1060192	Binding constant for EPHB4 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	=	Kd	nM	2800.0	CHEMBL5147	Homo sapiens	Kd	nM	2800.0
	2906003	CHEMBL1060192	Binding constant for EPHB4 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	uM	10.0
	2906004	CHEMBL1060192	Binding constant for EPHB4 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	uM	10.0
	2906005	CHEMBL1060192	Binding constant for EPHB4 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	uM	10.0
	2906006	CHEMBL1060192	Binding constant for EPHB4 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	uM	10.0
	2906007	CHEMBL1060192	Binding constant for EPHB4 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	uM	10.0
	2906008	CHEMBL1060192	Binding constant for EPHB4 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	uM	10.0
	2906009	CHEMBL1060192	Binding constant for EPHB4 kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	uM	10.0
	2906010	CHEMBL1060192	Binding constant for EPHB4 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	uM	10.0
	2906011	CHEMBL1060192	Binding constant for EPHB4 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	uM	10.0
	2906012	CHEMBL1060192	Binding constant for EPHB4 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	uM	10.0
	2906013	CHEMBL1060192	Binding constant for EPHB4 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	560.0	CHEMBL5147	Homo sapiens	Kd	nM	560.0
	2906014	CHEMBL1060192	Binding constant for EPHB4 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	uM	10.0
	2906015	CHEMBL1060192	Binding constant for EPHB4 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	uM	10.0
	2906016	CHEMBL1060192	Binding constant for EPHB4 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	uM	10.0
	2906017	CHEMBL1060192	Binding constant for EPHB4 kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	uM	10.0
	2906018	CHEMBL1060192	Binding constant for EPHB4 kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	uM	10.0
	2906019	CHEMBL1060192	Binding constant for EPHB4 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	uM	10.0
	2906020	CHEMBL1060192	Binding constant for EPHB4 kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	uM	10.0
	2906021	CHEMBL1060192	Binding constant for EPHB4 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	1800.0	CHEMBL5147	Homo sapiens	Kd	nM	1800.0
	2906022	CHEMBL1060192	Binding constant for EPHB4 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	uM	10.0
	2906023	CHEMBL1060192	Binding constant for EPHB4 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	uM	10.0
	2906024	CHEMBL1060192	Binding constant for EPHB4 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	uM	10.0
	2906025	CHEMBL1060192	Binding constant for EPHB4 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	1700.0	CHEMBL5147	Homo sapiens	Kd	nM	1700.0
	2906026	CHEMBL1060192	Binding constant for EPHB4 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	uM	10.0
	2906027	CHEMBL1060192	Binding constant for EPHB4 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	520.0	CHEMBL5147	Homo sapiens	Kd	nM	520.0
	2921349	CHEMBL1053716	Inhibition of EPHB4 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	6.5	CHEMBL5147	Homo sapiens	Activity	%	6.5
	2926154	CHEMBL1046768	Inhibition of EphB4 by [gamma33-P]ATP based assay	B	COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566515	=	IC50	nM	1.6	CHEMBL5147	Homo sapiens	IC50	nM	1.6
	2926155	CHEMBL1046767	Inhibition of EphB4 assessed as blockade of synthetic substrate phosphorylation by FRET assay	B	COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566515	=	IC50	nM	5.0	CHEMBL5147	Homo sapiens	IC50	nM	5.0
	2926156	CHEMBL1046769	Inhibition of EphB4 assessed as blockade of synthetic substrate phosphorylation at 10 uM by FRET assay	B	COc1ccccc1-n1c(-c2cccc3c2OCO3)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL575954	=	Activity	%	30.0	CHEMBL5147	Homo sapiens	Activity	%	30.0
	2926157	CHEMBL1046769	Inhibition of EphB4 assessed as blockade of synthetic substrate phosphorylation at 10 uM by FRET assay	B	CCCCn1c(-c2cccc(OC)c2)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL578025	=	Activity	%	36.0	CHEMBL5147	Homo sapiens	Activity	%	36.0
	2926158	CHEMBL1046769	Inhibition of EphB4 assessed as blockade of synthetic substrate phosphorylation at 10 uM by FRET assay	B	CCCCn1c(-c2cccc(C)c2)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL575120	=	Activity	%	37.0	CHEMBL5147	Homo sapiens	Activity	%	37.0
	2926159	CHEMBL1046769	Inhibition of EphB4 assessed as blockade of synthetic substrate phosphorylation at 10 uM by FRET assay	B	CCCCn1c(-c2ccc(C)cc2)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL573142	=	Activity	%	38.0	CHEMBL5147	Homo sapiens	Activity	%	38.0
	2926160	CHEMBL1046769	Inhibition of EphB4 assessed as blockade of synthetic substrate phosphorylation at 10 uM by FRET assay	B	Cn1c(=O)[nH]c(=O)c2c1nc1n(CCCCO)c(-c3ccc4c(c3)OCO4)cn21		CHEMBL574017	=	Activity	%	42.0	CHEMBL5147	Homo sapiens	Activity	%	42.0
	2926161	CHEMBL1046768	Inhibition of EphB4 by [gamma33-P]ATP based assay	B	COc1ccccc1-n1c(-c2ccccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL574236	=	IC50	nM	47.0	CHEMBL5147	Homo sapiens	IC50	nM	47.0
	2926162	CHEMBL1046769	Inhibition of EphB4 assessed as blockade of synthetic substrate phosphorylation at 10 uM by FRET assay	B	COc1ccccc1-n1c(-c2ccc(O)cc2)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL577596	=	Activity	%	59.0	CHEMBL5147	Homo sapiens	Activity	%	59.0
	2926163	CHEMBL1046769	Inhibition of EphB4 assessed as blockade of synthetic substrate phosphorylation at 10 uM by FRET assay	B	COc1ccccc1-n1c(-c2ccccc2O)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL575531	=	Activity	%	64.0	CHEMBL5147	Homo sapiens	Activity	%	64.0
	2926164	CHEMBL1046767	Inhibition of EphB4 assessed as blockade of synthetic substrate phosphorylation by FRET assay	B	COc1ccccc1-n1c(-c2ccccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL574236	=	IC50	nM	180.0	CHEMBL5147	Homo sapiens	IC50	nM	180.0
	2926165	CHEMBL1046768	Inhibition of EphB4 by [gamma33-P]ATP based assay	B	COc1ccccc1-n1c(-c2cccc(O)c2)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL575335	=	IC50	nM	213.0	CHEMBL5147	Homo sapiens	IC50	nM	213.0
	2926166	CHEMBL1046767	Inhibition of EphB4 assessed as blockade of synthetic substrate phosphorylation by FRET assay	B	COc1ccccc1-n1c(-c2ccc(O)cc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL583871	=	IC50	nM	236.0	CHEMBL5147	Homo sapiens	IC50	nM	236.0
	2926167	CHEMBL1046767	Inhibition of EphB4 assessed as blockade of synthetic substrate phosphorylation by FRET assay	B	COc1ccccc1-n1c(-c2cccc(O)c2)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL575335	=	IC50	nM	368.0	CHEMBL5147	Homo sapiens	IC50	nM	368.0
	2926168	CHEMBL1046767	Inhibition of EphB4 assessed as blockade of synthetic substrate phosphorylation by FRET assay	B	CCCCn1c(-c2ccc(O)cc2)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL575325	=	IC50	nM	558.0	CHEMBL5147	Homo sapiens	IC50	nM	558.0
	2926169	CHEMBL1046767	Inhibition of EphB4 assessed as blockade of synthetic substrate phosphorylation by FRET assay	B	CCCCn1c(-c2cccc(O)c2)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566959	=	IC50	nM	691.0	CHEMBL5147	Homo sapiens	IC50	nM	691.0
	2926170	CHEMBL1046767	Inhibition of EphB4 assessed as blockade of synthetic substrate phosphorylation by FRET assay	B	COc1ccccc1-n1c(-c2cccc(O)c2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL565871	=	IC50	nM	1200.0	CHEMBL5147	Homo sapiens	IC50	nM	1200.0
	2926171	CHEMBL1046767	Inhibition of EphB4 assessed as blockade of synthetic substrate phosphorylation by FRET assay	B	CCCCn1c(-c2ccccc2O)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL574461	=	IC50	nM	1600.0	CHEMBL5147	Homo sapiens	IC50	nM	1600.0
	2926172	CHEMBL1046767	Inhibition of EphB4 assessed as blockade of synthetic substrate phosphorylation by FRET assay	B	COc1ccccc1-n1c(-c2ccccc2)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL577156	=	IC50	nM	3300.0	CHEMBL5147	Homo sapiens	IC50	nM	3300.0
	2926173	CHEMBL1046768	Inhibition of EphB4 by [gamma33-P]ATP based assay	B	COc1ccccc1-n1c(-c2ccccc2)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL577156	=	IC50	nM	4350.0	CHEMBL5147	Homo sapiens	IC50	nM	4350.0
	2926174	CHEMBL1046767	Inhibition of EphB4 assessed as blockade of synthetic substrate phosphorylation by FRET assay	B	COc1ccccc1-n1c(-c2cc(O)ccc2O)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566516	=	IC50	nM	5000.0	CHEMBL5147	Homo sapiens	IC50	nM	5000.0
	2926175	CHEMBL1046767	Inhibition of EphB4 assessed as blockade of synthetic substrate phosphorylation by FRET assay	B	COc1ccccc1-n1c(-c2ccc(F)cc2)cn2c3c(=O)[nH]c(=O)[nH]c3nc12		CHEMBL577392	=	IC50	nM	5400.0	CHEMBL5147	Homo sapiens	IC50	nM	5400.0
	2926176	CHEMBL1046768	Inhibition of EphB4 by [gamma33-P]ATP based assay	B	Cn1c(=O)[nH]c(=O)c2c1nc1n(CCCCO)c(-c3ccccc3)cn21		CHEMBL271179	=	IC50	nM	5680.0	CHEMBL5147	Homo sapiens	IC50	nM	5680.0
	2926177	CHEMBL1046767	Inhibition of EphB4 assessed as blockade of synthetic substrate phosphorylation by FRET assay	B	Cn1c(=O)[nH]c(=O)c2c1nc1n(CCCCO)c(-c3ccccc3)cn21		CHEMBL271179	=	IC50	nM	7000.0	CHEMBL5147	Homo sapiens	IC50	nM	7000.0
	2926178	CHEMBL1046767	Inhibition of EphB4 assessed as blockade of synthetic substrate phosphorylation by FRET assay	B	COc1ccccc1-n1c(-c2ccc([N+](=O)[O-])cc2)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL575943	>	IC50	nM	20000.0	CHEMBL5147	Homo sapiens	IC50	nM	20000.0
	2926179	CHEMBL1046767	Inhibition of EphB4 assessed as blockade of synthetic substrate phosphorylation by FRET assay	B	COc1ccccc1-n1c(-c2ccc(C#N)cc2)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL575944	>	IC50	nM	20000.0	CHEMBL5147	Homo sapiens	IC50	nM	20000.0
	2926180	CHEMBL1046767	Inhibition of EphB4 assessed as blockade of synthetic substrate phosphorylation by FRET assay	B	COc1ccccc1-n1c(-c2ccc(C(=O)O)cc2)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL575334	>	IC50	nM	20000.0	CHEMBL5147	Homo sapiens	IC50	nM	20000.0
	2926181	CHEMBL1046767	Inhibition of EphB4 assessed as blockade of synthetic substrate phosphorylation by FRET assay	B	COc1ccccc1-n1c(-c2ccccc2)cn2c3c(=O)[nH]c(=O)n(Cc4ccccc4)c3nc12		CHEMBL577602	>	IC50	nM	10000.0	CHEMBL5147	Homo sapiens	IC50	nM	10000.0
	2926182	CHEMBL1046767	Inhibition of EphB4 assessed as blockade of synthetic substrate phosphorylation by FRET assay	B	COc1ccccc1-n1c(-c2ccc(F)cc2)cn2c3c(=O)[nH]c(=O)n(Cc4ccccc4)c3nc12		CHEMBL586052	>	IC50	nM	10000.0	CHEMBL5147	Homo sapiens	IC50	nM	10000.0
	2926183	CHEMBL1046767	Inhibition of EphB4 assessed as blockade of synthetic substrate phosphorylation by FRET assay	B	CCCCn1c(-c2ccccc2OC)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL575955	>	IC50	nM	10000.0	CHEMBL5147	Homo sapiens	IC50	nM	10000.0
	2926184	CHEMBL1046767	Inhibition of EphB4 assessed as blockade of synthetic substrate phosphorylation by FRET assay	B	CCCCn1c(-c2ccc(OC)cc2)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566741	>	IC50	nM	10000.0	CHEMBL5147	Homo sapiens	IC50	nM	10000.0
	2926185	CHEMBL1046767	Inhibition of EphB4 assessed as blockade of synthetic substrate phosphorylation by FRET assay	B	COc1ccccc1-n1c(-c2cccc(C)c2)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL578641	>	IC50	nM	10000.0	CHEMBL5147	Homo sapiens	IC50	nM	10000.0
	2926186	CHEMBL1046767	Inhibition of EphB4 assessed as blockade of synthetic substrate phosphorylation by FRET assay	B	COc1ccccc1-n1c(-c2ccc3c(c2)OCO3)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL575980	>	IC50	nM	20000.0	CHEMBL5147	Homo sapiens	IC50	nM	20000.0
	2928470	CHEMBL1049968	Binding affinity to EPHB4 assessed as percentage of kinase remaining bound to the bead at 1 uM by T7 phage display based binding assay	B	COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566515	=	Activity	%	1.2	CHEMBL5147	Homo sapiens	Activity	%	1.2
	2938509	CHEMBL1041356	Inhibition of EPH-B4 at 1 uM	B	Cc1cnc(Nc2ccc(F)cc2Cl)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1		CHEMBL583042	=	Inhibition	%	0.0	CHEMBL5147	Homo sapiens	INH	%	0.0
	2989958	CHEMBL1039185	Inhibition of EphB4 at 100 nM by radiometric protein kinase assay	B	CCn1cnc(-c2cc3nccc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccccc6)CC5)cc4F)c3s2)c1		CHEMBL565807	=	Inhibition	%	95.0	CHEMBL5147	Homo sapiens	INH	%	95.0
	2993558	CHEMBL1040933	Inhibition of human recombinant EphB4	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	IC50	nM	10000.0	CHEMBL5147	Homo sapiens	IC50	nM	10000.0
	3052601	CHEMBL1037577	Residual activity of EPHB4 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	114.0	CHEMBL5147	Homo sapiens	Residual activity	%	114.0
	3053910	CHEMBL1044310	Residual activity of EPHB4 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	99.0	CHEMBL5147	Homo sapiens	Residual activity	%	99.0
	3054162	CHEMBL1040630	Residual activity of EPHB4 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	108.0	CHEMBL5147	Homo sapiens	Residual activity	%	108.0
	3055449	CHEMBL1037577	Residual activity of EPHB4 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	127.0	CHEMBL5147	Homo sapiens	Residual activity	%	127.0
	3055701	CHEMBL1044310	Residual activity of EPHB4 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	154.0	CHEMBL5147	Homo sapiens	Residual activity	%	154.0
	3057006	CHEMBL1040630	Residual activity of EPHB4 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	98.0	CHEMBL5147	Homo sapiens	Residual activity	%	98.0
	3058326	CHEMBL1037577	Residual activity of EPHB4 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	127.0	CHEMBL5147	Homo sapiens	Residual activity	%	127.0
	3058578	CHEMBL1044310	Residual activity of EPHB4 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	122.0	CHEMBL5147	Homo sapiens	Residual activity	%	122.0
	3072924	CHEMBL1040630	Residual activity of EPHB4 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	98.0	CHEMBL5147	Homo sapiens	Residual activity	%	98.0
	3098426	CHEMBL1067991	Inhibition of human EphB4 at 0.1 uM	B	COc1ccccc1NC(=O)CC(Nc1ccc(Oc2ccnc3cc(-c4cn(C)cn4)sc23)c(F)c1)C(F)(F)F		CHEMBL591924	<	Inhibition	%	50.0	CHEMBL5147	Homo sapiens	INH	%	50.0
	3210406	CHEMBL1109419	Inhibition of EphB4 after 1 hr	B	COc1ccc(Br)cc1NC(=O)Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1		CHEMBL1080639	=	IC50	nM	26.0	CHEMBL5147	Homo sapiens	IC50	nM	26.0
	3210407	CHEMBL1109419	Inhibition of EphB4 after 1 hr	B	O=C(Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1079850	=	IC50	nM	49.0	CHEMBL5147	Homo sapiens	IC50	nM	49.0
	3210408	CHEMBL1109419	Inhibition of EphB4 after 1 hr	B	O=C(Nc1ccc(-c2cn3ccnc3c(NCc3ccncc3)n2)cc1)Nc1cccc(C(F)(F)F)c1		CHEMBL1081754	=	IC50	nM	50000.0	CHEMBL5147	Homo sapiens	IC50	uM	50.0
	3210409	CHEMBL1109419	Inhibition of EphB4 after 1 hr	B	O=C(NCc1cccc(C(F)(F)F)c1)c1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1		CHEMBL1079482	=	IC50	nM	11100.0	CHEMBL5147	Homo sapiens	IC50	uM	11.1
	3210410	CHEMBL1109419	Inhibition of EphB4 after 1 hr	B	O=C(NCc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1)Nc1cccc(C(F)(F)F)c1		CHEMBL1081228	=	IC50	nM	6800.0	CHEMBL5147	Homo sapiens	IC50	uM	6.8
	3210411	CHEMBL1109419	Inhibition of EphB4 after 1 hr	B	O=S(=O)(Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1)c1cccc(C(F)(F)F)c1		CHEMBL1080872	=	IC50	nM	50000.0	CHEMBL5147	Homo sapiens	IC50	uM	50.0
	3210412	CHEMBL1109419	Inhibition of EphB4 after 1 hr	B	O=C(NCc1cccc(C(F)(F)F)c1)Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1		CHEMBL1079621	=	IC50	nM	2100.0	CHEMBL5147	Homo sapiens	IC50	uM	2.1
	3210413	CHEMBL1109419	Inhibition of EphB4 after 1 hr	B	O=C(Cc1cccc(C(F)(F)F)c1)Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1		CHEMBL1079452	=	IC50	nM	2400.0	CHEMBL5147	Homo sapiens	IC50	uM	2.4
	3210414	CHEMBL1109419	Inhibition of EphB4 after 1 hr	B	O=C(Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1)c1cccc(C(F)(F)F)c1		CHEMBL1079795	=	IC50	nM	744.0	CHEMBL5147	Homo sapiens	IC50	uM	0.744
	3210415	CHEMBL1109419	Inhibition of EphB4 after 1 hr	B	O=C(Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1)Nc1cc(Cl)c(Cl)cc1Cl		CHEMBL1079794	=	IC50	nM	517.0	CHEMBL5147	Homo sapiens	IC50	uM	0.517
	3210416	CHEMBL1109419	Inhibition of EphB4 after 1 hr	B	CCOc1cc(OCC)c(C(F)(F)F)cc1NC(=O)Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1		CHEMBL1075667	=	IC50	nM	211.0	CHEMBL5147	Homo sapiens	IC50	uM	0.211
	3210417	CHEMBL1109419	Inhibition of EphB4 after 1 hr	B	COc1cc(OC)c(C(F)(F)F)cc1NC(=O)Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1		CHEMBL1075666	=	IC50	nM	518.0	CHEMBL5147	Homo sapiens	IC50	uM	0.518
	3210418	CHEMBL1109419	Inhibition of EphB4 after 1 hr	B	COc1cc(OC)c(NC(=O)Nc2cccc(-c3cn4ccnc4c(NCc4ccncc4)n3)c2)cc1Br		CHEMBL1080207	=	IC50	nM	206.0	CHEMBL5147	Homo sapiens	IC50	uM	0.206
	3210419	CHEMBL1109419	Inhibition of EphB4 after 1 hr	B	COc1cc(OC)c(NC(=O)Nc2cccc(-c3cn4ccnc4c(NCc4ccncc4)n3)c2)cc1Cl		CHEMBL1081013	=	IC50	nM	402.0	CHEMBL5147	Homo sapiens	IC50	uM	0.402
	3210420	CHEMBL1109419	Inhibition of EphB4 after 1 hr	B	O=C(Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1)Nc1ccc(Cl)c(C(F)(F)F)c1		CHEMBL1081916	=	IC50	nM	1200.0	CHEMBL5147	Homo sapiens	IC50	uM	1.2
	3210421	CHEMBL1109419	Inhibition of EphB4 after 1 hr	B	O=C(Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1)Nc1ccc(F)c(C(F)(F)F)c1		CHEMBL1081740	=	IC50	nM	850.0	CHEMBL5147	Homo sapiens	IC50	uM	0.85
	3210422	CHEMBL1109419	Inhibition of EphB4 after 1 hr	B	Cc1ccc(NC(=O)Nc2cccc(-c3cn4ccnc4c(NCc4ccncc4)n3)c2)cc1C(F)(F)F		CHEMBL1079751	=	IC50	nM	810.0	CHEMBL5147	Homo sapiens	IC50	uM	0.81
	3210423	CHEMBL1109419	Inhibition of EphB4 after 1 hr	B	COc1ccc(C#N)cc1NC(=O)Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1		CHEMBL1079750	=	IC50	nM	125.0	CHEMBL5147	Homo sapiens	IC50	uM	0.125
	3210424	CHEMBL1109419	Inhibition of EphB4 after 1 hr	B	COc1ccc(C)cc1NC(=O)Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1		CHEMBL1080640	=	IC50	nM	78.0	CHEMBL5147	Homo sapiens	IC50	uM	0.078
	3210425	CHEMBL1109419	Inhibition of EphB4 after 1 hr	B	Cc1ccc(Cl)cc1NC(=O)Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1		CHEMBL1081573	=	IC50	nM	160.0	CHEMBL5147	Homo sapiens	IC50	uM	0.16
	3210426	CHEMBL1109419	Inhibition of EphB4 after 1 hr	B	O=C(Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1)Nc1cc(Cl)ccc1Oc1ccccc1		CHEMBL1076138	=	IC50	nM	138.0	CHEMBL5147	Homo sapiens	IC50	uM	0.138
	3210427	CHEMBL1109419	Inhibition of EphB4 after 1 hr	B	COc1ccc(Cl)cc1NC(=O)Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1		CHEMBL1081403	=	IC50	nM	77.0	CHEMBL5147	Homo sapiens	IC50	uM	0.077
	3210428	CHEMBL1109419	Inhibition of EphB4 after 1 hr	B	O=C(Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1)Nc1c(Cl)cccc1Cl		CHEMBL1081402	=	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	uM	1.0
	3210429	CHEMBL1109419	Inhibition of EphB4 after 1 hr	B	O=C(Nc1cc(Cl)cc(Cl)c1)Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1		CHEMBL1081568	=	IC50	nM	1800.0	CHEMBL5147	Homo sapiens	IC50	uM	1.8
	3210430	CHEMBL1109419	Inhibition of EphB4 after 1 hr	B	O=C(Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1)Nc1ccc(Cl)c(Cl)c1		CHEMBL1081205	=	IC50	nM	2500.0	CHEMBL5147	Homo sapiens	IC50	uM	2.5
	3210431	CHEMBL1109419	Inhibition of EphB4 after 1 hr	B	O=C(Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1)Nc1ccc(Cl)cc1Cl		CHEMBL1081025	=	IC50	nM	1900.0	CHEMBL5147	Homo sapiens	IC50	uM	1.9
	3210432	CHEMBL1109419	Inhibition of EphB4 after 1 hr	B	O=C(Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1)Nc1cccc(Cl)c1Cl		CHEMBL1081024	=	IC50	nM	5700.0	CHEMBL5147	Homo sapiens	IC50	uM	5.7
	3210433	CHEMBL1109419	Inhibition of EphB4 after 1 hr	B	O=C(Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1)Nc1cc(C(F)(F)F)ccc1O		CHEMBL1079448	=	IC50	nM	37.0	CHEMBL5147	Homo sapiens	IC50	uM	0.037
	3210434	CHEMBL1109419	Inhibition of EphB4 after 1 hr	B	O=C(Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1)Nc1cc(Cl)ccc1Cl		CHEMBL1080353	=	IC50	nM	101.0	CHEMBL5147	Homo sapiens	IC50	uM	0.101
	3210435	CHEMBL1109419	Inhibition of EphB4 after 1 hr	B	Cc1ccc(C)c(NC(=O)Nc2cccc(-c3cn4ccnc4c(NCc4ccncc4)n3)c2)c1		CHEMBL1080191	=	IC50	nM	938.0	CHEMBL5147	Homo sapiens	IC50	uM	0.938
	3210436	CHEMBL1109419	Inhibition of EphB4 after 1 hr	B	O=C(Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1)Nc1cc(C(F)(F)F)ccc1Cl		CHEMBL1080190	=	IC50	nM	66.0	CHEMBL5147	Homo sapiens	IC50	uM	0.066
	3210437	CHEMBL1109419	Inhibition of EphB4 after 1 hr	B	COc1ccc(C(F)(F)F)cc1NC(=O)Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1		CHEMBL1079846	=	IC50	nM	37.0	CHEMBL5147	Homo sapiens	IC50	uM	0.037
	3210438	CHEMBL1109419	Inhibition of EphB4 after 1 hr	B	Cc1ccc(NC(=O)Nc2cccc(-c3cn4ccnc4c(NCc4ccncc4)n3)c2)cc1		CHEMBL1080000	=	IC50	nM	7900.0	CHEMBL5147	Homo sapiens	IC50	uM	7.9
	3210439	CHEMBL1109419	Inhibition of EphB4 after 1 hr	B	O=C(Nc1ccc(Cl)cc1)Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1		CHEMBL1079501	=	IC50	nM	4600.0	CHEMBL5147	Homo sapiens	IC50	uM	4.6
	3210440	CHEMBL1109419	Inhibition of EphB4 after 1 hr	B	O=C(Nc1ccc(F)cc1)Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1		CHEMBL1079500	=	IC50	nM	7400.0	CHEMBL5147	Homo sapiens	IC50	uM	7.4
	3210441	CHEMBL1109419	Inhibition of EphB4 after 1 hr	B	O=C(Nc1cccc(Oc2ccccc2)c1)Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1		CHEMBL1080669	=	IC50	nM	10500.0	CHEMBL5147	Homo sapiens	IC50	uM	10.5
	3210442	CHEMBL1109419	Inhibition of EphB4 after 1 hr	B	N#Cc1cccc(NC(=O)Nc2cccc(-c3cn4ccnc4c(NCc4ccncc4)n3)c2)c1		CHEMBL1080668	=	IC50	nM	1900.0	CHEMBL5147	Homo sapiens	IC50	uM	1.9
	3210443	CHEMBL1109419	Inhibition of EphB4 after 1 hr	B	CSc1cccc(NC(=O)Nc2cccc(-c3cn4ccnc4c(NCc4ccncc4)n3)c2)c1		CHEMBL1080841	=	IC50	nM	1200.0	CHEMBL5147	Homo sapiens	IC50	uM	1.2
	3210444	CHEMBL1109419	Inhibition of EphB4 after 1 hr	B	COc1cccc(NC(=O)Nc2cccc(-c3cn4ccnc4c(NCc4ccncc4)n3)c2)c1		CHEMBL1080530	=	IC50	nM	1700.0	CHEMBL5147	Homo sapiens	IC50	uM	1.7
	3210445	CHEMBL1109419	Inhibition of EphB4 after 1 hr	B	Cc1cccc(NC(=O)Nc2cccc(-c3cn4ccnc4c(NCc4ccncc4)n3)c2)c1		CHEMBL1080360	=	IC50	nM	300.0	CHEMBL5147	Homo sapiens	IC50	uM	0.3
	3210446	CHEMBL1109419	Inhibition of EphB4 after 1 hr	B	O=C(Nc1cccc(Br)c1)Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1		CHEMBL1080359	=	IC50	nM	213.0	CHEMBL5147	Homo sapiens	IC50	uM	0.213
	3210447	CHEMBL1109419	Inhibition of EphB4 after 1 hr	B	O=C(Nc1cccc(Cl)c1)Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1		CHEMBL1080024	=	IC50	nM	165.0	CHEMBL5147	Homo sapiens	IC50	uM	0.165
	3210448	CHEMBL1109419	Inhibition of EphB4 after 1 hr	B	O=C(Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1)Nc1ccccc1Br		CHEMBL1082108	=	IC50	nM	1700.0	CHEMBL5147	Homo sapiens	IC50	uM	1.7
	3210449	CHEMBL1109419	Inhibition of EphB4 after 1 hr	B	O=C(Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1)Nc1ccccc1Cl		CHEMBL1082107	=	IC50	nM	2900.0	CHEMBL5147	Homo sapiens	IC50	uM	2.9
	3210450	CHEMBL1109419	Inhibition of EphB4 after 1 hr	B	CN(Cc1ccncc1)c1nc(-c2cccc(NC(=O)Nc3cccc(C(F)(F)F)c3)c2)cn2ccnc12		CHEMBL1079810	=	IC50	nM	69.0	CHEMBL5147	Homo sapiens	IC50	uM	0.069
	3210451	CHEMBL1109419	Inhibition of EphB4 after 1 hr	B	O=C(Nc1cccc(-c2cn3ccnc3c(OCc3ccncc3)n2)c1)Nc1cccc(C(F)(F)F)c1		CHEMBL1079809	=	IC50	nM	105.0	CHEMBL5147	Homo sapiens	IC50	uM	0.105
	3210452	CHEMBL1109419	Inhibition of EphB4 after 1 hr	B	O=C(Nc1cccc(-c2cn3ccnc3c(NCc3ccc(C(=O)O)cc3)n2)c1)Nc1cccc(C(F)(F)F)c1		CHEMBL1081062	=	IC50	nM	5300.0	CHEMBL5147	Homo sapiens	IC50	uM	5.3
	3210453	CHEMBL1109419	Inhibition of EphB4 after 1 hr	B	O=C(Nc1cccc(-c2cn3ccnc3c(NCCc3ccncc3)n2)c1)Nc1cccc(C(F)(F)F)c1		CHEMBL1081061	=	IC50	nM	158.0	CHEMBL5147	Homo sapiens	IC50	uM	0.158
	3211512	CHEMBL1109419	Inhibition of EphB4 after 1 hr	B	O=C(Nc1cccc(-c2cn3ccnc3c(NCC3CCNCC3)n2)c1)Nc1cccc(C(F)(F)F)c1		CHEMBL1079960	=	IC50	nM	50000.0	CHEMBL5147	Homo sapiens	IC50	uM	50.0
	3211513	CHEMBL1109419	Inhibition of EphB4 after 1 hr	B	O=C(Nc1cccc(-c2cn3ccnc3c(NCc3cccnc3)n2)c1)Nc1cccc(C(F)(F)F)c1		CHEMBL1080206	=	IC50	nM	7800.0	CHEMBL5147	Homo sapiens	IC50	uM	7.8
	3211514	CHEMBL1109419	Inhibition of EphB4 after 1 hr	B	O=C(Nc1cccc(-c2cn3ccnc3c(NCc3ccccc3)n2)c1)Nc1cccc(C(F)(F)F)c1		CHEMBL1080362	=	IC50	nM	50000.0	CHEMBL5147	Homo sapiens	IC50	uM	50.0
	3211515	CHEMBL1109419	Inhibition of EphB4 after 1 hr	B	O=C(Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1)Nc1cccc(C(F)(F)F)c1		CHEMBL1081198	=	IC50	nM	62.0	CHEMBL5147	Homo sapiens	IC50	uM	0.062
	3211516	CHEMBL1109418	Inhibition of EphB4 at 10 uM after 1 hr	B	O=C(Nc1cccc(-c2cn3ccnc3c(Nc3ccccc3)n2)c1)Nc1cccc(C(F)(F)F)c1		CHEMBL1079964	=	Inhibition	%	36.0	CHEMBL5147	Homo sapiens	INH	%	36.0
	3211517	CHEMBL1109418	Inhibition of EphB4 at 10 uM after 1 hr	B	O=C(Nc1cccc(-c2cn3ccnc3c(Nc3ccncc3)n2)c1)Nc1cccc(C(F)(F)F)c1		CHEMBL1079796	=	Inhibition	%	32.0	CHEMBL5147	Homo sapiens	INH	%	32.0
	3211518	CHEMBL1109418	Inhibition of EphB4 at 10 uM after 1 hr	B	O=C(Nc1cccc(-c2cn3ccnc3c(NCc3ccccn3)n2)c1)Nc1cccc(C(F)(F)F)c1		CHEMBL1080205	=	Inhibition	%	32.0	CHEMBL5147	Homo sapiens	INH	%	32.0
	3211519	CHEMBL1109417	Inhibition of EphB4 at 1 uM after 1 hr	B	CCc1ccc(NC(=O)Nc2cccc(-c3cn4ccnc4c(NCc4ccncc4)n3)c2)cc1		CHEMBL1080670	=	Inhibition	%	10.0	CHEMBL5147	Homo sapiens	INH	%	10.0
	3211520	CHEMBL1109417	Inhibition of EphB4 at 1 uM after 1 hr	B	COc1ccc(C(F)(F)F)cc1NC(=O)CNc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1		CHEMBL1079648	=	Inhibition	%	2.9	CHEMBL5147	Homo sapiens	INH	%	2.9
	3211521	CHEMBL1109417	Inhibition of EphB4 at 1 uM after 1 hr	B	O=C(Nc1ccc(C(F)(F)F)cc1)Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1		CHEMBL1082113	=	Inhibition	%	10.0	CHEMBL5147	Homo sapiens	INH	%	10.0
	3211522	CHEMBL1109417	Inhibition of EphB4 at 1 uM after 1 hr	B	COc1ccc(NC(=O)Nc2cccc(-c3cn4ccnc4c(NCc4ccncc4)n3)c2)cc1		CHEMBL1081944	=	Inhibition	%	10.0	CHEMBL5147	Homo sapiens	INH	%	10.0
	3211523	CHEMBL1109417	Inhibition of EphB4 at 1 uM after 1 hr	B	O=C(Nc1ccc(Br)cc1)Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1		CHEMBL1079502	=	Inhibition	%	22.0	CHEMBL5147	Homo sapiens	INH	%	22.0
	3211524	CHEMBL1109417	Inhibition of EphB4 at 1 uM after 1 hr	B	O=C(Nc1cccc(F)c1)Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1		CHEMBL1080183	=	Inhibition	%	47.0	CHEMBL5147	Homo sapiens	INH	%	47.0
	3211525	CHEMBL1109417	Inhibition of EphB4 at 1 uM after 1 hr	B	O=C(Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1)Nc1ccccc1Oc1ccccc1		CHEMBL1080182	=	Inhibition	%	22.0	CHEMBL5147	Homo sapiens	INH	%	22.0
	3211526	CHEMBL1109417	Inhibition of EphB4 at 1 uM after 1 hr	B	CSc1ccccc1NC(=O)Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1		CHEMBL1080019	=	Inhibition	%	63.0	CHEMBL5147	Homo sapiens	INH	%	63.0
	3211527	CHEMBL1109417	Inhibition of EphB4 at 1 uM after 1 hr	B	O=C(Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1)Nc1ccccc1C(F)(F)F		CHEMBL1081948	=	Inhibition	%	41.0	CHEMBL5147	Homo sapiens	INH	%	41.0
	3211528	CHEMBL1109417	Inhibition of EphB4 at 1 uM after 1 hr	B	COc1ccccc1NC(=O)Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1		CHEMBL1080004	=	Inhibition	%	54.0	CHEMBL5147	Homo sapiens	INH	%	54.0
	3211529	CHEMBL1109417	Inhibition of EphB4 at 1 uM after 1 hr	B	Cc1ccccc1NC(=O)Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1		CHEMBL1082109	=	Inhibition	%	30.0	CHEMBL5147	Homo sapiens	INH	%	30.0
	3211530	CHEMBL1109417	Inhibition of EphB4 at 1 uM after 1 hr	B	O=C(Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1)Nc1ccccc1F		CHEMBL1081753	=	Inhibition	%	22.0	CHEMBL5147	Homo sapiens	INH	%	22.0
	3211531	CHEMBL1109417	Inhibition of EphB4 at 1 uM after 1 hr	B	O=C(Nc1ccccc1)Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1		CHEMBL1079811	=	Inhibition	%	10.0	CHEMBL5147	Homo sapiens	INH	%	10.0
	3211532	CHEMBL1109419	Inhibition of EphB4 after 1 hr	B	COc1ccc(Cl)cc1NC(=O)Nc1cccc(-c2cn3ccnc3c(N)n2)c1		CHEMBL1081222	=	IC50	nM	5400.0	CHEMBL5147	Homo sapiens	IC50	uM	5.4
	3211533	CHEMBL1109419	Inhibition of EphB4 after 1 hr	B	CNc1nc(-c2cccc(NC(=O)Nc3cc(Cl)ccc3OC)c2)cn2ccnc12		CHEMBL1081054	=	IC50	nM	5700.0	CHEMBL5147	Homo sapiens	IC50	uM	5.7
	3211547	CHEMBL1115704	Inhibition of EphB4 autophosphorylation by cell based assay	B	COc1ccc(C(F)(F)F)cc1NC(=O)Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1		CHEMBL1079846	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	3211548	CHEMBL1115704	Inhibition of EphB4 autophosphorylation by cell based assay	B	O=C(Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1079850	=	IC50	nM	400.0	CHEMBL5147	Homo sapiens	IC50	nM	400.0
	3211549	CHEMBL1115704	Inhibition of EphB4 autophosphorylation by cell based assay	B	COc1ccc(Br)cc1NC(=O)Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1		CHEMBL1080639	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	3211556	CHEMBL1109417	Inhibition of EphB4 at 1 uM after 1 hr	B	O=C(Nc1cccc(-c2cn3ccnc3c(Nc3cccnc3)n2)c1)Nc1cccc(C(F)(F)F)c1		CHEMBL1079963	=	Inhibition	%	1.0	CHEMBL5147	Homo sapiens	INH	%	1.0
	3213806	CHEMBL1108393	Inhibition of EPHB4 at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	103.0	CHEMBL5147	Homo sapiens	INH	%	103.0
	3224814	CHEMBL1099651	Inhibition of EPHB4 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL5147	Homo sapiens	INH	%	50.0
	3225064	CHEMBL1099651	Inhibition of EPHB4 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL5147	Homo sapiens	INH	%	50.0
	3294615	CHEMBL1103927	Inhibition of EphB4	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=O)c5cnn(-c6ccccc6)c5C(F)(F)F)cc4F)c3s2)c1		CHEMBL1094718	<	Inhibition	%	40.0	CHEMBL5147	Homo sapiens	INH	%	40.0
	3301990	CHEMBL1119044	Inhibition of EPHB4 at 1 uM	B	Clc1ccc(CN2CCN(c3c(Br)cnc4[nH]c(-c5ccc(CN6CCOCC6)cc5)nc34)CC2)cc1		CHEMBL1083772	=	Inhibition	%	4.0	CHEMBL5147	Homo sapiens	INH	%	4.0
	3331926	CHEMBL1169216	Inhibition of EPHB4 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL5147	Homo sapiens	INH	%	50.0
	3333341	CHEMBL1169216	Inhibition of EPHB4 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL5147	Homo sapiens	INH	%	50.0
	3334746	CHEMBL1169216	Inhibition of EPHB4 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL5147	Homo sapiens	INH	%	50.0
	3336166	CHEMBL1169216	Inhibition of EPHB4 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL5147	Homo sapiens	INH	%	50.0
	3337521	CHEMBL1169216	Inhibition of EPHB4 at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL5147	Homo sapiens	INH	%	50.0
	3337770	CHEMBL1169216	Inhibition of EPHB4 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL5147	Homo sapiens	INH	%	50.0
	3339104	CHEMBL1169216	Inhibition of EPHB4 at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL5147	Homo sapiens	INH	%	50.0
	3340406	CHEMBL1169216	Inhibition of EPHB4 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL5147	Homo sapiens	INH	%	50.0
	3340694	CHEMBL1169216	Inhibition of EPHB4 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL5147	Homo sapiens	INH	%	50.0
	3342110	CHEMBL1169216	Inhibition of EPHB4 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL5147	Homo sapiens	INH	%	50.0
	3358561	CHEMBL1174406	Inhibition of EPHB4 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	1.6	CHEMBL5147	Homo sapiens	INH	%	1.6
	3359003	CHEMBL1174406	Inhibition of EPHB4 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	0.8	CHEMBL5147	Homo sapiens	INH	%	0.8
	3439118	CHEMBL1247965	Inhibition of EphB4 by HTRF assay	B	CNc1nccc(-c2cccnc2Oc2ccc(NC(=O)c3cccc(C(F)(F)F)c3)cc2C)n1		CHEMBL1242977	>	IC50	nM	8000.0	CHEMBL5147	Homo sapiens	IC50	nM	8000.0
	3439185	CHEMBL1247965	Inhibition of EphB4 by HTRF assay	B	CNc1nccc(-c2cccnc2Oc2ccc(NC(=O)c3ccccc3Nc3ccccc3)cc2)n1		CHEMBL1243200	>	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	nM	1000.0
	3439198	CHEMBL1247965	Inhibition of EphB4 by HTRF assay	B	CNc1nccc(-c2cccnc2Oc2ccc(Nc3nnc(-c4ccc(F)cc4)c4ccccc34)cc2)n1		CHEMBL1243326	>	IC50	nM	25000.0	CHEMBL5147	Homo sapiens	IC50	nM	25000.0
	3440727	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc(O)cc(Br)c2)c2c(N)ncnc21		CHEMBL1242285	=	IC50	nM	17.0	CHEMBL5147	Homo sapiens	IC50	uM	0.017
	3440741	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COCOc1cc(-c2nn(C(C)C)c3ncnc(N)c23)ccc1Br		CHEMBL1242286	=	IC50	nM	100000.0	CHEMBL5147	Homo sapiens	IC50	uM	100.0
	3440755	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241299	=	IC50	nM	5800.0	CHEMBL5147	Homo sapiens	IC50	uM	5.8
	3440769	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Br)c(O)c1)nn2C1CCC1		CHEMBL1242287	=	IC50	nM	322.0	CHEMBL5147	Homo sapiens	IC50	uM	0.322
	3440783	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Br)c(O)c1)nn2C1CCCC1		CHEMBL1242376	=	IC50	nM	347.0	CHEMBL5147	Homo sapiens	IC50	uM	0.347
	3440797	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(F)c(O)c2)c2c(N)ncnc21		CHEMBL1242377	=	IC50	nM	166.0	CHEMBL5147	Homo sapiens	IC50	uM	0.166
	3440811	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	C[C@H](CN)n1nc(-c2ccc(F)c(O)c2)c2c(N)ncnc21		CHEMBL1242378	=	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	uM	1.0
	3440825	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	C[C@@H](CN)n1nc(-c2ccc(F)c(O)c2)c2c(N)ncnc21		CHEMBL1242468	=	IC50	nM	100000.0	CHEMBL5147	Homo sapiens	IC50	uM	100.0
	3440839	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	N#CCCCn1nc(-c2ccc(F)c(O)c2)c2c(N)ncnc21		CHEMBL1242469	=	IC50	nM	13000.0	CHEMBL5147	Homo sapiens	IC50	uM	13.0
	3440853	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	N#CCCCCn1nc(-c2ccc(F)c(O)c2)c2c(N)ncnc21		CHEMBL1242470	=	IC50	nM	100000.0	CHEMBL5147	Homo sapiens	IC50	uM	100.0
	3440867	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(F)c(O)c1)nn2C1CCC1		CHEMBL1242566	=	IC50	nM	2000.0	CHEMBL5147	Homo sapiens	IC50	uM	2.0
Not Determined	3440881	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(F)c(O)c1)nn2C1CNC1		CHEMBL1242567		IC50			CHEMBL5147	Homo sapiens	IC50		
	3440895	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(F)c(O)c1)nn2C1CCCC1		CHEMBL1242568	=	IC50	nM	64.0	CHEMBL5147	Homo sapiens	IC50	uM	0.064
	3440909	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC1CCC(n2nc(-c3ccc(F)c(O)c3)c3c(N)ncnc32)C1		CHEMBL1242656	=	IC50	nM	54.0	CHEMBL5147	Homo sapiens	IC50	uM	0.054
	3440923	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(F)c(O)c1)nn2[C@H]1CCNC1		CHEMBL1242657	=	IC50	nM	492.0	CHEMBL5147	Homo sapiens	IC50	uM	0.492
	3440937	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(F)c(O)c1)nn2[C@@H]1CCNC1		CHEMBL1242658	=	IC50	nM	100000.0	CHEMBL5147	Homo sapiens	IC50	uM	100.0
	3440951	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(F)c(O)c1)nn2[C@H]1CCOC1		CHEMBL1242748	=	IC50	nM	882.0	CHEMBL5147	Homo sapiens	IC50	uM	0.882
	3440965	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(F)c(O)c1)nn2[C@@H]1CCOC1		CHEMBL1242749	=	IC50	nM	611.0	CHEMBL5147	Homo sapiens	IC50	uM	0.611
	3440979	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(F)c(O)c1)nn2C1CCCCCC1		CHEMBL1242750	=	IC50	nM	254.0	CHEMBL5147	Homo sapiens	IC50	uM	0.254
	3440993	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(F)c(O)c1)nn2CC1CCNCC1		CHEMBL1242844	=	IC50	nM	100000.0	CHEMBL5147	Homo sapiens	IC50	uM	100.0
	3441007	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1nn(-c2ccccc2)nc1Cn1nc(-c2ccc(F)c(O)c2)c2c(N)ncnc21		CHEMBL1242845	=	IC50	nM	18700.0	CHEMBL5147	Homo sapiens	IC50	uM	18.7
	3441021	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(F)c(O)c1)nn2Cc1ocnc1-c1ccccc1		CHEMBL1241482	=	IC50	nM	100000.0	CHEMBL5147	Homo sapiens	IC50	uM	100.0
	3441035	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1cc(-c2nn(C(C)C)c3ncnc(N)c23)ccc1F		CHEMBL1241483	=	IC50	nM	244.0	CHEMBL5147	Homo sapiens	IC50	uM	0.244
	3441049	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Cl)c(O)c2)c2c(N)ncnc21		CHEMBL1241484	=	IC50	nM	106.0	CHEMBL5147	Homo sapiens	IC50	uM	0.106
	3441063	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	C[C@H](CN)n1nc(-c2ccc(Cl)c(O)c2)c2c(N)ncnc21		CHEMBL1241579	=	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	uM	1.0
	3441077	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	C[C@@H](CN)n1nc(-c2ccc(Cl)c(O)c2)c2c(N)ncnc21		CHEMBL1240544	=	IC50	nM	10000.0	CHEMBL5147	Homo sapiens	IC50	uM	10.0
	3441627	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1cc(-c2nn(C(C)C)c3ncnc(N)c23)ccc1NC(=O)OC(C)(C)C		CHEMBL1241481	>	IC50	nM	50000.0	CHEMBL5147	Homo sapiens	IC50	uM	50.0
	3441641	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	IC50	nM	220.0	CHEMBL5147	Homo sapiens	IC50	uM	0.22
	3441655	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	IC50	nM	190.0	CHEMBL5147	Homo sapiens	IC50	uM	0.19
	3441669	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	IC50	nM	240.0	CHEMBL5147	Homo sapiens	IC50	uM	0.24
	3441683	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	IC50	nM	1400.0	CHEMBL5147	Homo sapiens	IC50	uM	1.4
	3441697	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	IC50	nM	3400.0	CHEMBL5147	Homo sapiens	IC50	uM	3.4
	3441711	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccn3ccnc3c1)nn2C1CCCC1		CHEMBL1241675	=	IC50	nM	21000.0	CHEMBL5147	Homo sapiens	IC50	uM	21.0
	3441725	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1ccccc1-n1c(Cn2nc(-c3cccc(O)c3)c3c(N)ncnc32)nc2cccc(C)c2c1=O		CHEMBL1241767	>	IC50	nM	50000.0	CHEMBL5147	Homo sapiens	IC50	uM	50.0
	3441868	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	IC50	nM	316.0	CHEMBL5147	Homo sapiens	IC50	uM	0.316
	3441882	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	IC50	nM	4300.0	CHEMBL5147	Homo sapiens	IC50	uM	4.3
Not Determined	3441896	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3ccccc3)c12		CHEMBL1241104		IC50			CHEMBL5147	Homo sapiens	IC50		
Not Determined	3441910	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1ccc(-c2n[nH]c3ncnc(N)c23)cc1		CHEMBL1241142		IC50			CHEMBL5147	Homo sapiens	IC50		
Not Determined	3441924	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1cccc(-c2n[nH]c3ncnc(N)c23)c1		CHEMBL1241143		IC50			CHEMBL5147	Homo sapiens	IC50		
Not Determined	3441938	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1ccccc1-c1n[nH]c2ncnc(N)c12		CHEMBL1241144		IC50			CHEMBL5147	Homo sapiens	IC50		
Not Determined	3441952	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1cccc(-c2n[nH]c3ncnc(N)c23)c1C		CHEMBL1241145		IC50			CHEMBL5147	Homo sapiens	IC50		
Not Determined	3441966	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)(C)c1ccc(-c2n[nH]c3ncnc(N)c23)cc1		CHEMBL1241240		IC50			CHEMBL5147	Homo sapiens	IC50		
	3441980	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(O)cc2)c2c(N)ncnc21		CHEMBL1241241	=	IC50	nM	1230.0	CHEMBL5147	Homo sapiens	IC50	uM	1.23
Not Determined	3441994	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3cccc(O)c3)c12		CHEMBL1241242		IC50			CHEMBL5147	Homo sapiens	IC50		
Not Determined	3442008	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1cc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1241269		IC50			CHEMBL5147	Homo sapiens	IC50		
Not Determined	3442022	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CNc1ncnc2c1c(-c1cccc(O)c1)nn2C(C)C		CHEMBL1241942		IC50			CHEMBL5147	Homo sapiens	IC50		
	3442036	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1cc(O)ccc1-c1nn(C(C)C)c2ncnc(N)c12		CHEMBL1242024	=	IC50	nM	316.0	CHEMBL5147	Homo sapiens	IC50	uM	0.316
	3442050	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1ccc(-c2n[nH]c3ncnc(N)c23)cc1OCc1ccccc1		CHEMBL1242025	=	IC50	nM	12200.0	CHEMBL5147	Homo sapiens	IC50	uM	12.2
	3442064	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1ccc(-c2n[nH]c3ncnc(N)c23)cc1O		CHEMBL1241270	=	IC50	nM	18300.0	CHEMBL5147	Homo sapiens	IC50	uM	18.3
	3442078	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1ccc(-c2nn(C)c3ncnc(N)c23)cc1O		CHEMBL1241271	=	IC50	nM	8930.0	CHEMBL5147	Homo sapiens	IC50	uM	8.93
	3442092	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1ccc(-c2nn(C(C)C)c3ncnc(N)c23)cc1O		CHEMBL1242026	=	IC50	nM	249.0	CHEMBL5147	Homo sapiens	IC50	uM	0.249
	3442106	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CCC(C)n1nc(-c2ccc(C)c(O)c2)c2c(N)ncnc21		CHEMBL1242109	=	IC50	nM	1020.0	CHEMBL5147	Homo sapiens	IC50	uM	1.02
	3442120	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2F)c2c(N)ncnc21		CHEMBL1242110	=	IC50	nM	566.0	CHEMBL5147	Homo sapiens	IC50	uM	0.566
	3442134	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cccc(O)c1F)nn2C1CCCC1		CHEMBL1242111	=	IC50	nM	1020.0	CHEMBL5147	Homo sapiens	IC50	uM	1.02
	3442148	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc(O)cc(F)c2)c2c(N)ncnc21		CHEMBL1242198	=	IC50	nM	251.0	CHEMBL5147	Homo sapiens	IC50	uM	0.251
	3442162	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cc(O)cc(F)c1)nn2C1CCCC1		CHEMBL1242199	=	IC50	nM	96.0	CHEMBL5147	Homo sapiens	IC50	uM	0.096
	3442176	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1cc(Br)cc(-c2nn(C(C)C)c3ncnc(N)c23)c1		CHEMBL1242200	=	IC50	nM	3300.0	CHEMBL5147	Homo sapiens	IC50	uM	3.3
	3442186	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C[C@H](C)CO)c3ncnc(N)c23)cc1OC		CHEMBL1242380	=	IC50	nM	17000.0	CHEMBL5147	Homo sapiens	IC50	uM	17.0
	3442200	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C[C@@H](C)CO)c3ncnc(N)c23)cc1OC		CHEMBL1242381	=	IC50	nM	19000.0	CHEMBL5147	Homo sapiens	IC50	uM	19.0
	3442214	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCCC3)c3ncnc(N)c23)cc1OC		CHEMBL1240553	=	IC50	nM	1500.0	CHEMBL5147	Homo sapiens	IC50	uM	1.5
	3442228	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CCOc1ccc(-c2n[nH]c3ncnc(N)c23)cc1OC		CHEMBL1242471	=	IC50	nM	100000.0	CHEMBL5147	Homo sapiens	IC50	uM	100.0
	3442242	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CCOc1ccc(-c2nn(C(C)C)c3ncnc(N)c23)cc1OC		CHEMBL1242472	=	IC50	nM	4450.0	CHEMBL5147	Homo sapiens	IC50	uM	4.45
	3442256	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	C=CCn1nc(-c2ccc(OCC)c(OC)c2)c2c(N)ncnc21		CHEMBL1242569	=	IC50	nM	100000.0	CHEMBL5147	Homo sapiens	IC50	uM	100.0
	3442270	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CCOc1ccc(-c2nn(C3CCCC3)c3ncnc(N)c23)cc1OC		CHEMBL1240554	=	IC50	nM	456.0	CHEMBL5147	Homo sapiens	IC50	uM	0.456
	3442284	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CCOc1ccc(-c2nn(C3CCCCC3)c3ncnc(N)c23)cc1OC		CHEMBL1242659	=	IC50	nM	100000.0	CHEMBL5147	Homo sapiens	IC50	uM	100.0
	3442298	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1cc(-c2nn(C(C)C)c3ncnc(N)c23)cc(OC)c1OC		CHEMBL1242660	=	IC50	nM	760.0	CHEMBL5147	Homo sapiens	IC50	uM	0.76
	3442312	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1cccc(-c2nn(C(C)C)c3ncnc(N)c23)c1OC		CHEMBL1242751	=	IC50	nM	1100.0	CHEMBL5147	Homo sapiens	IC50	uM	1.1
	3442326	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CCOc1cc(-c2nn(C(C)C)c3ncnc(N)c23)ccc1OC		CHEMBL1242752	=	IC50	nM	14700.0	CHEMBL5147	Homo sapiens	IC50	uM	14.7
	3442340	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CCOc1cc(-c2nn(CCO)c3ncnc(N)c23)ccc1OC		CHEMBL1242753	=	IC50	nM	100000.0	CHEMBL5147	Homo sapiens	IC50	uM	100.0
	3442354	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ncc(-c2nn(C(C)C)c3ncnc(N)c23)c(OC)n1		CHEMBL1242846	=	IC50	nM	1090.0	CHEMBL5147	Homo sapiens	IC50	uM	1.09
	3442368	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C(C)C)c3ncnc(N)c23)cc1		CHEMBL1242847	=	IC50	nM	2980.0	CHEMBL5147	Homo sapiens	IC50	uM	2.98
Not Determined	3442382	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3ccccc3O)c12		CHEMBL1241355		IC50			CHEMBL5147	Homo sapiens	IC50		
	3442396	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(N)c(O)c2)c2c(N)ncnc21		CHEMBL1242848	=	IC50	nM	27200.0	CHEMBL5147	Homo sapiens	IC50	uM	27.2
	3442410	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1cc(-c2nn(C(C)C)c3ncnc(N)c23)ccc1N		CHEMBL1241485	=	IC50	nM	2630.0	CHEMBL5147	Homo sapiens	IC50	uM	2.63
	3442424	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1cc(-c2nn(C(C)C)c3ncnc(N)c23)ccc1NC(C)CO		CHEMBL1241486	=	IC50	nM	11000.0	CHEMBL5147	Homo sapiens	IC50	uM	11.0
	3442438	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ccc(-c2nn(C3CCCC3)c3ncnc(N)c23)cc1O		CHEMBL1241487	=	IC50	nM	764.0	CHEMBL5147	Homo sapiens	IC50	uM	0.764
	3442452	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1cc(-c2nn(C3CCCC3)c3ncnc(N)c23)ccc1N		CHEMBL1241581	=	IC50	nM	45.0	CHEMBL5147	Homo sapiens	IC50	uM	0.045
Not Determined	3442466	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ccc(-c2n[nH]c3ncnc(N)c23)cc1		CHEMBL1241356		IC50			CHEMBL5147	Homo sapiens	IC50		
Not Determined	3442480	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1cccc(-c2n[nH]c3ncnc(N)c23)c1		CHEMBL1241357		IC50			CHEMBL5147	Homo sapiens	IC50		
Not Determined	3442494	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3ccc([N+](=O)[O-])cc3)c12		CHEMBL1241358		IC50			CHEMBL5147	Homo sapiens	IC50		
Not Determined	3442508	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3cccc([N+](=O)[O-])c3)c12		CHEMBL1241389		IC50			CHEMBL5147	Homo sapiens	IC50		
	3442522	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(CO)c2)c2c(N)ncnc21		CHEMBL1241582	=	IC50	nM	100000.0	CHEMBL5147	Homo sapiens	IC50	uM	100.0
	3442536	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(CC#N)c2)c2c(N)ncnc21		CHEMBL1241583	=	IC50	nM	13000.0	CHEMBL5147	Homo sapiens	IC50	uM	13.0
	3442550	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(CC#N)cc2)c2c(N)ncnc21		CHEMBL1240545	=	IC50	nM	100000.0	CHEMBL5147	Homo sapiens	IC50	uM	100.0
	3442563	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(C#N)c2)c2c(N)ncnc21		CHEMBL1241679	=	IC50	nM	10000.0	CHEMBL5147	Homo sapiens	IC50	uM	10.0
	3442577	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(F)c(C#N)c2)c2c(N)ncnc21		CHEMBL1241680	=	IC50	nM	12000.0	CHEMBL5147	Homo sapiens	IC50	uM	12.0
	3442591	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(C#N)c(F)c2)c2c(N)ncnc21		CHEMBL1241771	=	IC50	nM	14000.0	CHEMBL5147	Homo sapiens	IC50	uM	14.0
	3442605	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(C#N)nc2)c2c(N)ncnc21		CHEMBL1241772	=	IC50	nM	100000.0	CHEMBL5147	Homo sapiens	IC50	uM	100.0
	3442619	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccnc2)c2c(N)ncnc21		CHEMBL1241390	=	IC50	nM	100000.0	CHEMBL5147	Homo sapiens	IC50	uM	100.0
	3442633	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cncnc2)c2c(N)ncnc21		CHEMBL1241391	=	IC50	nM	100000.0	CHEMBL5147	Homo sapiens	IC50	uM	100.0
	3442647	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(=O)c1ccc(-c2nn(C(C)C)c3ncnc(N)c23)cc1		CHEMBL1241773	=	IC50	nM	100000.0	CHEMBL5147	Homo sapiens	IC50	uM	100.0
	3442661	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(C=O)c(F)c2)c2c(N)ncnc21		CHEMBL1241860	=	IC50	nM	15000.0	CHEMBL5147	Homo sapiens	IC50	uM	15.0
	3442675	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc(F)c(C=O)c(F)c2)c2c(N)ncnc21		CHEMBL1241861	=	IC50	nM	7100.0	CHEMBL5147	Homo sapiens	IC50	uM	7.1
	3442689	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(C(N)=O)c(Cl)c2)c2c(N)ncnc21		CHEMBL1241862	=	IC50	nM	3100.0	CHEMBL5147	Homo sapiens	IC50	uM	3.1
	3442703	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(=O)c1cccc(-c2nn(C(C)C)c3ncnc(N)c23)c1		CHEMBL1241946	=	IC50	nM	3800.0	CHEMBL5147	Homo sapiens	IC50	uM	3.8
	3442717	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc(C=O)co2)c2c(N)ncnc21		CHEMBL1241439	=	IC50	nM	17000.0	CHEMBL5147	Homo sapiens	IC50	uM	17.0
	3442731	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1cc(-c2nn(C(C)C)c3ncnc(N)c23)sc1C=O		CHEMBL1241947	=	IC50	nM	23000.0	CHEMBL5147	Homo sapiens	IC50	uM	23.0
	3442744	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(NS(C)(=O)=O)c2)c2c(N)ncnc21		CHEMBL1241948	=	IC50	nM	100000.0	CHEMBL5147	Homo sapiens	IC50	uM	100.0
	3442757	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(NS(C)(=O)=O)cc2)c2c(N)ncnc21		CHEMBL1242030	=	IC50	nM	100000.0	CHEMBL5147	Homo sapiens	IC50	uM	100.0
	3442771	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(S(N)(=O)=O)c2)c2c(N)ncnc21		CHEMBL1242031	=	IC50	nM	18000.0	CHEMBL5147	Homo sapiens	IC50	uM	18.0
	3442785	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(S(N)(=O)=O)cc2)c2c(N)ncnc21		CHEMBL1242032	=	IC50	nM	15000.0	CHEMBL5147	Homo sapiens	IC50	uM	15.0
	3442799	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(C(=O)NC3=NCCS3)c2)c2c(N)ncnc21		CHEMBL1242115	=	IC50	nM	2910.0	CHEMBL5147	Homo sapiens	IC50	uM	2.91
Not Determined	3442813	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3ccc(NC(=O)c4ccc(-c5ccccc5)cc4)cc3)c12		CHEMBL1242116		IC50			CHEMBL5147	Homo sapiens	IC50		
Not Determined	3442827	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3ccc(Oc4ccccc4)cc3)c12		CHEMBL1242204		IC50			CHEMBL5147	Homo sapiens	IC50		
Not Determined	3442841	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3cccc(Oc4ccccc4)c3)c12		CHEMBL1242205		IC50			CHEMBL5147	Homo sapiens	IC50		
Not Determined	3442855	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc(OCc3ccccc3)cc2)c2c(N)ncnc21		CHEMBL1242206		IC50			CHEMBL5147	Homo sapiens	IC50		
Not Determined	3442869	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3cccc(OCc4ccccc4)c3)c12		CHEMBL1242291		IC50			CHEMBL5147	Homo sapiens	IC50		
Not Determined	3442883	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3cccc(OCc4c(Cl)cccc4Cl)c3)c12		CHEMBL1242292		IC50			CHEMBL5147	Homo sapiens	IC50		
Not Determined	3442897	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3ccccc3c1)nn2CCc1ccccc1		CHEMBL1242382		IC50			CHEMBL5147	Homo sapiens	IC50		
Not Determined	3442911	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	NC(=O)Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1242383		IC50			CHEMBL5147	Homo sapiens	IC50		
Not Determined	3442925	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3ccccc3c1)nn2CC1CC1		CHEMBL1242473		IC50			CHEMBL5147	Homo sapiens	IC50		
Not Determined	3442939	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)CCn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1242474		IC50			CHEMBL5147	Homo sapiens	IC50		
	3442950	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2C1CCC1		CHEMBL1241580	=	IC50	nM	1500.0	CHEMBL5147	Homo sapiens	IC50	uM	1.5
	3442964	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2C1CCCC1		CHEMBL1241676	=	IC50	nM	18.0	CHEMBL5147	Homo sapiens	IC50	uM	0.018
	3442978	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2[C@@H]1CCNC1		CHEMBL1241677	=	IC50	nM	468.0	CHEMBL5147	Homo sapiens	IC50	uM	0.468
	3442992	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2[C@H]1CCOC1		CHEMBL1241678	=	IC50	nM	256.0	CHEMBL5147	Homo sapiens	IC50	uM	0.256
	3443006	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2[C@@H]1CCOC1		CHEMBL1241768	=	IC50	nM	519.0	CHEMBL5147	Homo sapiens	IC50	uM	0.519
	3443020	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2CC1CCCN1		CHEMBL1241769	=	IC50	nM	8050.0	CHEMBL5147	Homo sapiens	IC50	uM	8.05
	3443034	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2CC1CCNC1		CHEMBL1241770	=	IC50	nM	352.0	CHEMBL5147	Homo sapiens	IC50	uM	0.352
	3443048	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2CC1CCCNC1		CHEMBL1241858	=	IC50	nM	100000.0	CHEMBL5147	Homo sapiens	IC50	uM	100.0
	3443062	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2CC1CCNCC1		CHEMBL1241859	=	IC50	nM	7270.0	CHEMBL5147	Homo sapiens	IC50	uM	7.27
	3443076	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc(Cl)c(O)c1)nn2CCC1CCCNC1		CHEMBL1241943	=	IC50	nM	3710.0	CHEMBL5147	Homo sapiens	IC50	uM	3.71
	3443090	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(C#N)c(O)c2)c2c(N)ncnc21		CHEMBL1241944	=	IC50	nM	5000.0	CHEMBL5147	Homo sapiens	IC50	uM	5.0
	3443104	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(O)c(F)c2)c2c(N)ncnc21		CHEMBL1241945	=	IC50	nM	628.0	CHEMBL5147	Homo sapiens	IC50	uM	0.628
	3443118	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1cc(F)c(-c2nn(C(C)C)c3ncnc(N)c23)cc1F		CHEMBL1242027	=	IC50	nM	1760.0	CHEMBL5147	Homo sapiens	IC50	uM	1.76
	3443132	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc(F)c(O)cc2F)c2c(N)ncnc21		CHEMBL1242028	=	IC50	nM	2700.0	CHEMBL5147	Homo sapiens	IC50	uM	2.7
	3443146	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1cccc(-c2nn(C(C)C)c3ncnc(N)c23)c1		CHEMBL1242029	=	IC50	nM	628.0	CHEMBL5147	Homo sapiens	IC50	uM	0.628
	3443160	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1cc(-c2nn(C(C)C)c3ncnc(N)c23)ccc1O		CHEMBL1242112	=	IC50	nM	1370.0	CHEMBL5147	Homo sapiens	IC50	uM	1.37
	3443174	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2n[nH]c3ncnc(N)c23)cc1O		CHEMBL1241300	=	IC50	nM	38100.0	CHEMBL5147	Homo sapiens	IC50	uM	38.1
	3443188	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C)c3ncnc(N)c23)cc1O		CHEMBL1241301	=	IC50	nM	7280.0	CHEMBL5147	Homo sapiens	IC50	uM	7.28
	3443202	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CCn1nc(-c2ccc(OC)c(O)c2)c2c(N)ncnc21		CHEMBL1242113	=	IC50	nM	2520.0	CHEMBL5147	Homo sapiens	IC50	uM	2.52
	3443216	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C(C)C)c3ncnc(N)c23)cc1O		CHEMBL1242114	=	IC50	nM	737.0	CHEMBL5147	Homo sapiens	IC50	uM	0.737
	3443230	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCCC3)c3ncnc(N)c23)cc1O		CHEMBL1242201	=	IC50	nM	258.0	CHEMBL5147	Homo sapiens	IC50	uM	0.258
	3443244	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC(C)C3)c3ncnc(N)c23)cc1O		CHEMBL1242202	=	IC50	nM	166.0	CHEMBL5147	Homo sapiens	IC50	uM	0.166
	3443258	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CNC3)c3ncnc(N)c23)cc1O		CHEMBL1242203	=	IC50	nM	3600.0	CHEMBL5147	Homo sapiens	IC50	uM	3.6
	3443272	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn([C@@H]3CCNC3)c3ncnc(N)c23)cc1O		CHEMBL1242288	=	IC50	nM	100000.0	CHEMBL5147	Homo sapiens	IC50	uM	100.0
	3443286	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CCOc1ccc(-c2nn(C3CCCC3)c3ncnc(N)c23)cc1O		CHEMBL1242289	=	IC50	nM	1250.0	CHEMBL5147	Homo sapiens	IC50	uM	1.25
	3443300	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C(C)C)c3ncnc(N)c23)cc1OC		CHEMBL1242290	=	IC50	nM	3500.0	CHEMBL5147	Homo sapiens	IC50	uM	3.5
	3443314	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1OC		CHEMBL1242379	=	IC50	nM	1180.0	CHEMBL5147	Homo sapiens	IC50	uM	1.18
	3443391	CHEMBL1244424	Inhibition of EPHB4 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	88.0	CHEMBL5147	Homo sapiens	INH	%	88.0
	3443608	CHEMBL1244424	Inhibition of EPHB4 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	86.0	CHEMBL5147	Homo sapiens	INH	%	86.0
Not Determined	3443747	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3ccccc3c1)nn2C/C=C/c1ccccc1		CHEMBL1242570		IC50			CHEMBL5147	Homo sapiens	IC50		
Not Determined	3443761	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	C#CCn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1242571		IC50			CHEMBL5147	Homo sapiens	IC50		
	3443775	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CCOc1ccc2cc(-c3nn(C)c4ncnc(N)c34)ccc2c1		CHEMBL1242661	=	IC50	nM	1100.0	CHEMBL5147	Homo sapiens	IC50	uM	1.1
	3443789	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3cc(O)ccc3c2)c2c(N)ncnc21		CHEMBL1242662	=	IC50	nM	95.0	CHEMBL5147	Homo sapiens	IC50	uM	0.095
	3443803	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3ccccc3nc2Cl)c2c(N)ncnc21		CHEMBL1242663	=	IC50	nM	2500.0	CHEMBL5147	Homo sapiens	IC50	uM	2.5
	3443817	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cnc3ccccc3c2)c2c(N)ncnc21		CHEMBL1242754	=	IC50	nM	1700.0	CHEMBL5147	Homo sapiens	IC50	uM	1.7
	3443831	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3ccccc3c1)nn2C1CCCC1		CHEMBL1242755	=	IC50	nM	660.0	CHEMBL5147	Homo sapiens	IC50	uM	0.66
	3443845	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1242756	=	IC50	nM	10000.0	CHEMBL5147	Homo sapiens	IC50	uM	10.0
Not Determined	3443859	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cn1nc(-c2cccc(-c3ccccc3)c2)c2c(N)ncnc21		CHEMBL1242849		IC50			CHEMBL5147	Homo sapiens	IC50		
Not Determined	3443873	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3ccc(-c4ccccc4)cc3)c12		CHEMBL1242850		IC50			CHEMBL5147	Homo sapiens	IC50		
Not Determined	3443887	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(C3CCc4ccccc4C3)c12		CHEMBL1241440		IC50			CHEMBL5147	Homo sapiens	IC50		
Not Determined	3443901	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3ccc4ccccc4c3)c12		CHEMBL1241441		IC50			CHEMBL5147	Homo sapiens	IC50		
Not Determined	3443915	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CCn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1242851		IC50			CHEMBL5147	Homo sapiens	IC50		
Not Determined	3443929	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	C=CCn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1241488		IC50			CHEMBL5147	Homo sapiens	IC50		
Not Determined	3443943	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1241489		IC50			CHEMBL5147	Homo sapiens	IC50		
Not Determined	3443957	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)(C)n1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1231371		IC50			CHEMBL5147	Homo sapiens	IC50		
Not Determined	3443971	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3ccccc3c1)nn2C1CCCC1		CHEMBL1241584		IC50			CHEMBL5147	Homo sapiens	IC50		
Not Determined	3443985	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3ccccc3c1)nn2Cc1ccccc1		CHEMBL1241585		IC50			CHEMBL5147	Homo sapiens	IC50		
	3443999	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3ncccc3c1)nn2C1CCCC1		CHEMBL1241681	=	IC50	nM	2700.0	CHEMBL5147	Homo sapiens	IC50	uM	2.7
	3444013	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1ccc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2n1		CHEMBL1241682	=	IC50	nM	2700.0	CHEMBL5147	Homo sapiens	IC50	uM	2.7
	3444027	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3nc(Cl)ccc3c2)c2c(N)ncnc21		CHEMBL1241683	=	IC50	nM	3200.0	CHEMBL5147	Homo sapiens	IC50	uM	3.2
	3444041	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3nccnc3c2)c2c(N)ncnc21		CHEMBL1241774	=	IC50	nM	32000.0	CHEMBL5147	Homo sapiens	IC50	uM	32.0
	3444055	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cnc3nccnc3c2)c2c(N)ncnc21		CHEMBL1241775	=	IC50	nM	100000.0	CHEMBL5147	Homo sapiens	IC50	uM	100.0
	3444069	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3nc[nH]c(=O)c3c2)c2c(N)ncnc21		CHEMBL1241776	=	IC50	nM	14000.0	CHEMBL5147	Homo sapiens	IC50	uM	14.0
	3444083	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3[nH]c(=O)ccc3c2)c2c(N)ncnc21		CHEMBL1241863	=	IC50	nM	12000.0	CHEMBL5147	Homo sapiens	IC50	uM	12.0
	3444097	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3[nH]c(=O)ccc3c1)nn2C1CCCC1		CHEMBL1241864	=	IC50	nM	100000.0	CHEMBL5147	Homo sapiens	IC50	uM	100.0
	3444111	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3nc(N)ccc3c2)c2c(N)ncnc21		CHEMBL1241949	=	IC50	nM	18000.0	CHEMBL5147	Homo sapiens	IC50	uM	18.0
	3444125	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3nc(NN)ccc3c2)c2c(N)ncnc21		CHEMBL1241950	=	IC50	nM	87000.0	CHEMBL5147	Homo sapiens	IC50	uM	87.0
	3444139	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3nccc(NC(=O)OC(C)(C)C)c3c2)c2c(N)ncnc21		CHEMBL1242033	=	IC50	nM	17000.0	CHEMBL5147	Homo sapiens	IC50	uM	17.0
	3444153	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3nccc(N)c3c2)c2c(N)ncnc21		CHEMBL1242034	=	IC50	nM	14000.0	CHEMBL5147	Homo sapiens	IC50	uM	14.0
	3444167	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3occc(=O)c3c2)c2c(N)ncnc21		CHEMBL1242117	=	IC50	nM	100000.0	CHEMBL5147	Homo sapiens	IC50	uM	100.0
	3444181	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3occc(=O)c3c2)c2c(N)ncnc21		CHEMBL1242118	=	IC50	nM	8600.0	CHEMBL5147	Homo sapiens	IC50	uM	8.6
	3444195	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3occc(=O)c3c1)nn2C1CCCC1		CHEMBL1242119	=	IC50	nM	18000.0	CHEMBL5147	Homo sapiens	IC50	uM	18.0
	3444209	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3cnccc3c2)c2c(N)ncnc21		CHEMBL1242207	=	IC50	nM	12000.0	CHEMBL5147	Homo sapiens	IC50	uM	12.0
	3444223	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ccncc3c2)c2c(N)ncnc21		CHEMBL1242208	=	IC50	nM	12000.0	CHEMBL5147	Homo sapiens	IC50	uM	12.0
	3444237	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1ccc2ccc(-c3nn(C(C)C)c4ncnc(N)c34)cc2n1		CHEMBL1242209	=	IC50	nM	3800.0	CHEMBL5147	Homo sapiens	IC50	uM	3.8
	3444251	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cn1nc(-c2cnc3[nH]ccc3c2)c2c(N)ncnc21		CHEMBL1240565	=	IC50	nM	2900.0	CHEMBL5147	Homo sapiens	IC50	uM	2.9
	3444265	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cnc3[nH]ccc3c2)c2c(N)ncnc21		CHEMBL1242293	=	IC50	nM	340.0	CHEMBL5147	Homo sapiens	IC50	uM	0.34
	3444279	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3[nH]ccc3c2)c2c(N)ncnc21		CHEMBL1242294	=	IC50	nM	230.0	CHEMBL5147	Homo sapiens	IC50	uM	0.23
	3444293	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1242295	=	IC50	nM	105.0	CHEMBL5147	Homo sapiens	IC50	uM	0.105
	3444307	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3c(ccn3C)c2)c2c(N)ncnc21		CHEMBL1242384	=	IC50	nM	100000.0	CHEMBL5147	Homo sapiens	IC50	uM	100.0
	3444321	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cn1ccc2cc(-c3nn(C4CCCC4)c4ncnc(N)c34)ccc21		CHEMBL1242385	=	IC50	nM	2200.0	CHEMBL5147	Homo sapiens	IC50	uM	2.2
	3444335	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3[nH]ncc3c2)c2c(N)ncnc21		CHEMBL1242386	=	IC50	nM	2300.0	CHEMBL5147	Homo sapiens	IC50	uM	2.3
	3444349	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3[nH]ncc3c1)nn2C1CCCC1		CHEMBL1242475	=	IC50	nM	2000.0	CHEMBL5147	Homo sapiens	IC50	uM	2.0
	3444363	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3c(N)n[nH]c3c2)c2c(N)ncnc21		CHEMBL1242476	=	IC50	nM	1300.0	CHEMBL5147	Homo sapiens	IC50	uM	1.3
	3444377	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3cn[nH]c3c2)c2c(N)ncnc21		CHEMBL1242477	=	IC50	nM	1600.0	CHEMBL5147	Homo sapiens	IC50	uM	1.6
	3444391	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3cn[nH]c3c1)nn2C1CCCC1		CHEMBL1242572	=	IC50	nM	1400.0	CHEMBL5147	Homo sapiens	IC50	uM	1.4
	3444405	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc(F)c3cn[nH]c3c2)c2c(N)ncnc21		CHEMBL1242573	=	IC50	nM	4500.0	CHEMBL5147	Homo sapiens	IC50	uM	4.5
	3444419	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3cc[nH]c3c2)c2c(N)ncnc21		CHEMBL1240566	=	IC50	nM	5000.0	CHEMBL5147	Homo sapiens	IC50	uM	5.0
	3444433	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3cc[nH]c3c2)c2c(N)ncnc21		CHEMBL1242574	=	IC50	nM	290.0	CHEMBL5147	Homo sapiens	IC50	uM	0.29
	3444447	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3cc[nH]c3c1)nn2C1CCCC1		CHEMBL1242664	=	IC50	nM	170.0	CHEMBL5147	Homo sapiens	IC50	uM	0.17
	3444461	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccn3ccnc3c2)c2c(N)ncnc21		CHEMBL1242665	=	IC50	nM	100000.0	CHEMBL5147	Homo sapiens	IC50	uM	100.0
	3444475	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3c(C=O)c[nH]c3c2)c2c(N)ncnc21		CHEMBL1242666	=	IC50	nM	2050.0	CHEMBL5147	Homo sapiens	IC50	uM	2.05
	3444489	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc3[nH]ccc23)c2c(N)ncnc21		CHEMBL1242757	=	IC50	nM	2900.0	CHEMBL5147	Homo sapiens	IC50	uM	2.9
	3444503	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cccc3[nH]ccc13)nn2C1CCCC1		CHEMBL1242758	=	IC50	nM	1600.0	CHEMBL5147	Homo sapiens	IC50	uM	1.6
	3444517	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3c(ccn3C(=O)OC(C)(C)C)c2)c2c(N)ncnc21		CHEMBL1242852	=	IC50	nM	353.0	CHEMBL5147	Homo sapiens	IC50	uM	0.353
	3444531	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)(C)OC(=O)n1ccc2cc(-c3nn(C4CCCC4)c4ncnc(N)c34)ccc21		CHEMBL1242853	=	IC50	nM	871.0	CHEMBL5147	Homo sapiens	IC50	uM	0.871
	3444545	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3occc3c2)c2c(N)ncnc21		CHEMBL1241490	=	IC50	nM	675.0	CHEMBL5147	Homo sapiens	IC50	uM	0.675
	3444559	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1ccc3occc3c1)nn2C1CCCC1		CHEMBL1241491	=	IC50	nM	380.0	CHEMBL5147	Homo sapiens	IC50	uM	0.38
	3444573	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3nonc3c2)c2c(N)ncnc21		CHEMBL1241492	=	IC50	nM	100000.0	CHEMBL5147	Homo sapiens	IC50	uM	100.0
	3444587	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3[nH]c(=O)[nH]c3c2)c2c(N)ncnc21		CHEMBL1241586	=	IC50	nM	17000.0	CHEMBL5147	Homo sapiens	IC50	uM	17.0
	3444601	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3c(c2)CCO3)c2c(N)ncnc21		CHEMBL1241587	=	IC50	nM	3000.0	CHEMBL5147	Homo sapiens	IC50	uM	3.0
Not Determined	3444615	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Nc1ncnc2[nH]nc(-c3ccc4c(c3)OCO4)c12		CHEMBL1240567		IC50			CHEMBL5147	Homo sapiens	IC50		
	3444629	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3c(c2)OCCO3)c2c(N)ncnc21		CHEMBL1241588	=	IC50	nM	6760.0	CHEMBL5147	Homo sapiens	IC50	uM	6.76
Not Determined	3444643	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cn1nc(-c2cc3ccccc3s2)c2c(N)ncnc21		CHEMBL1240594		IC50			CHEMBL5147	Homo sapiens	IC50		
	3444657	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(C=O)ccc3s2)c2c(N)ncnc21		CHEMBL1241684	=	IC50	nM	22000.0	CHEMBL5147	Homo sapiens	IC50	uM	22.0
	3444670	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	uM	1.0
	3444683	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	IC50	nM	1.0	CHEMBL5147	Homo sapiens	IC50	uM	0.001
	3444696	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	IC50	nM	50000.0	CHEMBL5147	Homo sapiens	IC50	uM	50.0
	3444763	CHEMBL1244424	Inhibition of EPHB4 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	80.0	CHEMBL5147	Homo sapiens	INH	%	80.0
	3445387	CHEMBL1244424	Inhibition of EPHB4 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	61.0	CHEMBL5147	Homo sapiens	INH	%	61.0
	3445604	CHEMBL1244424	Inhibition of EPHB4 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	37.0	CHEMBL5147	Homo sapiens	INH	%	37.0
	3445813	CHEMBL1244424	Inhibition of EPHB4 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	93.0	CHEMBL5147	Homo sapiens	INH	%	93.0
	3446003	CHEMBL1244424	Inhibition of EPHB4 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	70.0	CHEMBL5147	Homo sapiens	INH	%	70.0
	3446175	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	IC50	nM	1900.0	CHEMBL5147	Homo sapiens	IC50	uM	1.9
	3446176	CHEMBL1243978	Inhibition of recombinant EphB4R by radioactive phosphotransfer assay in presence of 10 uM ATP	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	IC50	nM	1900.0	CHEMBL5147	Homo sapiens	IC50	uM	1.9
	3446194	CHEMBL1244334	Inhibition of EPHB4	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	IC50	nM	5.5	CHEMBL5147	Homo sapiens	IC50	nM	5.5
	3448420	CHEMBL1244823	Binding affinity to EPHB4	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	uM	10.0
	3448745	CHEMBL1244823	Binding affinity to EPHB4	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	uM	10.0
	3449428	CHEMBL1244823	Binding affinity to EPHB4	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	1800.0	CHEMBL5147	Homo sapiens	Kd	nM	1800.0
	3449656	CHEMBL1244823	Binding affinity to EPHB4	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	uM	10.0
	3449928	CHEMBL1244823	Binding affinity to EPHB4	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	uM	10.0
	3450332	CHEMBL1244823	Binding affinity to EPHB4	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	uM	10.0
	3450988	CHEMBL1244823	Binding affinity to EPHB4	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	uM	10.0
	3463224	CHEMBL1252412	Inhibition of EPHB4 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	16.0	CHEMBL5147	Homo sapiens	INH	%	16.0
	3463443	CHEMBL1252412	Inhibition of EPHB4 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	11.0	CHEMBL5147	Homo sapiens	INH	%	11.0
	3463987	CHEMBL1252412	Inhibition of EPHB4 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	8.0	CHEMBL5147	Homo sapiens	INH	%	8.0
Not Active	3499127	CHEMBL1259871	Inhibition of EPHB4 at 10 uM relative to control	B	CCNC(=O)NCc1ccccc1-c1cc(-c2cnc(NC(C)C)s2)nc(NCCN(C)C)n1		CHEMBL1230171		Inhibition	%		CHEMBL5147	Homo sapiens	INH		
	3518517	CHEMBL1274251	Inhibition of EphB4 by acoustic dispensing assay	B	CS(=O)(=O)c1cccc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)c1		CHEMBL445162	=	IC50	nM	25.0	CHEMBL5147	Homo sapiens	IC50	uM	0.025
	3518518	CHEMBL1274251	Inhibition of EphB4 by acoustic dispensing assay	B	Clc1ccc2c(c1Nc1ccnc(Nc3cc(N4CCOCC4)cc(N4CCOCC4)c3)n1)OCO2		CHEMBL468970	=	IC50	nM	4.0	CHEMBL5147	Homo sapiens	IC50	uM	0.004
	3518519	CHEMBL1274251	Inhibition of EphB4 by acoustic dispensing assay	B	CS(=O)(=O)c1cccc(Nc2nccc(Nc3cccc4c3OCO4)n2)c1		CHEMBL1270569	=	IC50	nM	34.0	CHEMBL5147	Homo sapiens	IC50	uM	0.034
	3518520	CHEMBL1274251	Inhibition of EphB4 by acoustic dispensing assay	B	CS(=O)(=O)c1cccc(Nc2nccc(Nc3c(Cl)ccc4ccoc34)n2)c1		CHEMBL1270670	=	IC50	nM	300.0	CHEMBL5147	Homo sapiens	IC50	uM	0.3
	3518521	CHEMBL1274251	Inhibition of EphB4 by acoustic dispensing assay	B	CS(=O)(=O)c1cccc(Nc2nccc(Nc3cccc4ccoc34)n2)c1		CHEMBL1270671	=	IC50	nM	205.0	CHEMBL5147	Homo sapiens	IC50	uM	0.205
	3518522	CHEMBL1274251	Inhibition of EphB4 by acoustic dispensing assay	B	CS(=O)(=O)c1cccc(Nc2nccc(Nc3cccc4c3OCC4)n2)c1		CHEMBL1270772	=	IC50	nM	1160.0	CHEMBL5147	Homo sapiens	IC50	uM	1.16
	3518523	CHEMBL1274251	Inhibition of EphB4 by acoustic dispensing assay	B	CS(=O)(=O)c1cccc(Nc2nccc(Nc3cccc4ncoc34)n2)c1		CHEMBL1270773	=	IC50	nM	219.0	CHEMBL5147	Homo sapiens	IC50	uM	0.219
	3518524	CHEMBL1274251	Inhibition of EphB4 by acoustic dispensing assay	B	CS(=O)(=O)c1cccc(Nc2nccc(Nc3cccc4ocnc34)n2)c1		CHEMBL1270874	=	IC50	nM	549.0	CHEMBL5147	Homo sapiens	IC50	uM	0.549
	3518525	CHEMBL1274251	Inhibition of EphB4 by acoustic dispensing assay	B	CS(=O)(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL1236772	=	IC50	nM	61.0	CHEMBL5147	Homo sapiens	IC50	uM	0.061
	3518526	CHEMBL1274251	Inhibition of EphB4 by acoustic dispensing assay	B	CS(=O)(=O)c1cccc(Nc2nccc(Nc3cccc4c(Cl)c[nH]c34)n2)c1		CHEMBL1270975	=	IC50	nM	913.0	CHEMBL5147	Homo sapiens	IC50	uM	0.913
	3518527	CHEMBL1274251	Inhibition of EphB4 by acoustic dispensing assay	B	CN(c1ccnc(Nc2cccc(S(C)(=O)=O)c2)n1)c1c(Cl)ccc2c1OCO2		CHEMBL1270976	=	IC50	nM	36.0	CHEMBL5147	Homo sapiens	IC50	uM	0.036
	3518528	CHEMBL1274251	Inhibition of EphB4 by acoustic dispensing assay	B	CS(=O)(=O)c1cccc(Nc2nccc(N(CC#N)c3c(Cl)ccc4c3OCO4)n2)c1		CHEMBL1271081	=	IC50	nM	95.0	CHEMBL5147	Homo sapiens	IC50	uM	0.095
	3518529	CHEMBL1274251	Inhibition of EphB4 by acoustic dispensing assay	B	COCCN(c1ccnc(Nc2cccc(S(C)(=O)=O)c2)n1)c1c(Cl)ccc2c1OCO2		CHEMBL1271082	=	IC50	nM	246.0	CHEMBL5147	Homo sapiens	IC50	uM	0.246
	3518530	CHEMBL1274251	Inhibition of EphB4 by acoustic dispensing assay	B	CS(=O)(=O)c1cccc(Nc2nccc(N(CCO)c3c(Cl)ccc4c3OCO4)n2)c1		CHEMBL1271186	=	IC50	nM	121.0	CHEMBL5147	Homo sapiens	IC50	uM	0.121
	3518531	CHEMBL1274251	Inhibition of EphB4 by acoustic dispensing assay	B	c1cc(Nc2ccnc(Nc3cc(N4CCOCC4)cc(N4CCOCC4)c3)n2)c2cn[nH]c2c1		CHEMBL1271187	=	IC50	nM	11.0	CHEMBL5147	Homo sapiens	IC50	uM	0.011
	3518532	CHEMBL1274251	Inhibition of EphB4 by acoustic dispensing assay	B	c1cc(Nc2ccnc(Nc3cc(N4CCOCC4)cc(N4CCOCC4)c3)n2)c2[nH]ncc2c1		CHEMBL1271287	=	IC50	nM	89.0	CHEMBL5147	Homo sapiens	IC50	uM	0.089
	3518533	CHEMBL1274251	Inhibition of EphB4 by acoustic dispensing assay	B	c1cc(Nc2ccnc(Nc3cc(N4CCOCC4)cc(N4CCOCC4)c3)n2)c2cc[nH]c2c1		CHEMBL1271288	=	IC50	nM	117.0	CHEMBL5147	Homo sapiens	IC50	uM	0.117
	3518534	CHEMBL1274251	Inhibition of EphB4 by acoustic dispensing assay	B	c1cc(Nc2ccnc(Nc3cc(N4CCOCC4)cc(N4CCOCC4)c3)n2)c2nn[nH]c2c1		CHEMBL1271393	=	IC50	nM	115.0	CHEMBL5147	Homo sapiens	IC50	uM	0.115
	3518535	CHEMBL1274251	Inhibition of EphB4 by acoustic dispensing assay	B	CN(c1ccnc(Nc2cccc(S(C)(=O)=O)c2)n1)c1cccc2[nH]ncc12		CHEMBL1271394	=	IC50	nM	36.0	CHEMBL5147	Homo sapiens	IC50	uM	0.036
	3518536	CHEMBL1274251	Inhibition of EphB4 by acoustic dispensing assay	B	CN(c1ccnc(Nc2cc(N3CCOCC3)cc(N3CCOCC3)c2)n1)c1cccc2[nH]ncc12		CHEMBL1269858	=	IC50	nM	1.3	CHEMBL5147	Homo sapiens	IC50	uM	0.0013
	3518537	CHEMBL1274251	Inhibition of EphB4 by acoustic dispensing assay	B	OCc1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL1269859	=	IC50	nM	204.0	CHEMBL5147	Homo sapiens	IC50	uM	0.204
	3518538	CHEMBL1274251	Inhibition of EphB4 by acoustic dispensing assay	B	CN(c1ccnc(Nc2cccc(CO)c2)n1)c1cccc2[nH]ncc12		CHEMBL1269964	=	IC50	nM	21.0	CHEMBL5147	Homo sapiens	IC50	uM	0.021
	3518539	CHEMBL1274251	Inhibition of EphB4 by acoustic dispensing assay	B	CN(C)C(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL1269965	=	IC50	nM	246.0	CHEMBL5147	Homo sapiens	IC50	uM	0.246
	3518540	CHEMBL1274251	Inhibition of EphB4 by acoustic dispensing assay	B	CN(C)C(=O)c1cccc(Nc2nccc(N(C)c3cccc4[nH]ncc34)n2)c1		CHEMBL1270075	=	IC50	nM	29.0	CHEMBL5147	Homo sapiens	IC50	uM	0.029
	3518541	CHEMBL1274251	Inhibition of EphB4 by acoustic dispensing assay	B	CS(=O)(=O)Nc1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL1270076	=	IC50	nM	84.0	CHEMBL5147	Homo sapiens	IC50	uM	0.084
	3518542	CHEMBL1274251	Inhibition of EphB4 by acoustic dispensing assay	B	CN(c1ccnc(Nc2cccc(NS(C)(=O)=O)c2)n1)c1cccc2[nH]ncc12		CHEMBL1270182	=	IC50	nM	13.0	CHEMBL5147	Homo sapiens	IC50	uM	0.013
	3518543	CHEMBL1274251	Inhibition of EphB4 by acoustic dispensing assay	B	Cc1n[nH]c2cccc(Nc3ccnc(Nc4cc(N5CCOCC5)cc(N5CCOCC5)c4)n3)c12		CHEMBL1270183	=	IC50	nM	67.0	CHEMBL5147	Homo sapiens	IC50	uM	0.067
	3518544	CHEMBL1274251	Inhibition of EphB4 by acoustic dispensing assay	B	Clc1n[nH]c2cccc(Nc3ccnc(Nc4cc(N5CCOCC5)cc(N5CCOCC5)c4)n3)c12		CHEMBL1270279	=	IC50	nM	55.0	CHEMBL5147	Homo sapiens	IC50	uM	0.055
	3518545	CHEMBL1274251	Inhibition of EphB4 by acoustic dispensing assay	B	CN(c1ccnc(Nc2cc(N3CCOCC3)nc(N3CCOCC3)c2)n1)c1cccc2[nH]ncc12		CHEMBL1270280	=	IC50	nM	0.9	CHEMBL5147	Homo sapiens	IC50	uM	0.0009
	3518546	CHEMBL1274251	Inhibition of EphB4 by acoustic dispensing assay	B	CN(c1ccnc(Nc2cc(N3CCOCC3)nc(N3CCOCC3)n2)n1)c1cccc2[nH]ncc12		CHEMBL1270378	=	IC50	nM	2.6	CHEMBL5147	Homo sapiens	IC50	uM	0.0026
	3518547	CHEMBL1274251	Inhibition of EphB4 by acoustic dispensing assay	B	CN(c1ccnc(Nc2nc(N3CCOCC3)cc(N3CCOCC3)n2)n1)c1cccc2[nH]ncc12		CHEMBL1270379	=	IC50	nM	432.0	CHEMBL5147	Homo sapiens	IC50	uM	0.432
	3518548	CHEMBL1274252	Inhibition of EphB4 autophosphorylation expressed in CHOK1 cells	B	CS(=O)(=O)c1cccc(Nc2nccc(Nc3c(Cl)ccc4c3OCO4)n2)c1		CHEMBL445162	=	IC50	nM	187.0	CHEMBL5147	Homo sapiens	IC50	uM	0.187
	3518549	CHEMBL1274252	Inhibition of EphB4 autophosphorylation expressed in CHOK1 cells	B	Clc1ccc2c(c1Nc1ccnc(Nc3cc(N4CCOCC4)cc(N4CCOCC4)c3)n1)OCO2		CHEMBL468970	=	IC50	nM	14.0	CHEMBL5147	Homo sapiens	IC50	uM	0.014
	3518550	CHEMBL1274252	Inhibition of EphB4 autophosphorylation expressed in CHOK1 cells	B	CS(=O)(=O)c1cccc(Nc2nccc(Nc3cccc4c3OCO4)n2)c1		CHEMBL1270569	=	IC50	nM	186.0	CHEMBL5147	Homo sapiens	IC50	uM	0.186
	3518551	CHEMBL1274252	Inhibition of EphB4 autophosphorylation expressed in CHOK1 cells	B	CS(=O)(=O)c1cccc(Nc2nccc(Nc3c(Cl)ccc4ccoc34)n2)c1		CHEMBL1270670	=	IC50	nM	897.0	CHEMBL5147	Homo sapiens	IC50	uM	0.897
	3518552	CHEMBL1274252	Inhibition of EphB4 autophosphorylation expressed in CHOK1 cells	B	CS(=O)(=O)c1cccc(Nc2nccc(Nc3cccc4ccoc34)n2)c1		CHEMBL1270671	=	IC50	nM	460.0	CHEMBL5147	Homo sapiens	IC50	uM	0.46
	3518553	CHEMBL1274252	Inhibition of EphB4 autophosphorylation expressed in CHOK1 cells	B	CS(=O)(=O)c1cccc(Nc2nccc(Nc3cccc4c3OCC4)n2)c1		CHEMBL1270772	=	IC50	nM	1720.0	CHEMBL5147	Homo sapiens	IC50	uM	1.72
	3518554	CHEMBL1274252	Inhibition of EphB4 autophosphorylation expressed in CHOK1 cells	B	CS(=O)(=O)c1cccc(Nc2nccc(Nc3cccc4ncoc34)n2)c1		CHEMBL1270773	=	IC50	nM	1350.0	CHEMBL5147	Homo sapiens	IC50	uM	1.35
	3518555	CHEMBL1274252	Inhibition of EphB4 autophosphorylation expressed in CHOK1 cells	B	CS(=O)(=O)c1cccc(Nc2nccc(Nc3cccc4ocnc34)n2)c1		CHEMBL1270874	=	IC50	nM	1760.0	CHEMBL5147	Homo sapiens	IC50	uM	1.76
	3518556	CHEMBL1274252	Inhibition of EphB4 autophosphorylation expressed in CHOK1 cells	B	CS(=O)(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL1236772	=	IC50	nM	2530.0	CHEMBL5147	Homo sapiens	IC50	uM	2.53
	3518557	CHEMBL1274252	Inhibition of EphB4 autophosphorylation expressed in CHOK1 cells	B	CN(c1ccnc(Nc2cccc(S(C)(=O)=O)c2)n1)c1c(Cl)ccc2c1OCO2		CHEMBL1270976	=	IC50	nM	42.0	CHEMBL5147	Homo sapiens	IC50	uM	0.042
	3518558	CHEMBL1274252	Inhibition of EphB4 autophosphorylation expressed in CHOK1 cells	B	CS(=O)(=O)c1cccc(Nc2nccc(N(CC#N)c3c(Cl)ccc4c3OCO4)n2)c1		CHEMBL1271081	=	IC50	nM	190.0	CHEMBL5147	Homo sapiens	IC50	uM	0.19
	3518559	CHEMBL1274252	Inhibition of EphB4 autophosphorylation expressed in CHOK1 cells	B	COCCN(c1ccnc(Nc2cccc(S(C)(=O)=O)c2)n1)c1c(Cl)ccc2c1OCO2		CHEMBL1271082	=	IC50	nM	378.0	CHEMBL5147	Homo sapiens	IC50	uM	0.378
	3518560	CHEMBL1274252	Inhibition of EphB4 autophosphorylation expressed in CHOK1 cells	B	CS(=O)(=O)c1cccc(Nc2nccc(N(CCO)c3c(Cl)ccc4c3OCO4)n2)c1		CHEMBL1271186	=	IC50	nM	187.0	CHEMBL5147	Homo sapiens	IC50	uM	0.187
	3518561	CHEMBL1274252	Inhibition of EphB4 autophosphorylation expressed in CHOK1 cells	B	c1cc(Nc2ccnc(Nc3cc(N4CCOCC4)cc(N4CCOCC4)c3)n2)c2cn[nH]c2c1		CHEMBL1271187	=	IC50	nM	302.0	CHEMBL5147	Homo sapiens	IC50	uM	0.302
	3518562	CHEMBL1274252	Inhibition of EphB4 autophosphorylation expressed in CHOK1 cells	B	c1cc(Nc2ccnc(Nc3cc(N4CCOCC4)cc(N4CCOCC4)c3)n2)c2[nH]ncc2c1		CHEMBL1271287	=	IC50	nM	3500.0	CHEMBL5147	Homo sapiens	IC50	uM	3.5
	3518563	CHEMBL1274252	Inhibition of EphB4 autophosphorylation expressed in CHOK1 cells	B	c1cc(Nc2ccnc(Nc3cc(N4CCOCC4)cc(N4CCOCC4)c3)n2)c2cc[nH]c2c1		CHEMBL1271288	=	IC50	nM	856.0	CHEMBL5147	Homo sapiens	IC50	uM	0.856
	3518564	CHEMBL1274252	Inhibition of EphB4 autophosphorylation expressed in CHOK1 cells	B	c1cc(Nc2ccnc(Nc3cc(N4CCOCC4)cc(N4CCOCC4)c3)n2)c2nn[nH]c2c1		CHEMBL1271393	=	IC50	nM	8600.0	CHEMBL5147	Homo sapiens	IC50	uM	8.6
	3518565	CHEMBL1274252	Inhibition of EphB4 autophosphorylation expressed in CHOK1 cells	B	CN(c1ccnc(Nc2cccc(S(C)(=O)=O)c2)n1)c1cccc2[nH]ncc12		CHEMBL1271394	=	IC50	nM	51.0	CHEMBL5147	Homo sapiens	IC50	uM	0.051
	3518566	CHEMBL1274252	Inhibition of EphB4 autophosphorylation expressed in CHOK1 cells	B	CN(c1ccnc(Nc2cc(N3CCOCC3)cc(N3CCOCC3)c2)n1)c1cccc2[nH]ncc12		CHEMBL1269858	=	IC50	nM	9.0	CHEMBL5147	Homo sapiens	IC50	uM	0.009
	3518567	CHEMBL1274252	Inhibition of EphB4 autophosphorylation expressed in CHOK1 cells	B	OCc1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL1269859	=	IC50	nM	4400.0	CHEMBL5147	Homo sapiens	IC50	uM	4.4
	3518568	CHEMBL1274252	Inhibition of EphB4 autophosphorylation expressed in CHOK1 cells	B	CN(c1ccnc(Nc2cccc(CO)c2)n1)c1cccc2[nH]ncc12		CHEMBL1269964	=	IC50	nM	232.0	CHEMBL5147	Homo sapiens	IC50	uM	0.232
	3518569	CHEMBL1274252	Inhibition of EphB4 autophosphorylation expressed in CHOK1 cells	B	CN(C)C(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL1269965	=	IC50	nM	10400.0	CHEMBL5147	Homo sapiens	IC50	uM	10.4
	3518570	CHEMBL1274252	Inhibition of EphB4 autophosphorylation expressed in CHOK1 cells	B	CN(C)C(=O)c1cccc(Nc2nccc(N(C)c3cccc4[nH]ncc34)n2)c1		CHEMBL1270075	=	IC50	nM	453.0	CHEMBL5147	Homo sapiens	IC50	uM	0.453
	3518571	CHEMBL1274252	Inhibition of EphB4 autophosphorylation expressed in CHOK1 cells	B	CS(=O)(=O)Nc1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL1270076	=	IC50	nM	8420.0	CHEMBL5147	Homo sapiens	IC50	uM	8.42
	3518572	CHEMBL1274252	Inhibition of EphB4 autophosphorylation expressed in CHOK1 cells	B	Cc1n[nH]c2cccc(Nc3ccnc(Nc4cc(N5CCOCC5)cc(N5CCOCC5)c4)n3)c12		CHEMBL1270183	=	IC50	nM	513.0	CHEMBL5147	Homo sapiens	IC50	uM	0.513
	3518573	CHEMBL1274252	Inhibition of EphB4 autophosphorylation expressed in CHOK1 cells	B	Clc1n[nH]c2cccc(Nc3ccnc(Nc4cc(N5CCOCC5)cc(N5CCOCC5)c4)n3)c12		CHEMBL1270279	=	IC50	nM	227.0	CHEMBL5147	Homo sapiens	IC50	uM	0.227
	3518574	CHEMBL1274252	Inhibition of EphB4 autophosphorylation expressed in CHOK1 cells	B	CN(c1ccnc(Nc2cc(N3CCOCC3)nc(N3CCOCC3)c2)n1)c1cccc2[nH]ncc12		CHEMBL1270280	=	IC50	nM	5.0	CHEMBL5147	Homo sapiens	IC50	uM	0.005
	3518575	CHEMBL1274252	Inhibition of EphB4 autophosphorylation expressed in CHOK1 cells	B	CN(c1ccnc(Nc2cc(N3CCOCC3)nc(N3CCOCC3)n2)n1)c1cccc2[nH]ncc12		CHEMBL1270378	=	IC50	nM	24.0	CHEMBL5147	Homo sapiens	IC50	uM	0.024
	3518576	CHEMBL1274252	Inhibition of EphB4 autophosphorylation expressed in CHOK1 cells	B	CN(c1ccnc(Nc2nc(N3CCOCC3)cc(N3CCOCC3)n2)n1)c1cccc2[nH]ncc12		CHEMBL1270379	=	IC50	nM	12000.0	CHEMBL5147	Homo sapiens	IC50	uM	12.0
	5120403	CHEMBL1645957	Inhibition of human EphB4 at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	108.0	CHEMBL5147	Homo sapiens	INH	%	108.0
	5143818	CHEMBL1656205	Inhibition of EPHB4	B	CCN(Cc1cc(Nc2nc(C)cn3c(-c4cn[nH]c4)cnc23)sn1)C(C)(C)CO.Cl		CHEMBL1650533	=	IC50	nM	100.0	CHEMBL5147	Homo sapiens	IC50	nM	100.0
	5143824	CHEMBL1656205	Inhibition of EPHB4	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(CN3CCC(F)(F)C3)ns2)n1.Cl		CHEMBL1650545	=	IC50	nM	770.0	CHEMBL5147	Homo sapiens	IC50	nM	770.0
	5143830	CHEMBL1656205	Inhibition of EPHB4	B	Cl.[2H]C([2H])(c1cc(Nc2nc(C)cn3c(-c4cn[nH]c4)cnc23)sn1)N1CCC(F)(F)C1		CHEMBL1650551	=	IC50	nM	700.0	CHEMBL5147	Homo sapiens	IC50	nM	700.0
	5152421	CHEMBL1656373	Inhibition of EPHB4 by TR-FRET based LanthaScreen assay	B	COc1cc(O)c2c(c1)CCC[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL2012519	>	IC50	nM	10000.0	CHEMBL5147	Homo sapiens	IC50	nM	10000.0
	5152433	CHEMBL1656373	Inhibition of EPHB4 by TR-FRET based LanthaScreen assay	B	COc1cc(O)c2c(c1)CCC[C@H](O)CC(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1651521	=	IC50	nM	7400.0	CHEMBL5147	Homo sapiens	IC50	nM	7400.0
	5152445	CHEMBL1656373	Inhibition of EPHB4 by TR-FRET based LanthaScreen assay	B	COc1cc(O)c2c(c1)CCC[C@H](O)CC(=O)/C=C/C[C@H](C)OC2=O		CHEMBL1651522	>	IC50	nM	10000.0	CHEMBL5147	Homo sapiens	IC50	nM	10000.0
	5152457	CHEMBL1656373	Inhibition of EPHB4 by TR-FRET based LanthaScreen assay	B	COc1cc(O)c2c(c1)CCCCCC(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1651523	>	IC50	nM	10000.0	CHEMBL5147	Homo sapiens	IC50	nM	10000.0
	5243701	CHEMBL1685664	Inhibition of EphB4 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	101.0	CHEMBL5147	Homo sapiens	INH	%	101.0
	5243809	CHEMBL1685913	Inhibition of EphB4 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCN(Cc6ccccc6)CC5)cc34)[nH]c2c1		CHEMBL1684543	=	Inhibition	%	92.0	CHEMBL5147	Homo sapiens	INH	%	92.0
	5243922	CHEMBL1685664	Inhibition of EphB4 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	106.0	CHEMBL5147	Homo sapiens	INH	%	106.0
	5244030	CHEMBL1685913	Inhibition of EphB4 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NC5CCNC5)cc34)[nH]c2c1		CHEMBL1684654	=	Inhibition	%	62.0	CHEMBL5147	Homo sapiens	INH	%	62.0
	5244903	CHEMBL1685664	Inhibition of EphB4 at 0.1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	95.0	CHEMBL5147	Homo sapiens	INH	%	95.0
	5245011	CHEMBL1685913	Inhibition of EphB4 at 1 uM	B	O=C(Cc1ccc2cc(-c3n[nH]c4cccnc34)[nH]c2c1)c1ccccc1		CHEMBL1684662	=	Inhibition	%	69.0	CHEMBL5147	Homo sapiens	INH	%	69.0
	5245162	CHEMBL1685664	Inhibition of EphB4 at 0.1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	112.0	CHEMBL5147	Homo sapiens	INH	%	112.0
	5245992	CHEMBL1685913	Inhibition of EphB4 at 1 uM	B	Cc1ccc2cc(-c3n[nH]c4ccc(NS(=O)(=O)c5ncn(C)c5C)cc34)[nH]c2c1		CHEMBL1684525	=	Inhibition	%	85.0	CHEMBL5147	Homo sapiens	INH	%	85.0
	6151082	CHEMBL1764819	Inhibition of human EphB4 autophosphorylation expressed in CHOK1 cells	B	Cc1ccc(CO)cc1N(C)c1ccnc(Nc2cc(N3CCOCC3)nc(N3CCOCC3)n2)n1		CHEMBL1762551	=	IC50	nM	106.0	CHEMBL5147	Homo sapiens	IC50	uM	0.106
	6151083	CHEMBL1764819	Inhibition of human EphB4 autophosphorylation expressed in CHOK1 cells	B	Cc1ccc(CO)cc1N(C)c1ccnc(Nc2cc(N3CCOCC3)nc(N3CCOCC3)c2)n1		CHEMBL1762550	=	IC50	nM	8.0	CHEMBL5147	Homo sapiens	IC50	uM	0.008
	6151084	CHEMBL1764819	Inhibition of human EphB4 autophosphorylation expressed in CHOK1 cells	B	Cc1ccc(CO)cc1N(c1ccnc(Nc2cc(N3CCOCC3)cc(S(C)(=O)=O)c2)n1)C(C)C		CHEMBL1738764	=	IC50	nM	7.0	CHEMBL5147	Homo sapiens	IC50	uM	0.007
	6151085	CHEMBL1764819	Inhibition of human EphB4 autophosphorylation expressed in CHOK1 cells	B	COCCN(c1ccnc(Nc2cc(N3CCOCC3)cc(N3CCOCC3)c2)n1)c1cc(CO)ccc1C		CHEMBL1762549	=	IC50	nM	12.0	CHEMBL5147	Homo sapiens	IC50	uM	0.012
	6151086	CHEMBL1764819	Inhibition of human EphB4 autophosphorylation expressed in CHOK1 cells	B	Cc1ccc(CO)cc1N(c1ccnc(Nc2cc(N3CCOCC3)cc(N3CCOCC3)c2)n1)C(C)C		CHEMBL1762548	=	IC50	nM	13.0	CHEMBL5147	Homo sapiens	IC50	uM	0.013
	6151087	CHEMBL1764819	Inhibition of human EphB4 autophosphorylation expressed in CHOK1 cells	B	CCN(c1ccnc(Nc2cc(N3CCOCC3)cc(N3CCOCC3)c2)n1)c1cc(CO)ccc1C		CHEMBL1762547	=	IC50	nM	14.0	CHEMBL5147	Homo sapiens	IC50	uM	0.014
	6151088	CHEMBL1764819	Inhibition of human EphB4 autophosphorylation expressed in CHOK1 cells	B	Cc1ccc(CO)cc1N(C)c1ccnc(Nc2cc(N3CCOCC3)cc(S(C)(=O)=O)c2)n1		CHEMBL1762546	=	IC50	nM	11.0	CHEMBL5147	Homo sapiens	IC50	uM	0.011
	6151089	CHEMBL1764819	Inhibition of human EphB4 autophosphorylation expressed in CHOK1 cells	B	COc1cc(Nc2nccc(N(C)c3cc(CO)ccc3C)n2)cc(N2CCOCC2)c1		CHEMBL1762545	=	IC50	nM	32.0	CHEMBL5147	Homo sapiens	IC50	uM	0.032
	6151090	CHEMBL1764819	Inhibition of human EphB4 autophosphorylation expressed in CHOK1 cells	B	COCCOc1cc(Nc2nccc(N(C)c3cc(CO)ccc3C)n2)cc(N2CCOCC2)c1		CHEMBL1762544	=	IC50	nM	35.0	CHEMBL5147	Homo sapiens	IC50	uM	0.035
	6151091	CHEMBL1764819	Inhibition of human EphB4 autophosphorylation expressed in CHOK1 cells	B	Cc1ccc(CO)cc1N(C)c1ccnc(Nc2cc(OC3CCOCC3)cc(N3CCOCC3)c2)n1		CHEMBL1762543	=	IC50	nM	23.0	CHEMBL5147	Homo sapiens	IC50	uM	0.023
	6151092	CHEMBL1764819	Inhibition of human EphB4 autophosphorylation expressed in CHOK1 cells	B	Cc1ccc(CO)cc1N(C)c1ccnc(Nc2cc(C(=O)N3CCOCC3)cc(N3CCOCC3)c2)n1		CHEMBL1762542	=	IC50	nM	459.0	CHEMBL5147	Homo sapiens	IC50	uM	0.459
	6151093	CHEMBL1764819	Inhibition of human EphB4 autophosphorylation expressed in CHOK1 cells	B	Cc1ccc(CO)cc1N(C)c1ccnc(Nc2cc(CN3CCOCC3)cc(N3CCOCC3)c2)n1		CHEMBL1762541	=	IC50	nM	25.0	CHEMBL5147	Homo sapiens	IC50	uM	0.025
	6151094	CHEMBL1764819	Inhibition of human EphB4 autophosphorylation expressed in CHOK1 cells	B	Cc1ccc(CO)cc1N(C)c1ccnc(Nc2cc(N3CCOCC3)cc(N3CCN(O)CC3)c2)n1		CHEMBL1762540	=	IC50	nM	45.0	CHEMBL5147	Homo sapiens	IC50	uM	0.045
	6151095	CHEMBL1764819	Inhibition of human EphB4 autophosphorylation expressed in CHOK1 cells	B	Cc1ccc(CO)cc1N(C)c1ccnc(Nc2cc(N3CCOCC3)cc(N3CCN(C)CC3)c2)n1		CHEMBL1762539	=	IC50	nM	32.0	CHEMBL5147	Homo sapiens	IC50	uM	0.032
	6151096	CHEMBL1764819	Inhibition of human EphB4 autophosphorylation expressed in CHOK1 cells	B	Cc1ccc(CO)cc1N(C)c1ccnc(Nc2cc(N3CCCOCC3)cc(N3CCOCC3)c2)n1		CHEMBL1762538	=	IC50	nM	28.0	CHEMBL5147	Homo sapiens	IC50	uM	0.028
	6151097	CHEMBL1764819	Inhibition of human EphB4 autophosphorylation expressed in CHOK1 cells	B	Cc1ccc(CO)cc1N(C)c1ccnc(Nc2cc(N3CCCCC3)cc(N3CCOCC3)c2)n1		CHEMBL1762537	=	IC50	nM	11.0	CHEMBL5147	Homo sapiens	IC50	uM	0.011
	6151098	CHEMBL1764819	Inhibition of human EphB4 autophosphorylation expressed in CHOK1 cells	B	Cc1ccc(CO)cc1N(C)c1ccnc(Nc2cc(N3CCCC3)cc(N3CCOCC3)c2)n1		CHEMBL1762536	=	IC50	nM	27.0	CHEMBL5147	Homo sapiens	IC50	uM	0.027
	6151099	CHEMBL1764819	Inhibition of human EphB4 autophosphorylation expressed in CHOK1 cells	B	COc1cncc(N(C)c2ccnc(Nc3cc(N4CCOCC4)cc(N4CCOCC4)c3)n2)c1		CHEMBL1762535	=	IC50	nM	30.0	CHEMBL5147	Homo sapiens	IC50	uM	0.03
	6151100	CHEMBL1764819	Inhibition of human EphB4 autophosphorylation expressed in CHOK1 cells	B	COc1cccc(N(C)c2ccnc(Nc3cc(N4CCOCC4)cc(N4CCOCC4)c3)n2)n1		CHEMBL1762534	=	IC50	nM	28.0	CHEMBL5147	Homo sapiens	IC50	uM	0.028
	6151101	CHEMBL1764819	Inhibition of human EphB4 autophosphorylation expressed in CHOK1 cells	B	COc1ccnc(N(C)c2ccnc(Nc3cc(N4CCOCC4)cc(N4CCOCC4)c3)n2)c1		CHEMBL1762533	=	IC50	nM	41.0	CHEMBL5147	Homo sapiens	IC50	uM	0.041
	6151102	CHEMBL1764819	Inhibition of human EphB4 autophosphorylation expressed in CHOK1 cells	B	Cc1ccc(C(C)O)cc1N(C)c1ccnc(Nc2cc(N3CCOCC3)cc(N3CCOCC3)c2)n1		CHEMBL1762532	=	IC50	nM	180.0	CHEMBL5147	Homo sapiens	IC50	uM	0.18
	6151103	CHEMBL1764819	Inhibition of human EphB4 autophosphorylation expressed in CHOK1 cells	B	CN(c1ccc(Cl)c(CO)c1)c1ccnc(Nc2cc(N3CCOCC3)cc(N3CCOCC3)c2)n1		CHEMBL1762531	=	IC50	nM	13.0	CHEMBL5147	Homo sapiens	IC50	uM	0.013
	6151104	CHEMBL1764819	Inhibition of human EphB4 autophosphorylation expressed in CHOK1 cells	B	Cc1ccc(CO)cc1N(C)c1ccnc(Nc2cc(N3CCOCC3)cc(N3CCOCC3)c2)n1		CHEMBL1762530	=	IC50	nM	12.0	CHEMBL5147	Homo sapiens	IC50	uM	0.012
	6151105	CHEMBL1764819	Inhibition of human EphB4 autophosphorylation expressed in CHOK1 cells	B	COc1cc(CO)cc(N(C)c2ccnc(Nc3cc(N4CCOCC4)cc(N4CCOCC4)c3)n2)c1		CHEMBL1762529	=	IC50	nM	7.0	CHEMBL5147	Homo sapiens	IC50	uM	0.007
	6151106	CHEMBL1764819	Inhibition of human EphB4 autophosphorylation expressed in CHOK1 cells	B	CN(c1cccc(CO)c1)c1ccnc(Nc2cc(N3CCOCC3)cc(N3CCOCC3)c2)n1		CHEMBL1762528	=	IC50	nM	114.0	CHEMBL5147	Homo sapiens	IC50	uM	0.114
	6151107	CHEMBL1764819	Inhibition of human EphB4 autophosphorylation expressed in CHOK1 cells	B	COc1ccc(C)c(N(C)c2ccnc(Nc3cc(N4CCOCC4)cc(N4CCOCC4)c3)n2)c1		CHEMBL1762527	=	IC50	nM	21.0	CHEMBL5147	Homo sapiens	IC50	uM	0.021
	6151108	CHEMBL1764819	Inhibition of human EphB4 autophosphorylation expressed in CHOK1 cells	B	Cc1ccc(C)c(N(C)c2ccnc(Nc3cc(N4CCOCC4)cc(N4CCOCC4)c3)n2)c1		CHEMBL1762526	=	IC50	nM	38.0	CHEMBL5147	Homo sapiens	IC50	uM	0.038
	6151109	CHEMBL1764819	Inhibition of human EphB4 autophosphorylation expressed in CHOK1 cells	B	COc1cccc(N(C)c2ccnc(Nc3cc(N4CCOCC4)cc(N4CCOCC4)c3)n2)c1		CHEMBL1762525	=	IC50	nM	10.0	CHEMBL5147	Homo sapiens	IC50	uM	0.01
	6151110	CHEMBL1764819	Inhibition of human EphB4 autophosphorylation expressed in CHOK1 cells	B	CN(c1cccc(Cl)c1)c1ccnc(Nc2cc(N3CCOCC3)cc(N3CCOCC3)c2)n1		CHEMBL1762524	=	IC50	nM	12.0	CHEMBL5147	Homo sapiens	IC50	uM	0.012
	6151111	CHEMBL1764819	Inhibition of human EphB4 autophosphorylation expressed in CHOK1 cells	B	Cc1cccc(N(C)c2ccnc(Nc3cc(N4CCOCC4)cc(N4CCOCC4)c3)n2)c1		CHEMBL1762523	=	IC50	nM	28.0	CHEMBL5147	Homo sapiens	IC50	uM	0.028
	6151112	CHEMBL1764819	Inhibition of human EphB4 autophosphorylation expressed in CHOK1 cells	B	Cc1ccccc1N(C)c1ccnc(Nc2cc(N3CCOCC3)cc(N3CCOCC3)c2)n1		CHEMBL1762522	=	IC50	nM	28.0	CHEMBL5147	Homo sapiens	IC50	uM	0.028
	6151113	CHEMBL1764819	Inhibition of human EphB4 autophosphorylation expressed in CHOK1 cells	B	CN(c1ccccc1)c1ccnc(Nc2cc(N3CCOCC3)cc(N3CCOCC3)c2)n1		CHEMBL1762521	=	IC50	nM	84.0	CHEMBL5147	Homo sapiens	IC50	uM	0.084
	6151145	CHEMBL1764816	Inhibition of human EPHB4	B	Cc1ccc(CO)cc1N(C)c1ccnc(Nc2cc(N3CCOCC3)nc(N3CCOCC3)n2)n1		CHEMBL1762551	=	IC50	nM	15.0	CHEMBL5147	Homo sapiens	IC50	uM	0.015
	6151146	CHEMBL1764816	Inhibition of human EPHB4	B	Cc1ccc(CO)cc1N(C)c1ccnc(Nc2cc(N3CCOCC3)nc(N3CCOCC3)c2)n1		CHEMBL1762550	=	IC50	nM	14.0	CHEMBL5147	Homo sapiens	IC50	uM	0.014
	6151147	CHEMBL1764816	Inhibition of human EPHB4	B	Cc1ccc(CO)cc1N(c1ccnc(Nc2cc(N3CCOCC3)cc(S(C)(=O)=O)c2)n1)C(C)C		CHEMBL1738764	=	IC50	nM	2.0	CHEMBL5147	Homo sapiens	IC50	uM	0.002
	6151148	CHEMBL1764816	Inhibition of human EPHB4	B	COCCN(c1ccnc(Nc2cc(N3CCOCC3)cc(N3CCOCC3)c2)n1)c1cc(CO)ccc1C		CHEMBL1762549	=	IC50	nM	12.0	CHEMBL5147	Homo sapiens	IC50	uM	0.012
	6151149	CHEMBL1764816	Inhibition of human EPHB4	B	Cc1ccc(CO)cc1N(c1ccnc(Nc2cc(N3CCOCC3)cc(N3CCOCC3)c2)n1)C(C)C		CHEMBL1762548	=	IC50	nM	5.0	CHEMBL5147	Homo sapiens	IC50	uM	0.005
	6151150	CHEMBL1764816	Inhibition of human EPHB4	B	CCN(c1ccnc(Nc2cc(N3CCOCC3)cc(N3CCOCC3)c2)n1)c1cc(CO)ccc1C		CHEMBL1762547	=	IC50	nM	4.0	CHEMBL5147	Homo sapiens	IC50	uM	0.004
	6151151	CHEMBL1764816	Inhibition of human EPHB4	B	Cc1ccc(CO)cc1N(C)c1ccnc(Nc2cc(N3CCOCC3)cc(S(C)(=O)=O)c2)n1		CHEMBL1762546	=	IC50	nM	3.0	CHEMBL5147	Homo sapiens	IC50	uM	0.003
	6151152	CHEMBL1764816	Inhibition of human EPHB4	B	COc1cc(Nc2nccc(N(C)c3cc(CO)ccc3C)n2)cc(N2CCOCC2)c1		CHEMBL1762545	=	IC50	nM	5.0	CHEMBL5147	Homo sapiens	IC50	uM	0.005
	6151153	CHEMBL1764816	Inhibition of human EPHB4	B	COCCOc1cc(Nc2nccc(N(C)c3cc(CO)ccc3C)n2)cc(N2CCOCC2)c1		CHEMBL1762544	=	IC50	nM	8.0	CHEMBL5147	Homo sapiens	IC50	uM	0.008
	6152337	CHEMBL1764816	Inhibition of human EPHB4	B	Cc1ccc(CO)cc1N(C)c1ccnc(Nc2cc(OC3CCOCC3)cc(N3CCOCC3)c2)n1		CHEMBL1762543	=	IC50	nM	8.0	CHEMBL5147	Homo sapiens	IC50	uM	0.008
	6152338	CHEMBL1764816	Inhibition of human EPHB4	B	Cc1ccc(CO)cc1N(C)c1ccnc(Nc2cc(C(=O)N3CCOCC3)cc(N3CCOCC3)c2)n1		CHEMBL1762542	=	IC50	nM	17.0	CHEMBL5147	Homo sapiens	IC50	uM	0.017
	6152339	CHEMBL1764816	Inhibition of human EPHB4	B	Cc1ccc(CO)cc1N(C)c1ccnc(Nc2cc(CN3CCOCC3)cc(N3CCOCC3)c2)n1		CHEMBL1762541	=	IC50	nM	6.0	CHEMBL5147	Homo sapiens	IC50	uM	0.006
	6152340	CHEMBL1764816	Inhibition of human EPHB4	B	Cc1ccc(CO)cc1N(C)c1ccnc(Nc2cc(N3CCOCC3)cc(N3CCN(O)CC3)c2)n1		CHEMBL1762540	=	IC50	nM	7.0	CHEMBL5147	Homo sapiens	IC50	uM	0.007
	6152341	CHEMBL1764816	Inhibition of human EPHB4	B	Cc1ccc(CO)cc1N(C)c1ccnc(Nc2cc(N3CCOCC3)cc(N3CCN(C)CC3)c2)n1		CHEMBL1762539	=	IC50	nM	4.0	CHEMBL5147	Homo sapiens	IC50	uM	0.004
	6152342	CHEMBL1764816	Inhibition of human EPHB4	B	Cc1ccc(CO)cc1N(C)c1ccnc(Nc2cc(N3CCCOCC3)cc(N3CCOCC3)c2)n1		CHEMBL1762538	=	IC50	nM	9.0	CHEMBL5147	Homo sapiens	IC50	uM	0.009
	6152343	CHEMBL1764816	Inhibition of human EPHB4	B	Cc1ccc(CO)cc1N(C)c1ccnc(Nc2cc(N3CCCCC3)cc(N3CCOCC3)c2)n1		CHEMBL1762537	=	IC50	nM	10.0	CHEMBL5147	Homo sapiens	IC50	uM	0.01
	6152344	CHEMBL1764816	Inhibition of human EPHB4	B	Cc1ccc(CO)cc1N(C)c1ccnc(Nc2cc(N3CCCC3)cc(N3CCOCC3)c2)n1		CHEMBL1762536	=	IC50	nM	16.0	CHEMBL5147	Homo sapiens	IC50	uM	0.016
	6152345	CHEMBL1764816	Inhibition of human EPHB4	B	COc1cncc(N(C)c2ccnc(Nc3cc(N4CCOCC4)cc(N4CCOCC4)c3)n2)c1		CHEMBL1762535	=	IC50	nM	2.0	CHEMBL5147	Homo sapiens	IC50	uM	0.002
	6152346	CHEMBL1764816	Inhibition of human EPHB4	B	COc1cccc(N(C)c2ccnc(Nc3cc(N4CCOCC4)cc(N4CCOCC4)c3)n2)n1		CHEMBL1762534	=	IC50	nM	6.0	CHEMBL5147	Homo sapiens	IC50	uM	0.006
	6152347	CHEMBL1764816	Inhibition of human EPHB4	B	COc1ccnc(N(C)c2ccnc(Nc3cc(N4CCOCC4)cc(N4CCOCC4)c3)n2)c1		CHEMBL1762533	=	IC50	nM	13.0	CHEMBL5147	Homo sapiens	IC50	uM	0.013
	6152348	CHEMBL1764816	Inhibition of human EPHB4	B	Cc1ccc(C(C)O)cc1N(C)c1ccnc(Nc2cc(N3CCOCC3)cc(N3CCOCC3)c2)n1		CHEMBL1762532	=	IC50	nM	35.0	CHEMBL5147	Homo sapiens	IC50	uM	0.035
	6152349	CHEMBL1764816	Inhibition of human EPHB4	B	CN(c1ccc(Cl)c(CO)c1)c1ccnc(Nc2cc(N3CCOCC3)cc(N3CCOCC3)c2)n1		CHEMBL1762531	=	IC50	nM	2.0	CHEMBL5147	Homo sapiens	IC50	uM	0.002
	6152350	CHEMBL1764816	Inhibition of human EPHB4	B	Cc1ccc(CO)cc1N(C)c1ccnc(Nc2cc(N3CCOCC3)cc(N3CCOCC3)c2)n1		CHEMBL1762530	=	IC50	nM	4.0	CHEMBL5147	Homo sapiens	IC50	uM	0.004
	6152351	CHEMBL1764816	Inhibition of human EPHB4	B	COc1cc(CO)cc(N(C)c2ccnc(Nc3cc(N4CCOCC4)cc(N4CCOCC4)c3)n2)c1		CHEMBL1762529	=	IC50	nM	2.0	CHEMBL5147	Homo sapiens	IC50	uM	0.002
	6152352	CHEMBL1764816	Inhibition of human EPHB4	B	CN(c1cccc(CO)c1)c1ccnc(Nc2cc(N3CCOCC3)cc(N3CCOCC3)c2)n1		CHEMBL1762528	=	IC50	nM	10.0	CHEMBL5147	Homo sapiens	IC50	uM	0.01
	6152353	CHEMBL1764816	Inhibition of human EPHB4	B	COc1ccc(C)c(N(C)c2ccnc(Nc3cc(N4CCOCC4)cc(N4CCOCC4)c3)n2)c1		CHEMBL1762527	=	IC50	nM	10.0	CHEMBL5147	Homo sapiens	IC50	uM	0.01
	6152354	CHEMBL1764816	Inhibition of human EPHB4	B	Cc1ccc(C)c(N(C)c2ccnc(Nc3cc(N4CCOCC4)cc(N4CCOCC4)c3)n2)c1		CHEMBL1762526	=	IC50	nM	19.0	CHEMBL5147	Homo sapiens	IC50	uM	0.019
	6152355	CHEMBL1764816	Inhibition of human EPHB4	B	COc1cccc(N(C)c2ccnc(Nc3cc(N4CCOCC4)cc(N4CCOCC4)c3)n2)c1		CHEMBL1762525	=	IC50	nM	2.0	CHEMBL5147	Homo sapiens	IC50	uM	0.002
	6152356	CHEMBL1764816	Inhibition of human EPHB4	B	CN(c1cccc(Cl)c1)c1ccnc(Nc2cc(N3CCOCC3)cc(N3CCOCC3)c2)n1		CHEMBL1762524	=	IC50	nM	6.0	CHEMBL5147	Homo sapiens	IC50	uM	0.006
	6152357	CHEMBL1764816	Inhibition of human EPHB4	B	Cc1cccc(N(C)c2ccnc(Nc3cc(N4CCOCC4)cc(N4CCOCC4)c3)n2)c1		CHEMBL1762523	=	IC50	nM	8.0	CHEMBL5147	Homo sapiens	IC50	uM	0.008
	6152358	CHEMBL1764816	Inhibition of human EPHB4	B	Cc1ccccc1N(C)c1ccnc(Nc2cc(N3CCOCC3)cc(N3CCOCC3)c2)n1		CHEMBL1762522	=	IC50	nM	10.0	CHEMBL5147	Homo sapiens	IC50	uM	0.01
	6152359	CHEMBL1764816	Inhibition of human EPHB4	B	CN(c1ccccc1)c1ccnc(Nc2cc(N3CCOCC3)cc(N3CCOCC3)c2)n1		CHEMBL1762521	=	IC50	nM	17.0	CHEMBL5147	Homo sapiens	IC50	uM	0.017
	6341054	CHEMBL1828223	Activity of EPHB4 kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	100.0	CHEMBL5147	Homo sapiens	Activity	%	100.0
	6352205	CHEMBL1825742	Inhibition of EPH-B4 assessed as residual activity at 10 uM by radioactivity assay in presence of 50 uM ATP	B	Nc1n[nH]c(N)c1/N=N/c1ccc(O)cc1		CHEMBL215205	=	Activity	%	99.0	CHEMBL5147	Homo sapiens	Activity	%	99.0
	6375428	CHEMBL1840252	Inhibition of EPHB4 at 1 uM by radiometric assay	B	CC1(C)[C@@H](O)CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@@](C)(C(=O)NCCNC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)CC[C@]3(C)CC[C@]21C		CHEMBL1836927	=	Inhibition	%	64.0	CHEMBL5147	Homo sapiens	INH	%	64.0
	6386341	CHEMBL1839874	Inhibition of recombinant EPHB4	B	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1.O=P(O)(O)O		CHEMBL1834657	>	IC50	nM	10000.0	CHEMBL5147	Homo sapiens	IC50	uM	10.0
	7567354	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Kd	nM	1100.0	CHEMBL5147	Homo sapiens	Kd	nM	1100.0
	7567813	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	nM	10000.0
	7568310	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	=	Kd	nM	12.0	CHEMBL5147	Homo sapiens	Kd	nM	12.0
	7568742	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	nM	10000.0
	7569327	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	nM	10000.0
	7569817	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	nM	10000.0
	7570280	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	nM	10000.0
	7570707	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	3100.0	CHEMBL5147	Homo sapiens	Kd	nM	3100.0
	7571303	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	nM	10000.0
	7571318	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Kd	nM	570.0	CHEMBL5147	Homo sapiens	Kd	nM	570.0
	7571794	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	nM	10000.0
	7572257	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	nM	10000.0
	7572673	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	750.0	CHEMBL5147	Homo sapiens	Kd	nM	750.0
	7573299	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	0.34	CHEMBL5147	Homo sapiens	Kd	nM	0.34
	7573775	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	2700.0	CHEMBL5147	Homo sapiens	Kd	nM	2700.0
	7574244	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	nM	10000.0
	7574652	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	nM	10000.0
	7574820	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	1100.0	CHEMBL5147	Homo sapiens	Kd	nM	1100.0
	7575281	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	2200.0	CHEMBL5147	Homo sapiens	Kd	nM	2200.0
	7575752	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	nM	10000.0
	7576217	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	nM	10000.0
	7576625	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	2100.0	CHEMBL5147	Homo sapiens	Kd	nM	2100.0
	7576794	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	nM	10000.0
	7577253	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	12.0	CHEMBL5147	Homo sapiens	Kd	nM	12.0
	7577731	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	2900.0	CHEMBL5147	Homo sapiens	Kd	nM	2900.0
	7578201	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	nM	10000.0
	7578802	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	nM	10000.0
	7579176	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	nM	10000.0
	7579626	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	nM	10000.0
	7580100	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	nM	10000.0
	7580530	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	520.0	CHEMBL5147	Homo sapiens	Kd	nM	520.0
	7581160	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	nM	10000.0
	7581545	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	nM	10000.0
	7581990	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	nM	10000.0
	7582483	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	nM	10000.0
	7582883	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	1700.0	CHEMBL5147	Homo sapiens	Kd	nM	1700.0
	7583506	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Kd	nM	1400.0	CHEMBL5147	Homo sapiens	Kd	nM	1400.0
	7583903	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	nM	10000.0
	7584348	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	nM	10000.0
	7584377	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	nM	10000.0
	7584839	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	600.0	CHEMBL5147	Homo sapiens	Kd	nM	600.0
	7585243	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	nM	10000.0
	7585836	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	nM	10000.0
	7586244	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	nM	10000.0
	7586719	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	nM	10000.0
	7587173	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	nM	10000.0
	7588227	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Kd	nM	2500.0	CHEMBL5147	Homo sapiens	Kd	nM	2500.0
	7588698	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	nM	10000.0
	7589149	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	nM	10000.0
	7589320	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	nM	10000.0
	7589744	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	6900.0	CHEMBL5147	Homo sapiens	Kd	nM	6900.0
	7590211	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	nM	10000.0
	7590685	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	nM	10000.0
	7591136	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	nM	10000.0
	7591293	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	nM	10000.0
	7591715	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	nM	10000.0
	7592187	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	nM	10000.0
	7592660	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	560.0	CHEMBL5147	Homo sapiens	Kd	nM	560.0
	7593113	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	9.2	CHEMBL5147	Homo sapiens	Kd	nM	9.2
	7593260	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	nM	10000.0
	7593695	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	nM	10000.0
	7594167	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	nM	10000.0
	7594640	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	=	Kd	nM	730.0	CHEMBL5147	Homo sapiens	Kd	nM	730.0
	7595228	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	nM	10000.0
	7595672	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	1800.0	CHEMBL5147	Homo sapiens	Kd	nM	1800.0
	7596146	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	nM	10000.0
	7596622	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	1800.0	CHEMBL5147	Homo sapiens	Kd	nM	1800.0
	7597200	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	nM	10000.0
	7597653	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	nM	10000.0
	7598126	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	nM	10000.0
	7598154	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL5147	Homo sapiens	Kd	nM	10000.0
	7598596	CHEMBL1908653	Binding constant for EPHB4 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	2200.0	CHEMBL5147	Homo sapiens	Kd	nM	2200.0
	7922703	CHEMBL1919020	Inhibition of human recombinant EPHB4 at 0.5 uM by radiometric filter-binding assay	B	Clc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12		CHEMBL1915438	=	Inhibition	%	13.0	CHEMBL5147	Homo sapiens	INH	%	13.0
	7959751	CHEMBL1932850	Inhibition of EPHB4	B	CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O		CHEMBL1929238	=	IC50	nM	8700.0	CHEMBL5147	Homo sapiens	IC50	uM	8.7
	7959752	CHEMBL1932850	Inhibition of EPHB4	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	IC50	nM	900.0	CHEMBL5147	Homo sapiens	IC50	uM	0.9
	7969719	CHEMBL1931219	Inhibition of EPHB4 assessed as residual activity at 10 uM using [33P-ATP] by radiometric filter binding assay	B	Cc1ccc(F)cc1-c1nc2[nH]nc(N)c2c2c1CCCC2		CHEMBL1927262	=	Activity	%	6.0	CHEMBL5147	Homo sapiens	Activity	%	6.0
Not Active	8012231	CHEMBL1941639	Inhibition of EPHB4 at 10 uM by colorimetric analysis	B	Clc1ccc(-n2cc(-c3ccncc3)nn2)cc1		CHEMBL1938953		Inhibition	%		CHEMBL5147	Homo sapiens	INH		
Not Active	8012232	CHEMBL1941639	Inhibition of EPHB4 at 10 uM by colorimetric analysis	B	Clc1cccc(-n2cc(-c3ccncc3)nn2)c1		CHEMBL1938954		Inhibition	%		CHEMBL5147	Homo sapiens	INH		
Not Active	8012233	CHEMBL1941639	Inhibition of EPHB4 at 10 uM by colorimetric analysis	B	Clc1ccc(-n2nncc2-c2ccncc2)cc1		CHEMBL62965		Inhibition	%		CHEMBL5147	Homo sapiens	INH		
Not Active	8012234	CHEMBL1941639	Inhibition of EPHB4 at 10 uM by colorimetric analysis	B	Clc1cccc(-n2nncc2-c2ccncc2)c1		CHEMBL303351		Inhibition	%		CHEMBL5147	Homo sapiens	INH		
	8013063	CHEMBL1947850	Inhibition of EphB4 using ATP as substrate	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCNCC1)NC2=O		CHEMBL1945559	>	IC50	nM	10000.0	CHEMBL5147	Homo sapiens	IC50	uM	10.0
	8018762	CHEMBL1948824	Inhibition of EphB4 assessed as activity remaining at 10 uM	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CC1CCOCC1		CHEMBL1945953	=	Activity	%	97.0	CHEMBL5147	Homo sapiens	Activity	%	97.0
	8018763	CHEMBL1948824	Inhibition of EphB4 assessed as activity remaining at 10 uM	B	CC(C)(O)c1ccc(-c2cnc3[nH]c(=O)n(CC4CCCCC4)c3n2)cc1		CHEMBL1945950	=	Activity	%	90.0	CHEMBL5147	Homo sapiens	Activity	%	90.0
	8018764	CHEMBL1948824	Inhibition of EphB4 assessed as activity remaining at 10 uM	B	O=c1[nH]c2ncc(-c3ccc4[nH]cnc4c3)nc2n1CC1CCCCC1		CHEMBL1946262	=	Activity	%	96.0	CHEMBL5147	Homo sapiens	Activity	%	96.0
	8047111	CHEMBL1958852	Inhibition of EPHB4 at 1 uM	B	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4ccc5c(c4)OCCO5)s3)cc2)CC1		CHEMBL1956070	<	Inhibition	%	50.0	CHEMBL5147	Homo sapiens	INH	%	50.0
	8060113	CHEMBL1961281	Inhibition of human recombinant EPHB4 expressed in Sf9 cells using poly(E,Y)4:1 as substrate after 80 mins by scintillation counting	B	CC(C)n1c2c(c3c1-c1ccccc1C3=O)C(=O)CCC2		CHEMBL1957190	>	IC50	nM	35000.0	CHEMBL5147	Homo sapiens	IC50	uM	35.0
	8060114	CHEMBL1961281	Inhibition of human recombinant EPHB4 expressed in Sf9 cells using poly(E,Y)4:1 as substrate after 80 mins by scintillation counting	B	O=c1oc2c(O)c(O)cc3c(=O)oc4c(O)c(O)cc1c4c23		CHEMBL6246	=	IC50	nM	1830.0	CHEMBL5147	Homo sapiens	IC50	uM	1.83
	8061373	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	3.82	CHEMBL5147	Homo sapiens	Inhibition	%	3.82
	8061550	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	7.15	CHEMBL5147	Homo sapiens	Inhibition	%	7.15
	8061657	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	3.77	CHEMBL5147	Homo sapiens	Inhibition	%	3.77
	8061881	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	12.59	CHEMBL5147	Homo sapiens	Inhibition	%	12.59
	8062072	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	0.9	CHEMBL5147	Homo sapiens	Inhibition	%	0.9
	8062412	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	2.84	CHEMBL5147	Homo sapiens	Inhibition	%	2.84
	8062574	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	-1.46	CHEMBL5147	Homo sapiens	Inhibition	%	-1.46
	8062896	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	0.27	CHEMBL5147	Homo sapiens	Inhibition	%	0.27
	8063252	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	9.77	CHEMBL5147	Homo sapiens	Inhibition	%	9.77
	8063419	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	3.3	CHEMBL5147	Homo sapiens	Inhibition	%	3.3
	8063751	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	3.74	CHEMBL5147	Homo sapiens	Inhibition	%	3.74
	8063933	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	5.16	CHEMBL5147	Homo sapiens	Inhibition	%	5.16
	8064272	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	2.0	CHEMBL5147	Homo sapiens	Inhibition	%	2.0
	8064482	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	1.64	CHEMBL5147	Homo sapiens	Inhibition	%	1.64
	8064844	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	2.84	CHEMBL5147	Homo sapiens	Inhibition	%	2.84
	8065010	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	-0.34	CHEMBL5147	Homo sapiens	Inhibition	%	-0.34
	8065350	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	1.95	CHEMBL5147	Homo sapiens	Inhibition	%	1.95
	8065525	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	2.8	CHEMBL5147	Homo sapiens	Inhibition	%	2.8
	8065749	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	21.3	CHEMBL5147	Homo sapiens	Inhibition	%	21.3
	8065864	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	0.67	CHEMBL5147	Homo sapiens	Inhibition	%	0.67
	8066074	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	3.64	CHEMBL5147	Homo sapiens	Inhibition	%	3.64
	8066298	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	1.19	CHEMBL5147	Homo sapiens	Inhibition	%	1.19
	8066434	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	6.24	CHEMBL5147	Homo sapiens	Inhibition	%	6.24
	8066600	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	1.54	CHEMBL5147	Homo sapiens	Inhibition	%	1.54
	8066824	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	-0.15	CHEMBL5147	Homo sapiens	Inhibition	%	-0.15
	8066948	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	9.97	CHEMBL5147	Homo sapiens	Inhibition	%	9.97
	8067347	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	2.15	CHEMBL5147	Homo sapiens	Inhibition	%	2.15
	8067468	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	0.71	CHEMBL5147	Homo sapiens	Inhibition	%	0.71
	8067902	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	1.5	CHEMBL5147	Homo sapiens	Inhibition	%	1.5
	8068037	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	2.69	CHEMBL5147	Homo sapiens	Inhibition	%	2.69
	8068425	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	0.33	CHEMBL5147	Homo sapiens	Inhibition	%	0.33
	8068550	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	26.0	CHEMBL5147	Homo sapiens	Inhibition	%	26.0
	8068774	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	-0.69	CHEMBL5147	Homo sapiens	Inhibition	%	-0.69
	8068948	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	3.46	CHEMBL5147	Homo sapiens	Inhibition	%	3.46
	8069073	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	1.73	CHEMBL5147	Homo sapiens	Inhibition	%	1.73
	8069297	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	4.73	CHEMBL5147	Homo sapiens	Inhibition	%	4.73
	8069368	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	25.58	CHEMBL5147	Homo sapiens	Inhibition	%	25.58
	8069592	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	6.39	CHEMBL5147	Homo sapiens	Inhibition	%	6.39
	8069753	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	0.44	CHEMBL5147	Homo sapiens	Inhibition	%	0.44
	8070103	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	0.04	CHEMBL5147	Homo sapiens	Inhibition	%	0.04
	8070275	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	2.71	CHEMBL5147	Homo sapiens	Inhibition	%	2.71
	8070624	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	0.47	CHEMBL5147	Homo sapiens	Inhibition	%	0.47
	8070922	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	26.79	CHEMBL5147	Homo sapiens	Inhibition	%	26.79
	8071079	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	1.3	CHEMBL5147	Homo sapiens	Inhibition	%	1.3
	8071429	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	-0.2	CHEMBL5147	Homo sapiens	Inhibition	%	-0.2
	8071602	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	6.99	CHEMBL5147	Homo sapiens	Inhibition	%	6.99
	8071951	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	2.78	CHEMBL5147	Homo sapiens	Inhibition	%	2.78
	8072265	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	0.65	CHEMBL5147	Homo sapiens	Inhibition	%	0.65
	8072422	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	1.46	CHEMBL5147	Homo sapiens	Inhibition	%	1.46
	8072646	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	0.78	CHEMBL5147	Homo sapiens	Inhibition	%	0.78
	8072771	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	2.61	CHEMBL5147	Homo sapiens	Inhibition	%	2.61
	8072938	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	2.69	CHEMBL5147	Homo sapiens	Inhibition	%	2.69
	8073162	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	3.48	CHEMBL5147	Homo sapiens	Inhibition	%	3.48
	8073287	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	29.6	CHEMBL5147	Homo sapiens	Inhibition	%	29.6
	8073630	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	0.65	CHEMBL5147	Homo sapiens	Inhibition	%	0.65
	8073863	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	2.71	CHEMBL5147	Homo sapiens	Inhibition	%	2.71
	8074239	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	0.42	CHEMBL5147	Homo sapiens	Inhibition	%	0.42
	8074369	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	-1.02	CHEMBL5147	Homo sapiens	Inhibition	%	-1.02
	8074750	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	0.65	CHEMBL5147	Homo sapiens	Inhibition	%	0.65
	8074877	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	72.98	CHEMBL5147	Homo sapiens	Inhibition	%	72.98
	8075101	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	0.17	CHEMBL5147	Homo sapiens	Inhibition	%	0.17
	8075212	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	0.71	CHEMBL5147	Homo sapiens	Inhibition	%	0.71
	8075449	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	1.15	CHEMBL5147	Homo sapiens	Inhibition	%	1.15
	8075814	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	0.79	CHEMBL5147	Homo sapiens	Inhibition	%	0.79
	8075956	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	1.55	CHEMBL5147	Homo sapiens	Inhibition	%	1.55
	8076180	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	-1.21	CHEMBL5147	Homo sapiens	Inhibition	%	-1.21
	8076328	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	2.09	CHEMBL5147	Homo sapiens	Inhibition	%	2.09
	8076686	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	0.88	CHEMBL5147	Homo sapiens	Inhibition	%	0.88
	8076788	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	0.93	CHEMBL5147	Homo sapiens	Inhibition	%	0.93
	8077012	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-0.14	CHEMBL5147	Homo sapiens	Inhibition	%	-0.14
	8077035	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	0.96	CHEMBL5147	Homo sapiens	Inhibition	%	0.96
	8077259	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	-0.46	CHEMBL5147	Homo sapiens	Inhibition	%	-0.46
	8077387	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	0.05	CHEMBL5147	Homo sapiens	Inhibition	%	0.05
	8077762	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	1.77	CHEMBL5147	Homo sapiens	Inhibition	%	1.77
	8077905	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	2.03	CHEMBL5147	Homo sapiens	Inhibition	%	2.03
	8078268	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-0.68	CHEMBL5147	Homo sapiens	Inhibition	%	-0.68
	8078594	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	-0.77	CHEMBL5147	Homo sapiens	Inhibition	%	-0.77
	8078844	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	1.16	CHEMBL5147	Homo sapiens	Inhibition	%	1.16
	8078960	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	1.3	CHEMBL5147	Homo sapiens	Inhibition	%	1.3
	8079184	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	1.73	CHEMBL5147	Homo sapiens	Inhibition	%	1.73
	8079342	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	-3.41	CHEMBL5147	Homo sapiens	Inhibition	%	-3.41
	8079484	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	2.56	CHEMBL5147	Homo sapiens	Inhibition	%	2.56
	8079708	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	0.35	CHEMBL5147	Homo sapiens	Inhibition	%	0.35
	8079847	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-0.49	CHEMBL5147	Homo sapiens	Inhibition	%	-0.49
	8080176	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	1.02	CHEMBL5147	Homo sapiens	Inhibition	%	1.02
	8080428	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	-1.38	CHEMBL5147	Homo sapiens	Inhibition	%	-1.38
	8080767	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	2.58	CHEMBL5147	Homo sapiens	Inhibition	%	2.58
	8080931	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	-0.4	CHEMBL5147	Homo sapiens	Inhibition	%	-0.4
	8081290	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	2.22	CHEMBL5147	Homo sapiens	Inhibition	%	2.22
	8081434	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	3.08	CHEMBL5147	Homo sapiens	Inhibition	%	3.08
	8081761	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	1.15	CHEMBL5147	Homo sapiens	Inhibition	%	1.15
	8082013	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	1.51	CHEMBL5147	Homo sapiens	Inhibition	%	1.51
	8082350	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	0.41	CHEMBL5147	Homo sapiens	Inhibition	%	0.41
	8082523	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-1.79	CHEMBL5147	Homo sapiens	Inhibition	%	-1.79
	8082870	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	1.02	CHEMBL5147	Homo sapiens	Inhibition	%	1.02
	8083026	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	2.91	CHEMBL5147	Homo sapiens	Inhibition	%	2.91
	8083250	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	1.61	CHEMBL5147	Homo sapiens	Inhibition	%	1.61
	8083349	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	-0.03	CHEMBL5147	Homo sapiens	Inhibition	%	-0.03
	8083603	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-3.41	CHEMBL5147	Homo sapiens	Inhibition	%	-3.41
	8083937	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	1.15	CHEMBL5147	Homo sapiens	Inhibition	%	1.15
	8084122	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	1.69	CHEMBL5147	Homo sapiens	Inhibition	%	1.69
	8084346	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	2.29	CHEMBL5147	Homo sapiens	Inhibition	%	2.29
	8084464	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	3.17	CHEMBL5147	Homo sapiens	Inhibition	%	3.17
	8084849	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	5.27	CHEMBL5147	Homo sapiens	Inhibition	%	5.27
	8084947	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	0.62	CHEMBL5147	Homo sapiens	Inhibition	%	0.62
	8085171	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	0.5	CHEMBL5147	Homo sapiens	Inhibition	%	0.5
	8085203	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-1.63	CHEMBL5147	Homo sapiens	Inhibition	%	-1.63
	8085427	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	4.81	CHEMBL5147	Homo sapiens	Inhibition	%	4.81
	8085535	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	2.9	CHEMBL5147	Homo sapiens	Inhibition	%	2.9
	8085948	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	13.2	CHEMBL5147	Homo sapiens	Inhibition	%	13.2
	8086063	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	0.91	CHEMBL5147	Homo sapiens	Inhibition	%	0.91
	8086287	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	2.11	CHEMBL5147	Homo sapiens	Inhibition	%	2.11
	8086449	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	-1.77	CHEMBL5147	Homo sapiens	Inhibition	%	-1.77
	8086772	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	-0.26	CHEMBL5147	Homo sapiens	Inhibition	%	-0.26
	8086983	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	2.4	CHEMBL5147	Homo sapiens	Inhibition	%	2.4
	8087141	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	5.49	CHEMBL5147	Homo sapiens	Inhibition	%	5.49
	8087365	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	0.55	CHEMBL5147	Homo sapiens	Inhibition	%	0.55
	8087479	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	65.75	CHEMBL5147	Homo sapiens	Inhibition	%	65.75
	8087841	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	6.48	CHEMBL5147	Homo sapiens	Inhibition	%	6.48
	8087983	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	2.94	CHEMBL5147	Homo sapiens	Inhibition	%	2.94
	8088207	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	3.87	CHEMBL5147	Homo sapiens	Inhibition	%	3.87
	8088355	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	0.54	CHEMBL5147	Homo sapiens	Inhibition	%	0.54
	8088707	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	1.67	CHEMBL5147	Homo sapiens	Inhibition	%	1.67
	8088800	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	1.03	CHEMBL5147	Homo sapiens	Inhibition	%	1.03
	8089024	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	1.88	CHEMBL5147	Homo sapiens	Inhibition	%	1.88
	8089152	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	-0.64	CHEMBL5147	Homo sapiens	Inhibition	%	-0.64
	8089524	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	1.72	CHEMBL5147	Homo sapiens	Inhibition	%	1.72
	8089644	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	1.43	CHEMBL5147	Homo sapiens	Inhibition	%	1.43
	8090048	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	1.91	CHEMBL5147	Homo sapiens	Inhibition	%	1.91
	8090213	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	1.3	CHEMBL5147	Homo sapiens	Inhibition	%	1.3
	8090604	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	1.32	CHEMBL5147	Homo sapiens	Inhibition	%	1.32
	8090743	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	2.81	CHEMBL5147	Homo sapiens	Inhibition	%	2.81
	8091172	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	3.4	CHEMBL5147	Homo sapiens	Inhibition	%	3.4
	8091309	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	74.1	CHEMBL5147	Homo sapiens	Inhibition	%	74.1
	8091688	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	1.51	CHEMBL5147	Homo sapiens	Inhibition	%	1.51
	8091804	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	1.6	CHEMBL5147	Homo sapiens	Inhibition	%	1.6
	8092028	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	5.33	CHEMBL5147	Homo sapiens	Inhibition	%	5.33
	8092165	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-4.2	CHEMBL5147	Homo sapiens	Inhibition	%	-4.2
	8092540	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	-0.19	CHEMBL5147	Homo sapiens	Inhibition	%	-0.19
	8092688	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	0.87	CHEMBL5147	Homo sapiens	Inhibition	%	0.87
	8093041	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	4.23	CHEMBL5147	Homo sapiens	Inhibition	%	4.23
	8093353	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	1.6	CHEMBL5147	Homo sapiens	Inhibition	%	1.6
	8093493	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	0.69	CHEMBL5147	Homo sapiens	Inhibition	%	0.69
	8093856	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	2.38	CHEMBL5147	Homo sapiens	Inhibition	%	2.38
	8093976	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	1.77	CHEMBL5147	Homo sapiens	Inhibition	%	1.77
	8094200	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	1.22	CHEMBL5147	Homo sapiens	Inhibition	%	1.22
	8094380	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	0.18	CHEMBL5147	Homo sapiens	Inhibition	%	0.18
	8094555	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	2.98	CHEMBL5147	Homo sapiens	Inhibition	%	2.98
	8094779	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	1.77	CHEMBL5147	Homo sapiens	Inhibition	%	1.77
	8094935	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	4.69	CHEMBL5147	Homo sapiens	Inhibition	%	4.69
	8095075	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	1.79	CHEMBL5147	Homo sapiens	Inhibition	%	1.79
	8095299	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	30.67	CHEMBL5147	Homo sapiens	Inhibition	%	30.67
	8095502	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	3.0	CHEMBL5147	Homo sapiens	Inhibition	%	3.0
	8095643	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	2.74	CHEMBL5147	Homo sapiens	Inhibition	%	2.74
	8095867	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	3.5	CHEMBL5147	Homo sapiens	Inhibition	%	3.5
	8096015	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	1.36	CHEMBL5147	Homo sapiens	Inhibition	%	1.36
	8096356	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	0.96	CHEMBL5147	Homo sapiens	Inhibition	%	0.96
	8096495	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	1.66	CHEMBL5147	Homo sapiens	Inhibition	%	1.66
	8096875	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	2.96	CHEMBL5147	Homo sapiens	Inhibition	%	2.96
	8097022	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	1.37	CHEMBL5147	Homo sapiens	Inhibition	%	1.37
	8097246	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	1.29	CHEMBL5147	Homo sapiens	Inhibition	%	1.29
	8097333	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	-1.28	CHEMBL5147	Homo sapiens	Inhibition	%	-1.28
	8097553	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	7.56	CHEMBL5147	Homo sapiens	Inhibition	%	7.56
	8097703	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	-2.4	CHEMBL5147	Homo sapiens	Inhibition	%	-2.4
	8097927	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	1.73	CHEMBL5147	Homo sapiens	Inhibition	%	1.73
	8098060	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	-2.57	CHEMBL5147	Homo sapiens	Inhibition	%	-2.57
	8098404	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	-2.06	CHEMBL5147	Homo sapiens	Inhibition	%	-2.06
	8098584	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	2.02	CHEMBL5147	Homo sapiens	Inhibition	%	2.02
	8098993	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	1.31	CHEMBL5147	Homo sapiens	Inhibition	%	1.31
	8099137	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	2.88	CHEMBL5147	Homo sapiens	Inhibition	%	2.88
	8099503	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	0.64	CHEMBL5147	Homo sapiens	Inhibition	%	0.64
	8099697	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	-0.62	CHEMBL5147	Homo sapiens	Inhibition	%	-0.62
	8100068	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	3.6	CHEMBL5147	Homo sapiens	Inhibition	%	3.6
	8100214	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	2.63	CHEMBL5147	Homo sapiens	Inhibition	%	2.63
	8100554	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	3.51	CHEMBL5147	Homo sapiens	Inhibition	%	3.51
	8100694	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	-0.7	CHEMBL5147	Homo sapiens	Inhibition	%	-0.7
	8100918	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	-0.05	CHEMBL5147	Homo sapiens	Inhibition	%	-0.05
	8101078	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	1.0	CHEMBL5147	Homo sapiens	Inhibition	%	1.0
	8101444	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	1.05	CHEMBL5147	Homo sapiens	Inhibition	%	1.05
	8101629	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	-2.13	CHEMBL5147	Homo sapiens	Inhibition	%	-2.13
	8101882	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	3.21	CHEMBL5147	Homo sapiens	Inhibition	%	3.21
	8102261	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	22.18	CHEMBL5147	Homo sapiens	Inhibition	%	22.18
	8102392	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	-4.05	CHEMBL5147	Homo sapiens	Inhibition	%	-4.05
	8102736	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	1.33	CHEMBL5147	Homo sapiens	Inhibition	%	1.33
	8102914	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	-0.6	CHEMBL5147	Homo sapiens	Inhibition	%	-0.6
	8103138	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	1.67	CHEMBL5147	Homo sapiens	Inhibition	%	1.67
	8103334	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	1.68	CHEMBL5147	Homo sapiens	Inhibition	%	1.68
	8103472	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	4.04	CHEMBL5147	Homo sapiens	Inhibition	%	4.04
	8103696	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	-0.22	CHEMBL5147	Homo sapiens	Inhibition	%	-0.22
	8103846	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	3.47	CHEMBL5147	Homo sapiens	Inhibition	%	3.47
	8104031	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	2.45	CHEMBL5147	Homo sapiens	Inhibition	%	2.45
	8104403	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	3.21	CHEMBL5147	Homo sapiens	Inhibition	%	3.21
	8104549	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	-2.49	CHEMBL5147	Homo sapiens	Inhibition	%	-2.49
	8104773	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	-0.26	CHEMBL5147	Homo sapiens	Inhibition	%	-0.26
	8104887	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	-0.34	CHEMBL5147	Homo sapiens	Inhibition	%	-0.34
	8105251	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	-0.37	CHEMBL5147	Homo sapiens	Inhibition	%	-0.37
	8105417	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	2.03	CHEMBL5147	Homo sapiens	Inhibition	%	2.03
	8105779	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	3.25	CHEMBL5147	Homo sapiens	Inhibition	%	3.25
	8106059	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	1.66	CHEMBL5147	Homo sapiens	Inhibition	%	1.66
	8106224	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	13.46	CHEMBL5147	Homo sapiens	Inhibition	%	13.46
	8106448	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	-2.73	CHEMBL5147	Homo sapiens	Inhibition	%	-2.73
	8106604	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	72.09	CHEMBL5147	Homo sapiens	Inhibition	%	72.09
	8106733	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	0.17	CHEMBL5147	Homo sapiens	Inhibition	%	0.17
	8106957	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	7.93	CHEMBL5147	Homo sapiens	Inhibition	%	7.93
	8107078	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	-1.27	CHEMBL5147	Homo sapiens	Inhibition	%	-1.27
	8107474	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	0.19	CHEMBL5147	Homo sapiens	Inhibition	%	0.19
	8107675	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	1.24	CHEMBL5147	Homo sapiens	Inhibition	%	1.24
	8108034	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	5.23	CHEMBL5147	Homo sapiens	Inhibition	%	5.23
	8108192	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	0.98	CHEMBL5147	Homo sapiens	Inhibition	%	0.98
	8108367	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	4.66	CHEMBL5147	Homo sapiens	Inhibition	%	4.66
	8108591	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	14.36	CHEMBL5147	Homo sapiens	Inhibition	%	14.36
	8108738	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	5.24	CHEMBL5147	Homo sapiens	Inhibition	%	5.24
	8109104	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	1.15	CHEMBL5147	Homo sapiens	Inhibition	%	1.15
	8109218	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	2.48	CHEMBL5147	Homo sapiens	Inhibition	%	2.48
	8109442	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	0.3	CHEMBL5147	Homo sapiens	Inhibition	%	0.3
	8109572	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	1.29	CHEMBL5147	Homo sapiens	Inhibition	%	1.29
	8109743	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	-3.06	CHEMBL5147	Homo sapiens	Inhibition	%	-3.06
	8109967	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	-1.28	CHEMBL5147	Homo sapiens	Inhibition	%	-1.28
	8110099	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	1.28	CHEMBL5147	Homo sapiens	Inhibition	%	1.28
	8110378	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	2.84	CHEMBL5147	Homo sapiens	Inhibition	%	2.84
	8110768	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	0.9	CHEMBL5147	Homo sapiens	Inhibition	%	0.9
	8110926	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-2.64	CHEMBL5147	Homo sapiens	Inhibition	%	-2.64
	8111273	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	15.69	CHEMBL5147	Homo sapiens	Inhibition	%	15.69
	8111400	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	3.47	CHEMBL5147	Homo sapiens	Inhibition	%	3.47
	8111624	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	-1.76	CHEMBL5147	Homo sapiens	Inhibition	%	-1.76
	8111790	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	1.65	CHEMBL5147	Homo sapiens	Inhibition	%	1.65
	8111995	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	2.8	CHEMBL5147	Homo sapiens	Inhibition	%	2.8
	8112356	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	0.44	CHEMBL5147	Homo sapiens	Inhibition	%	0.44
	8112524	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	5.78	CHEMBL5147	Homo sapiens	Inhibition	%	5.78
	8112920	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	0.88	CHEMBL5147	Homo sapiens	Inhibition	%	0.88
	8113072	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	3.86	CHEMBL5147	Homo sapiens	Inhibition	%	3.86
	8113432	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	1.36	CHEMBL5147	Homo sapiens	Inhibition	%	1.36
	8113780	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	1.15	CHEMBL5147	Homo sapiens	Inhibition	%	1.15
	8113896	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-1.79	CHEMBL5147	Homo sapiens	Inhibition	%	-1.79
	8114296	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	0.6	CHEMBL5147	Homo sapiens	Inhibition	%	0.6
	8114428	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	4.64	CHEMBL5147	Homo sapiens	Inhibition	%	4.64
	8114704	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	1.61	CHEMBL5147	Homo sapiens	Inhibition	%	1.61
	8115094	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	30.57	CHEMBL5147	Homo sapiens	Inhibition	%	30.57
	8115259	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-2.62	CHEMBL5147	Homo sapiens	Inhibition	%	-2.62
	8115603	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	27.48	CHEMBL5147	Homo sapiens	Inhibition	%	27.48
	8115960	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	1.1	CHEMBL5147	Homo sapiens	Inhibition	%	1.1
	8116119	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	-2.31	CHEMBL5147	Homo sapiens	Inhibition	%	-2.31
	8116322	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	3.6	CHEMBL5147	Homo sapiens	Inhibition	%	3.6
	8116546	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	1.92	CHEMBL5147	Homo sapiens	Inhibition	%	1.92
	8116680	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	1.01	CHEMBL5147	Homo sapiens	Inhibition	%	1.01
	8116852	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	49.27	CHEMBL5147	Homo sapiens	Inhibition	%	49.27
	8117076	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	87.09	CHEMBL5147	Homo sapiens	Inhibition	%	87.09
	8117247	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	1.51	CHEMBL5147	Homo sapiens	Inhibition	%	1.51
	8117405	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	2.31	CHEMBL5147	Homo sapiens	Inhibition	%	2.31
	8117629	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	2.13	CHEMBL5147	Homo sapiens	Inhibition	%	2.13
	8117759	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	1.93	CHEMBL5147	Homo sapiens	Inhibition	%	1.93
	8118121	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	-4.11	CHEMBL5147	Homo sapiens	Inhibition	%	-4.11
	8118237	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-1.48	CHEMBL5147	Homo sapiens	Inhibition	%	-1.48
	8118461	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	5.71	CHEMBL5147	Homo sapiens	Inhibition	%	5.71
	8118633	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	2.19	CHEMBL5147	Homo sapiens	Inhibition	%	2.19
	8118769	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	4.0	CHEMBL5147	Homo sapiens	Inhibition	%	4.0
	8118993	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	2.19	CHEMBL5147	Homo sapiens	Inhibition	%	2.19
	8119040	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	0.58	CHEMBL5147	Homo sapiens	Inhibition	%	0.58
	8119264	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	2.62	CHEMBL5147	Homo sapiens	Inhibition	%	2.62
	8119423	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	84.85	CHEMBL5147	Homo sapiens	Inhibition	%	84.85
	8119590	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-0.8	CHEMBL5147	Homo sapiens	Inhibition	%	-0.8
	8119814	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	0.82	CHEMBL5147	Homo sapiens	Inhibition	%	0.82
	8119933	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	1.4	CHEMBL5147	Homo sapiens	Inhibition	%	1.4
	8120296	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	-1.12	CHEMBL5147	Homo sapiens	Inhibition	%	-1.12
	8120456	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	-0.62	CHEMBL5147	Homo sapiens	Inhibition	%	-0.62
	8120881	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	1.63	CHEMBL5147	Homo sapiens	Inhibition	%	1.63
	8121009	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	1.07	CHEMBL5147	Homo sapiens	Inhibition	%	1.07
	8121405	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	-0.73	CHEMBL5147	Homo sapiens	Inhibition	%	-0.73
	8121572	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	1.21	CHEMBL5147	Homo sapiens	Inhibition	%	1.21
	8121959	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	1.58	CHEMBL5147	Homo sapiens	Inhibition	%	1.58
	8122080	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	2.4	CHEMBL5147	Homo sapiens	Inhibition	%	2.4
	8122304	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	20.27	CHEMBL5147	Homo sapiens	Inhibition	%	20.27
	8122442	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	0.57	CHEMBL5147	Homo sapiens	Inhibition	%	0.57
	8122786	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	3.61	CHEMBL5147	Homo sapiens	Inhibition	%	3.61
	8122953	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	1.93	CHEMBL5147	Homo sapiens	Inhibition	%	1.93
	8123319	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	0.05	CHEMBL5147	Homo sapiens	Inhibition	%	0.05
	8123597	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	1.31	CHEMBL5147	Homo sapiens	Inhibition	%	1.31
	8123747	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	2.58	CHEMBL5147	Homo sapiens	Inhibition	%	2.58
	8124138	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-2.1	CHEMBL5147	Homo sapiens	Inhibition	%	-2.1
	8124257	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	8.6	CHEMBL5147	Homo sapiens	Inhibition	%	8.6
	8124481	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	2.75	CHEMBL5147	Homo sapiens	Inhibition	%	2.75
	8124620	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	1.46	CHEMBL5147	Homo sapiens	Inhibition	%	1.46
	8124785	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-1.51	CHEMBL5147	Homo sapiens	Inhibition	%	-1.51
	8125009	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	0.96	CHEMBL5147	Homo sapiens	Inhibition	%	0.96
	8125210	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	1.97	CHEMBL5147	Homo sapiens	Inhibition	%	1.97
	8125340	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	0.29	CHEMBL5147	Homo sapiens	Inhibition	%	0.29
	8125564	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	2.37	CHEMBL5147	Homo sapiens	Inhibition	%	2.37
	8125732	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	1.41	CHEMBL5147	Homo sapiens	Inhibition	%	1.41
	8125896	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	0.87	CHEMBL5147	Homo sapiens	Inhibition	%	0.87
	8126120	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	0.49	CHEMBL5147	Homo sapiens	Inhibition	%	0.49
	8126284	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	3.37	CHEMBL5147	Homo sapiens	Inhibition	%	3.37
	8126623	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	72.7	CHEMBL5147	Homo sapiens	Inhibition	%	72.7
	8126759	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	0.08	CHEMBL5147	Homo sapiens	Inhibition	%	0.08
	8127105	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	2.74	CHEMBL5147	Homo sapiens	Inhibition	%	2.74
	8127272	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	3.09	CHEMBL5147	Homo sapiens	Inhibition	%	3.09
	8127496	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	5.59	CHEMBL5147	Homo sapiens	Inhibition	%	5.59
	8127638	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	1.61	CHEMBL5147	Homo sapiens	Inhibition	%	1.61
	8127926	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	2.59	CHEMBL5147	Homo sapiens	Inhibition	%	2.59
	8128078	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	9.64	CHEMBL5147	Homo sapiens	Inhibition	%	9.64
	8128302	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	3.23	CHEMBL5147	Homo sapiens	Inhibition	%	3.23
	8128469	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	0.65	CHEMBL5147	Homo sapiens	Inhibition	%	0.65
	8128812	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	16.06	CHEMBL5147	Homo sapiens	Inhibition	%	16.06
	8128949	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	-0.74	CHEMBL5147	Homo sapiens	Inhibition	%	-0.74
	8129344	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	0.06	CHEMBL5147	Homo sapiens	Inhibition	%	0.06
	8129533	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	3.15	CHEMBL5147	Homo sapiens	Inhibition	%	3.15
	8129896	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	0.6	CHEMBL5147	Homo sapiens	Inhibition	%	0.6
	8130057	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	0.32	CHEMBL5147	Homo sapiens	Inhibition	%	0.32
	8130453	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-0.12	CHEMBL5147	Homo sapiens	Inhibition	%	-0.12
	8130613	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	1.62	CHEMBL5147	Homo sapiens	Inhibition	%	1.62
	8130953	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	-0.15	CHEMBL5147	Homo sapiens	Inhibition	%	-0.15
	8131092	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	8.11	CHEMBL5147	Homo sapiens	Inhibition	%	8.11
	8131316	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	0.68	CHEMBL5147	Homo sapiens	Inhibition	%	0.68
	8131436	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	2.19	CHEMBL5147	Homo sapiens	Inhibition	%	2.19
	8131827	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	31.74	CHEMBL5147	Homo sapiens	Inhibition	%	31.74
	8131968	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	31.21	CHEMBL5147	Homo sapiens	Inhibition	%	31.21
	8132254	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	2.97	CHEMBL5147	Homo sapiens	Inhibition	%	2.97
	8132625	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	7.53	CHEMBL5147	Homo sapiens	Inhibition	%	7.53
	8132793	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	-0.2	CHEMBL5147	Homo sapiens	Inhibition	%	-0.2
	8133138	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	0.83	CHEMBL5147	Homo sapiens	Inhibition	%	0.83
	8133276	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	1.7	CHEMBL5147	Homo sapiens	Inhibition	%	1.7
	8133500	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	-0.34	CHEMBL5147	Homo sapiens	Inhibition	%	-0.34
	8133672	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	1.37	CHEMBL5147	Homo sapiens	Inhibition	%	1.37
	8133852	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	2.21	CHEMBL5147	Homo sapiens	Inhibition	%	2.21
	8134076	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	11.01	CHEMBL5147	Homo sapiens	Inhibition	%	11.01
	8134224	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	0.49	CHEMBL5147	Homo sapiens	Inhibition	%	0.49
	8134384	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	1.93	CHEMBL5147	Homo sapiens	Inhibition	%	1.93
	8134608	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	0.88	CHEMBL5147	Homo sapiens	Inhibition	%	0.88
	8134792	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	0.19	CHEMBL5147	Homo sapiens	Inhibition	%	0.19
	8134952	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	8.4	CHEMBL5147	Homo sapiens	Inhibition	%	8.4
	8135176	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	1.86	CHEMBL5147	Homo sapiens	Inhibition	%	1.86
	8135291	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	2.72	CHEMBL5147	Homo sapiens	Inhibition	%	2.72
	8135656	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	3.62	CHEMBL5147	Homo sapiens	Inhibition	%	3.62
	8135777	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	1.62	CHEMBL5147	Homo sapiens	Inhibition	%	1.62
	8136001	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	-1.46	CHEMBL5147	Homo sapiens	Inhibition	%	-1.46
	8136169	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	0.66	CHEMBL5147	Homo sapiens	Inhibition	%	0.66
	8136313	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	84.37	CHEMBL5147	Homo sapiens	Inhibition	%	84.37
	8136537	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	1.53	CHEMBL5147	Homo sapiens	Inhibition	%	1.53
	8136603	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	-2.25	CHEMBL5147	Homo sapiens	Inhibition	%	-2.25
	8136827	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	-3.91	CHEMBL5147	Homo sapiens	Inhibition	%	-3.91
	8136962	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	1.18	CHEMBL5147	Homo sapiens	Inhibition	%	1.18
	8137125	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	4.63	CHEMBL5147	Homo sapiens	Inhibition	%	4.63
	8137349	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	1.55	CHEMBL5147	Homo sapiens	Inhibition	%	1.55
	8137469	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	0.64	CHEMBL5147	Homo sapiens	Inhibition	%	0.64
	8137841	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	1.27	CHEMBL5147	Homo sapiens	Inhibition	%	1.27
	8138007	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-2.29	CHEMBL5147	Homo sapiens	Inhibition	%	-2.29
	8138410	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	-1.44	CHEMBL5147	Homo sapiens	Inhibition	%	-1.44
	8138558	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	0.16	CHEMBL5147	Homo sapiens	Inhibition	%	0.16
	8138940	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	0.82	CHEMBL5147	Homo sapiens	Inhibition	%	0.82
	8139125	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-0.64	CHEMBL5147	Homo sapiens	Inhibition	%	-0.64
	8139508	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	4.98	CHEMBL5147	Homo sapiens	Inhibition	%	4.98
	8139622	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	3.21	CHEMBL5147	Homo sapiens	Inhibition	%	3.21
	8139987	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	2.75	CHEMBL5147	Homo sapiens	Inhibition	%	2.75
	8140334	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	3.71	CHEMBL5147	Homo sapiens	Inhibition	%	3.71
	8140493	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	1.2	CHEMBL5147	Homo sapiens	Inhibition	%	1.2
	8140860	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	3.9	CHEMBL5147	Homo sapiens	Inhibition	%	3.9
	8141162	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	1.0	CHEMBL5147	Homo sapiens	Inhibition	%	1.0
	8141292	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	1.59	CHEMBL5147	Homo sapiens	Inhibition	%	1.59
	8141676	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	5.77	CHEMBL5147	Homo sapiens	Inhibition	%	5.77
	8141795	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	7.98	CHEMBL5147	Homo sapiens	Inhibition	%	7.98
	8142019	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	45.71	CHEMBL5147	Homo sapiens	Inhibition	%	45.71
	8142180	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	-0.35	CHEMBL5147	Homo sapiens	Inhibition	%	-0.35
	8142348	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	0.07	CHEMBL5147	Homo sapiens	Inhibition	%	0.07
	8142572	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-1.38	CHEMBL5147	Homo sapiens	Inhibition	%	-1.38
	8142748	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	2.09	CHEMBL5147	Homo sapiens	Inhibition	%	2.09
	8142897	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-0.32	CHEMBL5147	Homo sapiens	Inhibition	%	-0.32
	8143121	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-2.91	CHEMBL5147	Homo sapiens	Inhibition	%	-2.91
	8143276	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	0.47	CHEMBL5147	Homo sapiens	Inhibition	%	0.47
	8143463	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	5.1	CHEMBL5147	Homo sapiens	Inhibition	%	5.1
	8143846	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	7.62	CHEMBL5147	Homo sapiens	Inhibition	%	7.62
	8143960	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	3.55	CHEMBL5147	Homo sapiens	Inhibition	%	3.55
	8144184	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	-1.9	CHEMBL5147	Homo sapiens	Inhibition	%	-1.9
	8144323	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	4.27	CHEMBL5147	Homo sapiens	Inhibition	%	4.27
	8144677	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	3.04	CHEMBL5147	Homo sapiens	Inhibition	%	3.04
	8144830	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	1.99	CHEMBL5147	Homo sapiens	Inhibition	%	1.99
	8145191	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	0.96	CHEMBL5147	Homo sapiens	Inhibition	%	0.96
	8145504	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	0.73	CHEMBL5147	Homo sapiens	Inhibition	%	0.73
	8145628	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	0.45	CHEMBL5147	Homo sapiens	Inhibition	%	0.45
	8145852	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	4.02	CHEMBL5147	Homo sapiens	Inhibition	%	4.02
	8146013	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	2.86	CHEMBL5147	Homo sapiens	Inhibition	%	2.86
	8146357	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	6.3	CHEMBL5147	Homo sapiens	Inhibition	%	6.3
	8146517	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	15.59	CHEMBL5147	Homo sapiens	Inhibition	%	15.59
	8146908	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	0.52	CHEMBL5147	Homo sapiens	Inhibition	%	0.52
	8147077	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	1.07	CHEMBL5147	Homo sapiens	Inhibition	%	1.07
	8147443	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	-0.91	CHEMBL5147	Homo sapiens	Inhibition	%	-0.91
	8147596	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	2.45	CHEMBL5147	Homo sapiens	Inhibition	%	2.45
	8147783	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	4.33	CHEMBL5147	Homo sapiens	Inhibition	%	4.33
	8148007	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	2.41	CHEMBL5147	Homo sapiens	Inhibition	%	2.41
	8148165	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	46.4	CHEMBL5147	Homo sapiens	Inhibition	%	46.4
	8148503	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	-0.22	CHEMBL5147	Homo sapiens	Inhibition	%	-0.22
	8148642	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	3.87	CHEMBL5147	Homo sapiens	Inhibition	%	3.87
	8148866	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	2.44	CHEMBL5147	Homo sapiens	Inhibition	%	2.44
	8149004	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	3.7	CHEMBL5147	Homo sapiens	Inhibition	%	3.7
	8149163	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	2.03	CHEMBL5147	Homo sapiens	Inhibition	%	2.03
	8149387	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-2.59	CHEMBL5147	Homo sapiens	Inhibition	%	-2.59
	8149521	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	2.99	CHEMBL5147	Homo sapiens	Inhibition	%	2.99
	8149843	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	9.51	CHEMBL5147	Homo sapiens	Inhibition	%	9.51
	8150192	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	8.82	CHEMBL5147	Homo sapiens	Inhibition	%	8.82
	8150352	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	8.72	CHEMBL5147	Homo sapiens	Inhibition	%	8.72
	8150696	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	57.18	CHEMBL5147	Homo sapiens	Inhibition	%	57.18
	8150861	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	-2.11	CHEMBL5147	Homo sapiens	Inhibition	%	-2.11
	8151248	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-2.42	CHEMBL5147	Homo sapiens	Inhibition	%	-2.42
	8151425	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	4.54	CHEMBL5147	Homo sapiens	Inhibition	%	4.54
	8151787	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	0.74	CHEMBL5147	Homo sapiens	Inhibition	%	0.74
	8151941	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	0.66	CHEMBL5147	Homo sapiens	Inhibition	%	0.66
	8152165	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	5.01	CHEMBL5147	Homo sapiens	Inhibition	%	5.01
	8152353	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	3.68	CHEMBL5147	Homo sapiens	Inhibition	%	3.68
	8152511	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	4.58	CHEMBL5147	Homo sapiens	Inhibition	%	4.58
	8152849	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	17.39	CHEMBL5147	Homo sapiens	Inhibition	%	17.39
	8153212	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	0.3	CHEMBL5147	Homo sapiens	Inhibition	%	0.3
	8153349	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	3.09	CHEMBL5147	Homo sapiens	Inhibition	%	3.09
	8153730	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-3.31	CHEMBL5147	Homo sapiens	Inhibition	%	-3.31
	8153863	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	-0.07	CHEMBL5147	Homo sapiens	Inhibition	%	-0.07
	8154087	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	0.78	CHEMBL5147	Homo sapiens	Inhibition	%	0.78
	8154184	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	49.69	CHEMBL5147	Homo sapiens	Inhibition	%	49.69
	8154534	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	63.8	CHEMBL5147	Homo sapiens	Inhibition	%	63.8
	8154693	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	-1.02	CHEMBL5147	Homo sapiens	Inhibition	%	-1.02
	8154917	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	0.31	CHEMBL5147	Homo sapiens	Inhibition	%	0.31
	8155037	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	0.67	CHEMBL5147	Homo sapiens	Inhibition	%	0.67
	8155213	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	1.55	CHEMBL5147	Homo sapiens	Inhibition	%	1.55
	8155437	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	0.18	CHEMBL5147	Homo sapiens	Inhibition	%	0.18
	8155598	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-0.31	CHEMBL5147	Homo sapiens	Inhibition	%	-0.31
	8155776	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	1.21	CHEMBL5147	Homo sapiens	Inhibition	%	1.21
	8156000	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	3.43	CHEMBL5147	Homo sapiens	Inhibition	%	3.43
	8156138	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	1.01	CHEMBL5147	Homo sapiens	Inhibition	%	1.01
	8156350	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	2.68	CHEMBL5147	Homo sapiens	Inhibition	%	2.68
	8156574	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	3.05	CHEMBL5147	Homo sapiens	Inhibition	%	3.05
	8156724	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	6.82	CHEMBL5147	Homo sapiens	Inhibition	%	6.82
	8156867	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	2.27	CHEMBL5147	Homo sapiens	Inhibition	%	2.27
	8157091	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	1.72	CHEMBL5147	Homo sapiens	Inhibition	%	1.72
	8157211	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	1.98	CHEMBL5147	Homo sapiens	Inhibition	%	1.98
	8157576	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	5.85	CHEMBL5147	Homo sapiens	Inhibition	%	5.85
	8157706	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	27.48	CHEMBL5147	Homo sapiens	Inhibition	%	27.48
	8157930	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	2.58	CHEMBL5147	Homo sapiens	Inhibition	%	2.58
	8158091	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	3.27	CHEMBL5147	Homo sapiens	Inhibition	%	3.27
	8158341	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	14.22	CHEMBL5147	Homo sapiens	Inhibition	%	14.22
	8158723	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	-2.95	CHEMBL5147	Homo sapiens	Inhibition	%	-2.95
	8158892	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	2.32	CHEMBL5147	Homo sapiens	Inhibition	%	2.32
	8159251	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	0.52	CHEMBL5147	Homo sapiens	Inhibition	%	0.52
	8159371	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	0.29	CHEMBL5147	Homo sapiens	Inhibition	%	0.29
	8159595	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	-4.56	CHEMBL5147	Homo sapiens	Inhibition	%	-4.56
	8159726	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	4.14	CHEMBL5147	Homo sapiens	Inhibition	%	4.14
	8160091	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	1.11	CHEMBL5147	Homo sapiens	Inhibition	%	1.11
	8160228	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	2.41	CHEMBL5147	Homo sapiens	Inhibition	%	2.41
	8160602	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	2.5	CHEMBL5147	Homo sapiens	Inhibition	%	2.5
	8160896	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	12.87	CHEMBL5147	Homo sapiens	Inhibition	%	12.87
	8161046	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	2.27	CHEMBL5147	Homo sapiens	Inhibition	%	2.27
	8161413	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	3.69	CHEMBL5147	Homo sapiens	Inhibition	%	3.69
	8161538	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	4.06	CHEMBL5147	Homo sapiens	Inhibition	%	4.06
	8161762	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	1.29	CHEMBL5147	Homo sapiens	Inhibition	%	1.29
	8161900	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	31.15	CHEMBL5147	Homo sapiens	Inhibition	%	31.15
	8162254	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	2.07	CHEMBL5147	Homo sapiens	Inhibition	%	2.07
	8162414	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-1.44	CHEMBL5147	Homo sapiens	Inhibition	%	-1.44
	8162667	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	6.15	CHEMBL5147	Homo sapiens	Inhibition	%	6.15
	8163039	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	4.95	CHEMBL5147	Homo sapiens	Inhibition	%	4.95
	8163208	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	4.67	CHEMBL5147	Homo sapiens	Inhibition	%	4.67
	8163566	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	1.52	CHEMBL5147	Homo sapiens	Inhibition	%	1.52
	8163913	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	-2.17	CHEMBL5147	Homo sapiens	Inhibition	%	-2.17
	8164047	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	2.18	CHEMBL5147	Homo sapiens	Inhibition	%	2.18
	8164411	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	0.27	CHEMBL5147	Homo sapiens	Inhibition	%	0.27
	8164566	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	0.41	CHEMBL5147	Homo sapiens	Inhibition	%	0.41
	8164934	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	14.72	CHEMBL5147	Homo sapiens	Inhibition	%	14.72
	8165228	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	1.64	CHEMBL5147	Homo sapiens	Inhibition	%	1.64
	8165369	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	3.53	CHEMBL5147	Homo sapiens	Inhibition	%	3.53
	8165593	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	1.31	CHEMBL5147	Homo sapiens	Inhibition	%	1.31
	8165736	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	12.46	CHEMBL5147	Homo sapiens	Inhibition	%	12.46
	8166086	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	3.19	CHEMBL5147	Homo sapiens	Inhibition	%	3.19
	8166224	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	0.66	CHEMBL5147	Homo sapiens	Inhibition	%	0.66
	8166578	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	6.41	CHEMBL5147	Homo sapiens	Inhibition	%	6.41
	8166903	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	54.84	CHEMBL5147	Homo sapiens	Inhibition	%	54.84
	8166991	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	2.54	CHEMBL5147	Homo sapiens	Inhibition	%	2.54
	8167215	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	3.21	CHEMBL5147	Homo sapiens	Inhibition	%	3.21
	8167356	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	12.19	CHEMBL5147	Homo sapiens	Inhibition	%	12.19
	8167520	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	3.79	CHEMBL5147	Homo sapiens	Inhibition	%	3.79
	8167744	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	3.28	CHEMBL5147	Homo sapiens	Inhibition	%	3.28
	8167877	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	1.64	CHEMBL5147	Homo sapiens	Inhibition	%	1.64
	8168225	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	-1.65	CHEMBL5147	Homo sapiens	Inhibition	%	-1.65
	8168366	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	4.67	CHEMBL5147	Homo sapiens	Inhibition	%	4.67
	8168590	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	4.6	CHEMBL5147	Homo sapiens	Inhibition	%	4.6
	8168726	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	0.62	CHEMBL5147	Homo sapiens	Inhibition	%	0.62
	8168890	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	5.63	CHEMBL5147	Homo sapiens	Inhibition	%	5.63
	8169114	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	22.48	CHEMBL5147	Homo sapiens	Inhibition	%	22.48
	8169256	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	2.13	CHEMBL5147	Homo sapiens	Inhibition	%	2.13
	8169560	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	2.22	CHEMBL5147	Homo sapiens	Inhibition	%	2.22
	8169918	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	0.98	CHEMBL5147	Homo sapiens	Inhibition	%	0.98
	8170063	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	9.24	CHEMBL5147	Homo sapiens	Inhibition	%	9.24
	8170412	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	1.36	CHEMBL5147	Homo sapiens	Inhibition	%	1.36
	8170552	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	3.57	CHEMBL5147	Homo sapiens	Inhibition	%	3.57
	8170776	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	-3.5	CHEMBL5147	Homo sapiens	Inhibition	%	-3.5
	8170911	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	9.99	CHEMBL5147	Homo sapiens	Inhibition	%	9.99
	8171108	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	16.37	CHEMBL5147	Homo sapiens	Inhibition	%	16.37
	8171332	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	11.24	CHEMBL5147	Homo sapiens	Inhibition	%	11.24
	8171549	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	3.05	CHEMBL5147	Homo sapiens	Inhibition	%	3.05
	8171690	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	2.71	CHEMBL5147	Homo sapiens	Inhibition	%	2.71
	8172067	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	-0.91	CHEMBL5147	Homo sapiens	Inhibition	%	-0.91
	8172199	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	1.12	CHEMBL5147	Homo sapiens	Inhibition	%	1.12
	8172423	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	5.44	CHEMBL5147	Homo sapiens	Inhibition	%	5.44
	8172551	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	0.92	CHEMBL5147	Homo sapiens	Inhibition	%	0.92
	8172917	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	11.38	CHEMBL5147	Homo sapiens	Inhibition	%	11.38
	8173053	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-1.93	CHEMBL5147	Homo sapiens	Inhibition	%	-1.93
	8173442	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	3.92	CHEMBL5147	Homo sapiens	Inhibition	%	3.92
	8173583	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	4.33	CHEMBL5147	Homo sapiens	Inhibition	%	4.33
	8173807	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	2.97	CHEMBL5147	Homo sapiens	Inhibition	%	2.97
	8173894	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	4.11	CHEMBL5147	Homo sapiens	Inhibition	%	4.11
	8174250	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	6.99	CHEMBL5147	Homo sapiens	Inhibition	%	6.99
	8174398	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	41.38	CHEMBL5147	Homo sapiens	Inhibition	%	41.38
	8174622	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	1.37	CHEMBL5147	Homo sapiens	Inhibition	%	1.37
	8174744	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	2.09	CHEMBL5147	Homo sapiens	Inhibition	%	2.09
	8175111	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	-2.94	CHEMBL5147	Homo sapiens	Inhibition	%	-2.94
	8175247	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	4.64	CHEMBL5147	Homo sapiens	Inhibition	%	4.64
	8175503	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	2.19	CHEMBL5147	Homo sapiens	Inhibition	%	2.19
	8175727	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	2.59	CHEMBL5147	Homo sapiens	Inhibition	%	2.59
	8175890	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	7.86	CHEMBL5147	Homo sapiens	Inhibition	%	7.86
	8176043	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	2.72	CHEMBL5147	Homo sapiens	Inhibition	%	2.72
	8176267	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	2.23	CHEMBL5147	Homo sapiens	Inhibition	%	2.23
	8176416	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	0.63	CHEMBL5147	Homo sapiens	Inhibition	%	0.63
	8176772	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	5.98	CHEMBL5147	Homo sapiens	Inhibition	%	5.98
	8176902	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	0.04	CHEMBL5147	Homo sapiens	Inhibition	%	0.04
	8177268	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	3.89	CHEMBL5147	Homo sapiens	Inhibition	%	3.89
	8177406	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-1.01	CHEMBL5147	Homo sapiens	Inhibition	%	-1.01
	8177630	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	-0.01	CHEMBL5147	Homo sapiens	Inhibition	%	-0.01
	8177794	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	13.66	CHEMBL5147	Homo sapiens	Inhibition	%	13.66
	8178158	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	3.11	CHEMBL5147	Homo sapiens	Inhibition	%	3.11
	8178246	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	6.29	CHEMBL5147	Homo sapiens	Inhibition	%	6.29
	8178470	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	2.43	CHEMBL5147	Homo sapiens	Inhibition	%	2.43
	8178597	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	38.66	CHEMBL5147	Homo sapiens	Inhibition	%	38.66
	8178970	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	1.03	CHEMBL5147	Homo sapiens	Inhibition	%	1.03
	8179093	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	3.25	CHEMBL5147	Homo sapiens	Inhibition	%	3.25
	8179461	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	1.83	CHEMBL5147	Homo sapiens	Inhibition	%	1.83
	8179598	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	2.76	CHEMBL5147	Homo sapiens	Inhibition	%	2.76
	8179822	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	3.87	CHEMBL5147	Homo sapiens	Inhibition	%	3.87
	8180079	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	2.18	CHEMBL5147	Homo sapiens	Inhibition	%	2.18
	8180233	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	39.56	CHEMBL5147	Homo sapiens	Inhibition	%	39.56
	8180613	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	1.42	CHEMBL5147	Homo sapiens	Inhibition	%	1.42
	8180761	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	2.11	CHEMBL5147	Homo sapiens	Inhibition	%	2.11
	8181118	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	91.64	CHEMBL5147	Homo sapiens	Inhibition	%	91.64
	8181249	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	-0.88	CHEMBL5147	Homo sapiens	Inhibition	%	-0.88
	8181473	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	-2.17	CHEMBL5147	Homo sapiens	Inhibition	%	-2.17
	8181613	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	46.2	CHEMBL5147	Homo sapiens	Inhibition	%	46.2
	8181976	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	4.21	CHEMBL5147	Homo sapiens	Inhibition	%	4.21
	8182139	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	1.8	CHEMBL5147	Homo sapiens	Inhibition	%	1.8
	8182503	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	2.27	CHEMBL5147	Homo sapiens	Inhibition	%	2.27
	8182819	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	3.92	CHEMBL5147	Homo sapiens	Inhibition	%	3.92
	8182941	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	1.79	CHEMBL5147	Homo sapiens	Inhibition	%	1.79
	8183314	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	3.32	CHEMBL5147	Homo sapiens	Inhibition	%	3.32
	8183443	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	4.36	CHEMBL5147	Homo sapiens	Inhibition	%	4.36
	8183667	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	0.48	CHEMBL5147	Homo sapiens	Inhibition	%	0.48
	8183809	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	4.17	CHEMBL5147	Homo sapiens	Inhibition	%	4.17
	8184169	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	1.36	CHEMBL5147	Homo sapiens	Inhibition	%	1.36
	8184435	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	1.12	CHEMBL5147	Homo sapiens	Inhibition	%	1.12
	8184582	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	-1.44	CHEMBL5147	Homo sapiens	Inhibition	%	-1.44
	8184806	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	-2.14	CHEMBL5147	Homo sapiens	Inhibition	%	-2.14
	8184963	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	20.1	CHEMBL5147	Homo sapiens	Inhibition	%	20.1
	8185112	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	3.08	CHEMBL5147	Homo sapiens	Inhibition	%	3.08
	8185336	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	0.57	CHEMBL5147	Homo sapiens	Inhibition	%	0.57
	8185467	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	95.59	CHEMBL5147	Homo sapiens	Inhibition	%	95.59
	8185822	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	-2.22	CHEMBL5147	Homo sapiens	Inhibition	%	-2.22
	8185961	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	2.92	CHEMBL5147	Homo sapiens	Inhibition	%	2.92
	8186326	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	1.49	CHEMBL5147	Homo sapiens	Inhibition	%	1.49
	8186490	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	5.58	CHEMBL5147	Homo sapiens	Inhibition	%	5.58
	8186714	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	3.74	CHEMBL5147	Homo sapiens	Inhibition	%	3.74
	8186853	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	1.26	CHEMBL5147	Homo sapiens	Inhibition	%	1.26
	8187175	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	9.23	CHEMBL5147	Homo sapiens	Inhibition	%	9.23
	8187299	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	3.45	CHEMBL5147	Homo sapiens	Inhibition	%	3.45
	8187523	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	0.79	CHEMBL5147	Homo sapiens	Inhibition	%	0.79
	8187671	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	11.91	CHEMBL5147	Homo sapiens	Inhibition	%	11.91
	8188024	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	10.25	CHEMBL5147	Homo sapiens	Inhibition	%	10.25
	8188167	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	1.05	CHEMBL5147	Homo sapiens	Inhibition	%	1.05
	8188391	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	2.86	CHEMBL5147	Homo sapiens	Inhibition	%	2.86
	8188526	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	-0.79	CHEMBL5147	Homo sapiens	Inhibition	%	-0.79
	8188800	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	3.67	CHEMBL5147	Homo sapiens	Inhibition	%	3.67
	8189172	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	3.42	CHEMBL5147	Homo sapiens	Inhibition	%	3.42
	8189328	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	64.82	CHEMBL5147	Homo sapiens	Inhibition	%	64.82
	8189701	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	2.91	CHEMBL5147	Homo sapiens	Inhibition	%	2.91
	8189833	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	1.68	CHEMBL5147	Homo sapiens	Inhibition	%	1.68
	8190189	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	1.76	CHEMBL5147	Homo sapiens	Inhibition	%	1.76
	8190329	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	4.63	CHEMBL5147	Homo sapiens	Inhibition	%	4.63
	8190553	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	7.68	CHEMBL5147	Homo sapiens	Inhibition	%	7.68
	8190690	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	7.6	CHEMBL5147	Homo sapiens	Inhibition	%	7.6
	8191078	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	4.2	CHEMBL5147	Homo sapiens	Inhibition	%	4.2
	8191216	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	2.45	CHEMBL5147	Homo sapiens	Inhibition	%	2.45
	8191536	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	46.15	CHEMBL5147	Homo sapiens	Inhibition	%	46.15
	8191882	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	4.73	CHEMBL5147	Homo sapiens	Inhibition	%	4.73
	8192031	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	1.12	CHEMBL5147	Homo sapiens	Inhibition	%	1.12
	8192255	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	1.84	CHEMBL5147	Homo sapiens	Inhibition	%	1.84
	8192384	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	1.69	CHEMBL5147	Homo sapiens	Inhibition	%	1.69
	8192752	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	1.77	CHEMBL5147	Homo sapiens	Inhibition	%	1.77
	8192888	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	6.93	CHEMBL5147	Homo sapiens	Inhibition	%	6.93
	8193160	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	3.12	CHEMBL5147	Homo sapiens	Inhibition	%	3.12
	8193529	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	21.38	CHEMBL5147	Homo sapiens	Inhibition	%	21.38
	8193686	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	4.23	CHEMBL5147	Homo sapiens	Inhibition	%	4.23
	8194059	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-1.4	CHEMBL5147	Homo sapiens	Inhibition	%	-1.4
	8194190	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	-1.52	CHEMBL5147	Homo sapiens	Inhibition	%	-1.52
	8194414	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	8.74	CHEMBL5147	Homo sapiens	Inhibition	%	8.74
	8194545	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	4.26	CHEMBL5147	Homo sapiens	Inhibition	%	4.26
	8194912	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	36.05	CHEMBL5147	Homo sapiens	Inhibition	%	36.05
	8195045	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	1.85	CHEMBL5147	Homo sapiens	Inhibition	%	1.85
	8195269	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	8.07	CHEMBL5147	Homo sapiens	Inhibition	%	8.07
	8195433	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	3.11	CHEMBL5147	Homo sapiens	Inhibition	%	3.11
	8195572	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	3.65	CHEMBL5147	Homo sapiens	Inhibition	%	3.65
	8195796	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	4.58	CHEMBL5147	Homo sapiens	Inhibition	%	4.58
	8195894	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	1.15	CHEMBL5147	Homo sapiens	Inhibition	%	1.15
	8196235	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	1.42	CHEMBL5147	Homo sapiens	Inhibition	%	1.42
	8196609	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	12.86	CHEMBL5147	Homo sapiens	Inhibition	%	12.86
	8196737	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	-0.88	CHEMBL5147	Homo sapiens	Inhibition	%	-0.88
	8197102	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	9.19	CHEMBL5147	Homo sapiens	Inhibition	%	9.19
	8197239	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	2.17	CHEMBL5147	Homo sapiens	Inhibition	%	2.17
	8197463	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	1.74	CHEMBL5147	Homo sapiens	Inhibition	%	1.74
	8197514	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	3.64	CHEMBL5147	Homo sapiens	Inhibition	%	3.64
	8197738	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	3.21	CHEMBL5147	Homo sapiens	Inhibition	%	3.21
	8197878	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	0.55	CHEMBL5147	Homo sapiens	Inhibition	%	0.55
	8198035	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	3.73	CHEMBL5147	Homo sapiens	Inhibition	%	3.73
	8198259	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	-0.26	CHEMBL5147	Homo sapiens	Inhibition	%	-0.26
	8198397	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-1.17	CHEMBL5147	Homo sapiens	Inhibition	%	-1.17
	8198751	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	36.9	CHEMBL5147	Homo sapiens	Inhibition	%	36.9
	8198882	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	3.92	CHEMBL5147	Homo sapiens	Inhibition	%	3.92
	8199106	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	1.54	CHEMBL5147	Homo sapiens	Inhibition	%	1.54
	8199254	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	4.92	CHEMBL5147	Homo sapiens	Inhibition	%	4.92
	8199612	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	1.3	CHEMBL5147	Homo sapiens	Inhibition	%	1.3
	8199775	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	2.52	CHEMBL5147	Homo sapiens	Inhibition	%	2.52
	8200137	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	4.09	CHEMBL5147	Homo sapiens	Inhibition	%	4.09
	8200241	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	2.78	CHEMBL5147	Homo sapiens	Inhibition	%	2.78
	8200465	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	6.02	CHEMBL5147	Homo sapiens	Inhibition	%	6.02
	8200580	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	1.8	CHEMBL5147	Homo sapiens	Inhibition	%	1.8
	8200954	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	56.88	CHEMBL5147	Homo sapiens	Inhibition	%	56.88
	8201084	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	-2.89	CHEMBL5147	Homo sapiens	Inhibition	%	-2.89
	8201308	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	-2.46	CHEMBL5147	Homo sapiens	Inhibition	%	-2.46
	8201443	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	2.88	CHEMBL5147	Homo sapiens	Inhibition	%	2.88
	8201800	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	4.17	CHEMBL5147	Homo sapiens	Inhibition	%	4.17
	8202079	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	2.87	CHEMBL5147	Homo sapiens	Inhibition	%	2.87
	8202219	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	3.38	CHEMBL5147	Homo sapiens	Inhibition	%	3.38
	8202610	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	-2.49	CHEMBL5147	Homo sapiens	Inhibition	%	-2.49
	8202735	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	3.71	CHEMBL5147	Homo sapiens	Inhibition	%	3.71
	8202959	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	0.96	CHEMBL5147	Homo sapiens	Inhibition	%	0.96
	8203089	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	3.88	CHEMBL5147	Homo sapiens	Inhibition	%	3.88
	8203444	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	0.19	CHEMBL5147	Homo sapiens	Inhibition	%	0.19
	8203590	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	3.25	CHEMBL5147	Homo sapiens	Inhibition	%	3.25
	8203948	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	2.18	CHEMBL5147	Homo sapiens	Inhibition	%	2.18
	8204114	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	24.82	CHEMBL5147	Homo sapiens	Inhibition	%	24.82
	8204338	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	70.42	CHEMBL5147	Homo sapiens	Inhibition	%	70.42
	8204475	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	87.34	CHEMBL5147	Homo sapiens	Inhibition	%	87.34
	8204804	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	37.2	CHEMBL5147	Homo sapiens	Inhibition	%	37.2
	8204919	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	5.34	CHEMBL5147	Homo sapiens	Inhibition	%	5.34
	8205143	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	20.95	CHEMBL5147	Homo sapiens	Inhibition	%	20.95
	8205292	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	0.45	CHEMBL5147	Homo sapiens	Inhibition	%	0.45
	8205652	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	2.78	CHEMBL5147	Homo sapiens	Inhibition	%	2.78
	8205791	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	2.91	CHEMBL5147	Homo sapiens	Inhibition	%	2.91
	8206147	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	22.51	CHEMBL5147	Homo sapiens	Inhibition	%	22.51
	8206423	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	0.47	CHEMBL5147	Homo sapiens	Inhibition	%	0.47
	8206566	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-0.3	CHEMBL5147	Homo sapiens	Inhibition	%	-0.3
	8206790	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-2.45	CHEMBL5147	Homo sapiens	Inhibition	%	-2.45
	8206970	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	3.38	CHEMBL5147	Homo sapiens	Inhibition	%	3.38
	8207320	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	2.58	CHEMBL5147	Homo sapiens	Inhibition	%	2.58
	8207450	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	3.24	CHEMBL5147	Homo sapiens	Inhibition	%	3.24
	8207806	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	10.26	CHEMBL5147	Homo sapiens	Inhibition	%	10.26
	8207951	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	1.21	CHEMBL5147	Homo sapiens	Inhibition	%	1.21
	8208175	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	1.07	CHEMBL5147	Homo sapiens	Inhibition	%	1.07
	8208307	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	2.71	CHEMBL5147	Homo sapiens	Inhibition	%	2.71
	8208697	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	3.21	CHEMBL5147	Homo sapiens	Inhibition	%	3.21
	8208830	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	95.12	CHEMBL5147	Homo sapiens	Inhibition	%	95.12
	8209159	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	0.78	CHEMBL5147	Homo sapiens	Inhibition	%	0.78
	8209499	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	2.74	CHEMBL5147	Homo sapiens	Inhibition	%	2.74
	8209649	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	1.96	CHEMBL5147	Homo sapiens	Inhibition	%	1.96
	8210009	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	0.5	CHEMBL5147	Homo sapiens	Inhibition	%	0.5
	8210150	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	0.66	CHEMBL5147	Homo sapiens	Inhibition	%	0.66
	8210374	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	3.43	CHEMBL5147	Homo sapiens	Inhibition	%	3.43
	8210510	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-1.44	CHEMBL5147	Homo sapiens	Inhibition	%	-1.44
	8210769	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	-0.5	CHEMBL5147	Homo sapiens	Inhibition	%	-0.5
	8211137	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	2.86	CHEMBL5147	Homo sapiens	Inhibition	%	2.86
	8211307	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	2.2	CHEMBL5147	Homo sapiens	Inhibition	%	2.2
	8211654	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	3.57	CHEMBL5147	Homo sapiens	Inhibition	%	3.57
	8211783	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	7.91	CHEMBL5147	Homo sapiens	Inhibition	%	7.91
	8212007	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	28.76	CHEMBL5147	Homo sapiens	Inhibition	%	28.76
	8212139	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	2.45	CHEMBL5147	Homo sapiens	Inhibition	%	2.45
	8212504	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	1.47	CHEMBL5147	Homo sapiens	Inhibition	%	1.47
	8212637	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	2.68	CHEMBL5147	Homo sapiens	Inhibition	%	2.68
	8212861	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	1.46	CHEMBL5147	Homo sapiens	Inhibition	%	1.46
	8213031	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	3.76	CHEMBL5147	Homo sapiens	Inhibition	%	3.76
	8213160	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	2.51	CHEMBL5147	Homo sapiens	Inhibition	%	2.51
	8213384	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	1.45	CHEMBL5147	Homo sapiens	Inhibition	%	1.45
	8213488	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	8.8	CHEMBL5147	Homo sapiens	Inhibition	%	8.8
	8213825	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	0.44	CHEMBL5147	Homo sapiens	Inhibition	%	0.44
	8213972	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	1.05	CHEMBL5147	Homo sapiens	Inhibition	%	1.05
	8214196	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	3.22	CHEMBL5147	Homo sapiens	Inhibition	%	3.22
	8214333	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	4.27	CHEMBL5147	Homo sapiens	Inhibition	%	4.27
	8214691	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	2.22	CHEMBL5147	Homo sapiens	Inhibition	%	2.22
	8214843	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-2.19	CHEMBL5147	Homo sapiens	Inhibition	%	-2.19
	8215094	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	-2.62	CHEMBL5147	Homo sapiens	Inhibition	%	-2.62
	8215318	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	2.19	CHEMBL5147	Homo sapiens	Inhibition	%	2.19
	8215471	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	3.16	CHEMBL5147	Homo sapiens	Inhibition	%	3.16
	8215635	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	2.46	CHEMBL5147	Homo sapiens	Inhibition	%	2.46
	8215859	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	3.04	CHEMBL5147	Homo sapiens	Inhibition	%	3.04
	8215978	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	-2.73	CHEMBL5147	Homo sapiens	Inhibition	%	-2.73
	8216321	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	-1.54	CHEMBL5147	Homo sapiens	Inhibition	%	-1.54
	8216457	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	2.84	CHEMBL5147	Homo sapiens	Inhibition	%	2.84
	8216819	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	2.87	CHEMBL5147	Homo sapiens	Inhibition	%	2.87
	8217177	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	2.08	CHEMBL5147	Homo sapiens	Inhibition	%	2.08
	8217351	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	2.42	CHEMBL5147	Homo sapiens	Inhibition	%	2.42
	8217706	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	4.74	CHEMBL5147	Homo sapiens	Inhibition	%	4.74
	8217807	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-0.68	CHEMBL5147	Homo sapiens	Inhibition	%	-0.68
	8218031	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-1.57	CHEMBL5147	Homo sapiens	Inhibition	%	-1.57
	8218146	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	1.85	CHEMBL5147	Homo sapiens	Inhibition	%	1.85
	8218497	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	6.37	CHEMBL5147	Homo sapiens	Inhibition	%	6.37
	8218640	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	7.03	CHEMBL5147	Homo sapiens	Inhibition	%	7.03
	8218995	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	29.06	CHEMBL5147	Homo sapiens	Inhibition	%	29.06
	8219155	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	-1.67	CHEMBL5147	Homo sapiens	Inhibition	%	-1.67
	8219379	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	0.63	CHEMBL5147	Homo sapiens	Inhibition	%	0.63
	8219629	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	3.04	CHEMBL5147	Homo sapiens	Inhibition	%	3.04
	8219790	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	2.3	CHEMBL5147	Homo sapiens	Inhibition	%	2.3
	8220183	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	3.38	CHEMBL5147	Homo sapiens	Inhibition	%	3.38
	8220312	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	-3.91	CHEMBL5147	Homo sapiens	Inhibition	%	-3.91
	8220650	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	0.48	CHEMBL5147	Homo sapiens	Inhibition	%	0.48
	8220788	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	1.66	CHEMBL5147	Homo sapiens	Inhibition	%	1.66
	8221012	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	2.84	CHEMBL5147	Homo sapiens	Inhibition	%	2.84
	8221148	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	-2.43	CHEMBL5147	Homo sapiens	Inhibition	%	-2.43
	8221505	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	2.82	CHEMBL5147	Homo sapiens	Inhibition	%	2.82
	8221670	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	0.76	CHEMBL5147	Homo sapiens	Inhibition	%	0.76
	8222025	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	17.11	CHEMBL5147	Homo sapiens	Inhibition	%	17.11
	8222347	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	1.8	CHEMBL5147	Homo sapiens	Inhibition	%	1.8
	8222481	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	2.33	CHEMBL5147	Homo sapiens	Inhibition	%	2.33
	8222823	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	30.46	CHEMBL5147	Homo sapiens	Inhibition	%	30.46
	8222967	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	83.66	CHEMBL5147	Homo sapiens	Inhibition	%	83.66
	8223191	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	96.63	CHEMBL5147	Homo sapiens	Inhibition	%	96.63
	8223320	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	3.63	CHEMBL5147	Homo sapiens	Inhibition	%	3.63
	8223705	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	0.94	CHEMBL5147	Homo sapiens	Inhibition	%	0.94
	8223955	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	4.32	CHEMBL5147	Homo sapiens	Inhibition	%	4.32
	8224117	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	3.43	CHEMBL5147	Homo sapiens	Inhibition	%	3.43
	8224341	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	-3.04	CHEMBL5147	Homo sapiens	Inhibition	%	-3.04
	8224511	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	4.3	CHEMBL5147	Homo sapiens	Inhibition	%	4.3
	8224646	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	1.83	CHEMBL5147	Homo sapiens	Inhibition	%	1.83
	8224870	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	1.48	CHEMBL5147	Homo sapiens	Inhibition	%	1.48
	8224984	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	-1.21	CHEMBL5147	Homo sapiens	Inhibition	%	-1.21
	8225342	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	1.74	CHEMBL5147	Homo sapiens	Inhibition	%	1.74
	8225480	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	-3.41	CHEMBL5147	Homo sapiens	Inhibition	%	-3.41
	8225704	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	0.53	CHEMBL5147	Homo sapiens	Inhibition	%	0.53
	8225839	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	2.84	CHEMBL5147	Homo sapiens	Inhibition	%	2.84
	8225997	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	2.99	CHEMBL5147	Homo sapiens	Inhibition	%	2.99
	8226221	CHEMBL1962279	GSK_PKIS: EPHB4 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	3.45	CHEMBL5147	Homo sapiens	Inhibition	%	3.45
	8226346	CHEMBL1962278	GSK_PKIS: EPHB4 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	1.01	CHEMBL5147	Homo sapiens	Inhibition	%	1.01
	10838578	CHEMBL2014151	Inhibition of EPHB4 at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	0.0	CHEMBL5147	Homo sapiens	INH	%	0.0
	10839587	CHEMBL2015956	Inhibition of EPH-B4 assessed as residual activity at 1 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	73.0	CHEMBL5147	Homo sapiens	Activity	%	73.0
	10839658	CHEMBL2015013	Inhibition of EPH-B4 assessed as residual activity at 10 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	23.0	CHEMBL5147	Homo sapiens	Activity	%	23.0
	10867520	CHEMBL2027410	Inhibition of EphB4 at 2 uM	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	=	Inhibition	%	16.0	CHEMBL5147	Homo sapiens	INH	%	16.0
	10925172	CHEMBL2046117	Inhibition of human EphB4 assessed as remaining activity at 0.8 uM after 40 mins by scintillation counting	B	CC(C)Nc1cc(-c2oc3ccccc3c(=O)c2-c2ccc(F)cc2)ccn1		CHEMBL2041958	=	Activity	%	97.0	CHEMBL5147	Homo sapiens	Activity	%	97.0
	10925173	CHEMBL2046117	Inhibition of human EphB4 assessed as remaining activity at 0.8 uM after 40 mins by scintillation counting	B	O=c1c(-c2ccc(F)cc2)c(-c2ccnc(NC3CCCCC3)c2)oc2ccccc12		CHEMBL2041962	=	Activity	%	98.0	CHEMBL5147	Homo sapiens	Activity	%	98.0
	10962870	CHEMBL2060384	Inhibition of EphB4 assessed as remaining enzyme activity at 10 uM	B	CC(C)n1nc(C#Cc2ccccc2)c2c(N)ncnc21		CHEMBL2058538	=	Activity	%	0.0	CHEMBL5147	Homo sapiens	Activity	%	0.0
	10978474	CHEMBL2066233	Inhibition of human recombinant EphB4 using ulight-TK peptide as substrate assessed as residual activity at 1 uM after 90 mins by Cerep assay	B	N#Cc1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCO5)o3)cc2)cc1		CHEMBL2064515	>	Activity	%	80.0	CHEMBL5147	Homo sapiens	Activity	%	80.0
	10993508	CHEMBL2073084	Inhibition of EphB4 at 10 uM	B	ClC(Cn1ncc2c(NCc3ccccc3)ncnc21)c1ccccc1		CHEMBL411043	=	Inhibition	%	25.0	CHEMBL5147	Homo sapiens	INH	%	25.0
	11020079	CHEMBL2089891	Inhibition of EphB4	B	CCN1CCC(Nc2ccc3c(c2)C(=C(c2ccccc2)c2nc4cc(OC)ccc4[nH]2)C(=O)N3)CC1		CHEMBL2086751	=	IC50	nM	765.0	CHEMBL5147	Homo sapiens	IC50	nM	765.0
	11020080	CHEMBL2089891	Inhibition of EphB4	B	CCN1CCC(Nc2ccc3c(c2)C(=C(c2ccc(Cl)cc2)c2ncc[nH]2)C(=O)N3)CC1		CHEMBL2086760	=	IC50	nM	1250.0	CHEMBL5147	Homo sapiens	IC50	nM	1250.0
	12046295	CHEMBL2156624	Inhibition of EphB4 at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	-0.3	CHEMBL5147	Homo sapiens	INH	%	-0.3
	12057065	CHEMBL2154042	Inhibition of EphB4 by FRET assay in presence of 30 uM ATP	B	COc1cccc(-n2c(=O)c3c(c4c(N)ncnc42)CCCC3)c1		CHEMBL2152699	=	IC50	nM	9400.0	CHEMBL5147	Homo sapiens	IC50	uM	9.4
	12057066	CHEMBL2154042	Inhibition of EphB4 by FRET assay in presence of 30 uM ATP	B	Cc1ccc(O)cc1-n1c(=O)c2c(c3c(N)ncnc31)CCCC2		CHEMBL2152704	=	IC50	nM	300.0	CHEMBL5147	Homo sapiens	IC50	uM	0.3
	12057067	CHEMBL2154041	Inhibition of EphB4 in presence of 1 uM radiolabeled ATP	B	Cc1ccccc1-n1c(=O)c2c(c3c(N)ncnc31)CCCC2		CHEMBL2152698	=	IC50	nM	8400.0	CHEMBL5147	Homo sapiens	IC50	uM	8.4
	12057068	CHEMBL2154041	Inhibition of EphB4 in presence of 1 uM radiolabeled ATP	B	COc1cccc(-n2c(=O)c3c(c4c(N)ncnc42)CCCC3)c1		CHEMBL2152699	=	IC50	nM	5200.0	CHEMBL5147	Homo sapiens	IC50	uM	5.2
	12057069	CHEMBL2154041	Inhibition of EphB4 in presence of 1 uM radiolabeled ATP	B	COc1cccc(-n2c(=O)c3c(c4c(N)ncnc42)CC(C)(C)OC3)c1		CHEMBL2152702	=	IC50	nM	14300.0	CHEMBL5147	Homo sapiens	IC50	uM	14.3
	12057070	CHEMBL2154041	Inhibition of EphB4 in presence of 1 uM radiolabeled ATP	B	Cc1ccc(O)cc1-n1c(=O)c2c(c3c(N)ncnc31)CCCC2		CHEMBL2152704	=	IC50	nM	160.0	CHEMBL5147	Homo sapiens	IC50	uM	0.16
	12057071	CHEMBL2154035	Inhibition of EphB4 at 30 uM in presence of 30 uM ATP	B	Cc1ccccc1-n1c(=O)c2c(c3c(N)ncnc31)CCCC2		CHEMBL2152698	=	Inhibition	%	48.0	CHEMBL5147	Homo sapiens	INH	%	48.0
	12057072	CHEMBL2154035	Inhibition of EphB4 at 30 uM in presence of 30 uM ATP	B	COc1cccc(-n2c(=O)c3c(c4c(N)ncnc42)CCCC3)c1		CHEMBL2152699	=	Inhibition	%	75.0	CHEMBL5147	Homo sapiens	INH	%	75.0
	12057073	CHEMBL2154035	Inhibition of EphB4 at 30 uM in presence of 30 uM ATP	B	COc1ccc(-n2c(=O)c3c(c4c(N)ncnc42)CCCC3)cc1		CHEMBL2152700	=	Inhibition	%	37.0	CHEMBL5147	Homo sapiens	INH	%	37.0
	12057074	CHEMBL2154035	Inhibition of EphB4 at 30 uM in presence of 30 uM ATP	B	COc1ccccc1-n1c(=O)c2c(c3c(N)ncnc31)CCCC2		CHEMBL2152701	=	Inhibition	%	5.0	CHEMBL5147	Homo sapiens	INH	%	5.0
	12057075	CHEMBL2154035	Inhibition of EphB4 at 30 uM in presence of 30 uM ATP	B	COc1cccc(-n2c(=O)c3c(c4c(N)ncnc42)CC(C)(C)OC3)c1		CHEMBL2152702	=	Inhibition	%	38.0	CHEMBL5147	Homo sapiens	INH	%	38.0
	12057076	CHEMBL2154035	Inhibition of EphB4 at 30 uM in presence of 30 uM ATP	B	COc1ccccc1-n1c(=O)c2c(c3c(N)ncnc31)CC(C)(C)OC2		CHEMBL2152703	=	Inhibition	%	0.0	CHEMBL5147	Homo sapiens	INH	%	0.0
	12057082	CHEMBL2154038	Inhibition of human full length EphB4 expressed in MEF cells assessed as inhibition of human ephrin B2/FC chimera-stimulated receptor autophosphorylation	B	Cc1ccc(O)cc1-n1c(=O)c2c(c3c(N)ncnc31)CCCC2		CHEMBL2152704	=	IC50	nM	930.0	CHEMBL5147	Homo sapiens	IC50	uM	0.93
	12074629	CHEMBL2161191	Inhibition of EphB4 at 1 uM	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1		CHEMBL1908842	<	Inhibition	%	50.0	CHEMBL5147	Homo sapiens	INH	%	50.0
	12170813	CHEMBL2210338	Inhibition of EPH-B4 assessed as residual activity at 1 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	118.0	CHEMBL5147	Homo sapiens	Activity	%	118.0
	12172114	CHEMBL2213940	Inhibition of EPH-B4 assessed as residual activity at 10 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	108.0	CHEMBL5147	Homo sapiens	Activity	%	108.0
	12173629	CHEMBL2214005	Inhibition of EPHB4 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	100.0	CHEMBL5147	Homo sapiens	Activity	%	100.0
	12183890	CHEMBL2211497	Inhibition of EPHB4	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	<	IC50	nM	10000.0	CHEMBL5147	Homo sapiens	pIC50		5.0
	12195618	CHEMBL2212867	Inhibition of human recombinant EPHB4 expressed in insect cells using Ulight-TK peptide as substrate assessed as residual activity at 1 uM after 90 mins relative to staurosporine	B	CCN(CC)CCOc1ccc(/C=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL2206008	=	Activity	%	101.8	CHEMBL5147	Homo sapiens	Activity	%	101.8
	12230906	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	102.0	CHEMBL5147	Homo sapiens	Residual Activity	%	102.0
	12230907	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	105.0	CHEMBL5147	Homo sapiens	Residual Activity	%	105.0
	12230908	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	97.0	CHEMBL5147	Homo sapiens	Residual Activity	%	97.0
	12230909	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	96.0	CHEMBL5147	Homo sapiens	Residual Activity	%	96.0
	12230910	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	63.0	CHEMBL5147	Homo sapiens	Residual Activity	%	63.0
	12230911	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	95.0	CHEMBL5147	Homo sapiens	Residual Activity	%	95.0
	12230912	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	57.0	CHEMBL5147	Homo sapiens	Residual Activity	%	57.0
	12230913	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	45.0	CHEMBL5147	Homo sapiens	Residual Activity	%	45.0
	12230914	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	108.0	CHEMBL5147	Homo sapiens	Residual Activity	%	108.0
	12230915	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	31.0	CHEMBL5147	Homo sapiens	Residual Activity	%	31.0
	12230916	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	87.0	CHEMBL5147	Homo sapiens	Residual Activity	%	87.0
	12230917	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	92.0	CHEMBL5147	Homo sapiens	Residual Activity	%	92.0
	12230918	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	81.0	CHEMBL5147	Homo sapiens	Residual Activity	%	81.0
	12230919	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	3.0	CHEMBL5147	Homo sapiens	Residual Activity	%	3.0
	12230920	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	102.0	CHEMBL5147	Homo sapiens	Residual Activity	%	102.0
	12230921	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	117.0	CHEMBL5147	Homo sapiens	Residual Activity	%	117.0
	12230922	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	114.0	CHEMBL5147	Homo sapiens	Residual Activity	%	114.0
	12230923	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	94.0	CHEMBL5147	Homo sapiens	Residual Activity	%	94.0
	12230924	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	98.0	CHEMBL5147	Homo sapiens	Residual Activity	%	98.0
	12230925	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	90.0	CHEMBL5147	Homo sapiens	Residual Activity	%	90.0
	12230926	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	92.0	CHEMBL5147	Homo sapiens	Residual Activity	%	92.0
	12230927	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	95.0	CHEMBL5147	Homo sapiens	Residual Activity	%	95.0
	12230928	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	114.0	CHEMBL5147	Homo sapiens	Residual Activity	%	114.0
	12230929	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	117.0	CHEMBL5147	Homo sapiens	Residual Activity	%	117.0
	12230930	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	104.0	CHEMBL5147	Homo sapiens	Residual Activity	%	104.0
	12230931	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	19.0	CHEMBL5147	Homo sapiens	Residual Activity	%	19.0
	12230932	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	72.0	CHEMBL5147	Homo sapiens	Residual Activity	%	72.0
	12230933	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	19.0	CHEMBL5147	Homo sapiens	Residual Activity	%	19.0
	12230934	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	98.0	CHEMBL5147	Homo sapiens	Residual Activity	%	98.0
	12230935	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	109.0	CHEMBL5147	Homo sapiens	Residual Activity	%	109.0
	12230936	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	109.0	CHEMBL5147	Homo sapiens	Residual Activity	%	109.0
	12230937	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	1.0	CHEMBL5147	Homo sapiens	Residual Activity	%	1.0
	12230938	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	109.0	CHEMBL5147	Homo sapiens	Residual Activity	%	109.0
	12230939	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	101.0	CHEMBL5147	Homo sapiens	Residual Activity	%	101.0
	12230940	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	99.0	CHEMBL5147	Homo sapiens	Residual Activity	%	99.0
	12230941	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	91.0	CHEMBL5147	Homo sapiens	Residual Activity	%	91.0
	12230942	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	77.0	CHEMBL5147	Homo sapiens	Residual Activity	%	77.0
	12230943	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	112.0	CHEMBL5147	Homo sapiens	Residual Activity	%	112.0
	12230944	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	126.0	CHEMBL5147	Homo sapiens	Residual Activity	%	126.0
	12230945	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	118.0	CHEMBL5147	Homo sapiens	Residual Activity	%	118.0
	12230946	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	109.0	CHEMBL5147	Homo sapiens	Residual Activity	%	109.0
	12230947	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	109.0	CHEMBL5147	Homo sapiens	Residual Activity	%	109.0
	12230948	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	91.0	CHEMBL5147	Homo sapiens	Residual Activity	%	91.0
	12230949	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	96.0	CHEMBL5147	Homo sapiens	Residual Activity	%	96.0
	12230950	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	112.0	CHEMBL5147	Homo sapiens	Residual Activity	%	112.0
	12230951	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	111.0	CHEMBL5147	Homo sapiens	Residual Activity	%	111.0
	12230952	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	105.0	CHEMBL5147	Homo sapiens	Residual Activity	%	105.0
	12230953	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	121.0	CHEMBL5147	Homo sapiens	Residual Activity	%	121.0
	12230954	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	118.0	CHEMBL5147	Homo sapiens	Residual Activity	%	118.0
	12230955	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	106.0	CHEMBL5147	Homo sapiens	Residual Activity	%	106.0
	12230956	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	93.0	CHEMBL5147	Homo sapiens	Residual Activity	%	93.0
	12230957	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	99.0	CHEMBL5147	Homo sapiens	Residual Activity	%	99.0
	12230958	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	79.0	CHEMBL5147	Homo sapiens	Residual Activity	%	79.0
	12230959	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	109.0	CHEMBL5147	Homo sapiens	Residual Activity	%	109.0
	12230960	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	129.0	CHEMBL5147	Homo sapiens	Residual Activity	%	129.0
	12230961	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	123.0	CHEMBL5147	Homo sapiens	Residual Activity	%	123.0
	12230962	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	120.0	CHEMBL5147	Homo sapiens	Residual Activity	%	120.0
	12230963	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	99.0	CHEMBL5147	Homo sapiens	Residual Activity	%	99.0
	12230964	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	100.0	CHEMBL5147	Homo sapiens	Residual Activity	%	100.0
	12230965	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	92.0	CHEMBL5147	Homo sapiens	Residual Activity	%	92.0
	12230966	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	103.0	CHEMBL5147	Homo sapiens	Residual Activity	%	103.0
	12230967	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	107.0	CHEMBL5147	Homo sapiens	Residual Activity	%	107.0
	12230968	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	116.0	CHEMBL5147	Homo sapiens	Residual Activity	%	116.0
	12230969	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	117.0	CHEMBL5147	Homo sapiens	Residual Activity	%	117.0
	12230970	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	114.0	CHEMBL5147	Homo sapiens	Residual Activity	%	114.0
	12230971	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	97.0	CHEMBL5147	Homo sapiens	Residual Activity	%	97.0
	12230972	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	94.0	CHEMBL5147	Homo sapiens	Residual Activity	%	94.0
	12230973	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	97.0	CHEMBL5147	Homo sapiens	Residual Activity	%	97.0
	12230974	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	95.0	CHEMBL5147	Homo sapiens	Residual Activity	%	95.0
	12230975	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	106.0	CHEMBL5147	Homo sapiens	Residual Activity	%	106.0
	12230976	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	118.0	CHEMBL5147	Homo sapiens	Residual Activity	%	118.0
	12230977	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	109.0	CHEMBL5147	Homo sapiens	Residual Activity	%	109.0
	12230978	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	124.0	CHEMBL5147	Homo sapiens	Residual Activity	%	124.0
	12230979	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	117.0	CHEMBL5147	Homo sapiens	Residual Activity	%	117.0
	12230980	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	109.0	CHEMBL5147	Homo sapiens	Residual Activity	%	109.0
	12230981	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	108.0	CHEMBL5147	Homo sapiens	Residual Activity	%	108.0
	12230982	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	118.0	CHEMBL5147	Homo sapiens	Residual Activity	%	118.0
	12230983	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	100.0	CHEMBL5147	Homo sapiens	Residual Activity	%	100.0
	12230984	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	125.0	CHEMBL5147	Homo sapiens	Residual Activity	%	125.0
	12230985	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	79.0	CHEMBL5147	Homo sapiens	Residual Activity	%	79.0
	12230986	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	105.0	CHEMBL5147	Homo sapiens	Residual Activity	%	105.0
	12230987	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	84.0	CHEMBL5147	Homo sapiens	Residual Activity	%	84.0
	12230988	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	102.0	CHEMBL5147	Homo sapiens	Residual Activity	%	102.0
	12230989	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	108.0	CHEMBL5147	Homo sapiens	Residual Activity	%	108.0
	12230990	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	70.0	CHEMBL5147	Homo sapiens	Residual Activity	%	70.0
	12230991	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	93.0	CHEMBL5147	Homo sapiens	Residual Activity	%	93.0
	12230992	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	99.0	CHEMBL5147	Homo sapiens	Residual Activity	%	99.0
	12230993	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	107.0	CHEMBL5147	Homo sapiens	Residual Activity	%	107.0
	12230994	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	113.0	CHEMBL5147	Homo sapiens	Residual Activity	%	113.0
	12230995	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	67.0	CHEMBL5147	Homo sapiens	Residual Activity	%	67.0
	12230996	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	97.0	CHEMBL5147	Homo sapiens	Residual Activity	%	97.0
	12230997	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	83.0	CHEMBL5147	Homo sapiens	Residual Activity	%	83.0
	12230998	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	75.0	CHEMBL5147	Homo sapiens	Residual Activity	%	75.0
	12230999	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	95.0	CHEMBL5147	Homo sapiens	Residual Activity	%	95.0
	12231000	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	105.0	CHEMBL5147	Homo sapiens	Residual Activity	%	105.0
	12231001	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	108.0	CHEMBL5147	Homo sapiens	Residual Activity	%	108.0
	12233615	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	109.0	CHEMBL5147	Homo sapiens	Residual Activity	%	109.0
	12233616	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	97.0	CHEMBL5147	Homo sapiens	Residual Activity	%	97.0
	12233617	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	98.0	CHEMBL5147	Homo sapiens	Residual Activity	%	98.0
	12233618	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	86.0	CHEMBL5147	Homo sapiens	Residual Activity	%	86.0
	12233619	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	82.0	CHEMBL5147	Homo sapiens	Residual Activity	%	82.0
	12233620	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	71.0	CHEMBL5147	Homo sapiens	Residual Activity	%	71.0
	12233621	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	94.0	CHEMBL5147	Homo sapiens	Residual Activity	%	94.0
	12233622	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	107.0	CHEMBL5147	Homo sapiens	Residual Activity	%	107.0
	12233623	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	97.0	CHEMBL5147	Homo sapiens	Residual Activity	%	97.0
	12233624	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	100.0	CHEMBL5147	Homo sapiens	Residual Activity	%	100.0
	12233625	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	96.0	CHEMBL5147	Homo sapiens	Residual Activity	%	96.0
	12233626	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	92.0	CHEMBL5147	Homo sapiens	Residual Activity	%	92.0
	12233627	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	86.0	CHEMBL5147	Homo sapiens	Residual Activity	%	86.0
	12233628	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	89.0	CHEMBL5147	Homo sapiens	Residual Activity	%	89.0
	12233629	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	89.0	CHEMBL5147	Homo sapiens	Residual Activity	%	89.0
	12233630	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	105.0	CHEMBL5147	Homo sapiens	Residual Activity	%	105.0
	12233631	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	86.0	CHEMBL5147	Homo sapiens	Residual Activity	%	86.0
	12233632	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	117.0	CHEMBL5147	Homo sapiens	Residual Activity	%	117.0
	12233633	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	89.0	CHEMBL5147	Homo sapiens	Residual Activity	%	89.0
	12233634	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	87.0	CHEMBL5147	Homo sapiens	Residual Activity	%	87.0
	12233635	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	49.0	CHEMBL5147	Homo sapiens	Residual Activity	%	49.0
	12233636	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	86.0	CHEMBL5147	Homo sapiens	Residual Activity	%	86.0
	12233637	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	77.0	CHEMBL5147	Homo sapiens	Residual Activity	%	77.0
	12233638	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	107.0	CHEMBL5147	Homo sapiens	Residual Activity	%	107.0
	12233639	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	74.0	CHEMBL5147	Homo sapiens	Residual Activity	%	74.0
	12233640	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	51.0	CHEMBL5147	Homo sapiens	Residual Activity	%	51.0
	12233641	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	67.0	CHEMBL5147	Homo sapiens	Residual Activity	%	67.0
	12233642	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	84.0	CHEMBL5147	Homo sapiens	Residual Activity	%	84.0
	12233643	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	49.0	CHEMBL5147	Homo sapiens	Residual Activity	%	49.0
	12233644	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	96.0	CHEMBL5147	Homo sapiens	Residual Activity	%	96.0
	12233645	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	37.0	CHEMBL5147	Homo sapiens	Residual Activity	%	37.0
	12233646	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	109.0	CHEMBL5147	Homo sapiens	Residual Activity	%	109.0
	12233647	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	78.0	CHEMBL5147	Homo sapiens	Residual Activity	%	78.0
	12233648	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	30.0	CHEMBL5147	Homo sapiens	Residual Activity	%	30.0
	12233649	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	87.0	CHEMBL5147	Homo sapiens	Residual Activity	%	87.0
	12233650	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	85.0	CHEMBL5147	Homo sapiens	Residual Activity	%	85.0
	12233651	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	89.0	CHEMBL5147	Homo sapiens	Residual Activity	%	89.0
	12233652	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	93.0	CHEMBL5147	Homo sapiens	Residual Activity	%	93.0
	12233653	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	2.0	CHEMBL5147	Homo sapiens	Residual Activity	%	2.0
	12233654	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	57.0	CHEMBL5147	Homo sapiens	Residual Activity	%	57.0
	12233655	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	97.0	CHEMBL5147	Homo sapiens	Residual Activity	%	97.0
	12233656	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	72.0	CHEMBL5147	Homo sapiens	Residual Activity	%	72.0
	12233657	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	17.0	CHEMBL5147	Homo sapiens	Residual Activity	%	17.0
	12233658	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	87.0	CHEMBL5147	Homo sapiens	Residual Activity	%	87.0
	12233659	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	93.0	CHEMBL5147	Homo sapiens	Residual Activity	%	93.0
	12233660	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	93.0	CHEMBL5147	Homo sapiens	Residual Activity	%	93.0
	12233661	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	102.0	CHEMBL5147	Homo sapiens	Residual Activity	%	102.0
	12233662	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	20.0	CHEMBL5147	Homo sapiens	Residual Activity	%	20.0
	12233663	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	85.0	CHEMBL5147	Homo sapiens	Residual Activity	%	85.0
	12233664	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	86.0	CHEMBL5147	Homo sapiens	Residual Activity	%	86.0
	12233665	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	71.0	CHEMBL5147	Homo sapiens	Residual Activity	%	71.0
	12233666	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	72.0	CHEMBL5147	Homo sapiens	Residual Activity	%	72.0
	12233667	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	42.0	CHEMBL5147	Homo sapiens	Residual Activity	%	42.0
	12233668	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	112.0	CHEMBL5147	Homo sapiens	Residual Activity	%	112.0
	12233669	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	98.0	CHEMBL5147	Homo sapiens	Residual Activity	%	98.0
	12233670	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	105.0	CHEMBL5147	Homo sapiens	Residual Activity	%	105.0
	12233671	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	90.0	CHEMBL5147	Homo sapiens	Residual Activity	%	90.0
	12233672	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	92.0	CHEMBL5147	Homo sapiens	Residual Activity	%	92.0
	12233673	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	90.0	CHEMBL5147	Homo sapiens	Residual Activity	%	90.0
	12233674	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	96.0	CHEMBL5147	Homo sapiens	Residual Activity	%	96.0
	12233675	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	103.0	CHEMBL5147	Homo sapiens	Residual Activity	%	103.0
	12233676	CHEMBL2219056	Millipore: Percentage of residual kinase activity of EPHB4 at 1uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	108.0	CHEMBL5147	Homo sapiens	Residual Activity	%	108.0
	12233677	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	110.0	CHEMBL5147	Homo sapiens	Residual Activity	%	110.0
	12233678	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	82.0	CHEMBL5147	Homo sapiens	Residual Activity	%	82.0
	12233679	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	82.0	CHEMBL5147	Homo sapiens	Residual Activity	%	82.0
	12233680	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	100.0	CHEMBL5147	Homo sapiens	Residual Activity	%	100.0
	12233681	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	13.0	CHEMBL5147	Homo sapiens	Residual Activity	%	13.0
	12233682	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	102.0	CHEMBL5147	Homo sapiens	Residual Activity	%	102.0
	12233683	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	11.0	CHEMBL5147	Homo sapiens	Residual Activity	%	11.0
	12233684	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	5.0	CHEMBL5147	Homo sapiens	Residual Activity	%	5.0
	12233685	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	119.0	CHEMBL5147	Homo sapiens	Residual Activity	%	119.0
	12233686	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	4.0	CHEMBL5147	Homo sapiens	Residual Activity	%	4.0
	12233687	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	108.0	CHEMBL5147	Homo sapiens	Residual Activity	%	108.0
	12233688	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	109.0	CHEMBL5147	Homo sapiens	Residual Activity	%	109.0
	12233689	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	57.0	CHEMBL5147	Homo sapiens	Residual Activity	%	57.0
	12233690	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	-3.0	CHEMBL5147	Homo sapiens	Residual Activity	%	-3.0
	12233691	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	101.0	CHEMBL5147	Homo sapiens	Residual Activity	%	101.0
	12233692	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	128.0	CHEMBL5147	Homo sapiens	Residual Activity	%	128.0
	12233693	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	159.0	CHEMBL5147	Homo sapiens	Residual Activity	%	159.0
	12233694	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	119.0	CHEMBL5147	Homo sapiens	Residual Activity	%	119.0
	12233695	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	120.0	CHEMBL5147	Homo sapiens	Residual Activity	%	120.0
	12233696	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	104.0	CHEMBL5147	Homo sapiens	Residual Activity	%	104.0
	12233697	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	101.0	CHEMBL5147	Homo sapiens	Residual Activity	%	101.0
	12233698	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	56.0	CHEMBL5147	Homo sapiens	Residual Activity	%	56.0
	12233699	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	127.0	CHEMBL5147	Homo sapiens	Residual Activity	%	127.0
	12233700	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	131.0	CHEMBL5147	Homo sapiens	Residual Activity	%	131.0
	12233701	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	120.0	CHEMBL5147	Homo sapiens	Residual Activity	%	120.0
	12233702	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	-1.0	CHEMBL5147	Homo sapiens	Residual Activity	%	-1.0
	12233703	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	13.0	CHEMBL5147	Homo sapiens	Residual Activity	%	13.0
	12233704	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	0.0	CHEMBL5147	Homo sapiens	Residual Activity	%	0.0
	12233705	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	112.0	CHEMBL5147	Homo sapiens	Residual Activity	%	112.0
	12233706	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	119.0	CHEMBL5147	Homo sapiens	Residual Activity	%	119.0
	12233707	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	105.0	CHEMBL5147	Homo sapiens	Residual Activity	%	105.0
	12233708	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	-4.0	CHEMBL5147	Homo sapiens	Residual Activity	%	-4.0
	12233709	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	117.0	CHEMBL5147	Homo sapiens	Residual Activity	%	117.0
	12233710	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	108.0	CHEMBL5147	Homo sapiens	Residual Activity	%	108.0
	12233711	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	113.0	CHEMBL5147	Homo sapiens	Residual Activity	%	113.0
	12233712	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	100.0	CHEMBL5147	Homo sapiens	Residual Activity	%	100.0
	12233713	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	35.0	CHEMBL5147	Homo sapiens	Residual Activity	%	35.0
	12233714	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	147.0	CHEMBL5147	Homo sapiens	Residual Activity	%	147.0
	12233715	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	136.0	CHEMBL5147	Homo sapiens	Residual Activity	%	136.0
	12233716	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	132.0	CHEMBL5147	Homo sapiens	Residual Activity	%	132.0
	12233717	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	133.0	CHEMBL5147	Homo sapiens	Residual Activity	%	133.0
	12233718	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	115.0	CHEMBL5147	Homo sapiens	Residual Activity	%	115.0
	12233719	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	104.0	CHEMBL5147	Homo sapiens	Residual Activity	%	104.0
	12233720	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	90.0	CHEMBL5147	Homo sapiens	Residual Activity	%	90.0
	12233721	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	96.0	CHEMBL5147	Homo sapiens	Residual Activity	%	96.0
	12233722	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	108.0	CHEMBL5147	Homo sapiens	Residual Activity	%	108.0
	12233723	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	115.0	CHEMBL5147	Homo sapiens	Residual Activity	%	115.0
	12233724	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	106.0	CHEMBL5147	Homo sapiens	Residual Activity	%	106.0
	12233725	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	115.0	CHEMBL5147	Homo sapiens	Residual Activity	%	115.0
	12233726	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	111.0	CHEMBL5147	Homo sapiens	Residual Activity	%	111.0
	12233727	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	82.0	CHEMBL5147	Homo sapiens	Residual Activity	%	82.0
	12233728	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	89.0	CHEMBL5147	Homo sapiens	Residual Activity	%	89.0
	12233729	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	29.0	CHEMBL5147	Homo sapiens	Residual Activity	%	29.0
	12233730	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	73.0	CHEMBL5147	Homo sapiens	Residual Activity	%	73.0
	12233731	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	102.0	CHEMBL5147	Homo sapiens	Residual Activity	%	102.0
	12233732	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	122.0	CHEMBL5147	Homo sapiens	Residual Activity	%	122.0
	12233733	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	126.0	CHEMBL5147	Homo sapiens	Residual Activity	%	126.0
	12233734	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	121.0	CHEMBL5147	Homo sapiens	Residual Activity	%	121.0
	12233735	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	116.0	CHEMBL5147	Homo sapiens	Residual Activity	%	116.0
	12233736	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	102.0	CHEMBL5147	Homo sapiens	Residual Activity	%	102.0
	12233737	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	102.0	CHEMBL5147	Homo sapiens	Residual Activity	%	102.0
	12233738	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	372.0	CHEMBL5147	Homo sapiens	Residual Activity	%	372.0
	12233739	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	119.0	CHEMBL5147	Homo sapiens	Residual Activity	%	119.0
	12233740	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	116.0	CHEMBL5147	Homo sapiens	Residual Activity	%	116.0
	12233741	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	148.0	CHEMBL5147	Homo sapiens	Residual Activity	%	148.0
	12233742	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	121.0	CHEMBL5147	Homo sapiens	Residual Activity	%	121.0
	12233743	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	113.0	CHEMBL5147	Homo sapiens	Residual Activity	%	113.0
	12233744	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	110.0	CHEMBL5147	Homo sapiens	Residual Activity	%	110.0
	12233745	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	111.0	CHEMBL5147	Homo sapiens	Residual Activity	%	111.0
	12233746	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	138.0	CHEMBL5147	Homo sapiens	Residual Activity	%	138.0
	12233747	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	117.0	CHEMBL5147	Homo sapiens	Residual Activity	%	117.0
	12233748	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	10.0	CHEMBL5147	Homo sapiens	Residual Activity	%	10.0
	12233749	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	118.0	CHEMBL5147	Homo sapiens	Residual Activity	%	118.0
	12233750	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	132.0	CHEMBL5147	Homo sapiens	Residual Activity	%	132.0
	12233751	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	64.0	CHEMBL5147	Homo sapiens	Residual Activity	%	64.0
	12233752	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	141.0	CHEMBL5147	Homo sapiens	Residual Activity	%	141.0
	12233753	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	121.0	CHEMBL5147	Homo sapiens	Residual Activity	%	121.0
	12233754	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	35.0	CHEMBL5147	Homo sapiens	Residual Activity	%	35.0
	12233755	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	123.0	CHEMBL5147	Homo sapiens	Residual Activity	%	123.0
	12233756	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	15.0	CHEMBL5147	Homo sapiens	Residual Activity	%	15.0
	12233757	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	103.0	CHEMBL5147	Homo sapiens	Residual Activity	%	103.0
	12233758	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	18.0	CHEMBL5147	Homo sapiens	Residual Activity	%	18.0
	12233759	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	93.0	CHEMBL5147	Homo sapiens	Residual Activity	%	93.0
	12233760	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	102.0	CHEMBL5147	Homo sapiens	Residual Activity	%	102.0
	12233761	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	69.0	CHEMBL5147	Homo sapiens	Residual Activity	%	69.0
	12233762	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	107.0	CHEMBL5147	Homo sapiens	Residual Activity	%	107.0
	12233763	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	88.0	CHEMBL5147	Homo sapiens	Residual Activity	%	88.0
	12233764	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	41.0	CHEMBL5147	Homo sapiens	Residual Activity	%	41.0
	12233765	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	118.0	CHEMBL5147	Homo sapiens	Residual Activity	%	118.0
	12233766	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	13.0	CHEMBL5147	Homo sapiens	Residual Activity	%	13.0
	12233767	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	102.0	CHEMBL5147	Homo sapiens	Residual Activity	%	102.0
	12233768	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	67.0	CHEMBL5147	Homo sapiens	Residual Activity	%	67.0
	12233769	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	20.0	CHEMBL5147	Homo sapiens	Residual Activity	%	20.0
	12233770	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	100.0	CHEMBL5147	Homo sapiens	Residual Activity	%	100.0
	12233771	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	93.0	CHEMBL5147	Homo sapiens	Residual Activity	%	93.0
	12233772	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	99.0	CHEMBL5147	Homo sapiens	Residual Activity	%	99.0
	12233773	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	108.0	CHEMBL5147	Homo sapiens	Residual Activity	%	108.0
	12233774	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	90.0	CHEMBL5147	Homo sapiens	Residual Activity	%	90.0
	12233775	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	96.0	CHEMBL5147	Homo sapiens	Residual Activity	%	96.0
	12233776	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	80.0	CHEMBL5147	Homo sapiens	Residual Activity	%	80.0
	12233777	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	73.0	CHEMBL5147	Homo sapiens	Residual Activity	%	73.0
	12233778	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	22.0	CHEMBL5147	Homo sapiens	Residual Activity	%	22.0
	12233779	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	109.0	CHEMBL5147	Homo sapiens	Residual Activity	%	109.0
	12233780	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	118.0	CHEMBL5147	Homo sapiens	Residual Activity	%	118.0
	12233781	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	95.0	CHEMBL5147	Homo sapiens	Residual Activity	%	95.0
	12233782	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	88.0	CHEMBL5147	Homo sapiens	Residual Activity	%	88.0
	12233783	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	89.0	CHEMBL5147	Homo sapiens	Residual Activity	%	89.0
	12233784	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	84.0	CHEMBL5147	Homo sapiens	Residual Activity	%	84.0
	12233785	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	82.0	CHEMBL5147	Homo sapiens	Residual Activity	%	82.0
	12233786	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	71.0	CHEMBL5147	Homo sapiens	Residual Activity	%	71.0
	12233787	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	76.0	CHEMBL5147	Homo sapiens	Residual Activity	%	76.0
	12233788	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	79.0	CHEMBL5147	Homo sapiens	Residual Activity	%	79.0
	12233789	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	77.0	CHEMBL5147	Homo sapiens	Residual Activity	%	77.0
	12233790	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	134.0	CHEMBL5147	Homo sapiens	Residual Activity	%	134.0
	12233791	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	93.0	CHEMBL5147	Homo sapiens	Residual Activity	%	93.0
	12233792	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	80.0	CHEMBL5147	Homo sapiens	Residual Activity	%	80.0
	12233793	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	6.0	CHEMBL5147	Homo sapiens	Residual Activity	%	6.0
	12233794	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	79.0	CHEMBL5147	Homo sapiens	Residual Activity	%	79.0
	12233795	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	18.0	CHEMBL5147	Homo sapiens	Residual Activity	%	18.0
	12233796	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	70.0	CHEMBL5147	Homo sapiens	Residual Activity	%	70.0
	12233797	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	16.0	CHEMBL5147	Homo sapiens	Residual Activity	%	16.0
	12233798	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	9.0	CHEMBL5147	Homo sapiens	Residual Activity	%	9.0
	12233799	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	22.0	CHEMBL5147	Homo sapiens	Residual Activity	%	22.0
	12233800	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	84.0	CHEMBL5147	Homo sapiens	Residual Activity	%	84.0
	12233801	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	4.0	CHEMBL5147	Homo sapiens	Residual Activity	%	4.0
	12233802	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	72.0	CHEMBL5147	Homo sapiens	Residual Activity	%	72.0
	12233803	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	4.0	CHEMBL5147	Homo sapiens	Residual Activity	%	4.0
	12233804	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	92.0	CHEMBL5147	Homo sapiens	Residual Activity	%	92.0
	12233805	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	81.0	CHEMBL5147	Homo sapiens	Residual Activity	%	81.0
	12233806	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	4.0	CHEMBL5147	Homo sapiens	Residual Activity	%	4.0
	12233807	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	77.0	CHEMBL5147	Homo sapiens	Residual Activity	%	77.0
	12233808	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	78.0	CHEMBL5147	Homo sapiens	Residual Activity	%	78.0
	12233809	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	55.0	CHEMBL5147	Homo sapiens	Residual Activity	%	55.0
	12233810	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	81.0	CHEMBL5147	Homo sapiens	Residual Activity	%	81.0
	12233811	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	-3.0	CHEMBL5147	Homo sapiens	Residual Activity	%	-3.0
	12233812	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	6.0	CHEMBL5147	Homo sapiens	Residual Activity	%	6.0
	12233813	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	77.0	CHEMBL5147	Homo sapiens	Residual Activity	%	77.0
	12233814	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	12.0	CHEMBL5147	Homo sapiens	Residual Activity	%	12.0
	12233815	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	4.0	CHEMBL5147	Homo sapiens	Residual Activity	%	4.0
	12233816	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	83.0	CHEMBL5147	Homo sapiens	Residual Activity	%	83.0
	12233817	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	92.0	CHEMBL5147	Homo sapiens	Residual Activity	%	92.0
	12233818	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	97.0	CHEMBL5147	Homo sapiens	Residual Activity	%	97.0
	12233819	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	100.0	CHEMBL5147	Homo sapiens	Residual Activity	%	100.0
	12233820	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	-1.0	CHEMBL5147	Homo sapiens	Residual Activity	%	-1.0
	12233821	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	41.0	CHEMBL5147	Homo sapiens	Residual Activity	%	41.0
	12233822	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	76.0	CHEMBL5147	Homo sapiens	Residual Activity	%	76.0
	12233823	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	65.0	CHEMBL5147	Homo sapiens	Residual Activity	%	65.0
	12233824	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	73.0	CHEMBL5147	Homo sapiens	Residual Activity	%	73.0
	12233825	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	6.0	CHEMBL5147	Homo sapiens	Residual Activity	%	6.0
	12233826	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	101.0	CHEMBL5147	Homo sapiens	Residual Activity	%	101.0
	12233827	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	77.0	CHEMBL5147	Homo sapiens	Residual Activity	%	77.0
	12233828	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	90.0	CHEMBL5147	Homo sapiens	Residual Activity	%	90.0
	12233829	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	90.0	CHEMBL5147	Homo sapiens	Residual Activity	%	90.0
	12233830	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	98.0	CHEMBL5147	Homo sapiens	Residual Activity	%	98.0
	12233831	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	105.0	CHEMBL5147	Homo sapiens	Residual Activity	%	105.0
	12233832	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	98.0	CHEMBL5147	Homo sapiens	Residual Activity	%	98.0
	12233833	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	41.0	CHEMBL5147	Homo sapiens	Residual Activity	%	41.0
	12233834	CHEMBL2219057	Millipore: Percentage of residual kinase activity of EPHB4 at 10uM relative to control. Control inhibitor: PP2 at 30.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	114.0	CHEMBL5147	Homo sapiens	Residual Activity	%	114.0
	12649134	CHEMBL2329864	Displacement of ephrin-B1-Fc from EphB4 receptor Fc ectodomain (unknown origin) after 1 hr by ELISA	B	C[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@H]1CC[C@H]2[C@@H]3CC[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL2322989	=	IC50	nM	4400.0	CHEMBL5147	Homo sapiens	IC50	uM	4.4
	12673051	CHEMBL2340167	Inhibition of recombinant EPH-B4 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336379	=	Activity	%	6.0	CHEMBL5147	Homo sapiens	Activity	%	6.0
	12673052	CHEMBL2340167	Inhibition of recombinant EPH-B4 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336377	=	Activity	%	6.0	CHEMBL5147	Homo sapiens	Activity	%	6.0
	12674067	CHEMBL2344159	Inhibition of EPHB4 (unknown origin)	B	O=C(NCCc1ccc(O)c(Br)c1)/C(Cc1cc(Br)c(O)c(Oc2ccc(CCNC(=O)/C(Cc3cc(Br)c(O)c(-c4cc(C/C(=N\O)C(=O)NCCc5ccc(O)c(Br)c5)cc(Br)c4O)c3)=N/O)cc2Br)c1)=N/O		CHEMBL2333163	=	IC50	nM	3400.0	CHEMBL5147	Homo sapiens	IC50	uM	3.4
	12674068	CHEMBL2344159	Inhibition of EPHB4 (unknown origin)	B	O=C(NCCc1ccc(O)c(Br)c1)/C(Cc1cc(Br)c(O)c(-c2cc(C/C(=N/O)C(=O)NCCc3ccc(O)c(Br)c3)cc(Br)c2O)c1)=N\O		CHEMBL505637	=	IC50	nM	3400.0	CHEMBL5147	Homo sapiens	IC50	uM	3.4
	12674069	CHEMBL2344159	Inhibition of EPHB4 (unknown origin)	B	O=C1N/C=C/c2ccc(c(Br)c2)Oc2cc(cc(Br)c2O)CCNC(=O)/C(=N/O)Cc2ccc(c(Br)c2)Oc2cc(cc(Br)c2O)C/C1=N\O		CHEMBL360190	=	IC50	nM	7700.0	CHEMBL5147	Homo sapiens	IC50	uM	7.7
	12674163	CHEMBL2344180	Inhibition of EphB4 (unknown origin) transfected in CHO cells using Z'-LYTE TYR-1 peptide as substrate at 10 uM after 2 hrs by FRET assay	B	CCCCn1c(-c2c(C)cccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL2333601	=	Inhibition	%	49.0	CHEMBL5147	Homo sapiens	INH	%	49.0
	12674164	CHEMBL2344180	Inhibition of EphB4 (unknown origin) transfected in CHO cells using Z'-LYTE TYR-1 peptide as substrate at 10 uM after 2 hrs by FRET assay	B	COc1ccccc1-n1c(-c2cccc(Cl)c2)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL2333599	=	Inhibition	%	12.0	CHEMBL5147	Homo sapiens	INH	%	12.0
	12674165	CHEMBL2344180	Inhibition of EphB4 (unknown origin) transfected in CHO cells using Z'-LYTE TYR-1 peptide as substrate at 10 uM after 2 hrs by FRET assay	B	CCCCn1c(-c2ccccc2C(F)(F)F)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL2333598	=	Inhibition	%	15.0	CHEMBL5147	Homo sapiens	INH	%	15.0
	12674166	CHEMBL2344180	Inhibition of EphB4 (unknown origin) transfected in CHO cells using Z'-LYTE TYR-1 peptide as substrate at 10 uM after 2 hrs by FRET assay	B	CCCCn1c(-c2cccc(Cl)c2)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL2333596	=	Inhibition	%	22.0	CHEMBL5147	Homo sapiens	INH	%	22.0
	12674173	CHEMBL2344181	Ratio of IC50 for human myc-tagged full length EphB4 in expressed in MEF cells to IC50 for EphB4 (unknown origin) by radiometric assay	B	COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566515	=	Ratio IC50		100.0	CHEMBL5147	Homo sapiens	Ratio IC50		100.0
	12674174	CHEMBL2344182	Inhibition of human EphB4 expressed in CHO cells assessed as inhibition of ephrinB2-Fc-induced autophosphorylation at 20 uM incubated for 90 mins prior to ephrinB2-Fc-induction measured after 2 hrs by sandwich ELISA	B	CCCCn1c(-c2ccccc2)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL271967	<	Inhibition	%	10.0	CHEMBL5147	Homo sapiens	INH	%	10.0
	12674175	CHEMBL2344182	Inhibition of human EphB4 expressed in CHO cells assessed as inhibition of ephrinB2-Fc-induced autophosphorylation at 20 uM incubated for 90 mins prior to ephrinB2-Fc-induction measured after 2 hrs by sandwich ELISA	B	COc1ccccc1-n1c(-c2ccccc2)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL577156	=	Inhibition	%	14.0	CHEMBL5147	Homo sapiens	INH	%	14.0
	12674176	CHEMBL2344183	Inhibition of EphB4 (unknown origin) using [gamma-33P]ATP by radiometric assay	B	COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566515	=	IC50	nM	1.6	CHEMBL5147	Homo sapiens	IC50	nM	1.6
	12674177	CHEMBL2344184	Inhibition of EphB4 (unknown origin) using Z'-LYTE TYR-1 peptide as substrate after 2 hrs by FRET assay	B	COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566515	=	IC50	nM	5.0	CHEMBL5147	Homo sapiens	IC50	nM	5.0
	12674217	CHEMBL2344192	Inhibition of human Eph-B4 using [gamma-33P]ATP assessed as residual activity at 3 uM after 30 mins by radiometric assay	B	CCCCn1c(-c2ccccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL2333603	=	Activity	%	18.0	CHEMBL5147	Homo sapiens	Activity	%	18.0
	12674263	CHEMBL2344645	Inhibition of EphB4 (unknown origin) transfected in CHO cells using Z'-LYTE TYR-1 peptide as substrate after 2 hrs by FRET assay	B	COc1ccccc1-n1c(-c2ccccc2)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL577156	=	IC50	nM	3300.0	CHEMBL5147	Homo sapiens	IC50	nM	3300.0
	12674264	CHEMBL2344645	Inhibition of EphB4 (unknown origin) transfected in CHO cells using Z'-LYTE TYR-1 peptide as substrate after 2 hrs by FRET assay	B	CCCCn1c(-c2ccccc2)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL271967	=	IC50	nM	1900.0	CHEMBL5147	Homo sapiens	IC50	nM	1900.0
	12674265	CHEMBL2344645	Inhibition of EphB4 (unknown origin) transfected in CHO cells using Z'-LYTE TYR-1 peptide as substrate after 2 hrs by FRET assay	B	CCCCn1c(-c2ccccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL2333603	=	IC50	nM	56.0	CHEMBL5147	Homo sapiens	IC50	nM	56.0
	12674266	CHEMBL2344645	Inhibition of EphB4 (unknown origin) transfected in CHO cells using Z'-LYTE TYR-1 peptide as substrate after 2 hrs by FRET assay	B	CCCCCn1c(-c2ccccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL2333593	=	IC50	nM	177.0	CHEMBL5147	Homo sapiens	IC50	nM	177.0
	12674267	CHEMBL2344645	Inhibition of EphB4 (unknown origin) transfected in CHO cells using Z'-LYTE TYR-1 peptide as substrate after 2 hrs by FRET assay	B	CCCCCCn1c(-c2ccccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL2333594	=	IC50	nM	1300.0	CHEMBL5147	Homo sapiens	IC50	nM	1300.0
	12674268	CHEMBL2344645	Inhibition of EphB4 (unknown origin) transfected in CHO cells using Z'-LYTE TYR-1 peptide as substrate after 2 hrs by FRET assay	B	CCCCn1c(-c2ccc(F)cc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL2333595	=	IC50	nM	91.0	CHEMBL5147	Homo sapiens	IC50	nM	91.0
	12674269	CHEMBL2344645	Inhibition of EphB4 (unknown origin) transfected in CHO cells using Z'-LYTE TYR-1 peptide as substrate after 2 hrs by FRET assay	B	CCCCn1c(-c2ccccc2Cl)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL2333597	=	IC50	nM	182.0	CHEMBL5147	Homo sapiens	IC50	nM	182.0
	12674270	CHEMBL2344645	Inhibition of EphB4 (unknown origin) transfected in CHO cells using Z'-LYTE TYR-1 peptide as substrate after 2 hrs by FRET assay	B	COc1ccccc1-n1c(-c2ccccc2Cl)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL2333600	=	IC50	nM	300.0	CHEMBL5147	Homo sapiens	IC50	nM	300.0
	12674271	CHEMBL2344645	Inhibition of EphB4 (unknown origin) transfected in CHO cells using Z'-LYTE TYR-1 peptide as substrate after 2 hrs by FRET assay	B	CCCCn1c(-c2cc(-c3cccc4[nH]ncc34)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL2333602	=	IC50	nM	14.0	CHEMBL5147	Homo sapiens	IC50	nM	14.0
	12674272	CHEMBL2344644	Inhibition of EphB4 (unknown origin) transfected in CHO cells using [gamma-33P]ATP by radiometric assay	B	COc1ccccc1-n1c(-c2ccccc2)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL577156	=	IC50	nM	4350.0	CHEMBL5147	Homo sapiens	IC50	nM	4350.0
	12674273	CHEMBL2344644	Inhibition of EphB4 (unknown origin) transfected in CHO cells using [gamma-33P]ATP by radiometric assay	B	CCCCn1c(-c2ccccc2)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL271967	=	IC50	nM	538.0	CHEMBL5147	Homo sapiens	IC50	nM	538.0
	12674274	CHEMBL2344644	Inhibition of EphB4 (unknown origin) transfected in CHO cells using [gamma-33P]ATP by radiometric assay	B	CCCCn1c(-c2ccccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL2333603	=	IC50	nM	82.0	CHEMBL5147	Homo sapiens	IC50	nM	82.0
Not Determined	12674275	CHEMBL2344644	Inhibition of EphB4 (unknown origin) transfected in CHO cells using [gamma-33P]ATP by radiometric assay	B	CCCCCn1c(-c2ccccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL2333593		IC50			CHEMBL5147	Homo sapiens	IC50		
Not Determined	12674276	CHEMBL2344644	Inhibition of EphB4 (unknown origin) transfected in CHO cells using [gamma-33P]ATP by radiometric assay	B	CCCCCCn1c(-c2ccccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL2333594		IC50			CHEMBL5147	Homo sapiens	IC50		
	12674277	CHEMBL2344644	Inhibition of EphB4 (unknown origin) transfected in CHO cells using [gamma-33P]ATP by radiometric assay	B	CCCCn1c(-c2ccc(F)cc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL2333595	=	IC50	nM	139.0	CHEMBL5147	Homo sapiens	IC50	nM	139.0
Not Determined	12674278	CHEMBL2344644	Inhibition of EphB4 (unknown origin) transfected in CHO cells using [gamma-33P]ATP by radiometric assay	B	CCCCn1c(-c2cccc(Cl)c2)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL2333596		IC50			CHEMBL5147	Homo sapiens	IC50		
Not Determined	12674279	CHEMBL2344644	Inhibition of EphB4 (unknown origin) transfected in CHO cells using [gamma-33P]ATP by radiometric assay	B	CCCCn1c(-c2ccccc2Cl)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL2333597		IC50			CHEMBL5147	Homo sapiens	IC50		
Not Determined	12674280	CHEMBL2344644	Inhibition of EphB4 (unknown origin) transfected in CHO cells using [gamma-33P]ATP by radiometric assay	B	CCCCn1c(-c2ccccc2C(F)(F)F)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL2333598		IC50			CHEMBL5147	Homo sapiens	IC50		
Not Determined	12674281	CHEMBL2344644	Inhibition of EphB4 (unknown origin) transfected in CHO cells using [gamma-33P]ATP by radiometric assay	B	COc1ccccc1-n1c(-c2cccc(Cl)c2)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL2333599		IC50			CHEMBL5147	Homo sapiens	IC50		
Not Determined	12674282	CHEMBL2344644	Inhibition of EphB4 (unknown origin) transfected in CHO cells using [gamma-33P]ATP by radiometric assay	B	COc1ccccc1-n1c(-c2ccccc2Cl)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL2333600		IC50			CHEMBL5147	Homo sapiens	IC50		
Not Determined	12674283	CHEMBL2344644	Inhibition of EphB4 (unknown origin) transfected in CHO cells using [gamma-33P]ATP by radiometric assay	B	CCCCn1c(-c2c(C)cccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL2333601		IC50			CHEMBL5147	Homo sapiens	IC50		
	12674284	CHEMBL2344644	Inhibition of EphB4 (unknown origin) transfected in CHO cells using [gamma-33P]ATP by radiometric assay	B	CCCCn1c(-c2cc(-c3cccc4[nH]ncc34)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL2333602	=	IC50	nM	133.0	CHEMBL5147	Homo sapiens	IC50	nM	133.0
	12674285	CHEMBL2344643	Inhibition of human myc-tagged full length EphB4 expressed in MEF cells assessed as inhibition of ephrinB2-Fc-induced autophosphorylation incubated for 90 mins prior to ephrinB2-Fc-induction measured after 2 hrs by sandwich ELISA	B	COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566515	=	IC50	nM	130.0	CHEMBL5147	Homo sapiens	IC50	nM	130.0
	12674286	CHEMBL2344643	Inhibition of human myc-tagged full length EphB4 expressed in MEF cells assessed as inhibition of ephrinB2-Fc-induced autophosphorylation incubated for 90 mins prior to ephrinB2-Fc-induction measured after 2 hrs by sandwich ELISA	B	CCCCn1c(-c2ccccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL2333603	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	12674287	CHEMBL2344643	Inhibition of human myc-tagged full length EphB4 expressed in MEF cells assessed as inhibition of ephrinB2-Fc-induced autophosphorylation incubated for 90 mins prior to ephrinB2-Fc-induction measured after 2 hrs by sandwich ELISA	B	CCCCCn1c(-c2ccccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL2333593	=	IC50	nM	230.0	CHEMBL5147	Homo sapiens	IC50	nM	230.0
Not Determined	12674288	CHEMBL2344643	Inhibition of human myc-tagged full length EphB4 expressed in MEF cells assessed as inhibition of ephrinB2-Fc-induced autophosphorylation incubated for 90 mins prior to ephrinB2-Fc-induction measured after 2 hrs by sandwich ELISA	B	CCCCCCn1c(-c2ccccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL2333594		IC50			CHEMBL5147	Homo sapiens	IC50		
	12674289	CHEMBL2344643	Inhibition of human myc-tagged full length EphB4 expressed in MEF cells assessed as inhibition of ephrinB2-Fc-induced autophosphorylation incubated for 90 mins prior to ephrinB2-Fc-induction measured after 2 hrs by sandwich ELISA	B	CCCCn1c(-c2ccc(F)cc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL2333595	=	IC50	nM	68.0	CHEMBL5147	Homo sapiens	IC50	nM	68.0
Not Determined	12674290	CHEMBL2344643	Inhibition of human myc-tagged full length EphB4 expressed in MEF cells assessed as inhibition of ephrinB2-Fc-induced autophosphorylation incubated for 90 mins prior to ephrinB2-Fc-induction measured after 2 hrs by sandwich ELISA	B	CCCCn1c(-c2cccc(Cl)c2)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL2333596		IC50			CHEMBL5147	Homo sapiens	IC50		
	12674291	CHEMBL2344643	Inhibition of human myc-tagged full length EphB4 expressed in MEF cells assessed as inhibition of ephrinB2-Fc-induced autophosphorylation incubated for 90 mins prior to ephrinB2-Fc-induction measured after 2 hrs by sandwich ELISA	B	CCCCn1c(-c2ccccc2Cl)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL2333597	=	IC50	nM	270.0	CHEMBL5147	Homo sapiens	IC50	nM	270.0
Not Determined	12674292	CHEMBL2344643	Inhibition of human myc-tagged full length EphB4 expressed in MEF cells assessed as inhibition of ephrinB2-Fc-induced autophosphorylation incubated for 90 mins prior to ephrinB2-Fc-induction measured after 2 hrs by sandwich ELISA	B	CCCCn1c(-c2ccccc2C(F)(F)F)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL2333598		IC50			CHEMBL5147	Homo sapiens	IC50		
Not Determined	12674293	CHEMBL2344643	Inhibition of human myc-tagged full length EphB4 expressed in MEF cells assessed as inhibition of ephrinB2-Fc-induced autophosphorylation incubated for 90 mins prior to ephrinB2-Fc-induction measured after 2 hrs by sandwich ELISA	B	COc1ccccc1-n1c(-c2cccc(Cl)c2)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL2333599		IC50			CHEMBL5147	Homo sapiens	IC50		
	12674294	CHEMBL2344643	Inhibition of human myc-tagged full length EphB4 expressed in MEF cells assessed as inhibition of ephrinB2-Fc-induced autophosphorylation incubated for 90 mins prior to ephrinB2-Fc-induction measured after 2 hrs by sandwich ELISA	B	COc1ccccc1-n1c(-c2ccccc2Cl)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL2333600	=	IC50	nM	2200.0	CHEMBL5147	Homo sapiens	IC50	nM	2200.0
Not Determined	12674295	CHEMBL2344643	Inhibition of human myc-tagged full length EphB4 expressed in MEF cells assessed as inhibition of ephrinB2-Fc-induced autophosphorylation incubated for 90 mins prior to ephrinB2-Fc-induction measured after 2 hrs by sandwich ELISA	B	CCCCn1c(-c2c(C)cccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL2333601		IC50			CHEMBL5147	Homo sapiens	IC50		
	12674296	CHEMBL2344643	Inhibition of human myc-tagged full length EphB4 expressed in MEF cells assessed as inhibition of ephrinB2-Fc-induced autophosphorylation incubated for 90 mins prior to ephrinB2-Fc-induction measured after 2 hrs by sandwich ELISA	B	CCCCn1c(-c2cc(-c3cccc4[nH]ncc34)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL2333602	=	IC50	nM	150.0	CHEMBL5147	Homo sapiens	IC50	nM	150.0
	12728840	CHEMBL2352913	Inhibition of EPHB4 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	89.0	CHEMBL5147	Homo sapiens	Activity	%	89.0
	12729969	CHEMBL2352205	Inhibition of EPHB4 (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	78.0	CHEMBL5147	Homo sapiens	Activity	%	78.0
	12729980	CHEMBL2352263	Inhibition of EPHB4 (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	99.0	CHEMBL5147	Homo sapiens	Activity	%	99.0
	12730228	CHEMBL2352913	Inhibition of EPHB4 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	105.0	CHEMBL5147	Homo sapiens	Activity	%	105.0
	13321286	CHEMBL2388355	Inhibition of EPHB4 (unknown origin)	B	O=C1c2oc(-c3ccc(Cl)cc3)cc2Cc2cc(N3CCNCC3)ccc2N1Cc1ccccc1-c1cccnc1		CHEMBL2385543	>	IC50	nM	30000.0	CHEMBL5147	Homo sapiens	IC50	uM	30.0
	13375871	CHEMBL2405133	Inhibition of EPHB4 (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	-1.0	CHEMBL5147	Homo sapiens	INH	%	-1.0
	13436554	CHEMBL2422436	Inhibition of EphB4 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(Cc2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420551	<	Inhibition	%	35.0	CHEMBL5147	Homo sapiens	INH	%	35.0
	13436555	CHEMBL2422436	Inhibition of EphB4 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420555	<	Inhibition	%	35.0	CHEMBL5147	Homo sapiens	INH	%	35.0
	13436556	CHEMBL2422436	Inhibition of EphB4 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccccc2)CCC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420573	<	Inhibition	%	35.0	CHEMBL5147	Homo sapiens	INH	%	35.0
	13436557	CHEMBL2422436	Inhibition of EphB4 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccccc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420572	<	Inhibition	%	35.0	CHEMBL5147	Homo sapiens	INH	%	35.0
	13436558	CHEMBL2422436	Inhibition of EphB4 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CC(C)(NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420570	<	Inhibition	%	35.0	CHEMBL5147	Homo sapiens	INH	%	35.0
	13436559	CHEMBL2422436	Inhibition of EphB4 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CCC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420565	<	Inhibition	%	35.0	CHEMBL5147	Homo sapiens	INH	%	35.0
	13436560	CHEMBL2422436	Inhibition of EphB4 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(N[C@H](CO)c1ccccc1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420564	<	Inhibition	%	35.0	CHEMBL5147	Homo sapiens	INH	%	35.0
	13436561	CHEMBL2422436	Inhibition of EphB4 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420562	<	Inhibition	%	35.0	CHEMBL5147	Homo sapiens	INH	%	35.0
	13436562	CHEMBL2422436	Inhibition of EphB4 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	C[C@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420560	<	Inhibition	%	35.0	CHEMBL5147	Homo sapiens	INH	%	35.0
	13436563	CHEMBL2422436	Inhibition of EphB4 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	C[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420556	<	Inhibition	%	35.0	CHEMBL5147	Homo sapiens	INH	%	35.0
	13436564	CHEMBL2422436	Inhibition of EphB4 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420587	<	Inhibition	%	35.0	CHEMBL5147	Homo sapiens	INH	%	35.0
	13436565	CHEMBL2422436	Inhibition of EphB4 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420585	<	Inhibition	%	35.0	CHEMBL5147	Homo sapiens	INH	%	35.0
	13442365	CHEMBL2427797	Competitive binding affinity to EPHB4 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL5147	Homo sapiens	INH	%	50.0
	13445500	CHEMBL2427797	Competitive binding affinity to EPHB4 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	=	Inhibition	%	100.0	CHEMBL5147	Homo sapiens	INH	%	100.0
	13448555	CHEMBL2427797	Competitive binding affinity to EPHB4 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL5147	Homo sapiens	INH	%	50.0
	13448691	CHEMBL2427797	Competitive binding affinity to EPHB4 (unknown origin) at 10 uM in presence of ATP relative to control	B	O=C([C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1)N1CCOCC1		CHEMBL2425649	<	Inhibition	%	50.0	CHEMBL5147	Homo sapiens	INH	%	50.0
	13451486	CHEMBL2427797	Competitive binding affinity to EPHB4 (unknown origin) at 10 uM in presence of ATP relative to control	B	N[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425652	<	Inhibition	%	50.0	CHEMBL5147	Homo sapiens	INH	%	50.0
	13454671	CHEMBL2427797	Competitive binding affinity to EPHB4 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	<	Inhibition	%	50.0	CHEMBL5147	Homo sapiens	INH	%	50.0
	13872152	CHEMBL3101777	Inhibition of human EphB4 assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	116.0	CHEMBL5147	Homo sapiens	Activity	%	116.0
	13953300	CHEMBL3130938	Inhibition of human EPHB4 assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125728	=	Activity	%	95.0	CHEMBL5147	Homo sapiens	Activity	%	95.0
	13954731	CHEMBL3130938	Inhibition of human EPHB4 assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125726	=	Activity	%	79.0	CHEMBL5147	Homo sapiens	Activity	%	79.0
	13954743	CHEMBL3130938	Inhibition of human EPHB4 assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125727	=	Activity	%	74.0	CHEMBL5147	Homo sapiens	Activity	%	74.0
Not Active	14545569	CHEMBL3225615	Binding affinity to human EphB4 (amino acid residues L16 to A539) at 0.125 to 2 uM by surface plasmon resonance assay	B	CCCCCCCCCCCCCCCCCC(=O)OCC(CO[C@@H]1O[C@H](CS(=O)(=O)[O-])[C@@H](O)[C@H](O)[C@H]1O)OC(=O)CCCCCCCCCCCCCCCCC.[Na+]		CHEMBL3219622		Activity			CHEMBL5147	Homo sapiens	Activity		
	14582493	CHEMBL3242345	Inhibition of human EphB4 assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	104.0	CHEMBL5147	Homo sapiens	Activity	%	104.0
Not Active	14982801	CHEMBL3377875	Inhibition of EphB4 (unknown origin) by FRET-based enzymatic assay in presence of 30 uM ATP	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667		IC50			CHEMBL5147	Homo sapiens	IC50		
	14982802	CHEMBL3377875	Inhibition of EphB4 (unknown origin) by FRET-based enzymatic assay in presence of 30 uM ATP	B	Cc1ccc(-c2csc(NC(=O)CCCC(=O)O)c2C(N)=O)cc1C		CHEMBL3356062	=	IC50	nM	8000.0	CHEMBL5147	Homo sapiens	IC50	nM	8000.0
	15008009	CHEMBL3367998	Inhibition of human EphB4 at 1 uM by radiometric Assay	B	NS(=O)(=O)c1cccc(-c2n[nH]c3ccc(NC(=O)Cc4ccccc4)cc23)c1		CHEMBL3330255	=	Inhibition	%	-5.0	CHEMBL5147	Homo sapiens	INH	%	-5.0
	15008010	CHEMBL3367998	Inhibition of human EphB4 at 1 uM by radiometric Assay	B	COC(C(=O)Nc1ccc2[nH]nc(-c3cccc(S(N)(=O)=O)c3)c2c1)c1ccccc1		CHEMBL3330401	=	Inhibition	%	-5.0	CHEMBL5147	Homo sapiens	INH	%	-5.0
	15008011	CHEMBL3367998	Inhibition of human EphB4 at 1 uM by radiometric Assay	B	NS(=O)(=O)c1cccc(-c2n[nH]c3ccc(NC(=O)C(c4ccsc4)N4CCCC4)cc23)c1	Outside typical range	CHEMBL3330410	=	Inhibition	%	-12.0	CHEMBL5147	Homo sapiens	INH	%	-12.0
	15008647	CHEMBL3361796	Inhibition of EphB4 (unknown origin) at 1 uM after 2 hrs by FRET based enzymatic assay	B	Cc1ccc(O)cc1-n1c(N)c(C(N)=O)c2nc3ccccc3nc21		CHEMBL3321809	=	Inhibition	%	105.0	CHEMBL5147	Homo sapiens	INH	%	105.0
	15008648	CHEMBL3361796	Inhibition of EphB4 (unknown origin) at 1 uM after 2 hrs by FRET based enzymatic assay	B	Cc1ccccc1-n1c(N)c(C(N)=O)c2nc3ccccc3nc21		CHEMBL3321800	=	Inhibition	%	66.0	CHEMBL5147	Homo sapiens	INH	%	66.0
	15008649	CHEMBL3361796	Inhibition of EphB4 (unknown origin) at 1 uM after 2 hrs by FRET based enzymatic assay	B	Cc1cccc(C)c1-n1c(N)c(C(N)=O)c2nc3ccccc3nc21		CHEMBL3321801	=	Inhibition	%	36.0	CHEMBL5147	Homo sapiens	INH	%	36.0
	15008650	CHEMBL3361796	Inhibition of EphB4 (unknown origin) at 1 uM after 2 hrs by FRET based enzymatic assay	B	Cc1cccc(Cl)c1-n1c(N)c(C(N)=O)c2nc3ccccc3nc21		CHEMBL3321802	=	Inhibition	%	45.0	CHEMBL5147	Homo sapiens	INH	%	45.0
	15008651	CHEMBL3361796	Inhibition of EphB4 (unknown origin) at 1 uM after 2 hrs by FRET based enzymatic assay	B	COc1ccc(C)c(-n2c(N)c(C(N)=O)c3nc4ccccc4nc32)c1		CHEMBL3321803	=	Inhibition	%	23.0	CHEMBL5147	Homo sapiens	INH	%	23.0
	15008652	CHEMBL3361796	Inhibition of EphB4 (unknown origin) at 1 uM after 2 hrs by FRET based enzymatic assay	B	Cc1ccc(CO)cc1-n1c(N)c(C(N)=O)c2nc3ccccc3nc21		CHEMBL3321804	=	Inhibition	%	68.0	CHEMBL5147	Homo sapiens	INH	%	68.0
	15008653	CHEMBL3361796	Inhibition of EphB4 (unknown origin) at 1 uM after 2 hrs by FRET based enzymatic assay	B	NC(=O)c1c(N)n(-c2ccccc2Cl)c2nc3ccccc3nc12		CHEMBL3321805	=	Inhibition	%	90.0	CHEMBL5147	Homo sapiens	INH	%	90.0
	15008654	CHEMBL3361796	Inhibition of EphB4 (unknown origin) at 1 uM after 2 hrs by FRET based enzymatic assay	B	NC(=O)c1c(N)n(-c2ccccc2F)c2nc3ccccc3nc12		CHEMBL3321806	=	Inhibition	%	90.0	CHEMBL5147	Homo sapiens	INH	%	90.0
	15008655	CHEMBL3361796	Inhibition of EphB4 (unknown origin) at 1 uM after 2 hrs by FRET based enzymatic assay	B	NC(=O)c1c(N)n(-c2cccc(O)c2)c2nc3ccccc3nc12		CHEMBL3321807	=	Inhibition	%	98.0	CHEMBL5147	Homo sapiens	INH	%	98.0
	15008656	CHEMBL3361796	Inhibition of EphB4 (unknown origin) at 1 uM after 2 hrs by FRET based enzymatic assay	B	Cc1nnc(-c2cccc(-n3c(N)c(C(N)=O)c4nc5ccccc5nc43)c2)[nH]1		CHEMBL3321808	=	Inhibition	%	7.0	CHEMBL5147	Homo sapiens	INH	%	7.0
	15008659	CHEMBL3361798	Inhibition of phosphorylation of full-length myc-tagged human EphB4 overexpressed in mouse embryonic fibroblasts after 90 mins by sandwich ELISA	B	Cc1ccc(O)cc1-n1c(N)c(C(N)=O)c2nc3ccccc3nc21		CHEMBL3321809	=	IC50	nM	5.4	CHEMBL5147	Homo sapiens	IC50	nM	5.4
	15008660	CHEMBL3361798	Inhibition of phosphorylation of full-length myc-tagged human EphB4 overexpressed in mouse embryonic fibroblasts after 90 mins by sandwich ELISA	B	NC(=O)c1c(N)n(-c2ccc(NC(=S)Nc3cccc(C(F)(F)F)c3)cc2)c2nc3ccccc3nc12		CHEMBL3321823	=	IC50	nM	560.0	CHEMBL5147	Homo sapiens	IC50	nM	560.0
	15008661	CHEMBL3361798	Inhibition of phosphorylation of full-length myc-tagged human EphB4 overexpressed in mouse embryonic fibroblasts after 90 mins by sandwich ELISA	B	Cc1ccccc1-n1c(N)c(C(N)=O)c2nc3ccccc3nc21		CHEMBL3321800	=	IC50	nM	230.0	CHEMBL5147	Homo sapiens	IC50	nM	230.0
	15008662	CHEMBL3361798	Inhibition of phosphorylation of full-length myc-tagged human EphB4 overexpressed in mouse embryonic fibroblasts after 90 mins by sandwich ELISA	B	Cc1cccc(C)c1-n1c(N)c(C(N)=O)c2nc3ccccc3nc21		CHEMBL3321801	=	IC50	nM	4400.0	CHEMBL5147	Homo sapiens	IC50	nM	4400.0
	15008663	CHEMBL3361798	Inhibition of phosphorylation of full-length myc-tagged human EphB4 overexpressed in mouse embryonic fibroblasts after 90 mins by sandwich ELISA	B	Cc1cccc(Cl)c1-n1c(N)c(C(N)=O)c2nc3ccccc3nc21		CHEMBL3321802	=	IC50	nM	2800.0	CHEMBL5147	Homo sapiens	IC50	nM	2800.0
	15008664	CHEMBL3361798	Inhibition of phosphorylation of full-length myc-tagged human EphB4 overexpressed in mouse embryonic fibroblasts after 90 mins by sandwich ELISA	B	COc1ccc(C)c(-n2c(N)c(C(N)=O)c3nc4ccccc4nc32)c1		CHEMBL3321803	=	IC50	nM	720.0	CHEMBL5147	Homo sapiens	IC50	nM	720.0
	15008665	CHEMBL3361798	Inhibition of phosphorylation of full-length myc-tagged human EphB4 overexpressed in mouse embryonic fibroblasts after 90 mins by sandwich ELISA	B	Cc1ccc(CO)cc1-n1c(N)c(C(N)=O)c2nc3ccccc3nc21		CHEMBL3321804	=	IC50	nM	160.0	CHEMBL5147	Homo sapiens	IC50	nM	160.0
	15008666	CHEMBL3361798	Inhibition of phosphorylation of full-length myc-tagged human EphB4 overexpressed in mouse embryonic fibroblasts after 90 mins by sandwich ELISA	B	NC(=O)c1c(N)n(-c2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2nc3ccccc3nc12		CHEMBL3321811	=	IC50	nM	20.0	CHEMBL5147	Homo sapiens	IC50	nM	20.0
	15008667	CHEMBL3361798	Inhibition of phosphorylation of full-length myc-tagged human EphB4 overexpressed in mouse embryonic fibroblasts after 90 mins by sandwich ELISA	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1-n1c(N)c(C(N)=O)c2nc3ccccc3nc21		CHEMBL3321812	=	IC50	nM	14.0	CHEMBL5147	Homo sapiens	IC50	nM	14.0
	15008668	CHEMBL3361798	Inhibition of phosphorylation of full-length myc-tagged human EphB4 overexpressed in mouse embryonic fibroblasts after 90 mins by sandwich ELISA	B	NC(=O)c1c(N)n(-c2cc(NC(=O)c3cccc(C(F)(F)F)c3)ccc2F)c2nc3ccccc3nc12		CHEMBL3321813	=	IC50	nM	15.0	CHEMBL5147	Homo sapiens	IC50	nM	15.0
	15008669	CHEMBL3361798	Inhibition of phosphorylation of full-length myc-tagged human EphB4 overexpressed in mouse embryonic fibroblasts after 90 mins by sandwich ELISA	B	Cc1cn(-c2cc(C(=O)Nc3ccc(C)c(-n4c(N)c(C(N)=O)c5nc6ccccc6nc54)c3)cc(C(F)(F)F)c2)cn1		CHEMBL3321814	=	IC50	nM	170.0	CHEMBL5147	Homo sapiens	IC50	nM	170.0
	15008670	CHEMBL3361798	Inhibition of phosphorylation of full-length myc-tagged human EphB4 overexpressed in mouse embryonic fibroblasts after 90 mins by sandwich ELISA	B	NC(=O)c1c(N)n(-c2cccc(C(=O)Nc3cccc(C(F)(F)F)c3)c2)c2nc3ccccc3nc12		CHEMBL3321816	=	IC50	nM	20.0	CHEMBL5147	Homo sapiens	IC50	nM	20.0
	15008671	CHEMBL3361798	Inhibition of phosphorylation of full-length myc-tagged human EphB4 overexpressed in mouse embryonic fibroblasts after 90 mins by sandwich ELISA	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-n1c(N)c(C(N)=O)c2nc3ccccc3nc21		CHEMBL3321817	=	IC50	nM	21.0	CHEMBL5147	Homo sapiens	IC50	nM	21.0
	15008672	CHEMBL3361798	Inhibition of phosphorylation of full-length myc-tagged human EphB4 overexpressed in mouse embryonic fibroblasts after 90 mins by sandwich ELISA	B	NC(=O)c1c(N)n(-c2cc(C(=O)Nc3cccc(C(F)(F)F)c3)ccc2F)c2nc3ccccc3nc12		CHEMBL3321818	=	IC50	nM	24.0	CHEMBL5147	Homo sapiens	IC50	nM	24.0
	15008673	CHEMBL3361798	Inhibition of phosphorylation of full-length myc-tagged human EphB4 overexpressed in mouse embryonic fibroblasts after 90 mins by sandwich ELISA	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(-n4c(N)c(C(N)=O)c5nc6ccccc6nc54)c3)cc(C(F)(F)F)c2)cn1		CHEMBL3321819	=	IC50	nM	270.0	CHEMBL5147	Homo sapiens	IC50	nM	270.0
	15008674	CHEMBL3361798	Inhibition of phosphorylation of full-length myc-tagged human EphB4 overexpressed in mouse embryonic fibroblasts after 90 mins by sandwich ELISA	B	NC(=O)c1c(N)n(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)c2nc3ccccc3nc12		CHEMBL3321822	=	IC50	nM	89.0	CHEMBL5147	Homo sapiens	IC50	nM	89.0
	15018585	CHEMBL3362249	Inhibition of EPHB4 (unknown origin) at 100 nM	B	O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3298678	=	Inhibition	%	-2.6	CHEMBL5147	Homo sapiens	INH	%	-2.6
	15053950	CHEMBL3367275	Inhibition of EPHB4 (unknown origin)	B	Clc1ccc(-c2ccc(-c3nccn3-c3ccc(N4CCNCC4)cc3)o2)cc1		CHEMBL3314140	>	IC50	nM	30000.0	CHEMBL5147	Homo sapiens	IC50	uM	30.0
	15055285	CHEMBL3380469	Inhibition of human recombinant EPHB4 using poly(Glu,Tyr) substrate	B	COc1cc(-c2nc(-c3c[nH]c4ccccc34)c[nH]c2=O)cc(OC)c1OC		CHEMBL3358966	>	IC50	nM	100000.0	CHEMBL5147	Homo sapiens	IC50	uM	100.0
	15072605	CHEMBL3382665	Inhibition of EPHB4 (unknown origin) assessed as remaining enzyme activity at 10 uM by radioactive [33P]-ATP filter binding assay	B	Cc1ccc(-c2cc(C(=O)Nc3ccnc(Cl)c3)nn2-c2ccc3ccccc3n2)cc1		CHEMBL3338802	=	Activity	%	125.0	CHEMBL5147	Homo sapiens	Activity	%	125.0
	15091097	CHEMBL3381532	Inhibition of human recombinant EphB4 kinase expressed insect cells using Ulight-TK peptide substrate assessed as remaining enzyme activity at 1 uM after 90 mins relative to control	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Br)c(O)c(Br)c1		CHEMBL2206014	=	Activity	%	108.0	CHEMBL5147	Homo sapiens	Activity	%	108.0
	15116489	CHEMBL3376477	Inhibition of EPHB4 (unknown origin)	B	CC(=O)c1ccc(N2CCN(C(=O)CN3CC[C@@H](C(=O)Nc4ccc(O)c(Cl)c4)C3)CC2)cc1		CHEMBL3356117	>	IC50	nM	30000.0	CHEMBL5147	Homo sapiens	IC50	uM	30.0
	15149963	CHEMBL3395924	Inhibition of EPHB4 (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2C2CC2)ccn1		CHEMBL3394102	<	Inhibition	%	50.0	CHEMBL5147	Homo sapiens	INH	%	50.0
	15149964	CHEMBL3395924	Inhibition of EPHB4 (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2C2CCCCC2)ccn1		CHEMBL3394105	<	Inhibition	%	50.0	CHEMBL5147	Homo sapiens	INH	%	50.0
	15149965	CHEMBL3395924	Inhibition of EPHB4 (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(S/C=C\C(=O)O)n2CC2CCCO2)ccn1		CHEMBL3394108	<	Inhibition	%	50.0	CHEMBL5147	Homo sapiens	INH	%	50.0
	15149966	CHEMBL3395924	Inhibition of EPHB4 (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	COC(Cn1c(SC2CCC(C(=O)O)CC2O)nc(-c2ccc(F)cc2)c1-c1ccnc(NC(C)=O)c1)OC		CHEMBL3394112	<	Inhibition	%	50.0	CHEMBL5147	Homo sapiens	INH	%	50.0
	15149967	CHEMBL3395924	Inhibition of EPHB4 (unknown origin) at 5.5 uM by Caliper Mobility Shift Assay	B	CC(=O)Nc1cc(-c2c(-c3ccc(F)cc3)nc(Sc3cccc(I)n3)n2C2CCCCC2)ccn1		CHEMBL3394118	<	Inhibition	%	50.0	CHEMBL5147	Homo sapiens	INH	%	50.0
	15237506	CHEMBL3424913	Inhibition of EphB4 (unknown origin) by fluorescence-based enzymatic assay	B	CCCCn1c(-c2ccccc2)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL271967	=	IC50	nM	1500.0	CHEMBL5147	Homo sapiens	IC50	uM	1.5
	15251812	CHEMBL3428408	Inhibition of EPH-B4 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL443738	=	Activity	%	72.0	CHEMBL5147	Homo sapiens	Activity	%	72.0
	15251985	CHEMBL3428408	Inhibition of EPH-B4 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427170	=	Activity	%	91.0	CHEMBL5147	Homo sapiens	Activity	%	91.0
	15252630	CHEMBL3428408	Inhibition of EPH-B4 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427171	=	Activity	%	97.0	CHEMBL5147	Homo sapiens	Activity	%	97.0
	15252732	CHEMBL3428408	Inhibition of EPH-B4 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427172	=	Activity	%	105.0	CHEMBL5147	Homo sapiens	Activity	%	105.0
	15252834	CHEMBL3428408	Inhibition of EPH-B4 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)CS3)sc2c1		CHEMBL3427173	=	Activity	%	90.0	CHEMBL5147	Homo sapiens	Activity	%	90.0
	15253508	CHEMBL3428408	Inhibition of EPH-B4 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)CS3)sc2c1		CHEMBL3427174	=	Activity	%	102.0	CHEMBL5147	Homo sapiens	Activity	%	102.0
	15253610	CHEMBL3428408	Inhibition of EPH-B4 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427175	=	Activity	%	91.0	CHEMBL5147	Homo sapiens	Activity	%	91.0
	15253712	CHEMBL3428408	Inhibition of EPH-B4 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427176	=	Activity	%	103.0	CHEMBL5147	Homo sapiens	Activity	%	103.0
	15254378	CHEMBL3428408	Inhibition of EPH-B4 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427177	=	Activity	%	92.0	CHEMBL5147	Homo sapiens	Activity	%	92.0
	15254480	CHEMBL3428408	Inhibition of EPH-B4 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427178	=	Activity	%	111.0	CHEMBL5147	Homo sapiens	Activity	%	111.0
	15254582	CHEMBL3428408	Inhibition of EPH-B4 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@H]1C(=O)O		CHEMBL3427179	=	Activity	%	103.0	CHEMBL5147	Homo sapiens	Activity	%	103.0
	15255272	CHEMBL3428408	Inhibition of EPH-B4 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@@H]1C(=O)O		CHEMBL3427180	=	Activity	%	95.0	CHEMBL5147	Homo sapiens	Activity	%	95.0
	15255375	CHEMBL3428408	Inhibition of EPH-B4 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427181	=	Activity	%	92.0	CHEMBL5147	Homo sapiens	Activity	%	92.0
	15255477	CHEMBL3428408	Inhibition of EPH-B4 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427182	=	Activity	%	97.0	CHEMBL5147	Homo sapiens	Activity	%	97.0
	15256209	CHEMBL3428408	Inhibition of EPH-B4 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427183	=	Activity	%	88.0	CHEMBL5147	Homo sapiens	Activity	%	88.0
	15256311	CHEMBL3428408	Inhibition of EPH-B4 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427184	=	Activity	%	86.0	CHEMBL5147	Homo sapiens	Activity	%	86.0
	15605123	CHEMBL3578504	Competitive binding affinity to EphB4 in human A375 cells after 15 mins in presence of ATP analogue	B	CNc1ncc2cc(-c3cc(NC(=O)NCCC(C)(C)C)c(F)cc3C)c(C)nc2n1		CHEMBL3577124	=	IC50	nM	100.0	CHEMBL5147	Homo sapiens	IC50	nM	100.0
	15745902	CHEMBL3624476	Inhibition of recombinant EpHB4 (unknown origin) at 1 uM after 40 mins by scintillation counting analysis in presence of [gamma33P]-ATP	B	COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1OC(=O)N1CCN(C)C[C@H]1C		CHEMBL3623290	=	Inhibition	%	83.0	CHEMBL5147	Homo sapiens	INH	%	83.0
	15756997	CHEMBL3630486	Inhibition of EPHB4 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	96.02	CHEMBL5147	Homo sapiens	INH	%	96.02
	15757726	CHEMBL3630486	Inhibition of EPHB4 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	93.75	CHEMBL5147	Homo sapiens	INH	%	93.75
	15758705	CHEMBL3630486	Inhibition of EPHB4 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	29.29	CHEMBL5147	Homo sapiens	INH	%	29.29
213946	16266218	CHEMBL3707878	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(C(=O)NCCN4CCCC4)o3)nnc2c1		CHEMBL3648058	=	IC50	nM	68.7	CHEMBL5147	Homo sapiens	IC50	nM	68.7
213950	16266289	CHEMBL3707878	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2ccccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL268825	=	IC50	nM	58.0	CHEMBL5147	Homo sapiens	IC50	nM	58.0
213943	16277687	CHEMBL3707878	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(C(=O)N4CCN(C)CC4)cc3)nnc2c1		CHEMBL3648039	=	IC50	nM	66.0	CHEMBL5147	Homo sapiens	IC50	nM	66.0
213948	16290981	CHEMBL3707878	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	=	IC50	nM	15.9	CHEMBL5147	Homo sapiens	IC50	nM	15.9
213951	16292986	CHEMBL3707878	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2ccccc2)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL230685	=	IC50	nM	391.0	CHEMBL5147	Homo sapiens	IC50	nM	391.0
213952	16321792	CHEMBL3707878	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Oc1ccc(Nc2nnc3cc(-c4c(Cl)cccc4Cl)ccc3n2)cc1		CHEMBL3651299	=	IC50	nM	596.0	CHEMBL5147	Homo sapiens	IC50	nM	596.0
213947	16324743	CHEMBL3707878	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3nc(C(=O)NCCN4CCCC4)cs3)nnc2c1		CHEMBL3648061	=	IC50	nM	66.1	CHEMBL5147	Homo sapiens	IC50	nM	66.1
213942	16328690	CHEMBL3707878	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2c(Cl)cccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL230686	=	IC50	nM	40.0	CHEMBL5147	Homo sapiens	IC50	nM	40.0
213941	16331287	CHEMBL3707878	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(OCCC4CCCC4)cc3)nnc2c1		CHEMBL3651296	=	IC50	nM	49.0	CHEMBL5147	Homo sapiens	IC50	nM	49.0
213949	16336839	CHEMBL3707878	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc12		CHEMBL249821	=	IC50	nM	30.8	CHEMBL5147	Homo sapiens	IC50	nM	30.8
213945	16355589	CHEMBL3707878	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2c1		CHEMBL231218	=	IC50	nM	73.7	CHEMBL5147	Homo sapiens	IC50	nM	73.7
213944	16355680	CHEMBL3707878	Luciferase-Based Assay: Recombinant human c-Src or Yes (28 ng/well, Panvera/Invitrogen, Madison Wis.), ATP (3 μM), a tyrosine kinase substrate (PTK2, 250 μM, Promega Corp., Madison Wis.), and test agents (at concentrations ranging from about 1 nM/l to about 100 μM/l), in the presence of Src kinase reaction buffer (Upstate USA, Lake Placid N.Y.). After reacting for about 90 minutes at room temperature, residual ATP was determined using a luciferase-based assay (KinaseGlo, Promega Corp.) as a measure of kinase activity.	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccnc(OCCN4CCCC4)c3)nnc2c1		CHEMBL437004	=	IC50	nM	128.0	CHEMBL5147	Homo sapiens	IC50	nM	128.0
	16379609	CHEMBL3738403	Inhibition of EPHB4 (unknown origin) at 200 nM by electrophoretic mobility shift assay	B	COc1ccc2c(c1CN1CCNCC1)O/C(=C\c1n[nH]c3ncccc13)C2=O		CHEMBL3735816	=	Inhibition	%	-3.1	CHEMBL5147	Homo sapiens	INH	%	-3.1
	16379610	CHEMBL3738403	Inhibition of EPHB4 (unknown origin) at 200 nM by electrophoretic mobility shift assay	B	COc1ccc2c(c1C(C)N1CCNCC1)O/C(=C\c1n[nH]c3ncccc13)C2=O		CHEMBL3735890	=	Inhibition	%	9.4	CHEMBL5147	Homo sapiens	INH	%	9.4
Dose-dependent effect	16392509	CHEMBL3738312	Displacement of biotinylated ephrin-B1-Fc from EphB4 (unknown origin) preincubated for 1 hr followed by biotinylated-ephrin-B1-Fc addition measured after 4 hrs by ELISA	B	C[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL3734863		Inhibition	%		CHEMBL5147	Homo sapiens	INH		
	16392522	CHEMBL3738312	Displacement of biotinylated ephrin-B1-Fc from EphB4 (unknown origin) preincubated for 1 hr followed by biotinylated-ephrin-B1-Fc addition measured after 4 hrs by ELISA	B	C[C@H](CCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL3734863	=	IC50	nM	2900.0	CHEMBL5147	Homo sapiens	IC50	uM	2.9
	16421907	CHEMBL3750389	Inhibition of EPHB4 (unknown origin)	B	C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1		CHEMBL3651966	>	IC50	nM	10000.0	CHEMBL5147	Homo sapiens	IC50	uM	10.0
	16431822	CHEMBL3748176	Inhibition of human EPHB4 using poly[Glu:Tyr] (4:1) as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL5147	Homo sapiens	IC50	uM	10.0
	16450836	CHEMBL3762692	Inhibition of EPHB4 (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	40.7	CHEMBL5147	Homo sapiens	INH	%	40.7
	16495986	CHEMBL3778577	Inhibition of N-terminal His6-tagged recombinant human EPHB4 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-20.0	CHEMBL5147	Homo sapiens	Activity	%	-20.0
	16508173	CHEMBL3778577	Inhibition of N-terminal His6-tagged recombinant human EPHB4 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	3.0	CHEMBL5147	Homo sapiens	Activity	%	3.0
	16509150	CHEMBL3778577	Inhibition of N-terminal His6-tagged recombinant human EPHB4 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	-3.0	CHEMBL5147	Homo sapiens	Activity	%	-3.0
	16509268	CHEMBL3777628	Inhibition of N-terminal GST-fused His6-tagged human recombinant EphB4	B	COc1cccc(-n2c(N)c(C(N)=O)c3nc4ccccc4nc32)c1		CHEMBL3774835	=	IC50	nM	300.0	CHEMBL5147	Homo sapiens	IC50	nM	300.0
	16539459	CHEMBL3789402	Inhibition of EphB4 receptor (unknown origin)	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL1614712	>	IC50	nM	10000.0	CHEMBL5147	Homo sapiens	IC50	uM	10.0
	16539460	CHEMBL3789402	Inhibition of EphB4 receptor (unknown origin)	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL3787112	=	IC50	nM	5.0	CHEMBL5147	Homo sapiens	IC50	uM	0.005
	16539461	CHEMBL3789402	Inhibition of EphB4 receptor (unknown origin)	B	Nc1ncnc2c1c(-c1cccc(OC[C@@H]3CCCO3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL3787614	=	IC50	nM	2700.0	CHEMBL5147	Homo sapiens	IC50	uM	2.7
	16539462	CHEMBL3789402	Inhibition of EphB4 receptor (unknown origin)	B	CC1(C)CC[C@@H](COc2cccc(-c3cn([C@H]4C[C@@H](CN5CCC5)C4)c4ncnc(N)c34)c2)O1		CHEMBL3786567	=	IC50	nM	690.0	CHEMBL5147	Homo sapiens	IC50	uM	0.69
	16540771	CHEMBL3789982	Inhibition of EphB4 (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL1614712	>	IC50	nM	10000.0	CHEMBL5147	Homo sapiens	IC50	uM	10.0
	16540772	CHEMBL3789982	Inhibition of EphB4 (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(OC[C@@H]3CCCO3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL3787614	=	IC50	nM	2700.0	CHEMBL5147	Homo sapiens	IC50	uM	2.7
	16540773	CHEMBL3789982	Inhibition of EphB4 (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL3787112	=	IC50	nM	5.0	CHEMBL5147	Homo sapiens	IC50	uM	0.005
	16540774	CHEMBL3789982	Inhibition of EphB4 (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(OCC34CCC(CC3)O4)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL3785500	>	IC50	nM	10000.0	CHEMBL5147	Homo sapiens	IC50	uM	10.0
	16540775	CHEMBL3789982	Inhibition of EphB4 (unknown origin) in presence of [gamma33P]ATP	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cccc(OC[C@@H]5CCCO5)c4F)c4c(N)ncnc43)C2)CC1		CHEMBL3786167	>	IC50	nM	10000.0	CHEMBL5147	Homo sapiens	IC50	uM	10.0
	16540776	CHEMBL3789982	Inhibition of EphB4 (unknown origin) in presence of [gamma33P]ATP	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cc(OC[C@@H]5CCCO5)ccc4F)c4c(N)ncnc43)C2)CC1		CHEMBL3785951	>	IC50	nM	10000.0	CHEMBL5147	Homo sapiens	IC50	uM	10.0
	16559576	CHEMBL3794765	Inhibition of human N-terminal GST-tagged EPHB4 cytoplasmic domain (577 to 987 residues) expressed in baculovirus expression system using fluorescence labelled Blk/Lyntide as substrate at 50 times IC50 by electrophoretic mobility shift assay relative to control	B	O=C(Nc1ccc(CN2CCN(c3ccccc3)CC2)cc1)c1n[nH]c2ccccc12		CHEMBL3792850	=	Inhibition	%	-0.4	CHEMBL5147	Homo sapiens	INH	%	-0.4
	16559577	CHEMBL3794765	Inhibition of human N-terminal GST-tagged EPHB4 cytoplasmic domain (577 to 987 residues) expressed in baculovirus expression system using fluorescence labelled Blk/Lyntide as substrate at 50 times IC50 by electrophoretic mobility shift assay relative to control	B	O=C(Nc1ccc(C(=O)N2CCN(c3ccccc3)CC2)cc1)c1n[nH]c2ccccc12		CHEMBL3793843	=	Inhibition	%	-1.2	CHEMBL5147	Homo sapiens	INH	%	-1.2
	16559578	CHEMBL3794765	Inhibition of human N-terminal GST-tagged EPHB4 cytoplasmic domain (577 to 987 residues) expressed in baculovirus expression system using fluorescence labelled Blk/Lyntide as substrate at 50 times IC50 by electrophoretic mobility shift assay relative to control	B	O=C(Nc1ccccc1)c1n[nH]c2ccccc12		CHEMBL508964	=	Inhibition	%	0.4	CHEMBL5147	Homo sapiens	INH	%	0.4
	16593544	CHEMBL3811547	Inhibition of His-tagged human recombinant EPHB4 (561 to 987 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808884	<	Inhibition	%	40.0	CHEMBL5147	Homo sapiens	INH	%	40.0
	16611852	CHEMBL3816752	Inhibition of human EPHB4 (561 to 987 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL405665	=	Activity	%	4.0	CHEMBL5147	Homo sapiens	Activity	%	4.0
	16614467	CHEMBL3816597	Inhibition of human EPHB4 at 1 uM using poly[Glu:Tyr] (4:1) as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	-2.0	CHEMBL5147	Homo sapiens	INH	%	-2.0
	16618225	CHEMBL3816329	Inhibition of recombinant human His-tagged cytoplasmic EPHB4 (561 to 987 residues) expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL5147	Homo sapiens	INH	%	50.0
	16627510	CHEMBL3820331	Inhibition of recombinant human N-terminal His6-tagged EPHB4 (561-end residues) expressed in baculovirus infected Sf21 cells at 1 uM by radiometric assay relative to control	B	Cc1cc(-c2cnn3c(NCC4CCOCC4)nc(Oc4ccccc4)nc23)ccc1C(=O)NC1CC1		CHEMBL3819210	=	Inhibition	%	4.0	CHEMBL5147	Homo sapiens	INH	%	4.0
	16627511	CHEMBL3820331	Inhibition of recombinant human N-terminal His6-tagged EPHB4 (561-end residues) expressed in baculovirus infected Sf21 cells at 1 uM by radiometric assay relative to control	B	O=C(N[C@@H](c1ccccn1)C1CC1)c1ccc2[nH]nc(-c3ccc(N4C5CCC4CC(O)C5)cc3)c2c1		CHEMBL3818239	=	Inhibition	%	-2.0	CHEMBL5147	Homo sapiens	INH	%	-2.0
	16654253	CHEMBL3829899	Inhibition of human EPHB4 (561 to 997 residues) assessed as remaining enzyme activity at 50 uM after 30 mins by 33P-ATP filter-binding assay	B	Cc1cc(=O)c2c(O)cc(O)c([C@H]3CCN(C)C[C@H]3O)c2o1		CHEMBL1077604	=	Activity	%	84.0	CHEMBL5147	Homo sapiens	Activity	%	84.0
	16905275	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	CCN1CCC(c2nc(COc3cc4ncnc(Nc5ccc(Cl)c(Cl)c5)c4cc3OC)cs2)CC1		CHEMBL3904481	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905276	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1nc([C@@H]2CCCN2)no1		CHEMBL3952023	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905277	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1csc([C@@H]2CCCN2)n1		CHEMBL3949400	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905278	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1csc(COC(=O)c2ccccc2)n1		CHEMBL3900567	=	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	nM	1000.0
	16905279	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3)ncnc2cc1O[C@H]1CO[C@@H]2[C@@H](OC)CO[C@H]12		CHEMBL3910031	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905280	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	CCO[C@H]1CO[C@@H]2[C@@H](Oc3cc4ncnc(Nc5ccc(Br)c(Cl)c5)c4cc3OC)CO[C@H]12		CHEMBL3907230	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905281	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3cccc(Br)c3C)ncnc2cc1O[C@H]1CO[C@@H]2[C@@H](OC)CO[C@H]12		CHEMBL3895458	=	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	nM	1000.0
	16905282	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3cccc(Cl)c3C)ncnc2cc1O[C@H]1CO[C@@H]2[C@@H](OC)CO[C@H]12		CHEMBL3959160	=	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	nM	1000.0
	16905283	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3)ncnc2cc1O[C@H]1CO[C@@H]2CCO[C@H]12		CHEMBL3932115	=	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	nM	1000.0
	16905284	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3)ncnc2cc1O[C@H]1CO[C@@H]2[C@H](OC)CO[C@H]12		CHEMBL3929354	=	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	nM	1000.0
	16905285	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CCCCO1		CHEMBL3975704	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905286	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1noc(CN(C)C)n1		CHEMBL3928212	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905287	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1nc(CN(C)C)no1		CHEMBL3936440	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905288	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1nc(CN2CCN(C)CC2)no1		CHEMBL3939199	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905289	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1noc(C2CCNCC2)n1		CHEMBL3959559	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905290	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1noc(C2CCN(C)CC2)n1		CHEMBL3960132	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905291	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1nc(CN2CCOCC2)no1		CHEMBL3944984	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905292	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CNCCO1		CHEMBL3924779	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905293	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1noc(C2CCCCN2)n1		CHEMBL3962335	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905294	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1csc(CN(C)C)n1		CHEMBL3971051	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905295	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(Cc2ccccc2)CCO1		CHEMBL3934158	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905296	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C(=O)OC(C)(C)C)CCO1		CHEMBL3924455	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905297	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1csc(CN2CCOCC2)n1		CHEMBL3973688	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905298	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1csc(CN2CCN(C)CC2)n1		CHEMBL3972190	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905299	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3951527	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905300	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CNCCCO1		CHEMBL3935392	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905301	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1noc(C2CCCNC2)n1		CHEMBL3985163	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905302	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1noc(C2CCCCN2C)n1		CHEMBL3984168	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905303	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C)CCCO1		CHEMBL3926466	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905304	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1noc(C2CCCN(C)C2)n1		CHEMBL3916706	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905305	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1cscn1		CHEMBL3968322	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905306	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CC1		CHEMBL3928696	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905307	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CCCO1		CHEMBL3926038	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905308	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OC1CCCC1		CHEMBL3952048	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905309	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OC[C@@H]1O[C@@H](OC)[C@@H](O)[C@H](O)[C@H]1O		CHEMBL3949434	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905310	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC(=O)N1CCOCC1		CHEMBL3914264	=	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	nM	1000.0
	16905311	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1noc(C2CCCCN2C(=O)OC(C)(C)C)n1		CHEMBL3904510	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905312	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1noc(C2CCN(C(=O)OC(C)(C)C)CC2)n1		CHEMBL3958507	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905313	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1nc(-c2ccc(N3CCCC3)cc2)cs1		CHEMBL3955873	=	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	nM	1000.0
	16905314	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	CCN(CC)c1ccc(-c2csc(COc3cc4ncnc(Nc5ccc(Cl)c(Cl)c5)c4cc3OC)n2)cc1		CHEMBL3922630	=	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	nM	1000.0
	16905315	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1nc(-c2ccc(O)c(C(N)=O)c2)cs1		CHEMBL3943632	=	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	nM	1000.0
	16905316	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCCC1CCCCC1		CHEMBL3979687	=	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	nM	1000.0
	16905317	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CCCCC1		CHEMBL3954731	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905318	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CCC1		CHEMBL3919501	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905319	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCCC1OCCO1		CHEMBL3929188	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905320	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCCC1OCCCO1		CHEMBL3949535	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905321	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCCN1CCOCC1		CHEMBL3968843	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905322	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCCN1CCCC1		CHEMBL3905012	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905323	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCCN1CCCCC1		CHEMBL3907764	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905324	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCCN1C(=O)c2ccccc2C1=O		CHEMBL3909626	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905325	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1nc(-c2cccnc2)cs1		CHEMBL3896044	=	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	nM	1000.0
	16905326	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1nc(-c2ccccn2)cs1		CHEMBL3976826	=	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	nM	1000.0
	16905327	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1nc(-c2ccncc2)cs1		CHEMBL3916485	=	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	nM	1000.0
	16905328	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1nc(N(C)C)no1		CHEMBL3960730	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905329	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1nc(CN2CCN(C)CC2)cs1		CHEMBL3913860	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905330	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1nc2c(s1)CNCC2		CHEMBL3945353	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905331	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1nc(CN2CCOCC2)cs1		CHEMBL3942671	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905332	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1nc(CN2CCCN(C)CC2)cs1		CHEMBL3952188	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905333	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1nc(COCc2ccccc2)no1		CHEMBL3984213	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905334	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	CCN1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3936151	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905335	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1csc(C2CCNCC2)n1		CHEMBL3945860	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905336	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1csc(C2CCN(C)CC2)n1		CHEMBL3898088	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905337	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1nc(N2CCN(C(=O)OC(C)(C)C)CC2)no1		CHEMBL3900858	=	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	nM	1000.0
	16905338	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1nc(N2CCNCC2)no1		CHEMBL3957171	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905339	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1nc(N2CCN(C)CC2)no1		CHEMBL3959857	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905340	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	CCN1CCCCC1c1nc(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)no1		CHEMBL3952693	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905341	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	CCN1CCN(c2noc(COc3cc4ncnc(Nc5ccc(Cl)c(Cl)c5)c4cc3OC)n2)CC1		CHEMBL3977320	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905342	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1ccc(-c2nc(COc3cc4ncnc(Nc5ccc(Cl)c(Cl)c5)c4cc3OC)no2)cc1		CHEMBL3985840	=	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	nM	1000.0
	16905343	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1csc(-c2ccc(C(F)(F)F)cc2)n1		CHEMBL3983201	=	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	nM	1000.0
	16905344	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1csc(-c2ccc(Cl)cc2)n1		CHEMBL3963620	=	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	nM	1000.0
	16905345	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1noc(-c2c(C)noc2C)n1		CHEMBL3937857	=	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	nM	1000.0
	16905346	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1csc2ccc(Cl)cc12		CHEMBL3929002	=	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	nM	1000.0
	16905347	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1nc(-c2ccc(C(C)(C)C)cc2)no1		CHEMBL3951099	=	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	nM	1000.0
	16905349	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COCCN1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3923013	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905350	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(CCCc2ccccc2)CCO1		CHEMBL3899485	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905351	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C(C)C)CCO1		CHEMBL3952315	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905352	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C2CCCC2)CCO1		CHEMBL3965096	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905353	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C)CCN1C		CHEMBL3983179	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905354	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	CCN1CCN(c2nc(COc3cc4ncnc(Nc5ccc(Cl)c(Cl)c5)c4cc3OC)cs2)CC1		CHEMBL3895123	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905355	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1csc([C@@H]2CCCN2C)n1		CHEMBL3930429	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905356	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1nc([C@@H]2CCCN2C)no1		CHEMBL3933123	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905357	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	CCN1CCCC1c1nc(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)no1		CHEMBL3906789	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905358	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1noc(C2CCCN2)n1		CHEMBL3909596	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905359	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1csc(N2CCNCC2)n1		CHEMBL3944780	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905360	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C(C)C)CCCO1		CHEMBL3947408	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905361	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COCCN1CCCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3986301	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905362	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(CC2CC2)CCCO1		CHEMBL3966752	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905363	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	CCCN1CCCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3914599	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905364	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	CCN1CCC2N=C(COc3cc4ncnc(Nc5ccc(Cl)c(Cl)c5)c4cc3OC)SC2C1		CHEMBL3959195	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905365	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	CCN1CCC[C@H]1c1nc(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)cs1		CHEMBL3910064	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905366	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	CCN1CCC[C@H]1c1noc(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)n1		CHEMBL3898627	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905367	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	CCN1CCCC(c2nc(COc3cc4ncnc(Nc5ccc(Cl)c(Cl)c5)c4cc3OC)cs2)C1		CHEMBL3897215	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905368	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	CCN1CCCCC1c1nc(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)cs1		CHEMBL3952805	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905369	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1csc(C2CCCN(C)C2)n1		CHEMBL3930406	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905370	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1csc(C2CCCNC2)n1		CHEMBL3893575	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905371	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1csc(C2CCCCN2C)n1		CHEMBL3967776	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905372	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1csc(C2CCCCN2)n1		CHEMBL3977030	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905373	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1csc([C@@H]2CSCN2)n1		CHEMBL3927549	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905374	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1nc2c(s1)CN(C)CC2		CHEMBL3938621	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905375	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1csc(CO)n1		CHEMBL3939717	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905379	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	CCN1CCCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3983938	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905380	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1csc(N(C)C)n1		CHEMBL3971864	=	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	nM	1000.0
	16905381	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	CCN1CCCC(c2nc(COc3cc4ncnc(Nc5ccc(Cl)c(Cl)c5)c4cc3OC)no2)C1		CHEMBL3960016	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905382	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	CCN1CCC(c2nc(COc3cc4ncnc(Nc5ccc(Cl)c(Cl)c5)c4cc3OC)no2)CC1		CHEMBL3959254	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905383	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCCC1CCCN1C		CHEMBL3914671	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905384	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1ccc2nc(C(F)(F)F)cc(Cl)c2c1		CHEMBL3948661	=	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	nM	1000.0
	16905385	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1noc(-c2ccccc2)n1		CHEMBL3946018	=	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	nM	1000.0
	16905386	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1nc(CS(=O)(=O)c2ccccn2)no1		CHEMBL3903022	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905387	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1cc(F)cc(F)c1		CHEMBL3900296	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905388	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1cc(Br)cc(Br)c1		CHEMBL3961982	=	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	nM	1000.0
	16905389	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1cc(F)cc2c1OCOC2		CHEMBL3952493	=	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	nM	1000.0
	16905390	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1c(-c2c(Cl)cccc2Cl)noc1C		CHEMBL3893128	=	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	nM	1000.0
	16905391	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1nccn1Cc1ccccc1		CHEMBL3895848	=	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	nM	1000.0
	16905392	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1nnc(-c2ccc(C)cc2)o1		CHEMBL3944502	=	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	nM	1000.0
	16905393	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1noc(-c2ccccc2OC)n1		CHEMBL3933848	=	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	nM	1000.0
	16905394	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1O[C@H]1CO[C@@H]2[C@@H](OC)CO[C@H]12		CHEMBL3964556	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905395	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3cccc(Cl)c3F)ncnc2cc1O[C@H]1CO[C@@H]2[C@@H](OC)CO[C@H]12		CHEMBL3955359	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905396	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3)ncnc2cc1O[C@H]1CO[C@@H]2[C@@H](OC(F)F)CO[C@H]12		CHEMBL3921689	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905397	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3cc(Cl)c(Cl)cc3F)ncnc2cc1O[C@@H]1C[C@H]2OC[C@H](OC)[C@H]2O1		CHEMBL3924380	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905398	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(F)c(Cl)c3F)ncnc2cc1O[C@@H]1C[C@H]2OC[C@H](OC)[C@H]2O1		CHEMBL3955486	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905399	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3)ncnc2cc1O[C@@H]1C[C@H]2OCC3(OCCO3)[C@H]2O1		CHEMBL3964605	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905400	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3Cl)ncnc2cc1O[C@@H]1C[C@H]2OC[C@H](OC)[C@H]2O1		CHEMBL3895424	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905401	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1O[C@@H]1C[C@H]2OC[C@H](OC)[C@H]2O1		CHEMBL3919145	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905402	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3Cl)ncnc2cc1O[C@@H]1C[C@H]2OC[C@H](OC)[C@H]2O1		CHEMBL3958481	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905403	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3F)ncnc2cc1O[C@@H]1C[C@H]2OC[C@H](OC)[C@H]2O1		CHEMBL3961005	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905404	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1O[C@@H]1C[C@H]2OC[C@H](OC)[C@H]2O1		CHEMBL3986404	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905405	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3cc(Cl)c(Br)cc3F)ncnc2cc1O[C@@H]1C[C@H]2OC[C@H](OC)[C@H]2O1		CHEMBL3946590	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905406	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OC1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3920036	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905407	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN2CSC[C@H]2CO1		CHEMBL3917294	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905408	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1CN2CCC[C@H]2C(=O)N1C		CHEMBL3983466	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905409	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3F)ncnc2cc1OC[C@@H]1CN2CCC[C@H]2C(=O)N1		CHEMBL3986135	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905410	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1CN2CCC[C@@H]2C(=O)N1		CHEMBL3945072	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905411	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1CN2CCC[C@H]2C(=O)N1		CHEMBL3947712	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905412	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1CN2CCCC[C@@H]2C(=O)N1		CHEMBL3900059	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905413	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1CN2CCCC[C@H]2C(=O)N1		CHEMBL3940489	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905414	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3cc(Cl)c(Cl)cc3F)ncnc2cc1OC[C@@H]1CO[C@@H]2[C@@H](OC)CO[C@H]12		CHEMBL3931427	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905415	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3Cl)ncnc2cc1OC[C@@H]1CO[C@@H]2[C@@H](OC)CO[C@H]12		CHEMBL3934134	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905416	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OC[C@@H]1CO[C@@H]2[C@@H](OC)CO[C@H]12		CHEMBL3893416	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905417	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3cc(Cl)c(Cl)cc3F)ncnc2cc1OC[C@@H]1CN2CCC[C@H]2CO1		CHEMBL3896122	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905418	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3Cl)ncnc2cc1OC[C@@H]1CN2CCC[C@H]2CO1		CHEMBL3924998	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905419	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(F)c(Cl)c3F)ncnc2cc1OC[C@@H]1CN2CCC[C@H]2CO1		CHEMBL3922278	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905420	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3F)ncnc2cc1OC[C@@H]1CN2CCC[C@H]2CO1		CHEMBL3962487	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905421	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1CN2CCC[C@H]2CO1		CHEMBL3959774	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905422	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OC[C@H]1CN2CCC[C@H]2CO1		CHEMBL3931623	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905423	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OC[C@@H]1CN2CCC[C@H]2CO1		CHEMBL3928883	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905424	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OC[C@@H]1CN2CCC[C@@H]2CO1		CHEMBL3977759	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905425	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3cc(Cl)c(Br)cc3F)ncnc2cc1OC[C@@H]1CN2CCC[C@H]2CO1		CHEMBL3968522	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905426	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OC[C@H]1CN2CCC[C@@H]2CO1		CHEMBL3917220	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905427	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3F)ncnc2cc1OC[C@H]1CN2CCOC[C@H]2CO1		CHEMBL3914441	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905428	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@H]1CN2CCOC[C@H]2CO1		CHEMBL3971781	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905429	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3cc(Cl)c(Br)cc3F)ncnc2cc1OC[C@@H]1CN2CCOC[C@H]2CO1		CHEMBL3924147	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905430	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3Cl)ncnc2cc1OC[C@@H]1CN2CCOC[C@H]2CO1		CHEMBL3905501	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905431	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3cc(Cl)c(Cl)cc3F)ncnc2cc1OC[C@@H]1CN2CCOC[C@H]2CO1		CHEMBL3908311	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905432	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN2CCOCC2CO1		CHEMBL3943570	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905433	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(F)c(Cl)c3F)ncnc2cc1OC[C@@H]1CN2CCOC[C@H]2CO1		CHEMBL3946242	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905434	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3F)ncnc2cc1OC[C@@H]1CN2CCOC[C@H]2CO1		CHEMBL3928396	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905435	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1CN2CCOC[C@H]2CO1		CHEMBL3893890	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905436	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(F)c(Cl)c3F)ncnc2cc1OC[C@H]1CN2CCOC[C@H]2CO1		CHEMBL3956820	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905437	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3cc(Cl)c(Br)cc3F)ncnc2cc1OC[C@H]1CN2CCOC[C@H]2CO1		CHEMBL3959516	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905438	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3cc(Cl)c(Cl)cc3F)ncnc2cc1OC[C@H]1CN2CCOC[C@H]2CO1		CHEMBL3977450	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905439	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3Cl)ncnc2cc1OC[C@H]1CN2CCCC[C@H]2CO1		CHEMBL3968192	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905440	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905441	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	CCOC(=O)C(C)N1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3937598	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905442	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	C=CCCCCN1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3955495	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905443	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(CCOCCO)CCO1		CHEMBL3918670	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905444	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COC(=O)CCN1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3978177	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905445	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(CCCCCC#N)CCO1		CHEMBL3923153	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905446	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(CC2C=CC=CO2)CCO1		CHEMBL3925935	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905447	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(CCCC#N)CCO1		CHEMBL3898808	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905448	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(Cc2ccc(F)cc2)CCO1		CHEMBL3910102	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905449	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COC(=O)CCCCN1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3979195	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905450	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	C=CCCCCCCN1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3981613	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905451	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	CCCN1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3942082	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905452	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(CCCCCCO)CCO1		CHEMBL3949560	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905453	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C(C)=O)CCO1		CHEMBL3985254	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905454	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(CC2CC2)CCO1		CHEMBL3897256	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905455	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	C#CCN1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3932578	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905456	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(c2ccncc2)CCO1		CHEMBL3935265	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905457	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(Cc2ccccn2)CCO1		CHEMBL3916759	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905458	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	CCC#CCN1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3919493	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905459	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1csc(N2CCN(C)CC2)n1		CHEMBL3958678	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905460	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1noc(C2CCCN2C)n1		CHEMBL3956056	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905461	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3893032	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905462	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	CCN1CCN(C(C)=O)CC1COc1cc2ncnc(Nc3ccc(Cl)c(Cl)c3)c2cc1OC		CHEMBL3890263	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905463	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc(Nc2ncnc3cc(OCC4CN(C)CCO4)c(OC)cc23)c(OC)cc1Cl		CHEMBL3944702	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905464	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3cccc(Br)c3C)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3912287	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905465	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3cc(Cl)c(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3906715	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905466	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3cccc(Cl)c3C)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3896927	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905467	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3cccc(Cl)c3Cl)ncnc2cc1OCC1CN(C(C)=N)CCCO1		CHEMBL3968519	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905468	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3966040	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905469	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3cc(Cl)ccc3F)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3949155	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905470	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3951755	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905471	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)cc3Cl)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3904192	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905472	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)cc3Br)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3913993	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905473	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3Cl)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3944791	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905474	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	CCN1CCN(C)CC1COc1cc2ncnc(Nc3ccc(Cl)c(Cl)c3)c2cc1OC		CHEMBL3968030	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905475	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(/C(N)=N/C#N)CCO1		CHEMBL3897525	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905476	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1csc(CN2CCCC2)n1		CHEMBL3900295	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905477	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C2CCOCC2)CCO1		CHEMBL3928180	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905478	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	CCC(CC)CN1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3921228	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905479	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(CC2CCCCC2)CCO1		CHEMBL3895890	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905480	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(CCO)CCO1		CHEMBL3893176	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905481	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	CC#CCN1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3933897	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905482	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C2CCC2)CCO1		CHEMBL3931193	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905483	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(CCC2OCCO2)CCO1		CHEMBL3979728	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905484	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(CCC2CCCCC2)CCO1		CHEMBL3951403	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905485	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	C=CCCCN1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3944857	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905486	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	CC[C@@H](C)CN1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3985896	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905487	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(CCCCF)CCO1		CHEMBL3983245	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905488	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C(C)C(C)=O)CCO1		CHEMBL3895645	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905489	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	CCC(=O)CN1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3965938	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905490	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	CCCCCN1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3929942	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905491	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	CCCCCCN1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3932698	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905492	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	CCCCCCCN1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3976896	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905493	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	CCCCCCCCN1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3979317	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905494	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(CCc2ccccc2)CCO1		CHEMBL3916297	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905495	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	CCCCN1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3919051	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905496	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	C=CCN1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3946469	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905497	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1OCCN(CC(=O)c2ccccc2)C1=O		CHEMBL3965160	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905498	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(CCF)CCO1		CHEMBL3955447	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905499	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(CC=C(C)C)CCO1		CHEMBL3932218	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905500	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C/C=C/Br)CCO1		CHEMBL3898138	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905501	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(CC(N)=O)CCO1		CHEMBL3916567	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905502	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(CCCOC2CCCCO2)CCCO1		CHEMBL3963821	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905503	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(CCC(C)C)CCCO1		CHEMBL3947769	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905504	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(CC2CCCCC2)CCCO1		CHEMBL3912646	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905505	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(CCC2CCCCC2)CCCO1		CHEMBL3914394	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905506	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	CCC(CC)CN1CCCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3928439	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905507	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(S(C)(=O)=O)CCCO1		CHEMBL3925803	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905508	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C2CCN(C)CC2)CCO1		CHEMBL3951258	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905509	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3cccc(Cl)c3F)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3953937	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905510	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3cccc(Cl)c3F)ncnc2cc1OCC1CN(/C(N)=N/C#N)CCCO1		CHEMBL3913496	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905511	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(C)c(Br)c3)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3916225	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905512	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	CCN1CCN(CC)C(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3937092	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905513	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(/C(N)=N/C#N)CC1		CHEMBL3939874	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905514	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(S(C)(=O)=O)CCO1		CHEMBL3892030	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905515	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(S(=O)(=O)Cc2ccccc2)CCO1		CHEMBL3901787	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905516	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(S(=O)(=O)c2ccc(F)cc2)CCO1		CHEMBL3958778	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905517	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	CCS(=O)(=O)N1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3961472	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905518	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(S(=O)(=O)c2ccccc2)CCO1		CHEMBL3933398	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905519	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(S(=O)(=O)CCCCl)CCO1		CHEMBL3923692	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905520	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	CCCCS(=O)(=O)N1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3893845	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905521	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(S(=O)(=O)c2ccc(C)cc2)CCO1		CHEMBL3970332	=	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	nM	1000.0
	16905522	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C(=O)c2c(C)noc2C)CCO1		CHEMBL3947700	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905523	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cccc(CC(=O)N2CCOC(COc3cc4ncnc(Nc5ccc(Cl)c(Cl)c5)c4cc3OC)C2)c1		CHEMBL3945062	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905524	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	CCCC(C)C(=O)N1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3986123	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905525	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	CCCCc1ccc(C(=O)N2CCOC(COc3cc4ncnc(Nc5ccc(Cl)c(Cl)c5)c4cc3OC)C2)cc1		CHEMBL3983450	=	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	nM	1000.0
	16905526	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C(=O)Cc2ccc(Cl)cc2)CCO1		CHEMBL3941200	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905527	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	CCCC(CCC)C(=O)N1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3959038	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905528	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C(=O)CCC(C)C)CCO1		CHEMBL3942387	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905529	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C(=O)c2cc(F)ccc2F)CCO1		CHEMBL3982666	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905530	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C(=O)C2CCCC2)CCO1		CHEMBL3920114	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905531	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	CCC(C(=O)N1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1)c1ccccc1		CHEMBL3894418	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905532	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C(=O)c2c(F)ccc(F)c2F)CCO1		CHEMBL3929966	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905533	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C(=O)c2ccoc2)CCO1		CHEMBL3969472	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905534	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	CCC(=O)N1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3976226	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905535	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	CCCCCC(=O)N1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3931724	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905536	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	CCCCC(CC)C(=O)N1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3953606	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905537	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C(=O)CCc2ccccc2)CCO1		CHEMBL3918306	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905538	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C(=O)C(C)(C)C)CCO1		CHEMBL3907879	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905539	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C(=O)c2cccc3ccccc23)CCO1		CHEMBL3905114	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905540	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C(=O)c2cccnc2Cl)CCO1		CHEMBL3968956	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905541	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C(=O)c2ccc(Cl)nc2)CCO1		CHEMBL3966429	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905542	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C(=O)c2ccc3c(c2)OCO3)CCO1		CHEMBL3962355	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905543	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	CC(C)Oc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CNCCO1		CHEMBL3959638	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905544	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COCCOc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CNCCO1		CHEMBL3964536	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905545	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	CCOc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CNCCO1		CHEMBL3917442	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905546	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	CCOc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3941402	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905547	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)cc3C)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3892117	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905548	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(C)c3)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3907215	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905549	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	CN/C(=N\C#N)N1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(C)c4)c3cc2OC)C1		CHEMBL3904460	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905550	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3945177	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905551	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	CC(C)Oc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3937297	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905552	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COCCOc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3913719	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905553	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)cc3Cl)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3911207	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905554	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C(C)=O)CCCO1		CHEMBL3958466	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905555	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	CN1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2O)C1		CHEMBL3955824	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905556	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Br)c3)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3899410	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905557	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C(=O)CC(=O)O)CCO1		CHEMBL3896699	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905558	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COC(=O)CCC(=O)N1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3899440	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905559	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3cccc(Br)c3Cl)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3977221	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905560	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COCCN/C(=N\C#N)N1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3986102	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905561	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	CCN/C(=N\C#N)N1CCOC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)C1		CHEMBL3942161	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905562	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(/C(=N/C#N)N2CCCCC2)CCO1		CHEMBL3940839	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905563	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(/C(=N/C#N)N2CCCC2)CCO1		CHEMBL3971050	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905564	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(/C(=N/C#N)N2CCN(C)CC2)CCO1		CHEMBL3973632	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905565	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	CCC1(C)CN(C)CC(COc2cc3ncnc(Nc4ccc(Cl)c(Cl)c4)c3cc2OC)O1		CHEMBL3931393	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905566	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)c(C)c3)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3934095	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905567	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CNCC(C)(C)O1		CHEMBL3914189	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905568	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C)CC(C)(C)O1		CHEMBL3928601	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905569	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCCC1CNC(C)(C)CO1		CHEMBL3962203	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905570	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCCC1CN(C)C(C)(C)CO1		CHEMBL3959495	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905571	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCCC1CN(C(=O)OC(C)(C)C)C(C)(C)CO1		CHEMBL3916953	=	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	nM	1000.0
	16905572	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C)C(C)(C)CO1		CHEMBL3914180	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905573	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3Cl)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3977503	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905574	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3cc(Cl)c(Cl)cc3F)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3968233	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905575	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCCC1CN(C)CC(C)(C)O1		CHEMBL3939133	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905576	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)c(F)c3F)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3941947	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905577	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3cc(F)c(Br)cc3F)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3952465	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905578	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3cc(F)c(Br)c(F)c3)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3955083	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905579	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3C)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3921390	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905580	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3C)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3924098	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905581	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3cc(Cl)c(Br)cc3F)ncnc2cc1OCC1COCCN1C		CHEMBL3958898	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905582	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3F)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3923449	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905583	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3906936	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905584	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(F)c(Cl)c3F)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3909744	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905585	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(C)c(Cl)c3Cl)ncnc2cc1OCC1CN(C)CCO1		CHEMBL3891059	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905586	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN(C)C(C)(C)C(=O)O1		CHEMBL3893846	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905587	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3Cl)ncnc2cc1OCC1CN(C)C(C)(C)CO1		CHEMBL3981432	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905588	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3cc(Cl)c(Br)cc3F)ncnc2cc1OCC1CN(C)C(C)(C)CO1		CHEMBL3972712	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905589	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3cc(Cl)c(Cl)cc3F)ncnc2cc1OCC1CN(C)C(C)(C)CO1		CHEMBL3921482	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905590	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OCC1CN(C)C(C)(C)CO1		CHEMBL3918761	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905591	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3F)ncnc2cc1OCC1CN(C)C(C)(C)CO1		CHEMBL3939671	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905592	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(F)c(Cl)c3F)ncnc2cc1OCC1CN(C)C(C)(C)CO1		CHEMBL3895129	<	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905593	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3F)ncnc2cc1OC[C@@H]1CN(C)CC(=O)N1		CHEMBL3935851	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905594	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1CN(C)CC(=O)N1		CHEMBL3933130	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905595	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3F)ncnc2cc1OC[C@@H]1CN(C)CC(=O)N1C		CHEMBL3891130	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905596	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1CN(C)CC(=O)N1C		CHEMBL3909603	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905597	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3)ncnc2cc1OC1=CO[C@H]2[C@H]1OC[C@@]21COC(C)(C)O1		CHEMBL3965625	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905598	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3)ncnc2cc1O[C@@H]1CO[C@@H]2[C@@H](OS(C)(=O)=O)CO[C@@H]21		CHEMBL3986082	=	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	nM	1000.0
	16905599	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3)ncnc2cc1O[C@@H]1CO[C@@H]2[C@@H](O)CO[C@H]12		CHEMBL3945028	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905600	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3)ncnc2cc1O[C@H]1CO[C@@H]2[C@@H](SC)CO[C@H]12		CHEMBL3947643	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905601	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3)ncnc2cc1O[C@H]1CO[C@H]2[C@@H]1OC[C@@H]2N1CCOCC1		CHEMBL3921861	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905602	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3)ncnc2cc1O[C@H]1CO[C@H]2[C@@H]1OC[C@@H]2N1CCN(C)CC1		CHEMBL3972940	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905603	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3)ncnc2cc1O[C@H]1CO[C@H]2[C@@H]1OC[C@@H]2N1CCCC1		CHEMBL3923645	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905604	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3)ncnc2cc1O[C@H]1CO[C@@H]2[C@@H](OC(C)=O)CO[C@H]12		CHEMBL3933359	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905605	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3)ncnc2cc1O[C@H]1CO[C@@H]2[C@@H](O)CO[C@H]12		CHEMBL3893363	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905606	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3)ncnc2cc1O[C@H]1CO[C@@H]2[C@@H](S(C)(=O)=O)CO[C@H]12		CHEMBL3896067	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905607	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3)ncnc2cc1O[C@H]1CO[C@@H]2[C@@H](N)CO[C@H]12		CHEMBL3976788	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905608	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	CN[C@H]1CO[C@@H]2[C@@H](Oc3cc4ncnc(Nc5ccc(Br)c(Cl)c5)c4cc3OC)CO[C@H]12		CHEMBL3974328	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905609	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	CCN(CC)[C@H]1CO[C@@H]2[C@@H](Oc3cc4ncnc(Nc5ccc(Br)c(Cl)c5)c4cc3OC)CO[C@@H]21		CHEMBL3909572	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905610	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3)ncnc2cc1O[C@H]1CO[C@H]2[C@@H]1OC[C@@H]2N1CCCCC1		CHEMBL3927849	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905611	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3)ncnc2cc1O[C@H]1CO[C@@H]2[C@@H](NC(C)=O)CO[C@H]12		CHEMBL3961417	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905612	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3)ncnc2cc1O[C@@H]1CO[C@@H]2[C@@H](NC(F)(F)F)CO[C@H]12		CHEMBL3958721	=	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	nM	1000.0
	16905613	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3)ncnc2cc1O[C@@H]1CO[C@@H]2[C@@H](NS(C)(=O)=O)CO[C@H]12		CHEMBL3943734	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905614	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3)ncnc2cc1OC1CCN(C)C1		CHEMBL3971560	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905615	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3)ncnc2cc1O[C@@H]1CCOC1		CHEMBL3939828	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905616	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3cccc(Cl)c3F)ncnc2cc1O[C@H]1CO[C@@H]2[C@@H](F)CO[C@H]12		CHEMBL3937048	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905617	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(N[C@H]3COC[C@@H]3OC)ncnc2cc1O[C@H]1CO[C@@H]2[C@@H](O)CO[C@H]12		CHEMBL3916828	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16905618	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(N4CCN(C)CC4)cc3)ncnc2cc1O[C@H]1CO[C@@H]2[C@@H](F)CO[C@H]12		CHEMBL3924442	=	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	nM	1000.0
	16905619	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(N4CCN(C)C(F)C4)cc3)ncnc2cc1O[C@H]1CO[C@@H]2[C@@H](F)CO[C@H]12		CHEMBL3890300	=	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	nM	1000.0
	16905620	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(N4CCN(C)CC4)c(Cl)c3Cl)ncnc2cc1O[C@H]1CO[C@@H]2[C@@H](F)CO[C@H]12		CHEMBL3893058	=	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	nM	1000.0
	16905621	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3N3CCN(C)CC3)ncnc2cc1O[C@H]1CO[C@@H]2[C@@H](F)CO[C@H]12		CHEMBL3985116	=	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	nM	1000.0
	16905622	CHEMBL3883066	Inhibition of recombinant human N-terminal His6-tagged EphB4 kinase domain (E605 to E890 residues) expressed in baculovirus using poly-AEKY as substrate after 150 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3)ncnc2cc1O[C@@H]1CO[C@H]2[C@@H]1OC[C@@H]2C(F)(F)F		CHEMBL3938869	=	IC50	nM	50.0	CHEMBL5147	Homo sapiens	IC50	nM	50.0
	16908246	CHEMBL3883090	Inhibition of active N-terminal His6-tagged human recombinant EphB4 (amino acids 561 to end) using poly(glu4tyr) substrate incubated for 60 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(OCCN4CCCC4)cc3)nnc2c1		CHEMBL436137	=	IC50	nM	49.0	CHEMBL5147	Homo sapiens	IC50	nM	49.0
	16908247	CHEMBL3883090	Inhibition of active N-terminal His6-tagged human recombinant EphB4 (amino acids 561 to end) using poly(glu4tyr) substrate incubated for 60 mins by luciferase-based assay	B	Cc1cc(-c2c(Cl)cccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL230686	=	IC50	nM	40.0	CHEMBL5147	Homo sapiens	IC50	nM	40.0
	16908248	CHEMBL3883090	Inhibition of active N-terminal His6-tagged human recombinant EphB4 (amino acids 561 to end) using poly(glu4tyr) substrate incubated for 60 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(C(=O)N4CCN(C)CC4)cc3)nnc2c1		CHEMBL3648039	=	IC50	nM	66.0	CHEMBL5147	Homo sapiens	IC50	nM	66.0
	16908249	CHEMBL3883090	Inhibition of active N-terminal His6-tagged human recombinant EphB4 (amino acids 561 to end) using poly(glu4tyr) substrate incubated for 60 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nnc2c1		CHEMBL231218	=	IC50	nM	73.7	CHEMBL5147	Homo sapiens	IC50	nM	73.7
	16908250	CHEMBL3883090	Inhibition of active N-terminal His6-tagged human recombinant EphB4 (amino acids 561 to end) using poly(glu4tyr) substrate incubated for 60 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3ccc(C(=O)NCCN4CCCC4)o3)nnc2c1		CHEMBL3648058	=	IC50	nM	68.7	CHEMBL5147	Homo sapiens	IC50	nM	68.7
	16908251	CHEMBL3883090	Inhibition of active N-terminal His6-tagged human recombinant EphB4 (amino acids 561 to end) using poly(glu4tyr) substrate incubated for 60 mins by luciferase-based assay	B	Cc1cccc(C)c1-c1cc(C)c2nc(Nc3nc(C(=O)NCCN4CCCC4)cs3)nnc2c1		CHEMBL3648061	=	IC50	nM	66.1	CHEMBL5147	Homo sapiens	IC50	nM	66.1
	16908252	CHEMBL3883090	Inhibition of active N-terminal His6-tagged human recombinant EphB4 (amino acids 561 to end) using poly(glu4tyr) substrate incubated for 60 mins by luciferase-based assay	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	=	IC50	nM	15.9	CHEMBL5147	Homo sapiens	IC50	nM	15.9
	16908253	CHEMBL3883090	Inhibition of active N-terminal His6-tagged human recombinant EphB4 (amino acids 561 to end) using poly(glu4tyr) substrate incubated for 60 mins by luciferase-based assay	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(S(=O)(=O)NCCN4CCCC4)cc3)nc12		CHEMBL249821	=	IC50	nM	30.8	CHEMBL5147	Homo sapiens	IC50	nM	30.8
	16908254	CHEMBL3883090	Inhibition of active N-terminal His6-tagged human recombinant EphB4 (amino acids 561 to end) using poly(glu4tyr) substrate incubated for 60 mins by luciferase-based assay	B	Cc1cc(-c2ccccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL268825	=	IC50	nM	58.0	CHEMBL5147	Homo sapiens	IC50	nM	58.0
	16908255	CHEMBL3883090	Inhibition of active N-terminal His6-tagged human recombinant EphB4 (amino acids 561 to end) using poly(glu4tyr) substrate incubated for 60 mins by luciferase-based assay	B	Cc1cc(-c2ccccc2)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL230685	=	IC50	nM	391.0	CHEMBL5147	Homo sapiens	IC50	nM	391.0
	16908256	CHEMBL3883090	Inhibition of active N-terminal His6-tagged human recombinant EphB4 (amino acids 561 to end) using poly(glu4tyr) substrate incubated for 60 mins by luciferase-based assay	B	Cc1cc(-c2c(Cl)cccc2Cl)cc2nnc(Nc3ccc(O)cc3)nc12		CHEMBL3651269	=	IC50	nM	596.0	CHEMBL5147	Homo sapiens	IC50	nM	596.0
Inactive	17900796	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900797	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900798	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900799	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900800	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900801	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Active	17900802	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Kd	nM	310.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	310.0
Inactive	17900803	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900804	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900805	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900806	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900807	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900808	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900809	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900810	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900811	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900812	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900813	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900814	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900815	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Active	17900816	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	4.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	4.0
Inactive	17900817	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900818	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900819	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900820	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900821	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900822	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900823	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900824	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900825	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Active	17900826	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	Kd	nM	1493.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	1493.0
Inactive	17900827	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Active	17900828	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	=	Kd	nM	340.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	340.0
Inactive	17900829	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900830	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900831	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900832	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900833	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900834	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Active	17900835	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	=	Kd	nM	109.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	109.0
Inactive	17900836	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900837	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900838	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900839	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900840	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900841	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900842	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Active	17900843	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	Kd	nM	18.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	18.0
Inactive	17900844	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900845	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900846	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900847	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900848	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900849	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900850	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900851	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900852	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900853	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900854	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900855	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900856	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900857	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900858	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900859	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900860	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900861	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900862	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900863	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900864	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900865	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900866	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900867	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900868	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900869	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900870	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900871	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Active	17900872	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	=	Kd	nM	1265.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	1265.0
Inactive	17900873	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900874	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900875	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900876	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900877	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900878	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900879	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900880	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900881	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900882	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900883	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900884	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900885	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Active	17900886	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	=	Kd	nM	1299.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	1299.0
Inactive	17900887	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900888	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900889	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Active	17900890	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	=	Kd	nM	0.9	CHEMBL5147	Homo sapiens	Kd apparent	nM	0.9
Inactive	17900891	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Active	17900892	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	=	Kd	nM	292.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	292.0
Inactive	17900893	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900894	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900895	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900896	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900897	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900898	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900899	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Active	17900900	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	99.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	99.0
Inactive	17900901	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Active	17900902	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	2083.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	2083.0
Active	17900903	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	=	Kd	nM	3878.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	3878.0
Inactive	17900904	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900905	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900906	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900907	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900908	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900909	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900910	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900911	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900912	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900913	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Active	17900914	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	=	Kd	nM	9818.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	9818.0
Inactive	17900915	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900916	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900917	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900918	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900919	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900920	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900921	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900922	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900923	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Active	17900924	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	=	Kd	nM	37.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	37.0
Inactive	17900925	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900926	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900927	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900928	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900929	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900930	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900931	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900932	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900933	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900934	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900935	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900936	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900937	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900938	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Active	17900939	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	1112.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	1112.0
Inactive	17900940	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900941	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900942	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900943	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900944	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900945	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900946	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Active	17900947	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	=	Kd	nM	656.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	656.0
Inactive	17900948	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900949	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900950	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900951	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900952	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900953	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900954	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900955	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Active	17900956	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	=	Kd	nM	711.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	711.0
Inactive	17900957	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900958	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900959	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Active	17900960	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	=	Kd	nM	26399.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	26399.0
Active	17900961	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	=	Kd	nM	143.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	143.0
Active	17900962	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	=	Kd	nM	556.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	556.0
Inactive	17900963	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900964	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900965	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900966	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900967	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900968	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900969	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900970	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900971	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900972	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900973	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900974	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900975	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900976	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900977	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900978	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900979	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900980	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900981	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900982	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900983	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900984	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900985	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900986	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900987	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Active	17900988	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Kd	nM	4608.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	4608.0
Inactive	17900989	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900990	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900991	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900992	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900993	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900994	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900995	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Active	17900996	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	=	Kd	nM	9434.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	9434.0
Inactive	17900997	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900998	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17900999	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17901000	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17901001	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17901002	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17901003	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17901004	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17901005	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17901006	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17901007	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17901008	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17901009	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17901010	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	=	Kd	nM	5210.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	5210.0
Inactive	17901011	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17901012	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17901013	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17901014	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17901015	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17901016	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17901017	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17901018	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17901019	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17901020	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17901021	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Active	17901022	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	804.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	804.0
Inactive	17901023	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17901024	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17901025	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17901026	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17901027	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17901028	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17901029	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17901030	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Active	17901031	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	=	Kd	nM	1075.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	1075.0
Inactive	17901032	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17901033	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17901034	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17901035	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17901036	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17901037	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17901038	CHEMBL3991707	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL5147	Homo sapiens	Kd apparent	nM	30000.0
	17955684	CHEMBL3993541	Inhibition of EphB4 (unknown origin) after 60 mins by ADP-Glo assay	B	Nc1n[nH]c2cccc(-c3ccc(NC(=O)C4(C(=O)Nc5cc(Br)cc(C(F)(F)F)c5)CC4)cc3)c12		CHEMBL4086694	=	IC50	nM	9.22	CHEMBL5147	Homo sapiens	IC50	nM	9.22
	17955685	CHEMBL3993541	Inhibition of EphB4 (unknown origin) after 60 mins by ADP-Glo assay	B	Nc1n[nH]c2cccc(-c3ccc(NC(=O)C4(C(=O)Nc5ccc(Br)cc5OC(F)(F)F)CC4)cc3)c12		CHEMBL4104599	=	IC50	nM	4.53	CHEMBL5147	Homo sapiens	IC50	nM	4.53
	17955686	CHEMBL3993541	Inhibition of EphB4 (unknown origin) after 60 mins by ADP-Glo assay	B	Nc1n[nH]c2cccc(-c3ccc(NC(=O)C4(C(=O)Nc5ccc(OC(F)(F)F)cc5Br)CC4)cc3)c12		CHEMBL4071731	=	IC50	nM	3.6	CHEMBL5147	Homo sapiens	IC50	nM	3.6
Not Determined	17955687	CHEMBL3993541	Inhibition of EphB4 (unknown origin) after 60 mins by ADP-Glo assay	B	Nc1n[nH]c2cccc(-c3ccc(NC(=O)C4(C(=O)Nc5cc(Br)ccc5OC(F)(F)F)CC4)cc3)c12		CHEMBL4092519		IC50			CHEMBL5147	Homo sapiens	IC50		
	17955688	CHEMBL3993541	Inhibition of EphB4 (unknown origin) after 60 mins by ADP-Glo assay	B	Nc1n[nH]c2cccc(-c3ccc(NC(=O)C4(C(=O)Nc5cc(OC(F)(F)F)ccc5Br)CC4)cc3)c12		CHEMBL4093247	=	IC50	nM	787.89	CHEMBL5147	Homo sapiens	IC50	nM	787.89
	17955689	CHEMBL3993541	Inhibition of EphB4 (unknown origin) after 60 mins by ADP-Glo assay	B	Nc1n[nH]c2cccc(-c3ccc(NC(=O)C4(C(=O)Nc5ccc(Cl)cc5Cl)CC4)cc3)c12		CHEMBL4072514	=	IC50	nM	383.59	CHEMBL5147	Homo sapiens	IC50	nM	383.59
	17955690	CHEMBL3993541	Inhibition of EphB4 (unknown origin) after 60 mins by ADP-Glo assay	B	Nc1n[nH]c2cccc(-c3ccc(NC(=O)C4(C(=O)Nc5ccc(F)c(F)c5)CC4)cc3)c12		CHEMBL4100979	=	IC50	nM	0.13	CHEMBL5147	Homo sapiens	IC50	nM	0.13
	17955691	CHEMBL3993541	Inhibition of EphB4 (unknown origin) after 60 mins by ADP-Glo assay	B	Nc1n[nH]c2cccc(-c3ccc(NC(=O)C4(C(=O)Nc5ccc(Cl)c(Cl)c5)CC4)cc3)c12		CHEMBL4083001	=	IC50	nM	170.11	CHEMBL5147	Homo sapiens	IC50	nM	170.11
	17955692	CHEMBL3993541	Inhibition of EphB4 (unknown origin) after 60 mins by ADP-Glo assay	B	Nc1n[nH]c2cccc(-c3ccc(NC(=O)C4(C(=O)Nc5cc(C(F)(F)F)cc(C(F)(F)F)c5)CC4)cc3)c12		CHEMBL4075266	=	IC50	nM	38.14	CHEMBL5147	Homo sapiens	IC50	nM	38.14
	17955693	CHEMBL3993541	Inhibition of EphB4 (unknown origin) after 60 mins by ADP-Glo assay	B	Nc1n[nH]c2cccc(-c3ccc(NC(=O)C4(C(=O)Nc5ccc6c(c5)OCO6)CC4)cc3)c12		CHEMBL4101918	=	IC50	nM	1.26	CHEMBL5147	Homo sapiens	IC50	nM	1.26
	17955694	CHEMBL3993541	Inhibition of EphB4 (unknown origin) after 60 mins by ADP-Glo assay	B	Nc1n[nH]c2cccc(-c3cccc(NC(=O)C4(C(=O)Nc5cc(Br)cc(C(F)(F)F)c5)CC4)c3)c12		CHEMBL4085495	=	IC50	nM	613.0	CHEMBL5147	Homo sapiens	IC50	nM	613.0
	17955695	CHEMBL3993541	Inhibition of EphB4 (unknown origin) after 60 mins by ADP-Glo assay	B	Nc1n[nH]c2cccc(-c3cccc(NC(=O)C4(C(=O)Nc5cc(Br)ccc5OC(F)(F)F)CC4)c3)c12		CHEMBL4063920	>	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	nM	1000.0
	17955696	CHEMBL3993541	Inhibition of EphB4 (unknown origin) after 60 mins by ADP-Glo assay	B	Nc1n[nH]c2cccc(-c3cccc(NC(=O)C4(C(=O)Nc5ccc(Cl)cc5Cl)CC4)c3)c12		CHEMBL4082005	>	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	nM	1000.0
	17955697	CHEMBL3993541	Inhibition of EphB4 (unknown origin) after 60 mins by ADP-Glo assay	B	Nc1n[nH]c2cccc(-c3cccc(NC(=O)C4(C(=O)Nc5ccc(Cl)c(Cl)c5)CC4)c3)c12		CHEMBL4060113	>	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	nM	1000.0
	17955698	CHEMBL3993541	Inhibition of EphB4 (unknown origin) after 60 mins by ADP-Glo assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	IC50	nM	0.2	CHEMBL5147	Homo sapiens	IC50	nM	0.2
	17955699	CHEMBL3993541	Inhibition of EphB4 (unknown origin) after 60 mins by ADP-Glo assay	B	Nc1ncc2ccc(-c3ccc(NC(=S)Nc4cc(Br)cc(C(F)(F)F)c4)cc3)cc2n1		CHEMBL4069517	=	IC50	nM	0.27	CHEMBL5147	Homo sapiens	IC50	nM	0.27
Not Determined	17955700	CHEMBL3993541	Inhibition of EphB4 (unknown origin) after 60 mins by ADP-Glo assay	B	Nc1ncc2ccc(-c3ccc(NC(=S)Nc4ccc(Br)cc4OC(F)(F)F)cc3)cc2n1		CHEMBL4089043		IC50			CHEMBL5147	Homo sapiens	IC50		
	17955701	CHEMBL3993541	Inhibition of EphB4 (unknown origin) after 60 mins by ADP-Glo assay	B	Nc1ncc2ccc(-c3ccc(NC(=S)Nc4ccc(OC(F)(F)F)cc4Br)cc3)cc2n1		CHEMBL4060841	=	IC50	nM	48.53	CHEMBL5147	Homo sapiens	IC50	nM	48.53
	17955702	CHEMBL3993541	Inhibition of EphB4 (unknown origin) after 60 mins by ADP-Glo assay	B	Nc1ncc2ccc(-c3ccc(NC(=S)Nc4cc(Br)ccc4OC(F)(F)F)cc3)cc2n1		CHEMBL4066813	=	IC50	nM	92.59	CHEMBL5147	Homo sapiens	IC50	nM	92.59
	17955703	CHEMBL3993541	Inhibition of EphB4 (unknown origin) after 60 mins by ADP-Glo assay	B	Nc1ncc2ccc(-c3ccc(NC(=S)Nc4cc(OC(F)(F)F)ccc4Br)cc3)cc2n1		CHEMBL4088100	>	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	nM	1000.0
	17955704	CHEMBL3993541	Inhibition of EphB4 (unknown origin) after 60 mins by ADP-Glo assay	B	Nc1ncc2ccc(-c3ccc(NC(=S)Nc4ccc(Cl)cc4Cl)cc3)cc2n1		CHEMBL4104466	>	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	nM	1000.0
	17955705	CHEMBL3993541	Inhibition of EphB4 (unknown origin) after 60 mins by ADP-Glo assay	B	Nc1ncc2ccc(-c3ccc(NC(=S)Nc4ccc(F)c(F)c4)cc3)cc2n1		CHEMBL4080224	>	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	nM	1000.0
	17955706	CHEMBL3993541	Inhibition of EphB4 (unknown origin) after 60 mins by ADP-Glo assay	B	Nc1ncc2ccc(-c3ccc(NC(=S)Nc4ccc(Cl)c(Cl)c4)cc3)cc2n1		CHEMBL4085653	=	IC50	nM	179.6	CHEMBL5147	Homo sapiens	IC50	nM	179.6
Not Determined	17955707	CHEMBL3993541	Inhibition of EphB4 (unknown origin) after 60 mins by ADP-Glo assay	B	Nc1ncc2ccc(-c3ccc(NC(=S)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)cc2n1		CHEMBL4103584		IC50			CHEMBL5147	Homo sapiens	IC50		
Not Determined	17955708	CHEMBL3993541	Inhibition of EphB4 (unknown origin) after 60 mins by ADP-Glo assay	B	Nc1ncc2ccc(-c3ccc(NC(=S)Nc4ccc5c(c4)OCO5)cc3)cc2n1		CHEMBL4087541		IC50			CHEMBL5147	Homo sapiens	IC50		
	18033109	CHEMBL4007925	Inhibition of human EPHB4 at 0.1 uM relative to control	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1NC(=O)[C@H]1CCCN1.Cl		CHEMBL4093614	=	Inhibition	%	-4.0	CHEMBL5147	Homo sapiens	INH	%	-4.0
	18053076	CHEMBL4011856	Inhibition of EPHB4 (unknown origin) at 0.1 uM pretreated for 30 mins followed by substrate addition measured after 5 hrs in presence of 1 mM ATP relative to control	B	COC(=O)C1=C(Nc2ccccc2Cl)O/C(=C\c2c[nH]c3ncccc23)C1=O		CHEMBL4089159	=	Inhibition	%	-1.4	CHEMBL5147	Homo sapiens	INH	%	-1.4
	18114370	CHEMBL4025124	Inhibition of wild-type human partial length EPHB4 (H585 to G892 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	88.0	CHEMBL5147	Homo sapiens	Activity	%	88.0
	18153202	CHEMBL4034526	Inhibition of EphB4 (unknown origin) labeling at activation loop at 10 uM relative to control	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	-6.7	CHEMBL5147	Homo sapiens	INH	%	-6.7
	18203648	CHEMBL4043935	Inhibition of wild-type human partial length EPHB4 (H585 to G892 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	100.0	CHEMBL5147	Homo sapiens	Activity	%	100.0
	18232147	CHEMBL4050358	Inhibition of human EPHB4 assessed as residual activity at 1 uM in presence of [33P]ATP by filter binding assay relative to control	B	NCCCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCCCCCCCOc1nc2cc(C(=O)O)ccc2c2cnccc12)C(=O)O		CHEMBL4077554	=	Activity	%	86.0	CHEMBL5147	Homo sapiens	Activity	%	86.0
	18253707	CHEMBL4055138	Inhibition of wild-type human partial length EPHB4 (H585 to G892 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	99.0	CHEMBL5147	Homo sapiens	Activity	%	99.0
	18253708	CHEMBL4055138	Inhibition of wild-type human partial length EPHB4 (H585 to G892 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	96.0	CHEMBL5147	Homo sapiens	Activity	%	96.0
	18265784	CHEMBL4057234	Inhibition of EPHB4 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	8.0	CHEMBL5147	Homo sapiens	INH	%	8.0
	18265982	CHEMBL4057432	Inhibition of EPHB4 (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	1.7	CHEMBL5147	Homo sapiens	INH	%	1.7
	18282753	CHEMBL4120338	Inhibition of EPHB4 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	8.0	CHEMBL5147	Homo sapiens	INH	%	8.0
	18282980	CHEMBL4120565	Inhibition of EPHB4 (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	0.3	CHEMBL5147	Homo sapiens	INH	%	0.3
	18283204	CHEMBL4120789	Inhibition of EPHB4 (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	-2.3	CHEMBL5147	Homo sapiens	INH	%	-2.3
	18328503	CHEMBL4135861	Inhibition of EphB4 (unknown origin) after 4 hrs by ADP-Glo luminescence assay	B	O=C(Nc1cccc(Cl)c1)Nc1cccc(-c2ccc3c(=O)[nH]cnc3c2)c1		CHEMBL4163581	=	IC50	nM	47.96	CHEMBL5147	Homo sapiens	IC50	nM	47.96
	18328504	CHEMBL4135861	Inhibition of EphB4 (unknown origin) after 4 hrs by ADP-Glo luminescence assay	B	O=C(Nc1cccc(-c2ccc3c(=O)[nH]cnc3c2)c1)Nc1ccc(F)c(F)c1		CHEMBL4174261	=	IC50	nM	38.52	CHEMBL5147	Homo sapiens	IC50	nM	38.52
	18328505	CHEMBL4135861	Inhibition of EphB4 (unknown origin) after 4 hrs by ADP-Glo luminescence assay	B	O=C(Nc1cccc(-c2ccc3c(=O)[nH]cnc3c2)c1)Nc1cccc(C(F)(F)F)c1		CHEMBL4167030	>	IC50	nM	500.0	CHEMBL5147	Homo sapiens	IC50	nM	500.0
	18328506	CHEMBL4135861	Inhibition of EphB4 (unknown origin) after 4 hrs by ADP-Glo luminescence assay	B	O=C(Nc1cccc(-c2ccc3c(=O)[nH]cnc3c2)c1)Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1		CHEMBL4159125	>	IC50	nM	500.0	CHEMBL5147	Homo sapiens	IC50	nM	500.0
	18328507	CHEMBL4135861	Inhibition of EphB4 (unknown origin) after 4 hrs by ADP-Glo luminescence assay	B	O=C(Nc1cccc(-c2ccc3c(=O)[nH]cnc3c2)c1)Nc1ccc(Cl)c(C(F)(F)F)c1		CHEMBL4163655	=	IC50	nM	491.93	CHEMBL5147	Homo sapiens	IC50	nM	491.93
	18328508	CHEMBL4135861	Inhibition of EphB4 (unknown origin) after 4 hrs by ADP-Glo luminescence assay	B	C=CC(=O)Nc1ccc(-c2ccc(NC(=O)Nc3cccc(Cl)c3)cc2)cn1		CHEMBL4171543	=	IC50	nM	3.87	CHEMBL5147	Homo sapiens	IC50	nM	3.87
	18328509	CHEMBL4135861	Inhibition of EphB4 (unknown origin) after 4 hrs by ADP-Glo luminescence assay	B	C=CC(=O)Nc1ccc(-c2ccc(NC(=O)Nc3c(C)cccc3C)cc2)cn1		CHEMBL4165168	=	IC50	nM	133.73	CHEMBL5147	Homo sapiens	IC50	nM	133.73
Not Determined	18328510	CHEMBL4135861	Inhibition of EphB4 (unknown origin) after 4 hrs by ADP-Glo luminescence assay	B	C=CC(=O)Nc1ccc(-c2ccc(NC(=O)Nc3ccc(OC(F)(F)F)cc3)cc2)cn1		CHEMBL4173072		IC50			CHEMBL5147	Homo sapiens	IC50		
Not Determined	18328511	CHEMBL4135861	Inhibition of EphB4 (unknown origin) after 4 hrs by ADP-Glo luminescence assay	B	C=CC(=O)Nc1ccc(-c2ccc(NC(=O)Nc3ccccc3Cl)cc2)cn1		CHEMBL4161735		IC50			CHEMBL5147	Homo sapiens	IC50		
	18328512	CHEMBL4135861	Inhibition of EphB4 (unknown origin) after 4 hrs by ADP-Glo luminescence assay	B	C=CC(=O)Nc1ccc(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)cn1		CHEMBL4169668	>	IC50	nM	500.0	CHEMBL5147	Homo sapiens	IC50	nM	500.0
Not Determined	18328513	CHEMBL4135861	Inhibition of EphB4 (unknown origin) after 4 hrs by ADP-Glo luminescence assay	B	C=CC(=O)Nc1ccc(-c2ccc(NC(=O)Nc3ccc(F)cc3)cc2)cn1		CHEMBL4171943		IC50			CHEMBL5147	Homo sapiens	IC50		
	18328514	CHEMBL4135861	Inhibition of EphB4 (unknown origin) after 4 hrs by ADP-Glo luminescence assay	B	C=CC(=O)Nc1ccc(-c2ccc(NC(=O)Nc3cccc(F)c3)cc2)cn1		CHEMBL4161345	>	IC50	nM	500.0	CHEMBL5147	Homo sapiens	IC50	nM	500.0
	18328515	CHEMBL4135861	Inhibition of EphB4 (unknown origin) after 4 hrs by ADP-Glo luminescence assay	B	C=CC(=O)Nc1ccc(-c2ccc(NC(=O)Nc3ccc(C)c(Cl)c3)cc2)cn1		CHEMBL4168590	=	IC50	nM	29.28	CHEMBL5147	Homo sapiens	IC50	nM	29.28
	18328516	CHEMBL4135861	Inhibition of EphB4 (unknown origin) after 4 hrs by ADP-Glo luminescence assay	B	C=CC(=O)Nc1ccc(-c2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)cn1		CHEMBL4176454	>	IC50	nM	500.0	CHEMBL5147	Homo sapiens	IC50	nM	500.0
	18328517	CHEMBL4135861	Inhibition of EphB4 (unknown origin) after 4 hrs by ADP-Glo luminescence assay	B	C=CC(=O)Nc1ccc(-c2ccc(NC(=O)Nc3cccc(C(C)C)c3)cc2)cn1		CHEMBL4175773	=	IC50	nM	23.55	CHEMBL5147	Homo sapiens	IC50	nM	23.55
	18328518	CHEMBL4135861	Inhibition of EphB4 (unknown origin) after 4 hrs by ADP-Glo luminescence assay	B	C=CC(=O)Nc1ccc(-c2ccc(NC(=O)Nc3ccc(C(C)(C)C)cc3)cc2)cn1		CHEMBL4167913	=	IC50	nM	24.92	CHEMBL5147	Homo sapiens	IC50	nM	24.92
	18328519	CHEMBL4135861	Inhibition of EphB4 (unknown origin) after 4 hrs by ADP-Glo luminescence assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	IC50	nM	4.46	CHEMBL5147	Homo sapiens	IC50	nM	4.46
	18328520	CHEMBL4135861	Inhibition of EphB4 (unknown origin) after 4 hrs by ADP-Glo luminescence assay	B	Nc1ncc2ccc(-c3ccc(NC(=O)C4(C(=O)Nc5ccc6c(c5)OCO6)CC4)cc3)cc2n1		CHEMBL4159588	>	IC50	nM	500.0	CHEMBL5147	Homo sapiens	IC50	nM	500.0
	18328521	CHEMBL4135861	Inhibition of EphB4 (unknown origin) after 4 hrs by ADP-Glo luminescence assay	B	Nc1ncc2ccc(-c3ccc(NC(=O)C4(C(=O)Nc5ccc(OCCCN6CCOCC6)c(F)c5)CC4)cc3)cc2n1		CHEMBL4164062	>	IC50	nM	500.0	CHEMBL5147	Homo sapiens	IC50	nM	500.0
	18328522	CHEMBL4135861	Inhibition of EphB4 (unknown origin) after 4 hrs by ADP-Glo luminescence assay	B	Nc1ncc2ccc(-c3ccc(NC(=O)C4(C(=O)Nc5cc(C(F)(F)F)cc(C(F)(F)F)c5)CC4)cc3)cc2n1		CHEMBL4174711	>	IC50	nM	500.0	CHEMBL5147	Homo sapiens	IC50	nM	500.0
	18328523	CHEMBL4135861	Inhibition of EphB4 (unknown origin) after 4 hrs by ADP-Glo luminescence assay	B	Nc1ncc2ccc(-c3ccc(NC(=O)C4(C(=O)Nc5ccc(Cl)c(Cl)c5)CC4)cc3)cc2n1		CHEMBL4174319	>	IC50	nM	500.0	CHEMBL5147	Homo sapiens	IC50	nM	500.0
	18328524	CHEMBL4135861	Inhibition of EphB4 (unknown origin) after 4 hrs by ADP-Glo luminescence assay	B	Nc1ncc2ccc(-c3ccc(NC(=O)C4(C(=O)Nc5ccc(F)c(F)c5)CC4)cc3)cc2n1		CHEMBL4166401	=	IC50	nM	37.78	CHEMBL5147	Homo sapiens	IC50	nM	37.78
	18328525	CHEMBL4135861	Inhibition of EphB4 (unknown origin) after 4 hrs by ADP-Glo luminescence assay	B	Nc1ncc2ccc(-c3ccc(NC(=O)C4(C(=O)Nc5ccc(Cl)cc5Cl)CC4)cc3)cc2n1		CHEMBL4170879	=	IC50	nM	160.1	CHEMBL5147	Homo sapiens	IC50	nM	160.1
	18328526	CHEMBL4135861	Inhibition of EphB4 (unknown origin) after 4 hrs by ADP-Glo luminescence assay	B	Nc1ncc2ccc(-c3ccc(NC(=O)C4(C(=O)Nc5cc(OC(F)(F)F)ccc5Br)CC4)cc3)cc2n1		CHEMBL4162947	=	IC50	nM	26.43	CHEMBL5147	Homo sapiens	IC50	nM	26.43
	18328527	CHEMBL4135861	Inhibition of EphB4 (unknown origin) after 4 hrs by ADP-Glo luminescence assay	B	Nc1ncc2ccc(-c3ccc(NC(=O)C4(C(=O)Nc5cc(Br)ccc5OC(F)(F)F)CC4)cc3)cc2n1		CHEMBL4177333	>	IC50	nM	500.0	CHEMBL5147	Homo sapiens	IC50	nM	500.0
	18328528	CHEMBL4135861	Inhibition of EphB4 (unknown origin) after 4 hrs by ADP-Glo luminescence assay	B	Nc1ncc2ccc(-c3ccc(NC(=O)C4(C(=O)Nc5ccc(OC(F)(F)F)cc5Br)CC4)cc3)cc2n1		CHEMBL4166703	>	IC50	nM	500.0	CHEMBL5147	Homo sapiens	IC50	nM	500.0
	18328529	CHEMBL4135861	Inhibition of EphB4 (unknown origin) after 4 hrs by ADP-Glo luminescence assay	B	Nc1ncc2ccc(-c3ccc(NC(=O)C4(C(=O)Nc5ccc(Br)cc5OC(F)(F)F)CC4)cc3)cc2n1		CHEMBL4175857	>	IC50	nM	500.0	CHEMBL5147	Homo sapiens	IC50	nM	500.0
	18328530	CHEMBL4135861	Inhibition of EphB4 (unknown origin) after 4 hrs by ADP-Glo luminescence assay	B	Nc1ncc2ccc(-c3ccc(NC(=O)C4(C(=O)Nc5cc(Br)cc(C(F)(F)F)c5)CC4)cc3)cc2n1		CHEMBL4165234	=	IC50	nM	78.92	CHEMBL5147	Homo sapiens	IC50	nM	78.92
	18356005	CHEMBL4140582	Inhibition of EPHB4 (unknown origin) after 4 hrs by ADP-Glo assay	B	Nc1n[nH]c2cccc(-c3ccc(NC(=S)Nc4cc(Br)ccc4OC(F)(F)F)cc3)c12		CHEMBL4160854	=	IC50	nM	4.71	CHEMBL5147	Homo sapiens	IC50	nM	4.71
	18356006	CHEMBL4140582	Inhibition of EPHB4 (unknown origin) after 4 hrs by ADP-Glo assay	B	Nc1n[nH]c2cccc(-c3ccc(NC(=S)Nc4cc(OC(F)(F)F)ccc4Br)cc3)c12		CHEMBL4168788	=	IC50	nM	12.1	CHEMBL5147	Homo sapiens	IC50	nM	12.1
	18356007	CHEMBL4140582	Inhibition of EPHB4 (unknown origin) after 4 hrs by ADP-Glo assay	B	Nc1n[nH]c2cccc(-c3ccc(NC(=S)Nc4ccc(Cl)cc4Cl)cc3)c12		CHEMBL4175949	=	IC50	nM	21.35	CHEMBL5147	Homo sapiens	IC50	nM	21.35
	18356008	CHEMBL4140582	Inhibition of EPHB4 (unknown origin) after 4 hrs by ADP-Glo assay	B	Nc1n[nH]c2cccc(-c3ccc(NC(=S)Nc4ccc(F)c(F)c4)cc3)c12		CHEMBL4167759	=	IC50	nM	15.46	CHEMBL5147	Homo sapiens	IC50	nM	15.46
	18356009	CHEMBL4140582	Inhibition of EPHB4 (unknown origin) after 4 hrs by ADP-Glo assay	B	Nc1n[nH]c2cccc(-c3ccc(NC(=S)Nc4ccc(Cl)c(Cl)c4)cc3)c12		CHEMBL4175943	=	IC50	nM	17.48	CHEMBL5147	Homo sapiens	IC50	nM	17.48
	18356010	CHEMBL4140582	Inhibition of EPHB4 (unknown origin) after 4 hrs by ADP-Glo assay	B	C=CC(=O)Nc1cccc(-c2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)n1		CHEMBL4165320	=	IC50	nM	7.23	CHEMBL5147	Homo sapiens	IC50	nM	7.23
	18356011	CHEMBL4140582	Inhibition of EPHB4 (unknown origin) after 4 hrs by ADP-Glo assay	B	C=CC(=O)Nc1cccc(-c2ccc(NC(=O)Nc3ccc(C)c(Cl)c3)cc2)n1		CHEMBL4160813	=	IC50	nM	7.68	CHEMBL5147	Homo sapiens	IC50	nM	7.68
	18356012	CHEMBL4140582	Inhibition of EPHB4 (unknown origin) after 4 hrs by ADP-Glo assay	B	C=CC(=O)Nc1cccc(-c2ccc(NC(=O)Nc3ccc(F)cc3)cc2)n1		CHEMBL4168735	>	IC50	nM	500.0	CHEMBL5147	Homo sapiens	IC50	nM	500.0
	18356013	CHEMBL4140582	Inhibition of EPHB4 (unknown origin) after 4 hrs by ADP-Glo assay	B	C=CC(=O)Nc1cccc(-c2ccc(NC(=O)Nc3ccc(C(C)(C)C)cc3)cc2)n1		CHEMBL4164213	=	IC50	nM	73.43	CHEMBL5147	Homo sapiens	IC50	nM	73.43
	18356014	CHEMBL4140582	Inhibition of EPHB4 (unknown origin) after 4 hrs by ADP-Glo assay	B	C=CC(=O)Nc1cccc(-c2ccc(NC(=O)Nc3ccccc3Cl)cc2)n1		CHEMBL4172089	=	IC50	nM	44.52	CHEMBL5147	Homo sapiens	IC50	nM	44.52
	18356015	CHEMBL4140582	Inhibition of EPHB4 (unknown origin) after 4 hrs by ADP-Glo assay	B	C=CC(=O)Nc1cccc(-c2ccc(NC(=O)Nc3cccc(C(C)C)c3)cc2)n1		CHEMBL4167663	=	IC50	nM	106.84	CHEMBL5147	Homo sapiens	IC50	nM	106.84
	18356016	CHEMBL4140582	Inhibition of EPHB4 (unknown origin) after 4 hrs by ADP-Glo assay	B	C=CC(=O)Nc1cccc(-c2ccc(NC(=O)Nc3cccc(Cl)c3)cc2)n1		CHEMBL4175530	>	IC50	nM	500.0	CHEMBL5147	Homo sapiens	IC50	nM	500.0
	18356017	CHEMBL4140582	Inhibition of EPHB4 (unknown origin) after 4 hrs by ADP-Glo assay	B	C=CC(=O)Nc1cccc(-c2ccc(NC(=O)Nc3ccc(OC(F)(F)F)cc3)cc2)n1		CHEMBL4171035	=	IC50	nM	86.65	CHEMBL5147	Homo sapiens	IC50	nM	86.65
	18356018	CHEMBL4140582	Inhibition of EPHB4 (unknown origin) after 4 hrs by ADP-Glo assay	B	C=CC(=O)Nc1cccc(-c2ccc(NC(=O)Nc3ccc(Cl)cc3Cl)cc2)n1		CHEMBL4160431	=	IC50	nM	87.24	CHEMBL5147	Homo sapiens	IC50	nM	87.24
	18356019	CHEMBL4140582	Inhibition of EPHB4 (unknown origin) after 4 hrs by ADP-Glo assay	B	C=CC(=O)Nc1cccc(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)n1		CHEMBL4159244	=	IC50	nM	321.05	CHEMBL5147	Homo sapiens	IC50	nM	321.05
	18356020	CHEMBL4140582	Inhibition of EPHB4 (unknown origin) after 4 hrs by ADP-Glo assay	B	C=CC(=O)Nc1cccc(-c2ccc(NC(=O)Nc3ccc(F)cc3F)cc2)n1		CHEMBL4169889	>	IC50	nM	500.0	CHEMBL5147	Homo sapiens	IC50	nM	500.0
	18356021	CHEMBL4140582	Inhibition of EPHB4 (unknown origin) after 4 hrs by ADP-Glo assay	B	C=CC(=O)Nc1cccc(-c2ccc(NC(=O)Nc3ccccc3F)cc2)n1		CHEMBL4174374	=	IC50	nM	15.34	CHEMBL5147	Homo sapiens	IC50	nM	15.34
	18356022	CHEMBL4140582	Inhibition of EPHB4 (unknown origin) after 4 hrs by ADP-Glo assay	B	C=CC(=O)Nc1cccc(-c2ccc(NC(=O)Nc3cccc(F)c3)cc2)n1		CHEMBL4166465	=	IC50	nM	106.84	CHEMBL5147	Homo sapiens	IC50	nM	106.84
	18356023	CHEMBL4140582	Inhibition of EPHB4 (unknown origin) after 4 hrs by ADP-Glo assay	B	C=CC(=O)Nc1cccc(-c2ccc(NC(=O)Nc3c(C)cccc3C)cc2)n1		CHEMBL4170942	=	IC50	nM	334.72	CHEMBL5147	Homo sapiens	IC50	nM	334.72
	18356024	CHEMBL4140582	Inhibition of EPHB4 (unknown origin) after 4 hrs by ADP-Glo assay	B	O=C(Nc1ccc(-c2ccc3c(=O)nc[nH]c3c2)cc1)C1(C(=O)Nc2cccc(F)c2)CCC1		CHEMBL4164800	>	IC50	nM	500.0	CHEMBL5147	Homo sapiens	IC50	nM	500.0
	18356025	CHEMBL4140582	Inhibition of EPHB4 (unknown origin) after 4 hrs by ADP-Glo assay	B	C#Cc1cccc(NC(=O)C2(C(=O)Nc3ccc(-c4ccc5c(=O)nc[nH]c5c4)cc3)CCC2)c1		CHEMBL4167570	>	IC50	nM	500.0	CHEMBL5147	Homo sapiens	IC50	nM	500.0
	18356026	CHEMBL4140582	Inhibition of EPHB4 (unknown origin) after 4 hrs by ADP-Glo assay	B	O=C(Nc1ccc(-c2ccc3c(=O)nc[nH]c3c2)cc1)C1(C(=O)Nc2ccc(Cl)c(C(F)(F)F)c2)CCC1		CHEMBL4159645	>	IC50	nM	500.0	CHEMBL5147	Homo sapiens	IC50	nM	500.0
	18356027	CHEMBL4140582	Inhibition of EPHB4 (unknown origin) after 4 hrs by ADP-Glo assay	B	O=C(Nc1ccc(-c2ccc3c(=O)nc[nH]c3c2)cc1)C1(C(=O)Nc2cccc(C(F)(F)F)c2)CCC1		CHEMBL4164127	=	IC50	nM	93.36	CHEMBL5147	Homo sapiens	IC50	nM	93.36
	18356028	CHEMBL4140582	Inhibition of EPHB4 (unknown origin) after 4 hrs by ADP-Glo assay	B	O=C(Nc1ccc(-c2ccc3c(=O)nc[nH]c3c2)cc1)C1(C(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)CCC1		CHEMBL4174775	=	IC50	nM	216.58	CHEMBL5147	Homo sapiens	IC50	nM	216.58
	18356029	CHEMBL4140582	Inhibition of EPHB4 (unknown origin) after 4 hrs by ADP-Glo assay	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(-c4ccc5c(=O)nc[nH]c5c4)cc3)CCC2)cc1Cl		CHEMBL4161287	>	IC50	nM	500.0	CHEMBL5147	Homo sapiens	IC50	nM	500.0
	18356030	CHEMBL4140582	Inhibition of EPHB4 (unknown origin) after 4 hrs by ADP-Glo assay	B	Cc1cc(Br)ccc1NC(=O)C1(C(=O)Nc2ccc(-c3ccc4c(=O)nc[nH]c4c3)cc2)CCC1		CHEMBL4169220	>	IC50	nM	500.0	CHEMBL5147	Homo sapiens	IC50	nM	500.0
	18356031	CHEMBL4140582	Inhibition of EPHB4 (unknown origin) after 4 hrs by ADP-Glo assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	IC50	nM	4.62	CHEMBL5147	Homo sapiens	IC50	nM	4.62
	18379911	CHEMBL4145813	Inhibition of EPHB4 (unknown origin) at 10 uM relative to control	B	COc1cc(NC(=O)Nc2cnc(Nc3ccc(N4CCOCC4)cc3)nc2Oc2ccc(C)cc2OC)cc(OC)c1		CHEMBL4159506	=	Inhibition	%	3.9	CHEMBL5147	Homo sapiens	INH	%	3.9
	18379963	CHEMBL4145864	Inhibition of EPHB4 (unknown origin)	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	126.4	CHEMBL5147	Homo sapiens	IC50	nM	126.4
	18420966	CHEMBL4153939	Inhibition of DNA-tagged EPHB4 (unknown origin) expressed in HEK293 cells at 10 uM after 1 hr by real-time fluorescent quantitative PCR analysis	B	Fc1ccc(Nc2nc(N3CCOCC3)c3nc[nH]c3n2)cc1		CHEMBL4175978	=	Inhibition	%	23.0	CHEMBL5147	Homo sapiens	INH	%	23.0
	18431055	CHEMBL4155736	Inhibition of recombinant His-tagged human EPHB4 cytoplasmic domain (561 to 987 residues) expressed in baculovirus expression system at 1 uM by Z'-Lyte assay relative to control	B	O=C1Nc2ccc(C(=O)N[C@H](CO)c3ccccc3)cc2/C1=C(\c1ccccc1)c1ncc[nH]1		CHEMBL4160587	=	Inhibition	%	54.0	CHEMBL5147	Homo sapiens	INH	%	54.0
	18440190	CHEMBL4157014	Binding affinity to wild-type human partial length EPHB4 (H585 to G892 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	100.0	CHEMBL5147	Homo sapiens	Activity	%	100.0
	18449898	CHEMBL4178132	Inhibition of human EPHB4 (561 to 987 residues) assessed as residual activity at 500 nM in presence of 33P-ATP by filter binding assay relative to control	B	Cc1cccc(-c2nc(N)sc2-c2ccc3ncccc3n2)c1		CHEMBL4209540	=	Activity	%	99.0	CHEMBL5147	Homo sapiens	Activity	%	99.0
	18463746	CHEMBL4181162	Inhibition of recombinant human N-terminal His6-tagged EphB4 (561 to end residues) expressed in baculovirus Sf21 insect cells at 10 uM by filter binding radioactive ATP transferase assay relative to control	B	C=C(C)n1c(=O)n(C(C)=O)c2cc(Br)cnc21		CHEMBL4212680	=	Inhibition	%	-8.0	CHEMBL5147	Homo sapiens	INH	%	-8.0
	18465743	CHEMBL4181666	Inhibition of EphB4 (unknown origin)	B	CC(=O)Nc1cn2cc(-c3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3C)ccc2n1		CHEMBL4216073	=	IC50	nM	150.0	CHEMBL5147	Homo sapiens	IC50	uM	0.15
	18484630	CHEMBL4185793	Binding affinity to wild-type human partial length EPHB4 (H585 to G892 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	100.0	CHEMBL5147	Homo sapiens	Activity	%	100.0
	18484991	CHEMBL4185793	Binding affinity to wild-type human partial length EPHB4 (H585 to G892 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	95.0	CHEMBL5147	Homo sapiens	Activity	%	95.0
	18507798	CHEMBL4190964	Inhibition of recombinant human EPHB4 (561 to end residues) at 1 uM using poly(Glu,Tyr) 4:1 as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	27.0	CHEMBL5147	Homo sapiens	INH	%	27.0
	18578771	CHEMBL4222447	Inhibition of EPHB4 (unknown origin)	B	CCN(CCO)Cc1cc(Nc2nc(C)cn3c(-c4cn[nH]c4)cnc23)sn1		CHEMBL4228240	=	IC50	nM	100.0	CHEMBL5147	Homo sapiens	IC50	nM	100.0
	18578772	CHEMBL4222447	Inhibition of EPHB4 (unknown origin)	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(Cc3ccccn3)ns2)n1		CHEMBL4227082	=	IC50	nM	390.0	CHEMBL5147	Homo sapiens	IC50	nM	390.0
	18578773	CHEMBL4222447	Inhibition of EPHB4 (unknown origin)	B	Cc1cn2c(-c3cn[nH]c3)cnc2c(Nc2cc(C(NC(C)(C)C)c3ccccn3)ns2)n1		CHEMBL4225923	=	IC50	nM	38.0	CHEMBL5147	Homo sapiens	IC50	nM	38.0
	18653649	CHEMBL4230079	Inhibition of EPH-B4 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	97.0	CHEMBL5147	Homo sapiens	INH	%	97.0
	18653650	CHEMBL4230079	Inhibition of EPH-B4 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	80.0	CHEMBL5147	Homo sapiens	INH	%	80.0
	18655542	CHEMBL4230693	Binding affinity to wild-type human partial length EPHB4 (H585 to G892 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	90.0	CHEMBL5147	Homo sapiens	Activity	%	90.0
	18665536	CHEMBL4233316	Inhibition of EPH-B4 (unknown origin)	B	O=C(Cc1cccc(OCCCN2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4245507	>	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	nM	1000.0
	18674646	CHEMBL4235349	Inhibition of EphB4 (unknown origin)	B	CS(=O)(=O)Nc1cccc(CC(=O)Nc2nc(-c3c[nH]c4ncccc34)cs2)c1		CHEMBL4249925	>	Ki	nM	2000.0	CHEMBL5147	Homo sapiens	Ki	nM	2000.0
	18674647	CHEMBL4235349	Inhibition of EphB4 (unknown origin)	B	O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2c[nH]c3ncccc23)cs1		CHEMBL4245242	>	Ki	nM	2000.0	CHEMBL5147	Homo sapiens	Ki	nM	2000.0
	18674648	CHEMBL4235349	Inhibition of EphB4 (unknown origin)	B	CN1CCN(CCCOc2cccc(CC(=O)Nc3nc(-c4c[nH]c5ncccc45)cs3)c2)CC1		CHEMBL4248525	>	Ki	nM	2000.0	CHEMBL5147	Homo sapiens	Ki	nM	2000.0
	18751117	CHEMBL4263797	Inhibition of EPH-B4 (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	4.0	CHEMBL5147	Homo sapiens	INH	%	4.0
	18751621	CHEMBL4264282	Binding affinity to wild-type human partial length EPHB4 (H585 to G892 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	86.0	CHEMBL5147	Homo sapiens	Activity	%	86.0
	18761478	CHEMBL4266556	Inhibition of recombinant human N-terminal His6-tagged EphB4 (561 to end residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1		CHEMBL4279192	=	Inhibition	%	2.0	CHEMBL5147	Homo sapiens	INH	%	2.0
	18761774	CHEMBL4266556	Inhibition of recombinant human N-terminal His6-tagged EphB4 (561 to end residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1		CHEMBL4278882	=	Inhibition	%	16.0	CHEMBL5147	Homo sapiens	INH	%	16.0
	18761937	CHEMBL4266556	Inhibition of recombinant human N-terminal His6-tagged EphB4 (561 to end residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C5CCOCC5)c34)CC2)CC1		CHEMBL4290222	=	Inhibition	%	10.0	CHEMBL5147	Homo sapiens	INH	%	10.0
	18778955	CHEMBL4269645	Inhibition of human EPHB4 using poly[Glu:Tyr] (4:1) as substrate at 1 uM by [gamma-33P]-ATP based assay relative to control	B	COc1cc2nccc(Nc3n[nH]c(C)c3C)c2cc1S(=O)(=O)C(C)(C)C		CHEMBL4293287	>	Inhibition	%	90.0	CHEMBL5147	Homo sapiens	INH	%	90.0
	18784720	CHEMBL4271241	Binding affinity to Fc-tagged EphB4 (unknown origin) assessed as reduction in ephrin-B2 binding by SPR assay	B	CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CO)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O		CHEMBL4291811	=	Kd	nM	2.0	CHEMBL5147	Homo sapiens	Kd	nM	2.0
	18857951	CHEMBL4307797	Binding affinity to wild-type human partial length EPHB4 (H585 to G892 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	100.0	CHEMBL5147	Homo sapiens	Activity	%	100.0
	18892609	CHEMBL4314692	Inhibition of recombinant human EphB4 (561 to end residues) assessed as residual activity at 10 uM using poly (Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	101.5	CHEMBL5147	Homo sapiens	Activity	%	101.5
	18919383	CHEMBL4322743	Binding affinity to recombinant N-terminal His-FLAG-GST-tagged EPHB4 (unknown origin) (577 to 987 residues) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4465866	=	Kd	nM	1799.0	CHEMBL5147	Homo sapiens	Kd	nM	1799.0
Not Determined	18919571	CHEMBL4322743	Binding affinity to recombinant N-terminal His-FLAG-GST-tagged EPHB4 (unknown origin) (577 to 987 residues) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4576489		Kd			CHEMBL5147	Homo sapiens	Kd		
	18937905	CHEMBL4327683	Inhibition of human EPHB4 assessed as residual activity at 1 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	103.66	CHEMBL5147	Homo sapiens	Activity	%	103.66
	18937906	CHEMBL4327683	Inhibition of human EPHB4 assessed as residual activity at 1 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	99.32	CHEMBL5147	Homo sapiens	Activity	%	99.32
	18938523	CHEMBL4328043	Inhibition of human EPHB4 assessed as residual activity at 100 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL5147	Homo sapiens	Activity	%	65.0
	18938901	CHEMBL4328407	Inhibition of human EPHB4 using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	238.0	CHEMBL5147	Homo sapiens	IC50	10'-7M	2.38
	18947865	CHEMBL4330410	Inhibition of EPHB4 (unknown origin) after 4 hrs by ADP-Glo reagent based luminescent assay	B	COc1ccc(-c2ccc(Cn3cc(-c4cccc(Cl)c4)nn3)cc2)cn1		CHEMBL4452256	=	IC50	nM	28.68	CHEMBL5147	Homo sapiens	IC50	nM	28.68
	18947866	CHEMBL4330410	Inhibition of EPHB4 (unknown origin) after 4 hrs by ADP-Glo reagent based luminescent assay	B	COc1ccc(-c2ccc(Cn3cc(-c4ccccc4F)nn3)cc2)cn1		CHEMBL4440813	=	IC50	nM	266.77	CHEMBL5147	Homo sapiens	IC50	nM	266.77
	18947867	CHEMBL4330410	Inhibition of EPHB4 (unknown origin) after 4 hrs by ADP-Glo reagent based luminescent assay	B	COc1ccc(-c2ccc(Cn3cc(-c4ccccc4)nn3)cc2)cn1		CHEMBL4470400	>	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	nM	1000.0
Not Determined	18947868	CHEMBL4330410	Inhibition of EPHB4 (unknown origin) after 4 hrs by ADP-Glo reagent based luminescent assay	B	COc1ccc(-c2ccc(Cn3cc(-c4ccc(C)cc4)nn3)cc2)cn1		CHEMBL4449700		IC50			CHEMBL5147	Homo sapiens	IC50		
Not Determined	18947869	CHEMBL4330410	Inhibition of EPHB4 (unknown origin) after 4 hrs by ADP-Glo reagent based luminescent assay	B	COc1ccc(-c2ccc(Cn3cc(-c4cccc(C)c4)nn3)cc2)cn1		CHEMBL4556899		IC50			CHEMBL5147	Homo sapiens	IC50		
	18947870	CHEMBL4330410	Inhibition of EPHB4 (unknown origin) after 4 hrs by ADP-Glo reagent based luminescent assay	B	COc1ccc(-c2ccc(Cn3cc(-c4ccc(C(F)(F)F)cc4)nn3)cc2)cn1		CHEMBL4528844	>	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	nM	1000.0
	18947871	CHEMBL4330410	Inhibition of EPHB4 (unknown origin) after 4 hrs by ADP-Glo reagent based luminescent assay	B	COc1ccc(-c2ccc(Cn3cc(-c4cccc(N)c4)nn3)cc2)cn1		CHEMBL4441465	=	IC50	nM	2.99	CHEMBL5147	Homo sapiens	IC50	nM	2.99
Not Determined	18947872	CHEMBL4330410	Inhibition of EPHB4 (unknown origin) after 4 hrs by ADP-Glo reagent based luminescent assay	B	COc1ccc(-c2ccc(Cn3cc(-c4ccc(NC(=O)C5CC5)cc4)nn3)cc2)cn1		CHEMBL4473253		IC50			CHEMBL5147	Homo sapiens	IC50		
Not Determined	18947873	CHEMBL4330410	Inhibition of EPHB4 (unknown origin) after 4 hrs by ADP-Glo reagent based luminescent assay	B	Clc1cccc(-c2cn(Cc3ccc(-c4cccnc4)cc3)nn2)c1		CHEMBL4447552		IC50			CHEMBL5147	Homo sapiens	IC50		
	18947874	CHEMBL4330410	Inhibition of EPHB4 (unknown origin) after 4 hrs by ADP-Glo reagent based luminescent assay	B	Fc1ccccc1-c1cn(Cc2ccc(-c3cccnc3)cc2)nn1		CHEMBL4454065	=	IC50	nM	96.86	CHEMBL5147	Homo sapiens	IC50	nM	96.86
Not Determined	18947875	CHEMBL4330410	Inhibition of EPHB4 (unknown origin) after 4 hrs by ADP-Glo reagent based luminescent assay	B	c1ccc(-c2cn(Cc3ccc(-c4cccnc4)cc3)nn2)cc1		CHEMBL4556134		IC50			CHEMBL5147	Homo sapiens	IC50		
	18947876	CHEMBL4330410	Inhibition of EPHB4 (unknown origin) after 4 hrs by ADP-Glo reagent based luminescent assay	B	Cc1ccc(-c2cn(Cc3ccc(-c4cccnc4)cc3)nn2)cc1		CHEMBL4519953	=	IC50	nM	0.44	CHEMBL5147	Homo sapiens	IC50	nM	0.44
	18947877	CHEMBL4330410	Inhibition of EPHB4 (unknown origin) after 4 hrs by ADP-Glo reagent based luminescent assay	B	Cc1cccc(-c2cn(Cc3ccc(-c4cccnc4)cc3)nn2)c1		CHEMBL4570075	>	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	nM	1000.0
	18947878	CHEMBL4330410	Inhibition of EPHB4 (unknown origin) after 4 hrs by ADP-Glo reagent based luminescent assay	B	FC(F)(F)c1ccc(-c2cn(Cc3ccc(-c4cccnc4)cc3)nn2)cc1		CHEMBL4449321	>	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	nM	1000.0
	18947879	CHEMBL4330410	Inhibition of EPHB4 (unknown origin) after 4 hrs by ADP-Glo reagent based luminescent assay	B	FC(F)(F)c1cccc(-c2cn(Cc3ccc(-c4cccnc4)cc3)nn2)c1		CHEMBL4443204	>	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	nM	1000.0
Not Determined	18947880	CHEMBL4330410	Inhibition of EPHB4 (unknown origin) after 4 hrs by ADP-Glo reagent based luminescent assay	B	Nc1cccc(-c2cn(Cc3ccc(-c4cccnc4)cc3)nn2)c1		CHEMBL4456856		IC50			CHEMBL5147	Homo sapiens	IC50		
	18947881	CHEMBL4330410	Inhibition of EPHB4 (unknown origin) after 4 hrs by ADP-Glo reagent based luminescent assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	IC50	nM	0.22	CHEMBL5147	Homo sapiens	IC50	nM	0.22
	18958868	CHEMBL4333387	Binding affinity to wild-type human partial length EPHB4 (H585 to G892 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	93.0	CHEMBL5147	Homo sapiens	Activity	%	93.0
	18964277	CHEMBL4335076	Inhibition of recombinant human EphB4 (561 to end residues) assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate at 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	93.0	CHEMBL5147	Homo sapiens	Activity	%	93.0
	18964278	CHEMBL4335076	Inhibition of recombinant human EphB4 (561 to end residues) assessed as residual activity at 1 uM using poly(Glu, Tyr) 4:1 as substrate at 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	94.0	CHEMBL5147	Homo sapiens	Activity	%	94.0
	18971893	CHEMBL4336903	Inhibition of recombinant human EphB4 (561 to end residues) assessed as residual activity at 10 uM using poly(Glu, Tyr) 4:1 as substrate at 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	71.0	CHEMBL5147	Homo sapiens	Activity	%	71.0
Not Active	19039788	CHEMBL4351854	Inhibition of recombinant human EphB4 (561 to end residues) at 10 uM using poly (Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL5147	Homo sapiens	INH		
Active	19041101	CHEMBL4352362	Inhibition of human EPHB4 at 10 uM using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL5147	Homo sapiens	INH		
	19059570	CHEMBL4357871	Binding affinity to wild-type human partial length EPHB4 (H585 to G892 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL5147	Homo sapiens	Activity	%	100.0
	19090141	CHEMBL4365715	Inhibition of wild-type human partial length EPHB4 (H585 to G892 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	97.0	CHEMBL5147	Homo sapiens	Activity	%	97.0
	19091916	CHEMBL4366390	Inhibition of human EPHB4 at 100 nM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	15.94	CHEMBL5147	Homo sapiens	INH	%	15.94
	19092269	CHEMBL4366689	Inhibition of EphB4 (unknown origin) at 1 uM relative to control	B	Nc1nccc(Oc2ccc(Nc3nccc4ccn(-c5ccc(F)cc5)c(=O)c34)cc2F)c1Cl		CHEMBL4474232	=	Inhibition	%	10.0	CHEMBL5147	Homo sapiens	INH	%	10.0
	19118424	CHEMBL4372386	Inhibition of recombinant human N-terminal His6-tagged EphB4 (561 to end residues) expressed in baculovirus infected Sf21 insect cells using poly (Glu, Tyr) (4:1) as substrate in presence of [gamma-33P]-ATP or [gamma-32P]-ATP relative to control	B	Cc1cccc(Cn2nc(C)c3c(NC(=O)c4csc5c(N)ncnc45)cccc32)n1		CHEMBL4483816	=	Inhibition	%	2.0	CHEMBL5147	Homo sapiens	INH	%	2.0
	19140798	CHEMBL4376562	Inhibition of recombinant full length human His-tagged EPHB4 expressed in baculovirus expression system at 1 uM using biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 to 60 mins in presence of ATP by HTRF assay relative to control	B	Cn1cc(-c2ccc(F)cc2)c(=O)c2c(Nc3ccc(Oc4ccnc(NC(=O)C5CC5)c4)c(F)c3)nccc21		CHEMBL4584949	=	Inhibition	%	50.0	CHEMBL5147	Homo sapiens	INH	%	50.0
	19144792	CHEMBL4377808	Inhibition of recombinant human EphB4 (561 to end residues) at 1 uM using poly(Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	-4.0	CHEMBL5147	Homo sapiens	INH	%	-4.0
	19146910	CHEMBL4378882	Inhibition of human EphB4 (561 to end residues) using poly (Glu, Tyr) 4:1 as substrate at 10 uM after 40 mins in presence of [gamma-33P]-ATP by scintillation counting relative to control	B	C=CS(=O)(=O)Nc1ccc(Cc2ccc3ccccc3c2)cc1		CHEMBL4459587	=	Inhibition	%	8.0	CHEMBL5147	Homo sapiens	INH	%	8.0
	19147844	CHEMBL4379318	Inhibition of recombinant human EphB4 (561 to end residues) using poly(Glu, Tyr) 4:1 as substrate after 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL5147	Homo sapiens	IC50	uM	10.0
	19159398	CHEMBL4382502	Binding affinity to wild-type human partial length EPHB4 (H585 to G892 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	76.0	CHEMBL5147	Homo sapiens	Activity	%	76.0
	19191609	CHEMBL4389221	Inhibition of wild-type human partial length EPHB4 (H585 to G892 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	98.0	CHEMBL5147	Homo sapiens	INH	%	98.0
	19191884	CHEMBL4389698	Inhibition of wild-type human partial length EPHB4 (H585 to G892 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	95.0	CHEMBL5147	Homo sapiens	INH	%	95.0
	19199898	CHEMBL4391324	Binding affinity to wild-type human partial length EPHB4 (H585 to G892 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	100.0	CHEMBL5147	Homo sapiens	Activity	%	100.0
	19225461	CHEMBL4395881	Inhibition of human recombinant EPHB4 at 1 uM using Ulight-TK peptide as substrate measured after 90 mins in presence of ATP by LANCE assay relative to control	B	CCc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4536012	=	Inhibition	%	94.67	CHEMBL5147	Homo sapiens	INH	%	94.67
	19242721	CHEMBL4400056	Inhibition of recombinant human EPHB4 (561 to end residues) assessed as residual activity at 10 uM using poly (Glu,Tyr) 4:1 as substrate incubated for 40 mins in presence of [gamma-33P]ATP at Km concentration by radiometric assay relative to control	B	COc1ccc2c(CCNc3nc(NCc4ccc(=O)[nH]c4)c4nc[nH]c4n3)c[nH]c2c1		CHEMBL4555782	=	Activity	%	69.0	CHEMBL5147	Homo sapiens	Activity	%	69.0
	19266412	CHEMBL4405362	Inhibition of wild-type human partial length EPHB4 (H585 to G892 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL5147	Homo sapiens	INH	%	50.0
	19275991	CHEMBL4407994	Inhibition of recombinant human EPhB4 (561 to end residues) at 1 uM using poly (Glu, Tyr) 4:1 as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	42.0	CHEMBL5147	Homo sapiens	INH	%	42.0
	19364888	CHEMBL4423710	Inhibition of EphB4 (unknown origin) after 1 hrs by ADP-Glo luminescence assay	B	Clc1cccc(-c2cn(Cc3ccc(-c4cncnc4)cc3)nn2)c1		CHEMBL4570733	>	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	nM	1000.0
	19364889	CHEMBL4423710	Inhibition of EphB4 (unknown origin) after 1 hrs by ADP-Glo luminescence assay	B	Fc1ccccc1-c1cn(Cc2ccc(-c3cncnc3)cc2)nn1		CHEMBL4459732	=	IC50	nM	0.25	CHEMBL5147	Homo sapiens	IC50	nM	0.25
	19364890	CHEMBL4423710	Inhibition of EphB4 (unknown origin) after 1 hrs by ADP-Glo luminescence assay	B	c1ccc(-c2cn(Cc3ccc(-c4cncnc4)cc3)nn2)cc1		CHEMBL4456738	=	IC50	nM	0.32	CHEMBL5147	Homo sapiens	IC50	nM	0.32
	19364891	CHEMBL4423710	Inhibition of EphB4 (unknown origin) after 1 hrs by ADP-Glo luminescence assay	B	Cc1ccc(-c2cn(Cc3ccc(-c4cncnc4)cc3)nn2)cc1		CHEMBL4452405	=	IC50	nM	3.3	CHEMBL5147	Homo sapiens	IC50	nM	3.3
	19364892	CHEMBL4423710	Inhibition of EphB4 (unknown origin) after 1 hrs by ADP-Glo luminescence assay	B	Cc1cccc(-c2cn(Cc3ccc(-c4cncnc4)cc3)nn2)c1		CHEMBL4553163	=	IC50	nM	28.62	CHEMBL5147	Homo sapiens	IC50	nM	28.62
	19364893	CHEMBL4423710	Inhibition of EphB4 (unknown origin) after 1 hrs by ADP-Glo luminescence assay	B	FC(F)(F)c1ccc(-c2cn(Cc3ccc(-c4cncnc4)cc3)nn2)cc1		CHEMBL4449073	>	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	nM	1000.0
	19364894	CHEMBL4423710	Inhibition of EphB4 (unknown origin) after 1 hrs by ADP-Glo luminescence assay	B	Nc1cccc(-c2cn(Cc3ccc(-c4cncnc4)cc3)nn2)c1		CHEMBL4448354	>	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	nM	1000.0
	19364895	CHEMBL4423710	Inhibition of EphB4 (unknown origin) after 1 hrs by ADP-Glo luminescence assay	B	O=C(Nc1cccc(-c2cn(Cc3ccc(-c4cncnc4)cc3)nn2)c1)C1CC1		CHEMBL4447942	>	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	nM	1000.0
	19364896	CHEMBL4423710	Inhibition of EphB4 (unknown origin) after 1 hrs by ADP-Glo luminescence assay	B	Fc1ccccc1-c1cn(Cc2ccc(-c3cn[nH]c3)cc2)nn1		CHEMBL4437530	=	IC50	nM	73.15	CHEMBL5147	Homo sapiens	IC50	nM	73.15
	19364897	CHEMBL4423710	Inhibition of EphB4 (unknown origin) after 1 hrs by ADP-Glo luminescence assay	B	Cc1cccc(-c2cn(Cc3ccc(-c4cn[nH]c4)cc3)nn2)c1		CHEMBL4472113	>	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	nM	1000.0
	19364898	CHEMBL4423710	Inhibition of EphB4 (unknown origin) after 1 hrs by ADP-Glo luminescence assay	B	FC(F)(F)c1ccc(-c2cn(Cc3ccc(-c4cn[nH]c4)cc3)nn2)cc1		CHEMBL4575350	=	IC50	nM	16.0	CHEMBL5147	Homo sapiens	IC50	nM	16.0
	19364899	CHEMBL4423710	Inhibition of EphB4 (unknown origin) after 1 hrs by ADP-Glo luminescence assay	B	Nc1cccc(-c2cn(Cc3ccc(-c4cn[nH]c4)cc3)nn2)c1		CHEMBL4470139	>	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	nM	1000.0
	19364900	CHEMBL4423710	Inhibition of EphB4 (unknown origin) after 1 hrs by ADP-Glo luminescence assay	B	Cn1cc(-c2ccc(Cn3cc(-c4ccccc4F)nn3)cc2)cn1		CHEMBL4469077	=	IC50	nM	0.16	CHEMBL5147	Homo sapiens	IC50	nM	0.16
	19364901	CHEMBL4423710	Inhibition of EphB4 (unknown origin) after 1 hrs by ADP-Glo luminescence assay	B	Cn1cc(-c2ccc(Cn3cc(-c4ccccc4)nn3)cc2)cn1		CHEMBL4453627	=	IC50	nM	1.49	CHEMBL5147	Homo sapiens	IC50	nM	1.49
	19364902	CHEMBL4423710	Inhibition of EphB4 (unknown origin) after 1 hrs by ADP-Glo luminescence assay	B	Cc1ccc(-c2cn(Cc3ccc(-c4cnn(C)c4)cc3)nn2)cc1		CHEMBL4543212	=	IC50	nM	2.13	CHEMBL5147	Homo sapiens	IC50	nM	2.13
Not Determined	19364903	CHEMBL4423710	Inhibition of EphB4 (unknown origin) after 1 hrs by ADP-Glo luminescence assay	B	Cc1cccc(-c2cn(Cc3ccc(-c4cnn(C)c4)cc3)nn2)c1		CHEMBL4436670		IC50			CHEMBL5147	Homo sapiens	IC50		
	19364904	CHEMBL4423710	Inhibition of EphB4 (unknown origin) after 1 hrs by ADP-Glo luminescence assay	B	Cn1cc(-c2ccc(Cn3cc(-c4ccc(C(F)(F)F)cc4)nn3)cc2)cn1		CHEMBL4525897	=	IC50	nM	2.21	CHEMBL5147	Homo sapiens	IC50	nM	2.21
Not Determined	19364905	CHEMBL4423710	Inhibition of EphB4 (unknown origin) after 1 hrs by ADP-Glo luminescence assay	B	Cn1cc(-c2ccc(Cn3cc(-c4cccc(C(F)(F)F)c4)nn3)cc2)cn1		CHEMBL4476000		IC50			CHEMBL5147	Homo sapiens	IC50		
	19364906	CHEMBL4423710	Inhibition of EphB4 (unknown origin) after 1 hrs by ADP-Glo luminescence assay	B	Cn1cc(-c2ccc(Cn3cc(-c4cccc(N)c4)nn3)cc2)cn1		CHEMBL4516255	>	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	nM	1000.0
	19364907	CHEMBL4423710	Inhibition of EphB4 (unknown origin) after 1 hrs by ADP-Glo luminescence assay	B	Cn1cc(-c2ccc(Cn3cc(-c4cccc(NC(=O)C5CC5)c4)nn3)cc2)cn1		CHEMBL4539395	>	IC50	nM	1000.0	CHEMBL5147	Homo sapiens	IC50	nM	1000.0
	19364908	CHEMBL4423710	Inhibition of EphB4 (unknown origin) after 1 hrs by ADP-Glo luminescence assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	IC50	nM	0.22	CHEMBL5147	Homo sapiens	IC50	nM	0.22
	19435842	CHEMBL4430396	Inhibition of human EphB4 at 0.1 uM	B	COc1ccc2c(c1)[C@]1(C[C@H]1c1ccc3c(-c4ccc(N5CCN(C)CC5)nc4)n[nH]c3c1)C(=O)N2		CHEMBL4516793	=	Inhibition	%	-1.0	CHEMBL5147	Homo sapiens	INH	%	-1.0
	19435843	CHEMBL4430396	Inhibition of human EphB4 at 0.1 uM	B	COc1ccc2c(c1)[C@]1(C[C@H]1c1ccc3c(-c4ccc(N5CCN(C)CC5)cc4)n[nH]c3c1)C(=O)N2		CHEMBL4448596	=	Inhibition	%	13.0	CHEMBL5147	Homo sapiens	INH	%	13.0
	19435844	CHEMBL4430396	Inhibition of human EphB4 at 0.1 uM	B	COc1ccc2c(c1)[C@]1(C[C@H]1c1ccc3c(/C=C/c4ccc(N5CCN(C)CC5)nc4)n[nH]c3c1)C(=O)N2		CHEMBL3353341	=	Inhibition	%	18.0	CHEMBL5147	Homo sapiens	INH	%	18.0
	20600523	CHEMBL4603475	Inhibition of recombinant human His-tagged EPHB4 (561 to 987 residues) catalytic domain expressed in baculovirus expression system using tyrosine-01 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL5147	Homo sapiens	IC50	uM	100.0
	20608962	CHEMBL4605657	Inhibition of EPHB4 (unknown origin) assessed as residual activity at 10 uM incubated for 5 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	Cc1ccc(C(=O)Nc2ccc(CN3CCC4C=NNC4C3)c(Cl)c2)cc1C#Cc1cnc2cccnn12		CHEMBL4640297	=	Activity	%	6.0	CHEMBL5147	Homo sapiens	Activity	%	6.0
	20608977	CHEMBL4605668	Inhibition of EPHB4 (unknown origin) assessed as residual activity incubated for 5 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay	B	Cc1ccc(C(=O)Nc2ccc(CN3CCC4C=NNC4C3)c(Cl)c2)cc1C#Cc1cnc2cccnn12		CHEMBL4640297	=	IC50	nM	138.1	CHEMBL5147	Homo sapiens	IC50	uM	0.1381
	20609005	CHEMBL4605657	Inhibition of EPHB4 (unknown origin) assessed as residual activity at 10 uM incubated for 5 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	Cc1ccc(C(=O)Nc2ccc(CN3Cc4cn[nH]c4C3)c(Cl)c2)cc1C#Cc1cnc2cccnn12		CHEMBL4638981	=	Activity	%	2.0	CHEMBL5147	Homo sapiens	Activity	%	2.0
	20609016	CHEMBL4605668	Inhibition of EPHB4 (unknown origin) assessed as residual activity incubated for 5 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay	B	Cc1ccc(C(=O)Nc2ccc(CN3Cc4cn[nH]c4C3)c(Cl)c2)cc1C#Cc1cnc2cccnn12		CHEMBL4638981	=	IC50	nM	84.6	CHEMBL5147	Homo sapiens	IC50	uM	0.0846
	20609037	CHEMBL4605657	Inhibition of EPHB4 (unknown origin) assessed as residual activity at 10 uM incubated for 5 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	=	Activity	%	23.0	CHEMBL5147	Homo sapiens	Activity	%	23.0
	20609053	CHEMBL4605657	Inhibition of EPHB4 (unknown origin) assessed as residual activity at 10 uM incubated for 5 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	Activity	%	4.0	CHEMBL5147	Homo sapiens	Activity	%	4.0
	22423103	CHEMBL4674118	Inhibition of human EPHB4 using poly[Glu:Tyr] (4:1) as substrate at 0.5 uM by [gamma-33P]-ATP assay relative to control	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Inhibition	%	80.0	CHEMBL5147	Homo sapiens	INH	%	80.0
	22423641	CHEMBL4674396	Inhibition of human EPHB4 using poly[Glu:Tyr] (4:1) as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	64.76	CHEMBL5147	Homo sapiens	Activity	%	64.76
	22423642	CHEMBL4674396	Inhibition of human EPHB4 using poly[Glu:Tyr] (4:1) as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	86.09	CHEMBL5147	Homo sapiens	Activity	%	86.09
	22751925	CHEMBL4700039	Inhibition of full-length human EPHB4 expressed in MEF cells assessed as autophosphorylation by sandwitch-ELISA	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(-n3c(N)c(C(N)=O)c4nc5ccccc5nc43)cc2)cc1		CHEMBL4792853	=	EC50	nM	360.0	CHEMBL5147	Homo sapiens	EC50	nM	360.0
	22751926	CHEMBL4700039	Inhibition of full-length human EPHB4 expressed in MEF cells assessed as autophosphorylation by sandwitch-ELISA	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-n3c(N)c(C(N)=O)c4nc5ccccc5nc43)cc2)n(-c2ccc3ncccc3c2)n1		CHEMBL4784484	=	EC50	nM	1100.0	CHEMBL5147	Homo sapiens	EC50	nM	1100.0
	22809738	CHEMBL4713273	Inhibition of recombinant human EphB4 (561 to end residues) assessed as residual activity at 1 uM using poly[Glu:Tyr] 4:1 as substrate incubated for 40 mins in presence of Km ATP by radiometric scintillation counting analysis relative to control	B	CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2ccc(Cl)cc2)[C@H](C)C1		CHEMBL4761365	=	Activity	%	92.0	CHEMBL5147	Homo sapiens	Activity	%	92.0
	22818102	CHEMBL4715325	Inhibition of recombinant human N-terminal GST-tagged EphB4 (561 to end residues) expressed in baculovirus infected Sf21 insect cells at 2 uM using poly (Glu,Tyr) (4:1) as substrate relative to control	B	C[C@@H](c1ccc2ncccc2c1)c1nnc2sc(-c3cnn(C)c3)nn12		CHEMBL4791034	<	Inhibition	%	50.0	CHEMBL5147	Homo sapiens	INH	%	50.0
	22822939	CHEMBL4716848	Inhibition of EphB4 (unknown origin)	B	Cc1cc(Nc2nc(Nc3ccccc3S(=O)(=O)C(C)C)c3c(C)[nH]nc3n2)c(OC(C)C)cc1C1CCN(C)CC1		CHEMBL3651854	=	IC50	nM	2900.0	CHEMBL5147	Homo sapiens	IC50	uM	2.9
	22826324	CHEMBL4717509	Inhibition of human EphB4 at 10 uM relative to control	B	CN1CCN(CCCOc2cccc3nc(Nc4ccc(Cl)c(C(F)(F)F)c4)ccc23)CC1		CHEMBL4797203	<	Inhibition	%	60.0	CHEMBL5147	Homo sapiens	INH	%	60.0
	22843758	CHEMBL4720744	Inhibition of human EPHB4 using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	150.0	CHEMBL5147	Homo sapiens	IC50	10^-7M	1.5
	22844109	CHEMBL4721095	Inhibition of human EPHB4 assessed as residual activity using poly[Glu:Tyr] (4:1) as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	77.13	CHEMBL5147	Homo sapiens	Activity	%	77.13
	22844700	CHEMBL4721375	Inhibition of wild-type human partial length EPHB4 (H585 to G892 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	96.28	CHEMBL5147	Homo sapiens	Activity	%	96.28
	22952832	CHEMBL4766769	Inhibition of recombinant human EphB4 (561 to end residues) assessed as residual activity at 10 uM using poly(Glu, Tyr) 4:1 as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	14.0	CHEMBL5147	Homo sapiens	Activity	%	14.0
	23122556	CHEMBL4804907	Inhibition of human EPHB4 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	89.0	CHEMBL5147	Homo sapiens	Activity	%	89.0
	23123251	CHEMBL4805495	Inhibition of human EPHB4 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	100.0	CHEMBL5147	Homo sapiens	Activity	%	100.0
	23123640	CHEMBL4805884	Inhibition of DNA-tagged human EPHB4 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	98.0	CHEMBL5147	Homo sapiens	Activity	%	98.0
	23124592	CHEMBL4806512	Inhibition of human EPHB4 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL5147	Homo sapiens	Activity	%	100.0
	23124593	CHEMBL4806512	Inhibition of human EPHB4 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL5147	Homo sapiens	Activity	%	100.0
	23127423	CHEMBL4807602	Inhibition of EPHB4 (unknown origin) assessed as residual activity at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	=	Activity	%	1.0	CHEMBL5147	Homo sapiens	Activity	%	1.0
	23127424	CHEMBL4807602	Inhibition of EPHB4 (unknown origin) assessed as residual activity at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Activity	%	0.0	CHEMBL5147	Homo sapiens	Activity	%	0.0
	23128074	CHEMBL4807833	Inhibition of EPHB4 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	<	Activity	%	25.0	CHEMBL5147	Homo sapiens	Activity	%	25.0
	23128075	CHEMBL4807833	Inhibition of EPHB4 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	<	Activity	%	25.0	CHEMBL5147	Homo sapiens	Activity	%	25.0
	23128076	CHEMBL4807833	Inhibition of EPHB4 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	Activity	%	25.0	CHEMBL5147	Homo sapiens	Activity	%	25.0
	23128845	CHEMBL4808074	Inhibition of EPHB4 (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(SC)[nH]c3-c3ccc(F)cc3)cc2)ccn1		CHEMBL4874174	=	Inhibition	%	82.0	CHEMBL5147	Homo sapiens	INH	%	82.0
	23128846	CHEMBL4808074	Inhibition of EPHB4 (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(SC)oc3-c3ccc(F)cc3)cc2)ccn1		CHEMBL4859179	=	Inhibition	%	42.0	CHEMBL5147	Homo sapiens	INH	%	42.0
	23128847	CHEMBL4808074	Inhibition of EPHB4 (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(S(C)(=O)=O)sc3-c3ccc(F)cc3)cc2)ccn1		CHEMBL4850066	=	Inhibition	%	24.0	CHEMBL5147	Homo sapiens	INH	%	24.0
	23128848	CHEMBL4808074	Inhibition of EPHB4 (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(C(F)(F)F)sc3-c3ccc(F)cc3)cc2)ccn1		CHEMBL4870763	=	Inhibition	%	24.0	CHEMBL5147	Homo sapiens	INH	%	24.0
	23128849	CHEMBL4808074	Inhibition of EPHB4 (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(SC)n(CCN(C)C)c3-c3ccc(F)cc3)cc2)ccn1		CHEMBL4847460	=	Inhibition	%	25.0	CHEMBL5147	Homo sapiens	INH	%	25.0
	23128850	CHEMBL4808074	Inhibition of EPHB4 (unknown origin) at 0.5 uM relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)c3nc(SC)oc3-c3ccc(F)cc3)cc2F)ccn1		CHEMBL4855209	=	Inhibition	%	43.0	CHEMBL5147	Homo sapiens	INH	%	43.0
Not Active	23317391	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	73.0	CHEMBL5147	Homo sapiens	% Control	%	73.0
Not Active	23317859	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23318528	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	98.0	CHEMBL5147	Homo sapiens	% Control	%	98.0
Not Active	23319009	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23319646	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23320121	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	98.5	CHEMBL5147	Homo sapiens	% Control	%	98.5
Not Active	23320799	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23321267	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23321897	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23322365	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	96.0	CHEMBL5147	Homo sapiens	% Control	%	96.0
Not Active	23323054	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	91.0	CHEMBL5147	Homo sapiens	% Control	%	91.0
Not Active	23323522	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	88.0	CHEMBL5147	Homo sapiens	% Control	%	88.0
Not Active	23324004	CHEMBL4880623	EphB4 (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1		CHEMBL4593677		Inhibition	%	-4.0	CHEMBL5147	Homo sapiens	% inhibition	%	-4.0
Not Active	23324376	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23325011	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	96.0	CHEMBL5147	Homo sapiens	% Control	%	96.0
Not Active	23325479	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23326126	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	98.0	CHEMBL5147	Homo sapiens	% Control	%	98.0
Not Active	23326594	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	57.0	CHEMBL5147	Homo sapiens	% Control	%	57.0
Not Active	23327294	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23327762	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	94.0	CHEMBL5147	Homo sapiens	% Control	%	94.0
Not Active	23328349	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23328817	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23329337	CHEMBL4881044	EphB4(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	103.0	CHEMBL5147	Homo sapiens	% residual kinase activity	%	103.0
Not Active	23329763	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23330231	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	92.0	CHEMBL5147	Homo sapiens	% Control	%	92.0
Not Active	23330987	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23331455	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23332042	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	99.6	CHEMBL5147	Homo sapiens	% Control	%	99.6
Not Active	23332508	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23333226	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23333865	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	99.0	CHEMBL5147	Homo sapiens	% Control	%	99.0
Not Active	23334333	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23334891	CHEMBL4881515	EphB4 (h) Upstate kinase activity assay	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		Inhibition	%	-9.0	CHEMBL5147	Homo sapiens	% inhibition	%	-9.0
Not Active	23335312	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23335780	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23336407	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23336875	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23337589	CHEMBL4881960	EPHB4 Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	101.0	CHEMBL5147	Homo sapiens	% Ctrl	%	101.0
Not Active	23337956	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23338424	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23339036	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23339504	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23340141	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23340609	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23341266	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23341734	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23342350	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	73.0	CHEMBL5147	Homo sapiens	% Control	%	73.0
Not Active	23342818	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23343448	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	99.0	CHEMBL5147	Homo sapiens	% Control	%	99.0
Not Active	23343916	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23344554	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23345127	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23345595	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23346172	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23346641	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23347249	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	87.6	CHEMBL5147	Homo sapiens	% Control	%	87.6
Not Active	23347732	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23348311	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23348779	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	92.0	CHEMBL5147	Homo sapiens	% Control	%	92.0
Not Active	23349366	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23349984	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23350452	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	92.0	CHEMBL5147	Homo sapiens	% Control	%	92.0
Not Active	23351057	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	95.0	CHEMBL5147	Homo sapiens	% Control	%	95.0
Not Active	23351525	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	95.0	CHEMBL5147	Homo sapiens	% Control	%	95.0
Not Active	23352040	CHEMBL4882731	EPHB4 Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	2.231	CHEMBL5147	Homo sapiens	% Inhibition	%	2.231
Not Active	23352549	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	79.0	CHEMBL5147	Homo sapiens	% Control	%	79.0
Not Active	23353017	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23353899	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23354367	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23355099	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23355567	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23356203	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23356671	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23357280	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23357927	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	69.0	CHEMBL5147	Homo sapiens	% Control	%	69.0
Not Active	23358395	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23358981	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	89.4	CHEMBL5147	Homo sapiens	% Control	%	89.4
Not Active	23359579	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	89.0	CHEMBL5147	Homo sapiens	% Control	%	89.0
Not Active	23360047	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	96.0	CHEMBL5147	Homo sapiens	% Control	%	96.0
Not Active	23360632	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	99.0	CHEMBL5147	Homo sapiens	% Control	%	99.0
Not Active	23361100	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23361673	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23362209	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23362677	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23364319	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23364787	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23365526	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23366069	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	90.0	CHEMBL5147	Homo sapiens	% Control	%	90.0
Not Active	23366659	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23367127	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	95.0	CHEMBL5147	Homo sapiens	% Control	%	95.0
Not Active	23367562	CHEMBL4883915	EPHB4 ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	128.0	CHEMBL5147	Homo sapiens	% Residual activity with Skepinone-L	%	128.0
Not Active	23368005	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23368473	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23369072	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23369540	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23370059	CHEMBL4884303	EphB4(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	77.0	CHEMBL5147	Homo sapiens	% residual kinase activity	%	77.0
Not Active	23370508	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	51.0	CHEMBL5147	Homo sapiens	% Control	%	51.0
Not Active	23370976	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	97.0	CHEMBL5147	Homo sapiens	% Control	%	97.0
Not Active	23371785	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	97.0	CHEMBL5147	Homo sapiens	% Control	%	97.0
Not Active	23372253	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	96.0	CHEMBL5147	Homo sapiens	% Control	%	96.0
	23372740	CHEMBL4884705	EphB4(EPB4LGY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL5147	Homo sapiens	pIC50		6.0
	23373149	CHEMBL4884996	EphB4(EPB4LGY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL5147	Homo sapiens	pIC50		6.0
	23373510	CHEMBL4885287	EphB4(EPB4LGY1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL5147	Homo sapiens	pIC50		6.0
Not Active	23375244	CHEMBL4886226	EPH receptor B4 Millipore kinase panel	B	COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1	Outside typical range	CHEMBL2180408		Inhibition	%	-35.0	CHEMBL5147	Homo sapiens	% inhibition	%	-35.0
Not Active	23375680	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23376148	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	98.0	CHEMBL5147	Homo sapiens	% Control	%	98.0
Not Active	23376725	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23377194	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23378053	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	80.0	CHEMBL5147	Homo sapiens	% Control	%	80.0
Not Active	23378521	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	91.0	CHEMBL5147	Homo sapiens	% Control	%	91.0
Not Active	23379688	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	83.0	CHEMBL5147	Homo sapiens	% Control	%	83.0
Not Active	23380156	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23380850	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	95.0	CHEMBL5147	Homo sapiens	% Control	%	95.0
Not Active	23381498	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23381966	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23382590	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	94.0	CHEMBL5147	Homo sapiens	% Control	%	94.0
Not Active	23383058	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	96.0	CHEMBL5147	Homo sapiens	% Control	%	96.0
Not Active	23383783	CHEMBL4887422	EPHB4 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	90.0	CHEMBL5147	Homo sapiens	% Ctrl	%	90.0
Not Active	23384268	CHEMBL4887863	EphB4(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	11.81	CHEMBL5147	Homo sapiens	% inhibition	%	11.81
Not Active	23384973	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
Not Active	23385440	CHEMBL4879697	KinomeScan assay: inhibition of EPHB4	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	100.0	CHEMBL5147	Homo sapiens	% Control	%	100.0
